data_2ck4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ck4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.378 0.609 . . . . 1.73 110.318 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.603 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -94.48 124.1 46.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.577 -0.738 . . . . 1.92 110.341 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.588 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 27.5 pt -103.39 142.53 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.158 -0.474 . . . . 1.16 109.962 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.796 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 24.6 p-10 -84.0 24.41 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 2.65 111.627 -174.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -76.03 135.6 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.727 -0.472 . . . . 1.16 109.727 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -63.37 105.91 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.467 0.651 . . . . 1.81 110.615 177.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 11.0 p -79.24 83.77 5.25 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.059 -0.973 . . . . 0.74 111.26 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.71 -18.5 65.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 3.08 108.41 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.663 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 pt -162.8 146.39 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.499 -1.682 . . . . 1.38 108.025 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.97 -28.4 64.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.925 0.343 . . . . 0.75 111.925 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -64.8 -29.04 69.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.86 0.318 . . . . 4.39 111.86 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.8 pt20 -74.6 -20.14 60.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.106 0.479 . . . . 2.2 110.256 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 25.7 m -92.25 -41.73 10.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.888 -0.596 . . . . 1.18 110.077 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.3 tp -69.24 -33.99 74.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 1.98 112.365 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' C ' ' HD3' ' A' ' 16' ' ' LYS . 6.9 tmtm? -55.85 -56.92 25.05 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 119.501 -0.285 . . . . 2.58 110.604 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 73.5 Cg_endo -72.91 -20.49 22.2 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.414 1.409 . . . . 0.77 112.714 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.742 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 59.5 m -77.98 -50.58 11.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.804 -0.358 . . . . 0.36 110.956 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -65.79 -21.27 66.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 2.09 110.172 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.8 -19.9 43.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.666 -0.697 . . . . 1.03 110.54 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.08 -30.19 12.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 1.15 110.977 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.79 45.82 0.1 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.151 -0.547 . . . . 0.81 112.106 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.742 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -130.95 106.63 8.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.042 0.448 . . . . 2.48 110.021 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.898 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -65.45 -27.32 68.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.667 -0.697 . . . . 3.87 111.869 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 60.5 m-85 -117.91 157.7 26.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 1.52 110.686 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.33 88.65 0.11 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.692 -0.963 . . . . 0.74 110.692 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -116.86 134.76 54.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.882 0.372 . . . . 3.34 110.686 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 13.9 t -74.14 120.84 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.081 -0.508 . . . . 0.76 110.832 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.408 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 85.4 mmm -138.66 116.67 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 2.56 111.177 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.22 12.09 5.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.1 0.56 . . . . 2.99 112.458 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.21 -17.05 22.1 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.718 . . . . 0.9 112.334 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.796 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 13.8 mptt -103.72 156.29 17.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 2.39 110.957 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.588 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 59.7 m -93.06 109.88 21.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.781 -0.645 . . . . 0.76 109.494 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.603 ' HA ' HG13 ' A' ' 3' ' ' ILE . 9.9 m170 -87.7 95.7 10.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.871 -0.604 . . . . 1.93 110.18 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.443 ' HB3' ' HG2' ' A' ' 23' ' ' MET . 74.4 m -100.43 110.29 22.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.591 0.71 . . . . 0.7 110.914 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.6 m -89.95 129.59 45.65 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.389 -0.823 . . . . 1.25 109.065 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -54.36 149.64 36.88 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.674 2.916 . . . . 0.91 113.984 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.898 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 27.8 tptp . . . . . 0 C--O 1.242 0.698 0 CA-C-N 115.248 -0.887 . . . . 2.61 110.114 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.476 HG23 ' HE3' ' A' ' 23' ' ' MET . 43.7 t . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 121.323 0.582 . . . . 1.73 110.348 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.8 mm -83.43 109.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 1.92 110.137 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.5 pt -99.59 130.6 48.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.051 0.453 . . . . 1.16 110.932 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.444 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 19.7 m-20 -74.53 63.79 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.482 -0.781 . . . . 2.65 111.13 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.64 134.13 59.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.705 -0.68 . . . . 1.16 109.513 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.65 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -64.86 106.7 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 1.81 110.781 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.878 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 21.1 p -85.96 83.23 7.85 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.893 -0.594 . . . . 0.74 110.568 173.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -61.97 -19.24 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.55 -0.907 . . . . 3.08 108.55 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.503 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 10.2 pt -160.52 164.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 113.37 -1.741 . . . . 1.38 107.032 174.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -61.98 -33.38 74.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.686 0.675 . . . . 0.75 111.391 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -57.67 -31.9 66.79 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.294 -0.412 . . . . 4.39 111.834 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.503 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 15.9 mm100 -62.87 -26.37 68.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.869 0.366 . . . . 2.2 111.302 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.878 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.5 m -95.27 -46.08 6.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.055 -0.521 . . . . 1.18 111.347 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.996 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.2 tt -73.89 -24.42 59.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.293 0.479 . . . . 1.98 112.293 -166.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 38.0 tptt -61.22 -57.84 23.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.295 -0.962 . . . . 2.58 109.63 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.5 Cg_exo -59.33 -33.96 97.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.437 1.425 . . . . 0.77 111.956 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.996 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 12.0 m -64.27 -63.03 1.25 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.36 111.506 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.18 -32.25 72.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.385 0.539 . . . . 2.09 111.052 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.39 -40.47 97.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.054 -0.521 . . . . 1.03 110.936 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.44 -26.47 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.128 0.49 . . . . 1.15 111.0 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.61 65.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.841 -0.618 . . . . 0.81 112.232 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.575 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 15.6 mmt -135.68 104.34 5.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.858 -0.793 . . . . 2.48 108.858 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.573 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.67 -28.27 69.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.593 -0.73 . . . . 3.87 110.962 -177.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.545 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.1 m-85 -117.71 153.95 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.207 -0.294 . . . . 1.52 110.207 173.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.662 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -156.08 110.18 0.43 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.836 -0.697 . . . . 0.74 111.849 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.702 ' HB3' ' HE3' ' A' ' 29' ' ' MET . 9.5 mmtp -129.23 134.95 48.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.931 0.396 . . . . 3.34 111.841 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 8.1 t -75.52 132.95 41.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.93 -0.577 . . . . 0.76 109.615 174.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.702 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 26.2 mmt -134.36 80.88 1.88 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.962 -0.295 . . . . 2.56 111.356 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 p30 62.87 -4.14 0.27 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.224 1.41 . . . . 2.99 113.846 171.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -55.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.748 -0.739 . . . . 0.9 111.722 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.4 mptm? -89.49 161.07 16.43 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.192 0.52 . . . . 2.39 110.908 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.529 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 56.4 m -96.73 115.64 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.76 109.905 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -97.24 93.15 6.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 1.93 109.808 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.7 m -112.69 127.02 56.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.042 -0.527 . . . . 0.7 111.346 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 35.1 m -86.96 124.99 67.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.42 -0.809 . . . . 1.25 109.07 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 50.0 Cg_exo -54.42 152.74 25.17 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.533 2.822 . . . . 0.91 113.45 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.4 tptp . . . . . 0 C--O 1.242 0.688 0 CA-C-O 118.189 -0.91 . . . . 2.61 111.038 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.489 HG23 ' HE3' ' A' ' 23' ' ' MET . 58.4 t . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.167 0.508 . . . . 1.73 110.238 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.808 HD13 ' HB3' ' A' ' 32' ' ' LYS . 7.0 tp -91.58 120.17 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.736 -0.666 . . . . 1.92 110.417 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.52 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 19.8 pt -102.6 136.54 34.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.041 0.448 . . . . 1.16 110.734 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -79.91 64.95 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.702 -0.681 . . . . 2.65 111.124 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -125.01 130.45 73.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.229 -0.896 . . . . 1.16 109.477 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.7 107.44 3.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.052 -0.721 . . . . 1.81 109.052 178.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 11.5 p -78.18 91.29 4.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.943 -1.026 . . . . 0.74 112.428 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' O ' HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -70.3 -11.14 60.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.622 0.725 . . . . 3.08 109.459 174.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.599 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.6 pt -165.83 145.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.055 -1.429 . . . . 1.38 108.19 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.6 m -70.95 -24.46 62.44 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.816 -0.354 . . . . 0.75 110.518 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.17 -34.45 78.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.836 0.31 . . . . 4.39 111.836 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 16.3 pt20 -70.63 -20.42 62.73 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.194 0.521 . . . . 2.2 110.119 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.537 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 12.5 m -94.98 -41.37 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.603 -0.726 . . . . 1.18 110.237 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.692 HD23 ' HE2' ' A' ' 19' ' ' LYS . 1.6 tt -77.02 -37.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.844 -0.617 . . . . 1.98 111.913 -171.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.549 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 27.0 tptp -50.46 -52.79 51.98 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-O 119.464 -0.303 . . . . 2.58 111.411 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 6.9 Cg_exo -73.93 -20.47 19.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.643 1.562 . . . . 0.77 112.505 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 37.4 m -83.39 -54.08 5.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.344 -0.543 . . . . 0.36 111.821 -175.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.692 ' HE2' HD23 ' A' ' 15' ' ' LEU . 23.0 ttmm -63.77 -35.78 81.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.408 -0.517 . . . . 2.09 110.334 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.94 -37.27 86.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.916 0.389 . . . . 1.03 110.184 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.03 0.85 46.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 1.15 111.335 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.49 60.02 1.06 Allowed Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.937 -0.649 . . . . 0.81 112.669 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.518 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 17.9 mmt -132.77 108.14 8.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.112 -0.699 . . . . 2.48 109.112 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -60.69 -31.4 70.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.867 -1.06 . . . . 3.87 110.983 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 51.1 m-85 -120.67 149.64 42.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.695 0.283 . . . . 1.52 111.072 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.681 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -158.48 78.27 0.18 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.695 -0.962 . . . . 0.74 110.695 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -114.5 135.0 54.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.955 0.407 . . . . 3.34 110.478 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 4.4 t -72.3 127.87 33.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.953 -0.567 . . . . 0.76 109.751 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.48 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.472 -0.331 . . . . 2.56 110.336 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 72.0 -66.42 0.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.223 0.952 . . . . 2.99 112.432 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -126.18 -25.51 1.33 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.236 -0.983 . . . . 0.9 113.23 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.808 ' HB3' HD13 ' A' ' 3' ' ' ILE . 35.2 mtmt -121.68 158.35 28.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.235 0.541 . . . . 2.39 112.213 -170.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.52 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 56.8 m -93.91 109.02 20.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.299 -0.864 . . . . 0.76 110.238 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.522 ' CD2' HD12 ' A' ' 3' ' ' ILE . 1.8 m-70 -87.05 100.47 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 1.93 111.0 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -104.23 118.03 35.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.144 0.497 . . . . 0.7 110.574 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.3 m -101.83 122.18 48.31 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.078 -0.712 . . . . 1.25 109.078 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -51.94 147.21 26.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.385 2.723 . . . . 0.91 113.484 -173.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.449 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 24.0 tptm . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.129 -0.941 . . . . 2.61 111.281 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.79 HG22 ' HG3' ' A' ' 37' ' ' PRO . 47.1 t . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.175 0.512 . . . . 1.73 110.469 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -115.24 109.63 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.88 -0.785 . . . . 1.92 108.88 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.445 HG13 ' HB2' ' A' ' 33' ' ' CYS . 15.8 pt -123.51 134.62 65.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.07 0.462 . . . . 1.16 111.464 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.708 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 m-20 -77.93 63.7 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.608 -0.724 . . . . 2.65 110.475 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -115.35 124.03 71.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 1.16 109.24 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -58.04 104.21 0.19 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.232 0.539 . . . . 1.81 110.172 175.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.6 p -89.87 87.27 6.88 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.781 -0.645 . . . . 0.74 110.084 174.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 21.0 tptt -64.43 -13.03 49.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 3.08 109.258 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.1 pt -154.65 159.41 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 113.782 -1.554 . . . . 1.38 108.165 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.4 m -67.22 -19.87 65.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.81 0.338 . . . . 0.75 111.217 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -59.29 -31.1 68.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.176 -0.465 . . . . 4.39 110.879 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -67.58 -24.38 65.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.905 -0.589 . . . . 2.2 110.676 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.1 m -92.57 -45.5 8.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.281 0.562 . . . . 1.18 109.875 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.598 HD11 ' SD ' ' A' ' 23' ' ' MET . 11.4 tp -52.48 -51.38 59.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.877 -1.056 . . . . 1.98 112.669 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 40.5 tptt -56.21 -59.73 11.02 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 119.01 -0.519 . . . . 2.58 111.42 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.3 Cg_exo -57.83 -34.23 97.99 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.571 1.514 . . . . 0.77 112.479 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.79 -54.46 6.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.36 111.421 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 25.2 tttm -74.5 -17.95 60.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.71 0.291 . . . . 2.09 110.829 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 5.4 t70 -68.3 -30.33 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.412 -0.588 . . . . 1.03 109.412 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.19 3.35 43.67 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.797 -0.638 . . . . 1.15 110.544 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 100.11 105.01 2.66 Favored Glycine 0 CA--C 1.499 -0.919 0 CA-C-N 115.465 -0.789 . . . . 0.81 111.435 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.598 ' SD ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -119.43 121.76 40.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.321 1.058 . . . . 2.48 109.564 174.07 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.67 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -89.0 -29.2 19.67 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.051 -1.431 . . . . 3.87 108.285 168.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.5 m-85 -140.02 151.52 45.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.136 -0.938 . . . . 1.52 109.347 170.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA2' ' SD ' ' A' ' 23' ' ' MET . . . -150.95 108.27 0.38 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.06 -0.591 . . . . 0.74 111.807 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -129.41 138.7 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.169 0.509 . . . . 3.34 112.0 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 t -87.24 132.49 33.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.014 -1.106 . . . . 0.76 108.014 167.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 52.6 mtt -126.14 77.69 1.7 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.041 -0.664 . . . . 2.56 111.208 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 70.97 -58.58 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.385 1.053 . . . . 2.99 112.563 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.91 -47.08 0.21 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.958 -0.639 . . . . 0.9 112.566 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.708 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.1 mptm? -107.46 164.43 12.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 2.39 111.293 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -92.77 123.46 36.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.36 -0.836 . . . . 0.76 110.365 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.41 98.04 5.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 1.93 109.613 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.588 ' SG ' ' HB ' ' A' ' 2' ' ' VAL . 7.6 p -121.13 159.22 26.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.036 -0.529 . . . . 0.7 110.902 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 24.2 m -112.65 113.37 50.48 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.588 -0.733 . . . . 1.25 109.151 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.79 ' HG3' HG22 ' A' ' 2' ' ' VAL . 32.7 Cg_exo -58.98 152.73 56.29 Favored 'Trans proline' 0 CA--C 1.519 -0.238 0 C-N-CA 122.836 2.357 . . . . 0.91 112.324 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.67 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 20.3 tptm . . . . . 0 C--O 1.246 0.906 0 CA-C-N 115.565 -0.743 . . . . 2.61 110.619 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.449 -0.525 0 N-CA-C 109.375 -0.602 . . . . 1.73 109.375 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.608 HD13 ' HB3' ' A' ' 32' ' ' LYS . 6.8 tp -88.07 110.42 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.855 0.836 . . . . 1.92 111.0 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.41 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -95.23 147.57 5.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.358 -0.837 . . . . 1.16 110.679 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -84.42 14.11 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 2.65 111.285 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.14 120.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.421 -0.585 . . . . 1.16 109.421 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.657 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 1.8 tmtp? -67.73 115.95 7.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.973 -0.751 . . . . 1.81 108.973 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 28.5 p -77.16 82.96 3.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.525 -0.761 . . . . 0.74 111.475 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.429 ' O ' HG21 ' A' ' 10' ' ' ILE . 13.8 mmmm -66.44 -17.58 64.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.744 0.783 . . . . 3.08 108.992 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.546 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.4 pt -166.04 148.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.86 -1.518 . . . . 1.38 108.123 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -74.08 -19.72 60.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.868 0.366 . . . . 0.75 110.897 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 12' ' ' ARG . 30.9 mtp180 -54.58 -47.08 73.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 4.39 110.731 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.6 pt20 -76.51 -4.15 41.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 2.2 111.125 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.536 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 75.3 m -95.61 -58.15 2.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.074 -0.512 . . . . 1.18 110.44 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.598 ' HG ' ' HA2' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -79.12 -31.74 44.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.638 0.607 . . . . 1.98 112.638 -169.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -54.79 -50.75 84.19 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.654 -0.418 . . . . 2.58 110.702 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 14.3 Cg_exo -71.59 -29.76 15.75 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.634 1.556 . . . . 0.77 112.923 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 81.3 m -74.18 -52.17 13.28 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.446 -0.501 . . . . 0.36 111.422 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HA ' ' H ' ' A' ' 23' ' ' MET . 41.2 ttmt -65.77 -27.35 68.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.067 0.46 . . . . 2.09 110.267 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.28 -28.42 69.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 1.03 110.082 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.52 5.51 41.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 1.15 111.244 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.86 53.01 1.99 Allowed Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.88 -0.676 . . . . 0.81 112.765 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.677 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 56.8 mtt -131.57 102.16 5.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.587 0.708 . . . . 2.48 109.366 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.642 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 10.9 ttt180 -60.39 -27.21 67.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.169 -1.378 . . . . 3.87 112.335 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.599 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.7 m-85 -117.62 163.3 16.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.852 0.358 . . . . 1.52 110.867 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.598 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -178.6 74.24 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.999 -0.841 . . . . 0.74 110.999 -177.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -104.16 133.69 48.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.664 -0.268 . . . . 3.34 110.469 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.2 t -70.42 126.84 30.78 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.881 -0.414 . . . . 0.76 109.881 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.8 mmm -137.39 103.52 5.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 2.56 110.261 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 72.7 -74.72 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.997 0.811 . . . . 2.99 110.997 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.657 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . -146.15 4.7 1.18 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.913 -0.66 . . . . 0.9 112.863 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.608 ' HB3' HD13 ' A' ' 3' ' ' ILE . 91.1 mttt -131.93 160.41 35.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.036 0.446 . . . . 2.39 111.478 -176.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 66.8 m -96.86 113.17 24.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.76 110.045 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.516 ' CD2' HD12 ' A' ' 3' ' ' ILE . 1.8 m-70 -86.55 94.6 9.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 1.93 110.498 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.4 m -104.3 115.35 30.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.453 0.644 . . . . 0.7 111.485 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 22.6 m -92.41 129.01 42.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.764 -0.828 . . . . 1.25 108.764 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 37.8 Cg_exo -57.14 155.12 30.39 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.852 2.368 . . . . 0.91 112.009 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.642 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 7.7 tptp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.078 -0.963 . . . . 2.61 112.356 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.575 HG12 ' HE1' ' A' ' 23' ' ' MET . 43.1 t . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 121.095 0.474 . . . . 1.73 110.034 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.16 109.51 28.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.75 -0.659 . . . . 1.92 110.494 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.409 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.1 pt -99.37 137.29 27.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.079 -0.51 . . . . 1.16 109.812 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -81.42 33.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 2.65 111.67 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.76 135.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.087 -1.079 . . . . 1.16 108.087 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.558 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 1.8 tmtt? -77.76 115.43 17.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.729 -0.788 . . . . 1.81 110.242 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 10.2 p -73.02 85.98 1.31 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.462 -1.244 . . . . 0.74 111.884 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' O ' HG21 ' A' ' 10' ' ' ILE . 1.4 mptm? -66.76 -13.44 61.42 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.556 -0.715 . . . . 3.08 109.352 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.626 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.2 pt -166.63 150.52 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.384 -1.28 . . . . 1.38 108.587 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 50.4 m -63.7 -52.96 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.791 0.293 . . . . 0.75 111.791 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -60.22 -19.47 54.56 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 4.39 113.246 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 11.4 pt20 -72.78 -25.43 61.16 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.201 -0.6 . . . . 2.2 109.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 32.8 m -93.67 -34.64 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.895 -0.593 . . . . 1.18 109.707 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.29 -41.27 94.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 1.98 112.104 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.506 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 18.2 tptm -57.63 -52.04 77.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.329 -0.548 . . . . 2.58 111.739 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 23.8 Cg_exo -65.43 -25.46 55.96 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.695 1.597 . . . . 0.77 111.94 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.724 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 66.2 m -82.39 -52.42 6.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.619 -0.264 . . . . 0.36 110.818 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -64.03 -27.58 69.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.782 0.325 . . . . 2.09 110.682 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.86 -45.78 90.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.058 -0.519 . . . . 1.03 110.035 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.83 61.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 1.15 110.664 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.84 54.56 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.834 -0.621 . . . . 0.81 112.16 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.724 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -130.95 105.09 7.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 2.48 110.545 175.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.569 ' N ' ' HB2' ' A' ' 38' ' ' LYS . 8.3 ptm180 -55.59 -27.49 49.68 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.264 -0.88 . . . . 3.87 112.698 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 26.9 m-85 -124.63 160.34 28.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 1.52 110.818 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.78 59.67 0.12 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.602 -0.999 . . . . 0.74 110.602 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.546 ' HB2' ' HE1' ' A' ' 29' ' ' MET . 97.1 mttt -98.41 152.58 19.34 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.19 0.519 . . . . 3.34 110.609 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t -77.61 112.75 14.74 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.323 -0.853 . . . . 0.76 110.528 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.546 ' HE1' ' HB2' ' A' ' 27' ' ' LYS . 62.4 mtt -137.99 125.74 22.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 2.56 109.874 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 68.45 -4.72 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.13 0.49 . . . . 2.99 111.674 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' HA3' ' HE2' ' A' ' 7' ' ' LYS . . . 114.47 -14.01 20.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.831 -0.7 . . . . 0.9 112.137 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -102.24 159.74 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.799 0.333 . . . . 2.39 110.504 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 56.8 m -91.13 95.62 10.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.02 -0.733 . . . . 0.76 109.02 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -76.8 93.95 3.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.268 -0.878 . . . . 1.93 111.046 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.0 m -98.68 111.16 23.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.394 0.616 . . . . 0.7 111.034 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.6 m -88.99 130.59 44.01 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.48 -0.933 . . . . 1.25 108.48 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 3.1 Cg_exo -72.22 151.53 54.9 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.175 2.583 . . . . 0.91 112.238 -170.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.569 ' HB2' ' N ' ' A' ' 24' ' ' ARG . 50.1 tttm . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.36 -0.829 . . . . 2.61 110.682 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.172 0.51 . . . . 1.73 110.256 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 mm -104.76 121.76 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.003 -0.544 . . . . 1.92 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.558 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.7 pt -106.26 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.905 0.383 . . . . 1.16 110.323 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.76 31.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 2.65 112.112 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.17 139.29 17.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.938 -0.764 . . . . 1.16 108.938 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.638 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 1.6 tmtp? -81.5 115.55 20.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.546 -0.539 . . . . 1.81 109.546 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.2 p -80.21 84.07 5.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.316 -0.856 . . . . 0.74 112.584 -173.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -72.99 -11.52 60.6 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.119 -0.988 . . . . 3.08 108.81 173.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.9 pt -169.67 139.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.915 -1.493 . . . . 1.38 107.927 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -71.98 -17.12 62.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.651 0.262 . . . . 0.75 111.616 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -68.64 -33.7 74.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.745 0.307 . . . . 4.39 110.918 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 3.4 pt20 -75.98 -20.48 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.027 0.442 . . . . 2.2 110.364 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.554 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 57.4 m -88.83 -33.66 17.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.896 -0.593 . . . . 1.18 110.461 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.795 ' HG ' ' HA2' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -83.85 -25.36 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.149 -0.478 . . . . 1.98 112.062 -172.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 28.0 tptp -56.21 -49.37 93.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.4 -0.52 . . . . 2.58 110.907 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 8.6 Cg_exo -73.95 -31.84 7.7 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.829 1.686 . . . . 0.77 112.67 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.771 ' HA ' ' HE3' ' A' ' 23' ' ' MET . 75.8 m -75.0 -52.19 11.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.291 -0.563 . . . . 0.36 111.303 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.576 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 1.7 tmtp? -61.95 -35.01 77.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.022 0.439 . . . . 2.09 110.355 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.85 -27.85 69.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.769 -0.65 . . . . 1.03 110.788 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.55 1.06 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 1.15 111.342 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.82 46.67 2.64 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.557 -0.83 . . . . 0.81 112.849 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.771 ' HE3' ' HA ' ' A' ' 18' ' ' CYS . 4.7 mpp? -123.05 104.46 9.23 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.573 0.702 . . . . 2.48 109.634 171.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.844 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -56.81 -35.81 69.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.328 -1.305 . . . . 3.87 111.681 -179.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.565 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 25.1 m-85 -110.25 163.25 13.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.252 0.549 . . . . 1.52 111.617 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.795 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -167.45 57.8 0.22 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.103 -1.199 . . . . 0.74 110.103 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -85.98 134.53 33.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.304 -0.448 . . . . 3.34 110.995 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 15.3 t -69.6 117.99 11.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.762 -0.654 . . . . 0.76 109.719 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.24 109.96 7.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.245 -0.434 . . . . 2.56 111.265 -175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.513 HD21 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER 59.64 21.46 10.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.088 -0.505 . . . . 2.99 111.698 172.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.638 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 113.18 -26.36 10.49 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.785 -0.721 . . . . 0.9 112.77 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -101.77 158.93 15.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.948 0.404 . . . . 2.39 110.798 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.558 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 23.7 m -93.48 107.98 19.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.341 -0.614 . . . . 0.76 109.341 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -90.32 95.34 10.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.732 -0.667 . . . . 1.93 110.158 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.1 m -98.81 119.26 37.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.578 . . . . 0.7 111.098 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 11.8 m -94.81 124.61 54.09 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 1.25 109.108 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 12.9 Cg_endo -56.22 144.56 80.91 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.892 2.395 . . . . 0.91 112.503 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.844 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tptp . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.512 -0.767 . . . . 2.61 111.159 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.911 ' HB ' ' HB2' ' A' ' 35' ' ' CYS . 31.9 t . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.171 0.51 . . . . 1.73 109.675 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.86 109.25 24.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.909 -0.587 . . . . 1.92 109.778 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.468 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 21.7 pt -108.4 147.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.167 -0.469 . . . . 1.16 110.96 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -83.51 28.12 0.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 2.65 111.398 -176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.56 132.65 31.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.603 -0.888 . . . . 1.16 108.603 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.598 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -73.08 114.36 11.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.101 -0.703 . . . . 1.81 109.101 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.3 p -74.94 82.72 2.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.594 0.712 . . . . 0.74 110.85 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.547 ' O ' HG22 ' A' ' 10' ' ' ILE . 12.4 tptm -79.96 -2.56 44.43 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.505 -0.924 . . . . 3.08 108.505 175.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 9' ' ' LYS . 4.8 pt -174.7 142.72 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 113.18 -1.827 . . . . 1.38 107.228 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -72.56 -20.7 61.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.531 0.205 . . . . 0.75 111.035 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -62.59 -38.78 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 4.39 111.504 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 7.1 pt20 -75.29 -14.02 60.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.278 0.561 . . . . 2.2 110.285 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 56.5 m -88.47 -37.98 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 1.18 109.385 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.618 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -75.21 -43.68 50.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.491 -1.231 . . . . 1.98 112.709 -170.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 48.9 tptt -55.47 -52.12 74.41 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.708 -0.397 . . . . 2.58 111.768 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 20.6 Cg_exo -67.45 -36.27 20.75 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.658 1.572 . . . . 0.77 112.203 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 23' ' ' MET . 87.2 m -79.16 -43.84 23.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.669 -0.413 . . . . 0.36 111.641 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 21.4 ttmm -70.65 -30.07 66.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.258 -0.177 . . . . 2.09 110.706 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.61 -36.55 84.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 1.03 109.882 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -41.1 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.671 . . . . 1.15 111.124 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 157.03 85.87 0.05 OUTLIER Glycine 0 CA--C 1.508 -0.4 0 N-CA-C 111.633 -0.587 . . . . 0.81 111.633 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.83 ' HE1' ' HA2' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -141.51 121.56 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.172 0.987 . . . . 2.48 110.166 176.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.517 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.6 -26.2 18.82 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.156 -1.384 . . . . 3.87 109.59 174.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.555 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.4 m-85 -141.78 164.02 31.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.355 -0.384 . . . . 1.52 110.36 171.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.83 ' HA2' ' HE1' ' A' ' 23' ' ' MET . . . -165.85 118.05 0.78 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 121.089 -0.576 . . . . 0.74 111.709 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HB2' ' HE1' ' A' ' 29' ' ' MET . 92.8 mttt -129.23 139.68 51.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.93 0.395 . . . . 3.34 110.828 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.0 t -68.79 123.33 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 0.76 109.563 170.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.479 ' HE1' ' HB2' ' A' ' 27' ' ' LYS . 66.1 mtt -137.11 118.01 14.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.728 -0.214 . . . . 2.56 110.921 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 43.01 37.41 1.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.215 0.947 . . . . 2.99 113.243 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.598 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 108.93 -27.98 12.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.049 -0.596 . . . . 0.9 112.916 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -107.28 159.06 16.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.357 0.598 . . . . 2.39 111.432 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 80.9 m -92.6 107.35 19.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.54 -0.755 . . . . 0.76 109.791 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -88.54 98.12 11.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.638 -0.71 . . . . 1.93 109.835 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.911 ' HB2' ' HB ' ' A' ' 2' ' ' VAL . 33.4 m -100.13 113.14 25.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.669 -0.696 . . . . 0.7 110.944 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.2 m -78.69 112.98 30.99 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.552 -0.749 . . . . 1.25 109.325 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 30.3 Cg_exo -60.21 147.1 94.76 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.479 2.119 . . . . 0.91 112.191 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 4.3 mmmp? . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.589 -0.72 . . . . 2.61 111.058 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.483 HG22 ' HE1' ' A' ' 23' ' ' MET . 2.4 m . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.847 0.832 . . . . 1.73 111.365 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -101.44 118.06 47.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.96 . . . . 1.92 109.086 176.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 33' ' ' CYS . 18.4 pt -101.88 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.057 0.456 . . . . 1.16 111.379 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.1 39.9 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 2.65 111.827 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.07 134.36 44.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.372 -0.603 . . . . 1.16 109.372 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.699 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 2.5 tmtp? -78.35 109.36 12.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.475 0.655 . . . . 1.81 109.832 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.557 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -80.49 98.26 7.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.172 -0.922 . . . . 0.74 111.841 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.44 ' O ' HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -66.45 -12.07 55.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.623 0.725 . . . . 3.08 109.824 172.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.661 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 11.9 pt -163.61 163.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.139 -1.391 . . . . 1.38 107.473 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.6 m -67.18 -39.82 86.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 118.474 0.579 . . . . 0.75 110.81 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -62.0 -19.5 62.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.813 -0.631 . . . . 4.39 112.326 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.661 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 11.9 mm100 -54.95 -35.94 64.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.849 0.356 . . . . 2.2 110.879 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -113.66 -18.87 11.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.093 -0.503 . . . . 1.18 111.871 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.49 -34.07 76.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.147 -0.621 . . . . 1.98 110.981 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -59.81 -56.39 36.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.835 -0.346 . . . . 2.58 110.468 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -66.06 -25.89 51.01 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.727 1.618 . . . . 0.77 112.65 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.6 m -79.19 -56.31 4.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.725 -0.39 . . . . 0.36 111.495 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.499 ' HA ' ' H ' ' A' ' 23' ' ' MET . 73.8 tttt -65.92 -26.61 67.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.372 -0.205 . . . . 2.09 111.064 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -65.39 -35.95 82.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 1.03 110.451 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.63 -13.27 58.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 1.15 110.881 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 64.94 0.6 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.57 -0.612 . . . . 0.81 111.57 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.619 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 46.8 mtt -141.13 110.79 6.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.675 0.75 . . . . 2.48 110.152 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.784 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 6.4 ptp180 -65.19 -21.24 66.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.579 -1.191 . . . . 3.87 112.176 -175.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 47.9 m-85 -128.39 148.07 50.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.043 0.449 . . . . 1.52 110.826 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.05 62.64 0.42 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 109.443 -1.463 . . . . 0.74 109.443 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 27' ' ' LYS . 52.1 mtpt -91.1 134.9 34.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.067 0.461 . . . . 3.34 111.066 -168.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 39.9 t -81.93 124.11 29.45 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.667 -0.697 . . . . 0.76 109.874 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.651 ' HA ' ' HE3' ' A' ' 29' ' ' MET . 1.5 mmt -138.64 105.9 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 2.56 111.162 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.05 20.94 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.804 -0.635 . . . . 2.99 112.186 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.699 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 119.71 -31.09 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.5 -0.857 . . . . 0.9 112.663 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -94.99 154.37 17.2 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.289 0.566 . . . . 2.39 111.259 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -93.68 104.27 16.38 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.149 -0.932 . . . . 0.76 109.803 176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.575 ' HA ' HG13 ' A' ' 3' ' ' ILE . 17.8 m-70 -88.73 94.13 9.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.7 -0.682 . . . . 1.93 109.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.6 m -98.66 130.06 45.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.7 110.617 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.7 m -108.36 129.86 23.5 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.139 -1.06 . . . . 1.25 108.139 175.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.1 Cg_exo -62.41 155.86 55.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.065 2.51 . . . . 0.91 112.396 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.784 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 17.1 mmmt . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.53 -0.748 . . . . 2.61 110.53 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.737 HG22 ' HE2' ' A' ' 23' ' ' MET . 57.1 t . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.629 0.728 . . . . 1.73 111.004 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.865 HD13 ' HB3' ' A' ' 32' ' ' LYS . 2.8 tp -91.94 126.71 44.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.252 -0.885 . . . . 1.92 109.893 175.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.523 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.6 pt -115.05 145.23 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.293 -0.412 . . . . 1.16 111.367 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.26 69.36 6.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 2.65 111.272 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.91 122.8 65.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.563 -0.532 . . . . 1.16 109.563 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -69.29 96.33 0.85 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.492 0.663 . . . . 1.81 110.089 -177.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.698 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 8.8 p -80.57 100.49 8.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.24 -0.891 . . . . 0.74 111.842 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.506 ' O ' HG21 ' A' ' 10' ' ' ILE . 3.3 mppt? -71.13 -8.1 51.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.171 -0.678 . . . . 3.08 109.171 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.752 HG13 ' HG3' ' A' ' 13' ' ' GLN . 3.8 pt -168.58 154.41 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 114.063 -1.426 . . . . 1.38 108.126 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.3 m -69.35 -22.23 63.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 0.75 111.409 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.415 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.3 mpt_? -60.91 -36.29 78.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.264 -0.425 . . . . 4.39 111.682 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.752 ' HG3' HG13 ' A' ' 10' ' ' ILE . 13.9 mt-30 -62.84 -27.63 69.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.5 . . . . 2.2 110.56 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.8 m -88.29 -48.74 7.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.394 -0.821 . . . . 1.18 111.261 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.7 tp -67.83 -34.08 76.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.003 -0.544 . . . . 1.98 112.304 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.478 ' C ' ' HD3' ' A' ' 16' ' ' LYS . 8.9 tmtt? -58.38 -58.42 19.13 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.295 -0.562 . . . . 2.58 110.448 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 70.5 Cg_endo -70.63 -21.0 30.03 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.612 1.541 . . . . 0.77 112.345 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.673 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 56.6 m -77.66 -58.63 3.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.629 -0.429 . . . . 0.36 109.95 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HA ' ' H ' ' A' ' 23' ' ' MET . 44.9 tttm -60.08 -32.04 70.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.208 -0.451 . . . . 2.09 110.637 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 13.9 t70 -56.22 -47.88 77.57 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 1.03 110.496 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.64 -29.23 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.695 . . . . 1.15 111.071 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.4 0.11 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.494 -0.642 . . . . 0.81 111.494 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.737 ' HE2' HG22 ' A' ' 2' ' ' VAL . 10.2 mmt -145.01 91.63 2.17 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.132 -1.062 . . . . 2.48 108.132 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HG3' ' CD2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -50.39 -47.77 56.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.508 -1.224 . . . . 3.87 111.524 -177.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 98.7 m-85 -99.27 147.3 25.32 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.687 -0.405 . . . . 1.52 110.084 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.88 95.07 0.13 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.708 -0.957 . . . . 0.74 110.708 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -122.32 141.17 51.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.198 0.523 . . . . 3.34 111.03 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.3 t -75.9 136.19 40.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.466 -0.788 . . . . 0.76 110.324 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 32' ' ' LYS . 2.7 ppp? -137.87 100.54 4.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 2.56 110.859 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 58.39 18.82 5.86 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.792 . . . . 2.99 112.55 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 119.42 -5.56 13.11 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.576 -0.821 . . . . 0.9 113.335 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.865 ' HB3' HD13 ' A' ' 3' ' ' ILE . 53.4 mtpt -120.36 168.62 11.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.045 0.422 . . . . 2.39 111.243 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.523 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 59.0 m -111.66 102.84 11.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.76 111.666 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.862 ' HD2' HD12 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -81.99 97.95 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 1.93 110.529 174.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.7 m -106.44 134.49 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.316 0.579 . . . . 0.7 110.772 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.616 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 17.3 m -112.38 124.09 32.75 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.076 -0.712 . . . . 1.25 109.076 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 53.1 Cg_exo -55.4 147.3 57.72 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.616 2.877 . . . . 0.91 113.477 -170.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 13.9 tptp . . . . . 0 C--O 1.249 1.047 0 CA-C-N 114.89 -1.05 . . . . 2.61 110.068 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.699 HG23 ' HE2' ' A' ' 23' ' ' MET . 64.2 t . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.354 0.597 . . . . 1.73 109.768 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.584 HD13 ' CD2' ' A' ' 34' ' ' HIS . 7.0 mm -100.28 121.42 51.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.448 -0.797 . . . . 1.92 110.005 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.502 HD12 ' SG ' ' A' ' 14' ' ' CYS . 24.8 pt -115.76 151.56 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.965 0.412 . . . . 1.16 110.61 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.03 45.25 1.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 2.65 111.686 -174.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -102.12 126.45 56.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.954 -0.758 . . . . 1.16 108.954 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -68.67 120.33 14.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.731 0.777 . . . . 1.81 109.94 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 13.0 p -85.35 86.42 7.38 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.012 -0.995 . . . . 0.74 111.734 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.44 ' O ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -55.96 -23.38 31.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.386 0.612 . . . . 3.08 109.614 173.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.597 HG13 ' HG2' ' A' ' 13' ' ' GLN . 7.2 pt -164.06 167.52 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.98 -1.464 . . . . 1.38 107.482 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 63.6 m -66.43 -36.93 84.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.295 0.498 . . . . 0.75 110.741 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -57.15 -28.84 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.754 -0.657 . . . . 4.39 111.828 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.597 ' HG2' HG13 ' A' ' 10' ' ' ILE . 15.4 mm100 -55.72 -34.55 65.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.125 -0.488 . . . . 2.2 111.698 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.613 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 4.9 t -108.63 -21.66 12.6 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.449 -0.5 . . . . 1.18 111.736 -176.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.546 HD23 ' HE3' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -74.47 -36.53 63.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.933 -0.707 . . . . 1.98 111.369 -174.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -56.29 -49.46 93.2 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 120.327 -0.549 . . . . 2.58 110.592 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 14' ' ' CYS . 21.5 Cg_exo -67.7 -35.96 20.4 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.81 1.674 . . . . 0.77 112.851 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.733 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 34.2 m -71.14 -54.14 12.08 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.55 -0.46 . . . . 0.36 111.713 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.546 ' HE3' HD23 ' A' ' 15' ' ' LEU . 38.2 ttmt -66.4 -25.9 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.833 -0.347 . . . . 2.09 110.456 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.78 -33.08 71.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.046 -0.525 . . . . 1.03 110.206 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -6.09 56.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 1.15 110.82 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.74 62.36 0.75 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.795 -0.717 . . . . 0.81 112.424 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.733 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 10.0 mmt -138.3 111.99 8.27 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.082 -0.71 . . . . 2.48 109.082 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.525 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 13.7 ptp180 -63.8 -22.81 67.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.552 -0.749 . . . . 3.87 111.894 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.547 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.2 m-85 -130.14 155.69 45.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.52 110.953 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -164.62 92.6 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.847 -1.301 . . . . 0.74 109.847 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 34.0 mmtp -123.19 147.89 46.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.187 0.517 . . . . 3.34 111.46 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 40.2 t -81.25 127.29 32.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.431 -0.804 . . . . 0.76 109.833 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.521 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 57.9 mtt -137.39 105.54 5.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.404 -0.591 . . . . 2.56 109.404 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 71.04 -73.8 0.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 124.525 1.141 . . . . 2.99 111.095 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.31 -33.23 0.13 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.84 -0.695 . . . . 0.9 112.813 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' HE1' ' A' ' 34' ' ' HIS . 2.4 ptpt -100.35 164.46 11.92 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.473 0.654 . . . . 2.39 111.672 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -92.81 128.37 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.166 -0.925 . . . . 0.76 109.26 177.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.584 ' CD2' HD13 ' A' ' 3' ' ' ILE . 42.6 m80 -110.64 109.24 19.44 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.293 -0.867 . . . . 1.93 109.931 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -111.07 133.19 53.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.504 0.668 . . . . 0.7 112.091 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.0 m -101.51 127.7 30.86 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.421 -0.955 . . . . 1.25 108.421 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 16.9 Cg_exo -66.64 158.74 54.36 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.135 2.557 . . . . 0.91 113.343 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 35.8 mmtt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.491 -0.766 . . . . 2.61 110.322 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.629 HG23 ' HE3' ' A' ' 23' ' ' MET . 45.2 t . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.14 0.495 . . . . 1.73 110.143 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 mm -96.44 109.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.705 -0.68 . . . . 1.92 110.388 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.4 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.2 pt -99.72 147.19 7.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.373 -0.376 . . . . 1.16 110.902 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.81 12.09 2.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.968 -0.56 . . . . 2.65 112.128 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.67 128.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.107 -0.701 . . . . 1.16 109.107 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.579 ' C ' ' HD3' ' A' ' 7' ' ' LYS . 6.1 tmtt? -73.25 115.85 13.09 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.781 -0.822 . . . . 1.81 108.781 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 17.4 p -66.33 85.07 0.1 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.731 -1.122 . . . . 0.74 111.644 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.593 ' HB2' HD12 ' A' ' 10' ' ' ILE . 71.0 mmtt -58.89 -25.83 63.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.117 -0.697 . . . . 3.08 109.117 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -168.77 152.47 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.545 -1.661 . . . . 1.38 107.143 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.5 m -65.51 -28.33 69.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.482 -0.487 . . . . 0.75 110.683 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -56.18 -34.41 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 4.39 111.266 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -87.61 -14.53 39.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 2.2 110.87 -173.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 57.2 m -89.26 -40.76 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.321 0.581 . . . . 1.18 110.029 176.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.411 HD11 ' N ' ' A' ' 26' ' ' GLY . 61.2 tp -73.71 -27.87 61.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.68 -0.691 . . . . 1.98 111.505 -175.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -55.05 -56.69 25.24 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.692 0.256 . . . . 2.58 111.692 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.54 -19.92 18.55 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.541 1.494 . . . . 0.77 112.45 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.808 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 57.5 m -81.72 -56.69 3.83 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 121.082 -0.247 . . . . 0.36 111.354 -176.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -62.35 -36.05 81.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.786 -0.366 . . . . 2.09 110.547 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.31 -36.25 79.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 1.03 110.687 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.39 -35.09 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 1.15 110.842 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.73 42.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.81 112.586 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.808 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -126.29 98.07 5.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.463 -0.569 . . . . 2.48 109.463 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.781 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -53.81 -34.83 60.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.987 . . . . 3.87 112.123 -178.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.575 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 59.2 m-85 -109.21 144.31 37.48 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.104 -0.332 . . . . 1.52 110.104 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.411 ' N ' HD11 ' A' ' 15' ' ' LEU . . . -158.06 75.39 0.21 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.325 -1.11 . . . . 0.74 110.325 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -108.93 143.89 37.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 3.34 111.288 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.3 t -71.95 125.62 27.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.859 -1.064 . . . . 0.76 110.492 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.401 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 95.9 mmm -124.7 82.44 2.05 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.572 -0.529 . . . . 2.56 109.572 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 73.75 -65.41 0.35 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.421 1.076 . . . . 2.99 111.626 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -131.11 -39.8 0.25 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.65 -0.786 . . . . 0.9 112.779 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.68 158.71 15.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.189 0.519 . . . . 2.39 111.181 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 68.1 m -92.42 116.07 28.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.513 -0.767 . . . . 0.76 109.119 174.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.401 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 12.2 m-70 -99.81 99.23 10.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.888 -0.412 . . . . 1.93 109.888 -177.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -101.07 135.48 42.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.7 111.692 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.575 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 16.6 m -115.77 132.74 23.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.372 -0.831 . . . . 1.25 109.012 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 51.0 Cg_exo -54.0 152.34 24.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.668 2.912 . . . . 0.91 114.032 -172.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.781 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.245 0.858 0 CA-C-N 114.945 -1.025 . . . . 2.61 110.921 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.182 0.515 . . . . 1.73 110.129 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.785 HD13 ' HB3' ' A' ' 32' ' ' LYS . 6.1 tp -92.87 122.94 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.871 -0.604 . . . . 1.92 110.627 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.489 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 20.5 pt -110.95 142.05 24.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 1.16 110.348 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -84.81 50.51 1.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.782 0.801 . . . . 2.65 111.231 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.63 138.11 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.95 -1.023 . . . . 1.16 108.293 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.52 ' C ' ' HD3' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -77.79 109.88 12.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 1.81 109.779 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.569 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.8 p -71.76 85.63 0.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.948 -1.023 . . . . 0.74 111.768 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -55.84 -23.84 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 3.08 108.986 173.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.559 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 8.9 pt -163.06 166.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.557 -1.656 . . . . 1.38 107.097 175.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -66.44 -37.65 85.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.392 0.542 . . . . 0.75 110.85 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -61.54 -19.81 62.54 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.094 -0.503 . . . . 4.39 111.966 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.559 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 13.6 mm100 -58.38 -34.59 70.88 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.878 0.37 . . . . 2.2 111.217 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.424 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 86.8 m -117.27 -25.32 7.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.162 -0.472 . . . . 1.18 112.234 -173.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.477 HD11 ' N ' ' A' ' 26' ' ' GLY . 57.0 tp -64.37 -37.98 89.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.28 -0.568 . . . . 1.98 111.418 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 25.8 tptp -58.8 -50.89 85.54 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 120.511 -0.475 . . . . 2.58 111.419 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 33.4 Cg_exo -60.54 -40.41 56.76 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.82 1.68 . . . . 0.77 112.563 170.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.8 m -70.83 -57.95 4.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.888 0.329 . . . . 0.36 111.888 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -63.17 -28.38 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.827 0.346 . . . . 2.09 110.81 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.75 -31.76 71.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 1.03 109.843 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.67 2.79 52.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 1.15 110.962 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.47 66.3 0.98 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 120.973 -0.632 . . . . 0.81 112.027 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.702 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 61.0 mtt -145.6 108.69 4.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 2.48 109.58 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -65.15 -18.72 65.54 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.421 -0.809 . . . . 3.87 111.981 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.3 m-85 -134.27 149.32 50.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.232 0.539 . . . . 1.52 111.378 175.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.477 ' N ' HD11 ' A' ' 15' ' ' LEU . . . -153.23 79.64 0.19 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.0 -1.64 . . . . 0.74 109.0 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -114.73 134.53 55.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.828 0.347 . . . . 3.34 110.661 -163.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.5 t -74.45 121.92 22.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.838 -0.619 . . . . 0.76 109.84 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.434 ' HB2' ' HD2' ' A' ' 34' ' ' HIS . 93.4 mmm -134.93 110.56 9.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 2.56 110.633 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 60.64 16.83 6.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 2.99 112.438 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.38 -11.1 21.85 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.433 -0.889 . . . . 0.9 113.142 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.785 ' HB3' HD13 ' A' ' 3' ' ' ILE . 67.4 mttm -116.79 160.16 21.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.081 0.467 . . . . 2.39 110.928 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.5 m -93.88 103.91 16.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.697 -0.683 . . . . 0.76 110.66 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.56 ' CD2' HD12 ' A' ' 3' ' ' ILE . 27.6 m-70 -92.0 99.49 12.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.751 -0.659 . . . . 1.93 109.854 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -99.41 129.41 45.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.7 110.777 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 8.7 m -104.77 126.47 31.14 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.598 -0.89 . . . . 1.25 108.598 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.702 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 6.9 Cg_exo -71.74 156.1 57.63 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.129 2.553 . . . . 0.91 113.037 -170.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.353 -0.832 . . . . 2.61 110.427 174.429 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.576 HG12 ' HE3' ' A' ' 23' ' ' MET . 44.9 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.095 0.474 . . . . 1.73 110.158 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mm -111.96 108.97 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.794 -0.639 . . . . 1.92 109.968 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 33' ' ' CYS . 28.0 pt -105.09 149.06 8.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.204 0.526 . . . . 1.16 111.336 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -86.66 48.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 2.65 111.515 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -112.1 125.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.72 -0.673 . . . . 1.16 109.211 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.974 ' HE2' ' HA3' ' A' ' 31' ' ' GLY . 2.5 tmtt? -73.65 102.9 4.06 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.695 0.759 . . . . 1.81 109.721 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.831 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 7.5 p -68.35 106.22 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.794 -1.094 . . . . 0.74 111.484 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HG21 ' A' ' 10' ' ' ILE . 1.3 mppt? -72.71 -2.16 19.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 3.08 110.008 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.88 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -178.74 168.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.787 1.635 . . . . 1.38 108.534 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -67.54 -40.95 85.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.936 0.334 . . . . 0.75 111.875 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -58.95 -27.45 65.33 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.097 0.406 . . . . 4.39 112.097 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.88 ' HG2' HG13 ' A' ' 10' ' ' ILE . 16.1 mm100 -62.98 -23.84 67.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.071 0.462 . . . . 2.2 110.858 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.831 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.2 m -102.19 -38.98 7.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.705 -0.679 . . . . 1.18 110.719 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.34 -34.83 78.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 1.98 111.707 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 32.8 tptt -57.59 -54.69 52.44 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 120.665 -0.414 . . . . 2.58 111.273 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 18.8 Cg_exo -67.75 -29.36 35.75 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.74 1.626 . . . . 0.77 112.313 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.746 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.3 m -76.62 -55.98 5.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 121.05 -0.26 . . . . 0.36 111.239 -174.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -66.63 -22.29 66.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 2.09 110.587 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.31 -37.39 83.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 1.03 110.638 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 -45.94 11.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 1.15 110.819 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.57 59.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.821 -0.704 . . . . 0.81 112.147 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.746 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -137.94 105.99 5.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.178 0.513 . . . . 2.48 110.144 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 8.9 ptm180 -62.77 -25.7 68.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.365 -0.834 . . . . 3.87 112.188 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.561 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 57.4 m-85 -126.5 151.83 47.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.699 0.285 . . . . 1.52 110.646 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.39 85.66 0.13 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.741 -0.944 . . . . 0.74 110.741 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HB3' ' HZ2' ' A' ' 27' ' ' LYS . 8.2 ttpm? -108.32 135.1 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 3.34 110.939 -173.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 t -76.8 131.11 38.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.813 -0.631 . . . . 0.76 109.925 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.455 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 91.1 mmm -137.25 91.79 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.581 -0.282 . . . . 2.56 111.659 -175.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.72 19.82 8.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.715 0.635 . . . . 2.99 112.715 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.974 ' HA3' ' HE2' ' A' ' 7' ' ' LYS . . . 134.92 -50.78 0.85 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.637 -0.792 . . . . 0.9 112.438 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -88.6 156.79 18.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.466 0.651 . . . . 2.39 111.636 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.558 ' HB2' HG12 ' A' ' 4' ' ' ILE . 65.3 m -94.05 117.95 30.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.821 -1.081 . . . . 0.76 109.846 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 11.8 m-70 -100.4 100.42 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.968 -0.56 . . . . 1.93 109.778 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -107.64 129.16 55.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.129 0.49 . . . . 0.7 111.396 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.4 m -98.06 130.21 29.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.606 -0.887 . . . . 1.25 108.606 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.8 Cg_exo -69.78 151.17 68.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.852 2.368 . . . . 0.91 113.012 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 18.5 mmmt . . . . . 0 C--O 1.245 0.855 0 CA-C-N 115.207 -0.906 . . . . 2.61 110.461 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.689 0.757 . . . . 1.73 110.742 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.536 HG22 ' HD3' ' A' ' 32' ' ' LYS . 21.8 mm -105.59 109.64 28.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.155 -0.93 . . . . 1.92 109.803 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.494 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 29.7 pt -91.09 140.63 15.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.062 0.458 . . . . 1.16 110.83 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -84.68 63.13 7.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.512 0.673 . . . . 2.65 110.1 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.95 126.57 75.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.227 -0.897 . . . . 1.16 109.513 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -55.53 102.57 0.07 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.058 0.456 . . . . 1.81 109.954 174.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.1 p -77.1 83.79 3.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.563 0.697 . . . . 0.74 110.518 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.449 ' O ' HG22 ' A' ' 10' ' ' ILE . 8.3 tptp -76.44 -5.95 49.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.561 -0.904 . . . . 3.08 108.561 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.4 pt -167.59 144.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.329 -1.76 . . . . 1.38 107.496 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.7 m -74.11 -20.33 60.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.831 0.348 . . . . 0.75 110.52 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.37 -37.46 85.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 4.39 111.223 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.648 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 18.2 pt20 -73.83 -14.78 61.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.947 0.403 . . . . 2.2 110.674 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.571 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 35.3 m -97.29 -49.66 4.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 1.18 110.721 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 26' ' ' GLY . 65.5 tp -69.97 -35.01 74.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.009 -0.541 . . . . 1.98 112.343 -173.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.52 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.4 tppt? -58.65 -51.41 82.05 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.796 -0.362 . . . . 2.58 111.261 -178.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 21.6 Cg_exo -67.5 -27.67 39.22 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.681 1.587 . . . . 0.77 111.911 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.88 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 54.1 m -71.16 -51.3 25.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.946 -0.302 . . . . 0.36 110.887 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -64.92 -28.54 69.6 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.739 -0.601 . . . . 2.09 111.007 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.43 -30.76 68.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 1.03 110.975 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.58 -42.85 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.268 -0.424 . . . . 1.15 111.226 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.09 56.59 0.02 OUTLIER Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 111.479 -0.648 . . . . 0.81 111.479 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.88 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.4 mpt? -137.71 109.07 6.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.255 -0.646 . . . . 2.48 109.255 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.583 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -74.32 -26.67 60.31 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.27 -0.877 . . . . 3.87 111.898 -175.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.5 m-85 -115.6 152.56 32.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.119 -0.326 . . . . 1.52 110.119 173.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.445 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -164.71 102.1 0.19 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.762 -0.935 . . . . 0.74 110.762 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -127.83 134.49 49.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.668 0.27 . . . . 3.34 110.496 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.3 t -73.92 127.73 33.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.76 109.788 173.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -138.47 114.72 10.28 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.478 -0.564 . . . . 2.56 109.478 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.4 -86.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.122 -0.945 . . . . 2.99 111.83 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' HA3' ' HZ2' ' A' ' 7' ' ' LYS . . . -132.53 -6.01 3.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.393 -0.908 . . . . 0.9 112.967 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.536 ' HD3' HG22 ' A' ' 3' ' ' ILE . 17.4 ptpt -121.6 160.86 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.312 0.577 . . . . 2.39 111.453 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 39.9 m -99.52 105.96 17.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.329 -0.85 . . . . 0.76 110.198 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.09 107.99 16.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.187 -0.46 . . . . 1.93 110.349 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -115.54 134.36 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.045 0.45 . . . . 0.7 110.683 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 7.4 m -105.52 125.34 33.65 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.814 -0.81 . . . . 1.25 108.814 176.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -53.32 146.91 38.46 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.278 2.652 . . . . 0.91 113.525 -174.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 25.3 mmtp . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.15 -0.929 . . . . 2.61 110.967 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.557 HG22 ' HE2' ' A' ' 23' ' ' MET . 97.4 t . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.504 0.669 . . . . 1.73 110.251 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.478 HD11 ' CG ' ' A' ' 34' ' ' HIS . 18.0 mm -89.44 115.65 29.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 1.92 109.758 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.29 147.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.808 0.337 . . . . 1.16 111.099 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.57 19.2 3.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.956 -0.565 . . . . 2.65 111.081 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.0 t -77.39 128.67 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.847 -0.797 . . . . 1.16 108.847 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.647 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 1.1 tmtp? -71.08 106.58 3.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.343 0.592 . . . . 1.81 109.81 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 13' ' ' GLN . 19.5 p -77.22 91.36 3.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.605 -0.725 . . . . 0.74 109.891 177.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' O ' HG21 ' A' ' 10' ' ' ILE . 15.3 tptp -66.25 -13.07 59.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.57 0.7 . . . . 3.08 109.484 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG13 ' HG2' ' A' ' 13' ' ' GLN . 3.1 pt -162.62 170.01 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 114.121 -1.4 . . . . 1.38 108.122 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.9 m -66.46 -26.95 67.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.58 0.627 . . . . 0.75 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -50.06 -42.27 49.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.164 -0.471 . . . . 4.39 110.548 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.501 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 16.0 mm100 -73.73 -8.34 55.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.721 -0.672 . . . . 2.2 111.231 -175.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.46 -52.63 3.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.317 0.579 . . . . 1.18 110.008 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 tp -75.6 -37.94 59.42 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 1.98 112.109 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 23.3 tptm -55.53 -52.47 71.56 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.861 0.319 . . . . 2.58 111.861 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 12.3 Cg_exo -71.49 -30.74 14.73 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.551 1.501 . . . . 0.77 112.046 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 31.4 m -80.51 -55.18 5.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.36 111.63 -172.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.468 ' HA ' ' H ' ' A' ' 23' ' ' MET . 56.4 tttm -61.46 -32.16 72.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 2.09 110.701 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.47 -36.78 81.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.706 -0.679 . . . . 1.03 110.646 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -34.69 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.422 . . . . 1.15 110.969 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.63 62.03 0.07 OUTLIER Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.465 -0.654 . . . . 0.81 111.465 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.598 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 12.6 mmt -134.68 105.28 6.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.541 -0.911 . . . . 2.48 108.541 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.634 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.88 -24.54 67.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.183 -0.917 . . . . 3.87 112.222 -174.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.554 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.4 m-85 -125.44 154.26 42.25 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.401 -0.187 . . . . 1.52 110.752 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.69 96.83 0.15 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 111.471 -0.652 . . . . 0.74 111.471 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -109.85 134.06 52.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.839 0.352 . . . . 3.34 110.06 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.1 t -77.37 129.54 35.94 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.005 -0.543 . . . . 0.76 109.635 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 58.3 mtt -129.89 98.19 4.71 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.53 -0.305 . . . . 2.56 110.679 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.8 m120 69.61 -77.04 0.06 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.135 0.897 . . . . 2.99 111.269 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.647 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . -135.67 -29.19 0.37 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.21 -0.519 . . . . 0.9 112.211 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -95.35 153.34 17.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.329 0.585 . . . . 2.39 111.077 -178.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.41 130.3 39.25 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.449 -0.796 . . . . 0.76 109.946 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.478 ' CG ' HD11 ' A' ' 3' ' ' ILE . 14.4 m-70 -116.18 87.2 2.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.515 -0.766 . . . . 1.93 109.194 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 p -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.878 0.847 . . . . 0.7 111.864 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.6 m -95.86 127.92 39.41 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.699 -1.137 . . . . 1.25 108.974 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 31.2 Cg_exo -59.39 151.45 68.22 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.167 2.578 . . . . 0.91 112.356 -173.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.634 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.249 1.045 0 CA-C-N 115.323 -0.853 . . . . 2.61 111.083 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.064 0.459 . . . . 1.73 110.335 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.436 HD11 ' HA ' ' A' ' 34' ' ' HIS . 17.4 mm -98.34 121.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.602 -0.726 . . . . 1.92 110.029 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 33' ' ' CYS . 27.1 pt -111.97 149.23 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.522 -0.308 . . . . 1.16 110.236 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.69 14.56 5.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 2.65 112.037 -172.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -65.12 123.47 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.631 -0.507 . . . . 1.16 109.631 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -69.85 104.97 2.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.251 0.548 . . . . 1.81 109.832 -176.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.85 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 25.8 p -76.81 103.01 6.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 0.74 111.113 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' O ' HG22 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.65 -18.88 61.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.029 -0.73 . . . . 3.08 109.029 172.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.555 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.0 pt -170.94 167.09 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 113.877 -1.511 . . . . 1.38 108.208 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 48.8 m -64.39 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.14 0.427 . . . . 0.75 110.969 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -52.38 -38.85 59.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.01 -0.541 . . . . 4.39 110.934 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.555 ' HG2' HG13 ' A' ' 10' ' ' ILE . 16.8 mm100 -67.11 -20.52 65.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 2.2 112.159 -173.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.85 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.7 m -105.38 -35.57 7.47 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.536 0.569 . . . . 1.18 112.536 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.658 ' HG ' ' HA2' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -80.89 -21.12 40.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.88 -0.728 . . . . 1.98 111.683 -172.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 34.3 tptt -60.72 -54.62 52.86 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 119.955 -0.698 . . . . 2.58 109.768 171.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.588 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 25.6 Cg_exo -64.75 -33.86 52.46 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.708 1.606 . . . . 0.77 112.838 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.548 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 84.6 m -75.02 -52.82 10.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.566 -0.454 . . . . 0.36 111.106 -176.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 44.8 tttm -64.67 -34.13 77.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.45 0.167 . . . . 2.09 110.834 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.87 -35.33 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 1.03 110.63 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -6.23 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 1.15 111.015 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 56.87 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.969 -0.634 . . . . 0.81 112.494 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.665 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 63.6 mtt -128.59 114.66 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 2.48 110.086 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.953 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 1.3 ptp180 -69.04 -23.57 64.08 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.926 -1.034 . . . . 3.87 112.587 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.567 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 13.8 m-85 -127.27 155.78 42.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 1.52 111.331 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.658 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -167.36 85.43 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.916 -0.873 . . . . 0.74 110.916 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -94.57 134.29 37.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.702 0.287 . . . . 3.34 110.683 -176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 24.4 t -83.89 107.95 16.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.646 -0.501 . . . . 0.76 109.646 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.464 ' HE1' ' HA ' ' A' ' 29' ' ' MET . 0.7 OUTLIER -139.87 131.61 27.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.533 -0.758 . . . . 2.56 109.556 -176.432 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.486 ' OD1' ' HE2' ' A' ' 32' ' ' LYS . 26.5 t-20 69.48 0.97 3.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.439 0.638 . . . . 2.99 111.058 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 95.39 4.05 61.11 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.903 -0.665 . . . . 0.9 111.84 -174.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HE2' ' OD1' ' A' ' 30' ' ' ASN . 56.6 mttm -112.17 156.78 21.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.048 0.452 . . . . 2.39 110.828 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.566 ' HB2' HG12 ' A' ' 4' ' ' ILE . 30.9 m -92.5 97.69 10.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 0.76 109.695 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.436 ' HA ' HD11 ' A' ' 3' ' ' ILE . 76.9 m80 -87.88 91.85 8.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.342 -0.844 . . . . 1.93 109.455 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.31 152.49 23.48 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.38 0.609 . . . . 0.7 111.736 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.1 m -129.41 131.91 23.93 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.412 -0.958 . . . . 1.25 108.412 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 22.7 Cg_exo -63.27 151.81 83.01 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.112 2.541 . . . . 0.91 113.013 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.953 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 50.2 tptt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.202 -0.904 . . . . 2.61 109.346 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.541 HG12 ' HE3' ' A' ' 23' ' ' MET . 39.9 t . . . . . 0 C--O 1.235 0.3 0 CA-C-O 120.983 0.421 . . . . 1.73 110.476 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' A' ' 32' ' ' LYS . 6.4 tp -104.61 119.5 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.243 0.544 . . . . 1.92 110.473 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.589 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.8 pt -114.55 154.02 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.799 -0.637 . . . . 1.16 110.821 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.96 24.34 2.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.05 -0.523 . . . . 2.65 111.531 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.5 t -81.39 134.36 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.212 -0.662 . . . . 1.16 109.212 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.592 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -78.18 117.64 19.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.587 0.708 . . . . 1.81 109.551 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.592 ' N ' ' HD3' ' A' ' 7' ' ' LYS . 14.5 p -78.05 85.65 4.25 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.03 -0.986 . . . . 0.74 111.996 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' O ' HG22 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.39 -16.14 43.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.662 0.744 . . . . 3.08 109.425 172.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.614 HG13 ' HG2' ' A' ' 13' ' ' GLN . 4.0 pt -169.03 173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 113.583 -1.644 . . . . 1.38 106.927 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -74.8 -25.2 58.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.392 0.542 . . . . 0.75 110.302 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -63.47 -32.61 74.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.468 . . . . 4.39 111.073 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.614 ' HG2' HG13 ' A' ' 10' ' ' ILE . 17.4 mm100 -58.73 -30.8 67.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.254 0.55 . . . . 2.2 110.628 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.636 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 11.0 m -94.98 -44.58 7.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.076 -0.966 . . . . 1.18 111.078 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.856 HD23 ' HE2' ' A' ' 19' ' ' LYS . 42.2 tp -74.34 -24.59 59.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 1.98 112.261 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.578 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -62.69 -52.75 62.43 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.823 -0.351 . . . . 2.58 111.099 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.636 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 7.8 Cg_exo -74.34 -17.93 20.94 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.84 1.693 . . . . 0.77 112.099 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.767 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.6 m -82.48 -56.75 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.6 -0.44 . . . . 0.36 111.518 -176.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.856 ' HE2' HD23 ' A' ' 15' ' ' LEU . 42.0 mttm -57.18 -38.27 73.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.254 0.479 . . . . 2.09 110.811 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.94 -32.41 73.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.937 -0.574 . . . . 1.03 111.152 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 -11.91 37.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.446 -0.343 . . . . 1.15 111.243 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.76 45.67 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.746 -0.74 . . . . 0.81 112.987 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.767 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.1 mpt? -125.7 106.75 9.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.981 0.896 . . . . 2.48 110.455 170.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.752 ' HB2' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -47.22 -55.3 8.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.517 -1.674 . . . . 3.87 112.137 173.246 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 46.5 m-85 -99.34 158.93 15.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.912 0.387 . . . . 1.52 111.208 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.71 91.69 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.189 -1.164 . . . . 0.74 110.189 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -121.76 138.8 54.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.848 0.356 . . . . 3.34 110.502 -170.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.1 t -70.25 122.67 19.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.76 109.864 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.8 mmt -137.77 102.36 4.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.34 -0.391 . . . . 2.56 111.004 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 64.59 16.56 10.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.841 -0.618 . . . . 2.99 111.788 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.56 -22.48 11.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.631 -0.795 . . . . 0.9 112.366 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.683 ' HB3' HD12 ' A' ' 3' ' ' ILE . 62.9 mttp -102.66 161.61 13.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.139 0.495 . . . . 2.39 110.7 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.589 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 85.3 m -99.32 109.8 22.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.774 -0.648 . . . . 0.76 111.096 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.578 ' CD2' HD11 ' A' ' 3' ' ' ILE . 3.2 m-70 -92.23 103.81 16.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.56 -0.746 . . . . 1.93 110.582 177.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.47 149.96 29.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.384 0.611 . . . . 0.7 111.044 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 9.0 m -126.91 131.81 24.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.707 -0.849 . . . . 1.25 108.707 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.0 Cg_exo -59.85 143.47 99.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.298 2.665 . . . . 0.91 113.124 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.752 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 18.9 ttpt . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.094 -0.957 . . . . 2.61 110.134 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.488 HG22 ' SD ' ' A' ' 23' ' ' MET . 59.0 t . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.203 0.525 . . . . 1.73 110.803 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.0 116.93 50.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.313 -0.858 . . . . 1.92 109.562 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -113.41 147.58 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.076 0.465 . . . . 1.16 111.7 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -82.57 69.54 9.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.454 -0.794 . . . . 2.65 111.07 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.2 t -131.65 129.52 61.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.604 . . . . 1.16 109.573 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HE2' ' CA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -75.42 86.43 2.56 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 1.81 109.29 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.3 p -58.79 98.46 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.567 -1.197 . . . . 0.74 112.786 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 10' ' ' ILE . 38.4 mmtm -72.36 -11.96 60.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.328 -0.989 . . . . 3.08 108.328 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.2 pt -169.13 154.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 113.521 -1.672 . . . . 1.38 108.237 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 23.8 m -72.87 -30.63 64.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.356 0.598 . . . . 0.75 110.008 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -62.32 -25.66 68.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.215 -0.902 . . . . 4.39 112.558 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 14.7 pt20 -79.25 -19.88 49.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 2.2 110.312 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.608 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 8.5 m -96.68 -31.23 12.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.98 -0.555 . . . . 1.18 110.193 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.585 HD13 ' HZ3' ' A' ' 19' ' ' LYS . 56.9 tp -69.71 -36.59 76.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.055 -0.521 . . . . 1.98 112.154 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 39.9 tptt -53.7 -55.95 30.17 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 119.225 -0.417 . . . . 2.58 111.086 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 19.1 Cg_exo -67.31 -22.39 46.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.648 1.566 . . . . 0.77 112.249 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.765 ' HA ' ' HE3' ' A' ' 23' ' ' MET . 69.7 m -81.72 -56.03 4.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.798 -0.361 . . . . 0.36 111.952 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.585 ' HZ3' HD13 ' A' ' 15' ' ' LEU . 4.7 ttmp? -67.75 -26.27 66.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.299 0.5 . . . . 2.09 110.216 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.19 -34.21 77.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.696 -0.683 . . . . 1.03 109.926 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.18 -45.59 11.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.777 -0.647 . . . . 1.15 110.792 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.18 40.61 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.174 -0.536 . . . . 0.81 112.407 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.765 ' HE3' ' HA ' ' A' ' 18' ' ' CYS . 5.4 mpp? -124.59 103.44 8.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.249 0.547 . . . . 2.48 110.448 174.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.717 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 5.7 ptp180 -52.18 -33.83 42.48 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.232 -0.895 . . . . 3.87 112.485 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 33.1 m-85 -120.84 160.86 22.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.52 111.118 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -159.83 95.77 0.14 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.337 -1.105 . . . . 0.74 110.337 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 91.7 mttt -120.0 134.64 55.19 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 3.34 110.909 -171.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.7 t -74.34 123.54 24.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.018 -0.537 . . . . 0.76 109.995 176.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.446 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 24.7 mmt -126.16 96.37 4.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 2.56 110.727 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.2 t30 73.58 -62.7 0.46 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.724 -1.125 . . . . 2.99 112.034 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.95 -35.9 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.66 -0.781 . . . . 0.9 112.943 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -107.78 170.61 7.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.385 0.612 . . . . 2.39 110.429 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.524 ' HB2' HG12 ' A' ' 4' ' ' ILE . 15.3 m -94.87 125.89 39.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.153 -0.931 . . . . 0.76 110.018 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.446 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 11.9 m-70 -104.92 108.44 19.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.226 -0.657 . . . . 1.93 109.226 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.3 118.31 36.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.326 0.584 . . . . 0.7 111.493 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.0 m -80.53 130.14 66.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.174 -0.921 . . . . 1.25 108.937 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.5 Cg_exo -69.49 147.98 65.82 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.167 2.578 . . . . 0.91 112.508 -171.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.717 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.0 tttm . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.234 -0.894 . . . . 2.61 110.345 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.353 0.597 . . . . 1.73 110.431 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.871 HD12 ' HB3' ' A' ' 32' ' ' LYS . 6.9 tp -103.65 128.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.692 -0.686 . . . . 1.92 110.733 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.571 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 24.3 pt -121.0 143.49 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.599 -0.519 . . . . 1.16 109.599 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -83.32 14.32 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.836 0.31 . . . . 2.65 111.836 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.24 126.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.0 -0.741 . . . . 1.16 109.0 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.551 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 2.7 tmtp? -70.95 111.86 6.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.483 0.658 . . . . 1.81 109.81 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 11.8 p -76.94 93.36 3.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.102 -0.954 . . . . 0.74 111.547 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.541 ' O ' HG22 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -61.81 -14.21 31.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.404 0.621 . . . . 3.08 110.036 173.47 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.736 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -171.46 164.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 125.641 1.576 . . . . 1.38 107.577 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -62.03 -38.48 88.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.254 0.479 . . . . 0.75 111.006 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.41 -24.02 64.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.215 0.45 . . . . 4.39 112.215 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.736 ' HG2' HG13 ' A' ' 10' ' ' ILE . 15.7 mm100 -62.52 -30.54 71.37 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.2 0.524 . . . . 2.2 110.691 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 m -101.39 -40.08 7.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.777 -0.647 . . . . 1.18 111.17 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.796 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.4 tt -78.6 -23.69 45.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.286 -0.416 . . . . 1.98 111.614 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 11.1 tmtt? -56.4 -55.1 46.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.619 -0.511 . . . . 2.58 109.619 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 85.5 Cg_endo -77.87 -19.73 12.31 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.207 1.271 . . . . 0.77 112.227 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.796 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 1.2 m -71.42 -56.9 5.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.87 -0.332 . . . . 0.36 110.878 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 38.6 ttmt -64.1 -33.41 75.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.203 -0.295 . . . . 2.09 110.203 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.8 -39.33 84.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 1.03 110.554 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.78 0.69 54.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.015 -0.539 . . . . 1.15 111.39 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.91 53.7 1.88 Allowed Glycine 0 CA--C 1.506 -0.485 0 C-N-CA 120.941 -0.647 . . . . 0.81 112.43 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 17.0 mmt -131.31 97.4 4.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.664 -0.865 . . . . 2.48 108.664 172.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.72 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 6.0 ttt85 -55.54 -37.74 68.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.092 . . . . 3.87 111.454 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 71.6 m-85 -106.29 149.0 27.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.785 0.326 . . . . 1.52 110.613 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.578 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -165.07 72.3 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.221 -1.152 . . . . 0.74 110.221 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.95 135.01 44.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.137 0.494 . . . . 3.34 110.857 -168.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.6 t -78.48 121.77 24.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.76 110.264 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.492 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 21.7 mmt -138.26 106.43 5.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.516 -0.311 . . . . 2.56 111.556 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.7 m120 62.46 13.7 6.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.61 -0.723 . . . . 2.99 112.188 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.551 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 123.47 -32.68 4.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.492 -0.861 . . . . 0.9 112.634 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.871 ' HB3' HD12 ' A' ' 3' ' ' ILE . 10.9 mptt -94.47 157.71 15.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.283 0.563 . . . . 2.39 111.489 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.571 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 45.4 m -96.85 110.41 22.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.207 -0.906 . . . . 0.76 110.479 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.492 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 19.0 m-70 -92.76 95.39 9.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.01 -0.541 . . . . 1.93 110.399 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.73 147.74 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.455 0.645 . . . . 0.7 111.352 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 13.4 m -129.45 129.62 23.24 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.506 -0.924 . . . . 1.25 108.506 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 58.1 Cg_exo -51.39 148.82 18.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.384 2.722 . . . . 0.91 112.804 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.72 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.3 tptm . . . . . 0 C--O 1.248 1.007 0 O-C-N 124.082 0.864 . . . . 2.61 111.669 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 111.722 -0.551 . . . . 1.6 111.722 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.9 t -92.53 93.35 4.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.378 0.609 . . . . 1.73 110.318 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.603 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -94.48 124.1 46.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.577 -0.738 . . . . 1.92 110.341 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.588 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 27.5 pt -103.39 142.53 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.158 -0.474 . . . . 1.16 109.962 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.796 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 24.6 p-10 -84.0 24.41 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 2.65 111.627 -174.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -76.03 135.6 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.727 -0.472 . . . . 1.16 109.727 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -63.37 105.91 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.467 0.651 . . . . 1.81 110.615 177.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 11.0 p -79.24 83.77 5.25 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.059 -0.973 . . . . 0.74 111.26 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.71 -18.5 65.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 3.08 108.41 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.663 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 pt -162.8 146.39 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.499 -1.682 . . . . 1.38 108.025 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.97 -28.4 64.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.925 0.343 . . . . 0.75 111.925 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -64.8 -29.04 69.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.86 0.318 . . . . 4.39 111.86 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.8 pt20 -74.6 -20.14 60.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.106 0.479 . . . . 2.2 110.256 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 25.7 m -92.25 -41.73 10.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.888 -0.596 . . . . 1.18 110.077 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.3 tp -69.24 -33.99 74.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 1.98 112.365 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' C ' ' HD3' ' A' ' 16' ' ' LYS . 6.9 tmtm? -55.85 -56.92 25.05 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 119.501 -0.285 . . . . 2.58 110.604 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 73.5 Cg_endo -72.91 -20.49 22.2 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.414 1.409 . . . . 0.77 112.714 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.742 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 59.5 m -77.98 -50.58 11.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.804 -0.358 . . . . 0.36 110.956 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -65.79 -21.27 66.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 2.09 110.172 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.8 -19.9 43.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.666 -0.697 . . . . 1.03 110.54 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.08 -30.19 12.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 1.15 110.977 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.79 45.82 0.1 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.151 -0.547 . . . . 0.81 112.106 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.742 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -130.95 106.63 8.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.042 0.448 . . . . 2.48 110.021 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.898 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -65.45 -27.32 68.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.667 -0.697 . . . . 3.87 111.869 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 60.5 m-85 -117.91 157.7 26.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 1.52 110.686 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.33 88.65 0.11 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.692 -0.963 . . . . 0.74 110.692 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -116.86 134.76 54.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.882 0.372 . . . . 3.34 110.686 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 13.9 t -74.14 120.84 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.081 -0.508 . . . . 0.76 110.832 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.408 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 85.4 mmm -138.66 116.67 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 2.56 111.177 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.22 12.09 5.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.1 0.56 . . . . 2.99 112.458 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.21 -17.05 22.1 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.718 . . . . 0.9 112.334 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.796 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 13.8 mptt -103.72 156.29 17.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 2.39 110.957 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.588 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 59.7 m -93.06 109.88 21.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.781 -0.645 . . . . 0.76 109.494 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.603 ' HA ' HG13 ' A' ' 3' ' ' ILE . 9.9 m170 -87.7 95.7 10.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.871 -0.604 . . . . 1.93 110.18 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.443 ' HB3' ' HG2' ' A' ' 23' ' ' MET . 74.4 m -100.43 110.29 22.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.591 0.71 . . . . 0.7 110.914 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.6 m -89.95 129.59 45.65 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.389 -0.823 . . . . 1.25 109.065 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -54.36 149.64 36.88 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.674 2.916 . . . . 0.91 113.984 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.898 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 27.8 tptp . . . . . 0 C--O 1.242 0.698 0 CA-C-N 115.248 -0.887 . . . . 2.61 110.114 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 N-CA-C 111.444 -0.662 . . . . 1.6 111.444 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.476 HG23 ' HE3' ' A' ' 23' ' ' MET . 43.7 t -92.99 94.26 4.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.323 0.582 . . . . 1.73 110.348 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.8 mm -83.43 109.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 1.92 110.137 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.5 pt -99.59 130.6 48.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.051 0.453 . . . . 1.16 110.932 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.444 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 19.7 m-20 -74.53 63.79 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.482 -0.781 . . . . 2.65 111.13 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.64 134.13 59.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.705 -0.68 . . . . 1.16 109.513 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.65 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -64.86 106.7 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 1.81 110.781 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.878 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 21.1 p -85.96 83.23 7.85 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.893 -0.594 . . . . 0.74 110.568 173.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -61.97 -19.24 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.55 -0.907 . . . . 3.08 108.55 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.503 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 10.2 pt -160.52 164.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 113.37 -1.741 . . . . 1.38 107.032 174.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -61.98 -33.38 74.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.686 0.675 . . . . 0.75 111.391 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -57.67 -31.9 66.79 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.294 -0.412 . . . . 4.39 111.834 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.503 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 15.9 mm100 -62.87 -26.37 68.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.869 0.366 . . . . 2.2 111.302 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.878 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.5 m -95.27 -46.08 6.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.055 -0.521 . . . . 1.18 111.347 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.996 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.2 tt -73.89 -24.42 59.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.293 0.479 . . . . 1.98 112.293 -166.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 38.0 tptt -61.22 -57.84 23.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.295 -0.962 . . . . 2.58 109.63 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.5 Cg_exo -59.33 -33.96 97.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.437 1.425 . . . . 0.77 111.956 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.996 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 12.0 m -64.27 -63.03 1.25 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.36 111.506 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.18 -32.25 72.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.385 0.539 . . . . 2.09 111.052 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.39 -40.47 97.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.054 -0.521 . . . . 1.03 110.936 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.44 -26.47 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.128 0.49 . . . . 1.15 111.0 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.61 65.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.841 -0.618 . . . . 0.81 112.232 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.575 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 15.6 mmt -135.68 104.34 5.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.858 -0.793 . . . . 2.48 108.858 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.573 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.67 -28.27 69.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.593 -0.73 . . . . 3.87 110.962 -177.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.545 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.1 m-85 -117.71 153.95 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.207 -0.294 . . . . 1.52 110.207 173.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.662 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -156.08 110.18 0.43 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.836 -0.697 . . . . 0.74 111.849 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.702 ' HB3' ' HE3' ' A' ' 29' ' ' MET . 9.5 mmtp -129.23 134.95 48.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.931 0.396 . . . . 3.34 111.841 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 8.1 t -75.52 132.95 41.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.93 -0.577 . . . . 0.76 109.615 174.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.702 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 26.2 mmt -134.36 80.88 1.88 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.962 -0.295 . . . . 2.56 111.356 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 p30 62.87 -4.14 0.27 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.224 1.41 . . . . 2.99 113.846 171.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -55.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.748 -0.739 . . . . 0.9 111.722 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.4 mptm? -89.49 161.07 16.43 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.192 0.52 . . . . 2.39 110.908 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.529 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 56.4 m -96.73 115.64 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.76 109.905 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -97.24 93.15 6.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 1.93 109.808 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.7 m -112.69 127.02 56.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.042 -0.527 . . . . 0.7 111.346 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 35.1 m -86.96 124.99 67.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.42 -0.809 . . . . 1.25 109.07 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 50.0 Cg_exo -54.42 152.74 25.17 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.533 2.822 . . . . 0.91 113.45 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.4 tptp . . . . . 0 C--O 1.242 0.688 0 CA-C-O 118.189 -0.91 . . . . 2.61 111.038 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.038 -0.425 . . . . 1.6 112.038 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.489 HG23 ' HE3' ' A' ' 23' ' ' MET . 58.4 t -78.17 100.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.167 0.508 . . . . 1.73 110.238 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.808 HD13 ' HB3' ' A' ' 32' ' ' LYS . 7.0 tp -91.58 120.17 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.736 -0.666 . . . . 1.92 110.417 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.52 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 19.8 pt -102.6 136.54 34.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.041 0.448 . . . . 1.16 110.734 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -79.91 64.95 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.702 -0.681 . . . . 2.65 111.124 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -125.01 130.45 73.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.229 -0.896 . . . . 1.16 109.477 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.7 107.44 3.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.052 -0.721 . . . . 1.81 109.052 178.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 11.5 p -78.18 91.29 4.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.943 -1.026 . . . . 0.74 112.428 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' O ' HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -70.3 -11.14 60.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.622 0.725 . . . . 3.08 109.459 174.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.599 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.6 pt -165.83 145.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.055 -1.429 . . . . 1.38 108.19 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.6 m -70.95 -24.46 62.44 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.816 -0.354 . . . . 0.75 110.518 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.17 -34.45 78.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.836 0.31 . . . . 4.39 111.836 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 16.3 pt20 -70.63 -20.42 62.73 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.194 0.521 . . . . 2.2 110.119 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.537 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 12.5 m -94.98 -41.37 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.603 -0.726 . . . . 1.18 110.237 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.692 HD23 ' HE2' ' A' ' 19' ' ' LYS . 1.6 tt -77.02 -37.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.844 -0.617 . . . . 1.98 111.913 -171.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.549 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 27.0 tptp -50.46 -52.79 51.98 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-O 119.464 -0.303 . . . . 2.58 111.411 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 6.9 Cg_exo -73.93 -20.47 19.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.643 1.562 . . . . 0.77 112.505 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 37.4 m -83.39 -54.08 5.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.344 -0.543 . . . . 0.36 111.821 -175.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.692 ' HE2' HD23 ' A' ' 15' ' ' LEU . 23.0 ttmm -63.77 -35.78 81.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.408 -0.517 . . . . 2.09 110.334 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.94 -37.27 86.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.916 0.389 . . . . 1.03 110.184 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.03 0.85 46.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 1.15 111.335 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.49 60.02 1.06 Allowed Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.937 -0.649 . . . . 0.81 112.669 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.518 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 17.9 mmt -132.77 108.14 8.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.112 -0.699 . . . . 2.48 109.112 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -60.69 -31.4 70.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.867 -1.06 . . . . 3.87 110.983 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 51.1 m-85 -120.67 149.64 42.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.695 0.283 . . . . 1.52 111.072 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.681 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -158.48 78.27 0.18 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.695 -0.962 . . . . 0.74 110.695 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -114.5 135.0 54.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.955 0.407 . . . . 3.34 110.478 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 4.4 t -72.3 127.87 33.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.953 -0.567 . . . . 0.76 109.751 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.48 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.472 -0.331 . . . . 2.56 110.336 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 72.0 -66.42 0.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.223 0.952 . . . . 2.99 112.432 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -126.18 -25.51 1.33 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.236 -0.983 . . . . 0.9 113.23 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.808 ' HB3' HD13 ' A' ' 3' ' ' ILE . 35.2 mtmt -121.68 158.35 28.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.235 0.541 . . . . 2.39 112.213 -170.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.52 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 56.8 m -93.91 109.02 20.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.299 -0.864 . . . . 0.76 110.238 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.522 ' CD2' HD12 ' A' ' 3' ' ' ILE . 1.8 m-70 -87.05 100.47 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 1.93 111.0 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -104.23 118.03 35.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.144 0.497 . . . . 0.7 110.574 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.3 m -101.83 122.18 48.31 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.078 -0.712 . . . . 1.25 109.078 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -51.94 147.21 26.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.385 2.723 . . . . 0.91 113.484 -173.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.449 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 24.0 tptm . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.129 -0.941 . . . . 2.61 111.281 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.766 -0.534 . . . . 1.6 111.766 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.79 HG22 ' HG3' ' A' ' 37' ' ' PRO . 47.1 t -92.3 93.04 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.175 0.512 . . . . 1.73 110.469 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -115.24 109.63 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.88 -0.785 . . . . 1.92 108.88 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.445 HG13 ' HB2' ' A' ' 33' ' ' CYS . 15.8 pt -123.51 134.62 65.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.07 0.462 . . . . 1.16 111.464 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.708 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 m-20 -77.93 63.7 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.608 -0.724 . . . . 2.65 110.475 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -115.35 124.03 71.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 1.16 109.24 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -58.04 104.21 0.19 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.232 0.539 . . . . 1.81 110.172 175.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.6 p -89.87 87.27 6.88 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.781 -0.645 . . . . 0.74 110.084 174.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 21.0 tptt -64.43 -13.03 49.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 3.08 109.258 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.1 pt -154.65 159.41 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 113.782 -1.554 . . . . 1.38 108.165 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.4 m -67.22 -19.87 65.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.81 0.338 . . . . 0.75 111.217 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -59.29 -31.1 68.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.176 -0.465 . . . . 4.39 110.879 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -67.58 -24.38 65.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.905 -0.589 . . . . 2.2 110.676 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.1 m -92.57 -45.5 8.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.281 0.562 . . . . 1.18 109.875 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.598 HD11 ' SD ' ' A' ' 23' ' ' MET . 11.4 tp -52.48 -51.38 59.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.877 -1.056 . . . . 1.98 112.669 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 40.5 tptt -56.21 -59.73 11.02 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 119.01 -0.519 . . . . 2.58 111.42 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.3 Cg_exo -57.83 -34.23 97.99 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.571 1.514 . . . . 0.77 112.479 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.79 -54.46 6.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.36 111.421 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 25.2 tttm -74.5 -17.95 60.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.71 0.291 . . . . 2.09 110.829 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 5.4 t70 -68.3 -30.33 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.412 -0.588 . . . . 1.03 109.412 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.19 3.35 43.67 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.797 -0.638 . . . . 1.15 110.544 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 100.11 105.01 2.66 Favored Glycine 0 CA--C 1.499 -0.919 0 CA-C-N 115.465 -0.789 . . . . 0.81 111.435 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.598 ' SD ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -119.43 121.76 40.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.321 1.058 . . . . 2.48 109.564 174.07 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.67 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -89.0 -29.2 19.67 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.051 -1.431 . . . . 3.87 108.285 168.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.5 m-85 -140.02 151.52 45.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.136 -0.938 . . . . 1.52 109.347 170.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA2' ' SD ' ' A' ' 23' ' ' MET . . . -150.95 108.27 0.38 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.06 -0.591 . . . . 0.74 111.807 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -129.41 138.7 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.169 0.509 . . . . 3.34 112.0 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 t -87.24 132.49 33.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.014 -1.106 . . . . 0.76 108.014 167.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 52.6 mtt -126.14 77.69 1.7 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.041 -0.664 . . . . 2.56 111.208 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 70.97 -58.58 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.385 1.053 . . . . 2.99 112.563 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.91 -47.08 0.21 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.958 -0.639 . . . . 0.9 112.566 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.708 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.1 mptm? -107.46 164.43 12.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 2.39 111.293 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -92.77 123.46 36.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.36 -0.836 . . . . 0.76 110.365 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.41 98.04 5.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 1.93 109.613 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.588 ' SG ' ' HB ' ' A' ' 2' ' ' VAL . 7.6 p -121.13 159.22 26.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.036 -0.529 . . . . 0.7 110.902 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 24.2 m -112.65 113.37 50.48 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.588 -0.733 . . . . 1.25 109.151 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.79 ' HG3' HG22 ' A' ' 2' ' ' VAL . 32.7 Cg_exo -58.98 152.73 56.29 Favored 'Trans proline' 0 CA--C 1.519 -0.238 0 C-N-CA 122.836 2.357 . . . . 0.91 112.324 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.67 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 20.3 tptm . . . . . 0 C--O 1.246 0.906 0 CA-C-N 115.565 -0.743 . . . . 2.61 110.619 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.051 -0.42 . . . . 1.6 112.051 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.4 93.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.375 -0.602 . . . . 1.73 109.375 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.608 HD13 ' HB3' ' A' ' 32' ' ' LYS . 6.8 tp -88.07 110.42 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.855 0.836 . . . . 1.92 111.0 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.41 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -95.23 147.57 5.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.358 -0.837 . . . . 1.16 110.679 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -84.42 14.11 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 2.65 111.285 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.14 120.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.421 -0.585 . . . . 1.16 109.421 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.657 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 1.8 tmtp? -67.73 115.95 7.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.973 -0.751 . . . . 1.81 108.973 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 28.5 p -77.16 82.96 3.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.525 -0.761 . . . . 0.74 111.475 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' O ' HG21 ' A' ' 10' ' ' ILE . 13.8 mmmm -66.44 -17.58 64.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.744 0.783 . . . . 3.08 108.992 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.546 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.4 pt -166.04 148.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.86 -1.518 . . . . 1.38 108.123 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -74.08 -19.72 60.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.868 0.366 . . . . 0.75 110.897 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 12' ' ' ARG . 30.9 mtp180 -54.58 -47.08 73.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 4.39 110.731 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.6 pt20 -76.51 -4.15 41.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 2.2 111.125 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.536 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 75.3 m -95.61 -58.15 2.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.074 -0.512 . . . . 1.18 110.44 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.598 ' HG ' ' HA2' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -79.12 -31.74 44.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.638 0.607 . . . . 1.98 112.638 -169.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -54.79 -50.75 84.19 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.654 -0.418 . . . . 2.58 110.702 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 14.3 Cg_exo -71.59 -29.76 15.75 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.634 1.556 . . . . 0.77 112.923 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 81.3 m -74.18 -52.17 13.28 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.446 -0.501 . . . . 0.36 111.422 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HA ' ' H ' ' A' ' 23' ' ' MET . 41.2 ttmt -65.77 -27.35 68.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.067 0.46 . . . . 2.09 110.267 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.28 -28.42 69.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 1.03 110.082 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.52 5.51 41.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 1.15 111.244 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.86 53.01 1.99 Allowed Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.88 -0.676 . . . . 0.81 112.765 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.677 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 56.8 mtt -131.57 102.16 5.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.587 0.708 . . . . 2.48 109.366 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.642 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 10.9 ttt180 -60.39 -27.21 67.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.169 -1.378 . . . . 3.87 112.335 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.599 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.7 m-85 -117.62 163.3 16.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.852 0.358 . . . . 1.52 110.867 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.598 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -178.6 74.24 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.999 -0.841 . . . . 0.74 110.999 -177.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -104.16 133.69 48.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.664 -0.268 . . . . 3.34 110.469 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.2 t -70.42 126.84 30.78 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.881 -0.414 . . . . 0.76 109.881 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.8 mmm -137.39 103.52 5.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 2.56 110.261 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 72.7 -74.72 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.997 0.811 . . . . 2.99 110.997 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.657 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . -146.15 4.7 1.18 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.913 -0.66 . . . . 0.9 112.863 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.608 ' HB3' HD13 ' A' ' 3' ' ' ILE . 91.1 mttt -131.93 160.41 35.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.036 0.446 . . . . 2.39 111.478 -176.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 66.8 m -96.86 113.17 24.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.76 110.045 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.516 ' CD2' HD12 ' A' ' 3' ' ' ILE . 1.8 m-70 -86.55 94.6 9.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 1.93 110.498 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.4 m -104.3 115.35 30.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.453 0.644 . . . . 0.7 111.485 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 22.6 m -92.41 129.01 42.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.764 -0.828 . . . . 1.25 108.764 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 37.8 Cg_exo -57.14 155.12 30.39 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.852 2.368 . . . . 0.91 112.009 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.642 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 7.7 tptp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.078 -0.963 . . . . 2.61 112.356 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.773 -0.531 . . . . 1.6 111.773 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.575 HG12 ' HE1' ' A' ' 23' ' ' MET . 43.1 t -79.36 97.1 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.095 0.474 . . . . 1.73 110.034 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.16 109.51 28.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.75 -0.659 . . . . 1.92 110.494 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.409 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.1 pt -99.37 137.29 27.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.079 -0.51 . . . . 1.16 109.812 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -81.42 33.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 2.65 111.67 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.76 135.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.087 -1.079 . . . . 1.16 108.087 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.558 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 1.8 tmtt? -77.76 115.43 17.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.729 -0.788 . . . . 1.81 110.242 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 10.2 p -73.02 85.98 1.31 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.462 -1.244 . . . . 0.74 111.884 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' O ' HG21 ' A' ' 10' ' ' ILE . 1.4 mptm? -66.76 -13.44 61.42 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.556 -0.715 . . . . 3.08 109.352 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.626 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.2 pt -166.63 150.52 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.384 -1.28 . . . . 1.38 108.587 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 50.4 m -63.7 -52.96 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.791 0.293 . . . . 0.75 111.791 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -60.22 -19.47 54.56 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 4.39 113.246 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 11.4 pt20 -72.78 -25.43 61.16 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.201 -0.6 . . . . 2.2 109.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 32.8 m -93.67 -34.64 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.895 -0.593 . . . . 1.18 109.707 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.29 -41.27 94.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 1.98 112.104 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.506 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 18.2 tptm -57.63 -52.04 77.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.329 -0.548 . . . . 2.58 111.739 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 23.8 Cg_exo -65.43 -25.46 55.96 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.695 1.597 . . . . 0.77 111.94 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.724 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 66.2 m -82.39 -52.42 6.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.619 -0.264 . . . . 0.36 110.818 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -64.03 -27.58 69.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.782 0.325 . . . . 2.09 110.682 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.86 -45.78 90.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.058 -0.519 . . . . 1.03 110.035 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.83 61.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 1.15 110.664 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.84 54.56 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.834 -0.621 . . . . 0.81 112.16 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.724 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -130.95 105.09 7.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 2.48 110.545 175.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.569 ' N ' ' HB2' ' A' ' 38' ' ' LYS . 8.3 ptm180 -55.59 -27.49 49.68 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.264 -0.88 . . . . 3.87 112.698 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 26.9 m-85 -124.63 160.34 28.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 1.52 110.818 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.78 59.67 0.12 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.602 -0.999 . . . . 0.74 110.602 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.546 ' HB2' ' HE1' ' A' ' 29' ' ' MET . 97.1 mttt -98.41 152.58 19.34 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.19 0.519 . . . . 3.34 110.609 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t -77.61 112.75 14.74 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.323 -0.853 . . . . 0.76 110.528 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.546 ' HE1' ' HB2' ' A' ' 27' ' ' LYS . 62.4 mtt -137.99 125.74 22.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 2.56 109.874 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 68.45 -4.72 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.13 0.49 . . . . 2.99 111.674 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' HA3' ' HE2' ' A' ' 7' ' ' LYS . . . 114.47 -14.01 20.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.831 -0.7 . . . . 0.9 112.137 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -102.24 159.74 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.799 0.333 . . . . 2.39 110.504 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 56.8 m -91.13 95.62 10.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.02 -0.733 . . . . 0.76 109.02 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -76.8 93.95 3.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.268 -0.878 . . . . 1.93 111.046 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.0 m -98.68 111.16 23.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.394 0.616 . . . . 0.7 111.034 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.6 m -88.99 130.59 44.01 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.48 -0.933 . . . . 1.25 108.48 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 3.1 Cg_exo -72.22 151.53 54.9 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.175 2.583 . . . . 0.91 112.238 -170.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.569 ' HB2' ' N ' ' A' ' 24' ' ' ARG . 50.1 tttm . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.36 -0.829 . . . . 2.61 110.682 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.904 -0.478 . . . . 1.6 111.904 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.25 99.16 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.172 0.51 . . . . 1.73 110.256 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 mm -104.76 121.76 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.003 -0.544 . . . . 1.92 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.558 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.7 pt -106.26 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.905 0.383 . . . . 1.16 110.323 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.76 31.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 2.65 112.112 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.17 139.29 17.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.938 -0.764 . . . . 1.16 108.938 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.638 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 1.6 tmtp? -81.5 115.55 20.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.546 -0.539 . . . . 1.81 109.546 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.2 p -80.21 84.07 5.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.316 -0.856 . . . . 0.74 112.584 -173.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -72.99 -11.52 60.6 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.119 -0.988 . . . . 3.08 108.81 173.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.9 pt -169.67 139.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.915 -1.493 . . . . 1.38 107.927 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -71.98 -17.12 62.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.651 0.262 . . . . 0.75 111.616 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -68.64 -33.7 74.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.745 0.307 . . . . 4.39 110.918 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 3.4 pt20 -75.98 -20.48 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.027 0.442 . . . . 2.2 110.364 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.554 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 57.4 m -88.83 -33.66 17.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.896 -0.593 . . . . 1.18 110.461 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.795 ' HG ' ' HA2' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -83.85 -25.36 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.149 -0.478 . . . . 1.98 112.062 -172.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 28.0 tptp -56.21 -49.37 93.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.4 -0.52 . . . . 2.58 110.907 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 8.6 Cg_exo -73.95 -31.84 7.7 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.829 1.686 . . . . 0.77 112.67 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.771 ' HA ' ' HE3' ' A' ' 23' ' ' MET . 75.8 m -75.0 -52.19 11.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.291 -0.563 . . . . 0.36 111.303 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.576 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 1.7 tmtp? -61.95 -35.01 77.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.022 0.439 . . . . 2.09 110.355 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.85 -27.85 69.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.769 -0.65 . . . . 1.03 110.788 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.55 1.06 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 1.15 111.342 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.82 46.67 2.64 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.557 -0.83 . . . . 0.81 112.849 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.771 ' HE3' ' HA ' ' A' ' 18' ' ' CYS . 4.7 mpp? -123.05 104.46 9.23 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.573 0.702 . . . . 2.48 109.634 171.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.844 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -56.81 -35.81 69.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.328 -1.305 . . . . 3.87 111.681 -179.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.565 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 25.1 m-85 -110.25 163.25 13.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.252 0.549 . . . . 1.52 111.617 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.795 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -167.45 57.8 0.22 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.103 -1.199 . . . . 0.74 110.103 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -85.98 134.53 33.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.304 -0.448 . . . . 3.34 110.995 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 15.3 t -69.6 117.99 11.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.762 -0.654 . . . . 0.76 109.719 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.24 109.96 7.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.245 -0.434 . . . . 2.56 111.265 -175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.513 HD21 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER 59.64 21.46 10.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.088 -0.505 . . . . 2.99 111.698 172.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.638 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 113.18 -26.36 10.49 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.785 -0.721 . . . . 0.9 112.77 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -101.77 158.93 15.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.948 0.404 . . . . 2.39 110.798 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.558 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 23.7 m -93.48 107.98 19.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.341 -0.614 . . . . 0.76 109.341 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -90.32 95.34 10.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.732 -0.667 . . . . 1.93 110.158 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.1 m -98.81 119.26 37.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.578 . . . . 0.7 111.098 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 11.8 m -94.81 124.61 54.09 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 1.25 109.108 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 12.9 Cg_endo -56.22 144.56 80.91 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.892 2.395 . . . . 0.91 112.503 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.844 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tptp . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.512 -0.767 . . . . 2.61 111.159 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.549 -0.62 . . . . 1.6 111.549 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.911 ' HB ' ' HB2' ' A' ' 35' ' ' CYS . 31.9 t -90.23 93.18 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.171 0.51 . . . . 1.73 109.675 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.86 109.25 24.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.909 -0.587 . . . . 1.92 109.778 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.468 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 21.7 pt -108.4 147.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.167 -0.469 . . . . 1.16 110.96 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -83.51 28.12 0.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 2.65 111.398 -176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.56 132.65 31.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.603 -0.888 . . . . 1.16 108.603 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.598 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -73.08 114.36 11.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.101 -0.703 . . . . 1.81 109.101 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.3 p -74.94 82.72 2.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.594 0.712 . . . . 0.74 110.85 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.547 ' O ' HG22 ' A' ' 10' ' ' ILE . 12.4 tptm -79.96 -2.56 44.43 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.505 -0.924 . . . . 3.08 108.505 175.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 9' ' ' LYS . 4.8 pt -174.7 142.72 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 113.18 -1.827 . . . . 1.38 107.228 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -72.56 -20.7 61.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.531 0.205 . . . . 0.75 111.035 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -62.59 -38.78 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 4.39 111.504 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 7.1 pt20 -75.29 -14.02 60.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.278 0.561 . . . . 2.2 110.285 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 56.5 m -88.47 -37.98 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 1.18 109.385 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.618 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -75.21 -43.68 50.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.491 -1.231 . . . . 1.98 112.709 -170.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 48.9 tptt -55.47 -52.12 74.41 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.708 -0.397 . . . . 2.58 111.768 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 20.6 Cg_exo -67.45 -36.27 20.75 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.658 1.572 . . . . 0.77 112.203 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 23' ' ' MET . 87.2 m -79.16 -43.84 23.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.669 -0.413 . . . . 0.36 111.641 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 21.4 ttmm -70.65 -30.07 66.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.258 -0.177 . . . . 2.09 110.706 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.61 -36.55 84.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 1.03 109.882 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -41.1 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.671 . . . . 1.15 111.124 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 157.03 85.87 0.05 OUTLIER Glycine 0 CA--C 1.508 -0.4 0 N-CA-C 111.633 -0.587 . . . . 0.81 111.633 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.83 ' HE1' ' HA2' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -141.51 121.56 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.172 0.987 . . . . 2.48 110.166 176.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.517 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.6 -26.2 18.82 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.156 -1.384 . . . . 3.87 109.59 174.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.555 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.4 m-85 -141.78 164.02 31.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.355 -0.384 . . . . 1.52 110.36 171.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.83 ' HA2' ' HE1' ' A' ' 23' ' ' MET . . . -165.85 118.05 0.78 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 121.089 -0.576 . . . . 0.74 111.709 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HB2' ' HE1' ' A' ' 29' ' ' MET . 92.8 mttt -129.23 139.68 51.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.93 0.395 . . . . 3.34 110.828 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.0 t -68.79 123.33 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 0.76 109.563 170.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.479 ' HE1' ' HB2' ' A' ' 27' ' ' LYS . 66.1 mtt -137.11 118.01 14.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.728 -0.214 . . . . 2.56 110.921 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 43.01 37.41 1.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.215 0.947 . . . . 2.99 113.243 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.598 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 108.93 -27.98 12.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.049 -0.596 . . . . 0.9 112.916 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -107.28 159.06 16.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.357 0.598 . . . . 2.39 111.432 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 80.9 m -92.6 107.35 19.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.54 -0.755 . . . . 0.76 109.791 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -88.54 98.12 11.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.638 -0.71 . . . . 1.93 109.835 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.911 ' HB2' ' HB ' ' A' ' 2' ' ' VAL . 33.4 m -100.13 113.14 25.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.669 -0.696 . . . . 0.7 110.944 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.2 m -78.69 112.98 30.99 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.552 -0.749 . . . . 1.25 109.325 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 30.3 Cg_exo -60.21 147.1 94.76 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.479 2.119 . . . . 0.91 112.191 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 4.3 mmmp? . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.589 -0.72 . . . . 2.61 111.058 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 111.469 -0.652 . . . . 1.6 111.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.483 HG22 ' HE1' ' A' ' 23' ' ' MET . 2.4 m -92.41 93.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.847 0.832 . . . . 1.73 111.365 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -101.44 118.06 47.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.96 . . . . 1.92 109.086 176.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 33' ' ' CYS . 18.4 pt -101.88 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.057 0.456 . . . . 1.16 111.379 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.1 39.9 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 2.65 111.827 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.07 134.36 44.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.372 -0.603 . . . . 1.16 109.372 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.699 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 2.5 tmtp? -78.35 109.36 12.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.475 0.655 . . . . 1.81 109.832 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.557 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -80.49 98.26 7.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.172 -0.922 . . . . 0.74 111.841 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' O ' HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -66.45 -12.07 55.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.623 0.725 . . . . 3.08 109.824 172.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.661 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 11.9 pt -163.61 163.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.139 -1.391 . . . . 1.38 107.473 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.6 m -67.18 -39.82 86.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 118.474 0.579 . . . . 0.75 110.81 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -62.0 -19.5 62.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.813 -0.631 . . . . 4.39 112.326 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.661 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 11.9 mm100 -54.95 -35.94 64.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.849 0.356 . . . . 2.2 110.879 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -113.66 -18.87 11.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.093 -0.503 . . . . 1.18 111.871 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.49 -34.07 76.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.147 -0.621 . . . . 1.98 110.981 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -59.81 -56.39 36.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.835 -0.346 . . . . 2.58 110.468 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -66.06 -25.89 51.01 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.727 1.618 . . . . 0.77 112.65 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.6 m -79.19 -56.31 4.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.725 -0.39 . . . . 0.36 111.495 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.499 ' HA ' ' H ' ' A' ' 23' ' ' MET . 73.8 tttt -65.92 -26.61 67.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.372 -0.205 . . . . 2.09 111.064 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -65.39 -35.95 82.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 1.03 110.451 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.63 -13.27 58.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 1.15 110.881 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 64.94 0.6 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.57 -0.612 . . . . 0.81 111.57 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.619 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 46.8 mtt -141.13 110.79 6.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.675 0.75 . . . . 2.48 110.152 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.784 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 6.4 ptp180 -65.19 -21.24 66.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.579 -1.191 . . . . 3.87 112.176 -175.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 47.9 m-85 -128.39 148.07 50.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.043 0.449 . . . . 1.52 110.826 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.05 62.64 0.42 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 109.443 -1.463 . . . . 0.74 109.443 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 27' ' ' LYS . 52.1 mtpt -91.1 134.9 34.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.067 0.461 . . . . 3.34 111.066 -168.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 39.9 t -81.93 124.11 29.45 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.667 -0.697 . . . . 0.76 109.874 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.651 ' HA ' ' HE3' ' A' ' 29' ' ' MET . 1.5 mmt -138.64 105.9 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 2.56 111.162 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.05 20.94 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.804 -0.635 . . . . 2.99 112.186 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.699 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 119.71 -31.09 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.5 -0.857 . . . . 0.9 112.663 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -94.99 154.37 17.2 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.289 0.566 . . . . 2.39 111.259 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -93.68 104.27 16.38 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.149 -0.932 . . . . 0.76 109.803 176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.575 ' HA ' HG13 ' A' ' 3' ' ' ILE . 17.8 m-70 -88.73 94.13 9.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.7 -0.682 . . . . 1.93 109.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.6 m -98.66 130.06 45.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.7 110.617 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.7 m -108.36 129.86 23.5 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.139 -1.06 . . . . 1.25 108.139 175.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.1 Cg_exo -62.41 155.86 55.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.065 2.51 . . . . 0.91 112.396 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.784 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 17.1 mmmt . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.53 -0.748 . . . . 2.61 110.53 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.812 0 N-CA-C 111.436 -0.666 . . . . 1.6 111.436 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.737 HG22 ' HE2' ' A' ' 23' ' ' MET . 57.1 t -90.71 95.29 5.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.629 0.728 . . . . 1.73 111.004 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.865 HD13 ' HB3' ' A' ' 32' ' ' LYS . 2.8 tp -91.94 126.71 44.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.252 -0.885 . . . . 1.92 109.893 175.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.523 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.6 pt -115.05 145.23 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.293 -0.412 . . . . 1.16 111.367 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.26 69.36 6.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 2.65 111.272 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.91 122.8 65.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.563 -0.532 . . . . 1.16 109.563 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -69.29 96.33 0.85 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.492 0.663 . . . . 1.81 110.089 -177.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.698 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 8.8 p -80.57 100.49 8.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.24 -0.891 . . . . 0.74 111.842 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' O ' HG21 ' A' ' 10' ' ' ILE . 3.3 mppt? -71.13 -8.1 51.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.171 -0.678 . . . . 3.08 109.171 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.752 HG13 ' HG3' ' A' ' 13' ' ' GLN . 3.8 pt -168.58 154.41 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 114.063 -1.426 . . . . 1.38 108.126 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.3 m -69.35 -22.23 63.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 0.75 111.409 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.415 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.3 mpt_? -60.91 -36.29 78.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.264 -0.425 . . . . 4.39 111.682 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.752 ' HG3' HG13 ' A' ' 10' ' ' ILE . 13.9 mt-30 -62.84 -27.63 69.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.5 . . . . 2.2 110.56 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.8 m -88.29 -48.74 7.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.394 -0.821 . . . . 1.18 111.261 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.7 tp -67.83 -34.08 76.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.003 -0.544 . . . . 1.98 112.304 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.478 ' C ' ' HD3' ' A' ' 16' ' ' LYS . 8.9 tmtt? -58.38 -58.42 19.13 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.295 -0.562 . . . . 2.58 110.448 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 70.5 Cg_endo -70.63 -21.0 30.03 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.612 1.541 . . . . 0.77 112.345 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.673 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 56.6 m -77.66 -58.63 3.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.629 -0.429 . . . . 0.36 109.95 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HA ' ' H ' ' A' ' 23' ' ' MET . 44.9 tttm -60.08 -32.04 70.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.208 -0.451 . . . . 2.09 110.637 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 13.9 t70 -56.22 -47.88 77.57 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 1.03 110.496 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.64 -29.23 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.695 . . . . 1.15 111.071 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.4 0.11 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.494 -0.642 . . . . 0.81 111.494 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.737 ' HE2' HG22 ' A' ' 2' ' ' VAL . 10.2 mmt -145.01 91.63 2.17 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.132 -1.062 . . . . 2.48 108.132 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HG3' ' CD2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -50.39 -47.77 56.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.508 -1.224 . . . . 3.87 111.524 -177.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 98.7 m-85 -99.27 147.3 25.32 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.687 -0.405 . . . . 1.52 110.084 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.88 95.07 0.13 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.708 -0.957 . . . . 0.74 110.708 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -122.32 141.17 51.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.198 0.523 . . . . 3.34 111.03 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.3 t -75.9 136.19 40.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.466 -0.788 . . . . 0.76 110.324 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 32' ' ' LYS . 2.7 ppp? -137.87 100.54 4.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 2.56 110.859 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 58.39 18.82 5.86 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.792 . . . . 2.99 112.55 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 119.42 -5.56 13.11 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.576 -0.821 . . . . 0.9 113.335 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.865 ' HB3' HD13 ' A' ' 3' ' ' ILE . 53.4 mtpt -120.36 168.62 11.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.045 0.422 . . . . 2.39 111.243 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 59.0 m -111.66 102.84 11.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.76 111.666 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.862 ' HD2' HD12 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -81.99 97.95 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 1.93 110.529 174.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.7 m -106.44 134.49 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.316 0.579 . . . . 0.7 110.772 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.616 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 17.3 m -112.38 124.09 32.75 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.076 -0.712 . . . . 1.25 109.076 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 53.1 Cg_exo -55.4 147.3 57.72 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.616 2.877 . . . . 0.91 113.477 -170.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 13.9 tptp . . . . . 0 C--O 1.249 1.047 0 CA-C-N 114.89 -1.05 . . . . 2.61 110.068 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 112.012 -0.435 . . . . 1.6 112.012 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.699 HG23 ' HE2' ' A' ' 23' ' ' MET . 64.2 t -85.02 100.35 8.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.354 0.597 . . . . 1.73 109.768 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.584 HD13 ' CD2' ' A' ' 34' ' ' HIS . 7.0 mm -100.28 121.42 51.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.448 -0.797 . . . . 1.92 110.005 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.502 HD12 ' SG ' ' A' ' 14' ' ' CYS . 24.8 pt -115.76 151.56 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.965 0.412 . . . . 1.16 110.61 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.03 45.25 1.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 2.65 111.686 -174.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -102.12 126.45 56.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.954 -0.758 . . . . 1.16 108.954 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -68.67 120.33 14.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.731 0.777 . . . . 1.81 109.94 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 13.0 p -85.35 86.42 7.38 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.012 -0.995 . . . . 0.74 111.734 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' O ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -55.96 -23.38 31.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.386 0.612 . . . . 3.08 109.614 173.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.597 HG13 ' HG2' ' A' ' 13' ' ' GLN . 7.2 pt -164.06 167.52 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.98 -1.464 . . . . 1.38 107.482 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 63.6 m -66.43 -36.93 84.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.295 0.498 . . . . 0.75 110.741 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -57.15 -28.84 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.754 -0.657 . . . . 4.39 111.828 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.597 ' HG2' HG13 ' A' ' 10' ' ' ILE . 15.4 mm100 -55.72 -34.55 65.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.125 -0.488 . . . . 2.2 111.698 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.613 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 4.9 t -108.63 -21.66 12.6 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.449 -0.5 . . . . 1.18 111.736 -176.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.546 HD23 ' HE3' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -74.47 -36.53 63.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.933 -0.707 . . . . 1.98 111.369 -174.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -56.29 -49.46 93.2 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 120.327 -0.549 . . . . 2.58 110.592 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 14' ' ' CYS . 21.5 Cg_exo -67.7 -35.96 20.4 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.81 1.674 . . . . 0.77 112.851 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.733 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 34.2 m -71.14 -54.14 12.08 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.55 -0.46 . . . . 0.36 111.713 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.546 ' HE3' HD23 ' A' ' 15' ' ' LEU . 38.2 ttmt -66.4 -25.9 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.833 -0.347 . . . . 2.09 110.456 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.78 -33.08 71.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.046 -0.525 . . . . 1.03 110.206 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -6.09 56.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 1.15 110.82 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.74 62.36 0.75 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.795 -0.717 . . . . 0.81 112.424 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.733 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 10.0 mmt -138.3 111.99 8.27 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.082 -0.71 . . . . 2.48 109.082 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.525 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 13.7 ptp180 -63.8 -22.81 67.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.552 -0.749 . . . . 3.87 111.894 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.547 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.2 m-85 -130.14 155.69 45.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.52 110.953 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -164.62 92.6 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.847 -1.301 . . . . 0.74 109.847 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 34.0 mmtp -123.19 147.89 46.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.187 0.517 . . . . 3.34 111.46 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 40.2 t -81.25 127.29 32.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.431 -0.804 . . . . 0.76 109.833 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.521 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 57.9 mtt -137.39 105.54 5.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.404 -0.591 . . . . 2.56 109.404 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 71.04 -73.8 0.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 124.525 1.141 . . . . 2.99 111.095 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.31 -33.23 0.13 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.84 -0.695 . . . . 0.9 112.813 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' HE1' ' A' ' 34' ' ' HIS . 2.4 ptpt -100.35 164.46 11.92 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.473 0.654 . . . . 2.39 111.672 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -92.81 128.37 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.166 -0.925 . . . . 0.76 109.26 177.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.584 ' CD2' HD13 ' A' ' 3' ' ' ILE . 42.6 m80 -110.64 109.24 19.44 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.293 -0.867 . . . . 1.93 109.931 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -111.07 133.19 53.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.504 0.668 . . . . 0.7 112.091 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.0 m -101.51 127.7 30.86 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.421 -0.955 . . . . 1.25 108.421 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 16.9 Cg_exo -66.64 158.74 54.36 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.135 2.557 . . . . 0.91 113.343 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 35.8 mmtt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.491 -0.766 . . . . 2.61 110.322 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.206 -0.358 . . . . 1.6 112.206 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.629 HG23 ' HE3' ' A' ' 23' ' ' MET . 45.2 t -79.43 102.67 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.14 0.495 . . . . 1.73 110.143 -177.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 mm -96.44 109.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.705 -0.68 . . . . 1.92 110.388 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.4 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.2 pt -99.72 147.19 7.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.373 -0.376 . . . . 1.16 110.902 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.81 12.09 2.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.968 -0.56 . . . . 2.65 112.128 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.67 128.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.107 -0.701 . . . . 1.16 109.107 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.579 ' C ' ' HD3' ' A' ' 7' ' ' LYS . 6.1 tmtt? -73.25 115.85 13.09 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.781 -0.822 . . . . 1.81 108.781 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 17.4 p -66.33 85.07 0.1 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.731 -1.122 . . . . 0.74 111.644 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.593 ' HB2' HD12 ' A' ' 10' ' ' ILE . 71.0 mmtt -58.89 -25.83 63.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.117 -0.697 . . . . 3.08 109.117 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -168.77 152.47 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.545 -1.661 . . . . 1.38 107.143 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.5 m -65.51 -28.33 69.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.482 -0.487 . . . . 0.75 110.683 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -56.18 -34.41 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 4.39 111.266 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -87.61 -14.53 39.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 2.2 110.87 -173.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 57.2 m -89.26 -40.76 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.321 0.581 . . . . 1.18 110.029 176.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.411 HD11 ' N ' ' A' ' 26' ' ' GLY . 61.2 tp -73.71 -27.87 61.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.68 -0.691 . . . . 1.98 111.505 -175.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -55.05 -56.69 25.24 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.692 0.256 . . . . 2.58 111.692 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.54 -19.92 18.55 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.541 1.494 . . . . 0.77 112.45 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.808 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 57.5 m -81.72 -56.69 3.83 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 121.082 -0.247 . . . . 0.36 111.354 -176.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -62.35 -36.05 81.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.786 -0.366 . . . . 2.09 110.547 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.31 -36.25 79.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 1.03 110.687 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.39 -35.09 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 1.15 110.842 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.73 42.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.81 112.586 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.808 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -126.29 98.07 5.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.463 -0.569 . . . . 2.48 109.463 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.781 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -53.81 -34.83 60.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.987 . . . . 3.87 112.123 -178.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.575 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 59.2 m-85 -109.21 144.31 37.48 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.104 -0.332 . . . . 1.52 110.104 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.411 ' N ' HD11 ' A' ' 15' ' ' LEU . . . -158.06 75.39 0.21 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.325 -1.11 . . . . 0.74 110.325 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -108.93 143.89 37.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 3.34 111.288 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.3 t -71.95 125.62 27.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.859 -1.064 . . . . 0.76 110.492 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.401 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 95.9 mmm -124.7 82.44 2.05 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.572 -0.529 . . . . 2.56 109.572 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 73.75 -65.41 0.35 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.421 1.076 . . . . 2.99 111.626 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -131.11 -39.8 0.25 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.65 -0.786 . . . . 0.9 112.779 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.68 158.71 15.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.189 0.519 . . . . 2.39 111.181 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 68.1 m -92.42 116.07 28.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.513 -0.767 . . . . 0.76 109.119 174.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.401 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 12.2 m-70 -99.81 99.23 10.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.888 -0.412 . . . . 1.93 109.888 -177.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -101.07 135.48 42.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.7 111.692 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.575 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 16.6 m -115.77 132.74 23.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.372 -0.831 . . . . 1.25 109.012 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 51.0 Cg_exo -54.0 152.34 24.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.668 2.912 . . . . 0.91 114.032 -172.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.781 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.245 0.858 0 CA-C-N 114.945 -1.025 . . . . 2.61 110.921 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.647 -0.581 . . . . 1.6 111.647 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.9 t -77.18 93.7 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.182 0.515 . . . . 1.73 110.129 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.785 HD13 ' HB3' ' A' ' 32' ' ' LYS . 6.1 tp -92.87 122.94 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.871 -0.604 . . . . 1.92 110.627 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.489 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 20.5 pt -110.95 142.05 24.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 1.16 110.348 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -84.81 50.51 1.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.782 0.801 . . . . 2.65 111.231 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.63 138.11 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.95 -1.023 . . . . 1.16 108.293 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' C ' ' HD3' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -77.79 109.88 12.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 1.81 109.779 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.569 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.8 p -71.76 85.63 0.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.948 -1.023 . . . . 0.74 111.768 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -55.84 -23.84 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 3.08 108.986 173.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.559 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 8.9 pt -163.06 166.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.557 -1.656 . . . . 1.38 107.097 175.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -66.44 -37.65 85.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.392 0.542 . . . . 0.75 110.85 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -61.54 -19.81 62.54 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.094 -0.503 . . . . 4.39 111.966 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.559 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 13.6 mm100 -58.38 -34.59 70.88 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.878 0.37 . . . . 2.2 111.217 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.424 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 86.8 m -117.27 -25.32 7.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.162 -0.472 . . . . 1.18 112.234 -173.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.477 HD11 ' N ' ' A' ' 26' ' ' GLY . 57.0 tp -64.37 -37.98 89.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.28 -0.568 . . . . 1.98 111.418 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 25.8 tptp -58.8 -50.89 85.54 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 120.511 -0.475 . . . . 2.58 111.419 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 33.4 Cg_exo -60.54 -40.41 56.76 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.82 1.68 . . . . 0.77 112.563 170.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.8 m -70.83 -57.95 4.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.888 0.329 . . . . 0.36 111.888 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -63.17 -28.38 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.827 0.346 . . . . 2.09 110.81 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.75 -31.76 71.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 1.03 109.843 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.67 2.79 52.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 1.15 110.962 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.47 66.3 0.98 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 120.973 -0.632 . . . . 0.81 112.027 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.702 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 61.0 mtt -145.6 108.69 4.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 2.48 109.58 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -65.15 -18.72 65.54 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.421 -0.809 . . . . 3.87 111.981 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.3 m-85 -134.27 149.32 50.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.232 0.539 . . . . 1.52 111.378 175.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.477 ' N ' HD11 ' A' ' 15' ' ' LEU . . . -153.23 79.64 0.19 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.0 -1.64 . . . . 0.74 109.0 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -114.73 134.53 55.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.828 0.347 . . . . 3.34 110.661 -163.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.5 t -74.45 121.92 22.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.838 -0.619 . . . . 0.76 109.84 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.434 ' HB2' ' HD2' ' A' ' 34' ' ' HIS . 93.4 mmm -134.93 110.56 9.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 2.56 110.633 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 60.64 16.83 6.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 2.99 112.438 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.38 -11.1 21.85 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.433 -0.889 . . . . 0.9 113.142 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.785 ' HB3' HD13 ' A' ' 3' ' ' ILE . 67.4 mttm -116.79 160.16 21.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.081 0.467 . . . . 2.39 110.928 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.5 m -93.88 103.91 16.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.697 -0.683 . . . . 0.76 110.66 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.56 ' CD2' HD12 ' A' ' 3' ' ' ILE . 27.6 m-70 -92.0 99.49 12.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.751 -0.659 . . . . 1.93 109.854 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -99.41 129.41 45.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.7 110.777 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 8.7 m -104.77 126.47 31.14 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.598 -0.89 . . . . 1.25 108.598 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.702 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 6.9 Cg_exo -71.74 156.1 57.63 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.129 2.553 . . . . 0.91 113.037 -170.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.353 -0.832 . . . . 2.61 110.427 174.429 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.823 0 N-CA-C 112.371 -0.292 . . . . 1.6 112.371 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.576 HG12 ' HE3' ' A' ' 23' ' ' MET . 44.9 t -90.22 93.53 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.095 0.474 . . . . 1.73 110.158 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mm -111.96 108.97 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.794 -0.639 . . . . 1.92 109.968 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 33' ' ' CYS . 28.0 pt -105.09 149.06 8.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.204 0.526 . . . . 1.16 111.336 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -86.66 48.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 2.65 111.515 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -112.1 125.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.72 -0.673 . . . . 1.16 109.211 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.974 ' HE2' ' HA3' ' A' ' 31' ' ' GLY . 2.5 tmtt? -73.65 102.9 4.06 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.695 0.759 . . . . 1.81 109.721 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.831 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 7.5 p -68.35 106.22 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.794 -1.094 . . . . 0.74 111.484 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HG21 ' A' ' 10' ' ' ILE . 1.3 mppt? -72.71 -2.16 19.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 3.08 110.008 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.88 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -178.74 168.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.787 1.635 . . . . 1.38 108.534 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -67.54 -40.95 85.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.936 0.334 . . . . 0.75 111.875 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -58.95 -27.45 65.33 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.097 0.406 . . . . 4.39 112.097 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.88 ' HG2' HG13 ' A' ' 10' ' ' ILE . 16.1 mm100 -62.98 -23.84 67.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.071 0.462 . . . . 2.2 110.858 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.831 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.2 m -102.19 -38.98 7.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.705 -0.679 . . . . 1.18 110.719 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.34 -34.83 78.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 1.98 111.707 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 32.8 tptt -57.59 -54.69 52.44 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 120.665 -0.414 . . . . 2.58 111.273 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 18.8 Cg_exo -67.75 -29.36 35.75 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.74 1.626 . . . . 0.77 112.313 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.746 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.3 m -76.62 -55.98 5.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 121.05 -0.26 . . . . 0.36 111.239 -174.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -66.63 -22.29 66.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 2.09 110.587 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.31 -37.39 83.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 1.03 110.638 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 -45.94 11.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 1.15 110.819 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.57 59.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.821 -0.704 . . . . 0.81 112.147 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.746 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -137.94 105.99 5.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.178 0.513 . . . . 2.48 110.144 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 8.9 ptm180 -62.77 -25.7 68.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.365 -0.834 . . . . 3.87 112.188 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.561 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 57.4 m-85 -126.5 151.83 47.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.699 0.285 . . . . 1.52 110.646 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.39 85.66 0.13 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.741 -0.944 . . . . 0.74 110.741 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HB3' ' HZ2' ' A' ' 27' ' ' LYS . 8.2 ttpm? -108.32 135.1 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 3.34 110.939 -173.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 t -76.8 131.11 38.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.813 -0.631 . . . . 0.76 109.925 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.455 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 91.1 mmm -137.25 91.79 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.581 -0.282 . . . . 2.56 111.659 -175.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.72 19.82 8.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.715 0.635 . . . . 2.99 112.715 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.974 ' HA3' ' HE2' ' A' ' 7' ' ' LYS . . . 134.92 -50.78 0.85 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.637 -0.792 . . . . 0.9 112.438 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -88.6 156.79 18.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.466 0.651 . . . . 2.39 111.636 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.558 ' HB2' HG12 ' A' ' 4' ' ' ILE . 65.3 m -94.05 117.95 30.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.821 -1.081 . . . . 0.76 109.846 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.455 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 11.8 m-70 -100.4 100.42 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.968 -0.56 . . . . 1.93 109.778 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -107.64 129.16 55.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.129 0.49 . . . . 0.7 111.396 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.4 m -98.06 130.21 29.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.606 -0.887 . . . . 1.25 108.606 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.8 Cg_exo -69.78 151.17 68.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.852 2.368 . . . . 0.91 113.012 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 18.5 mmmt . . . . . 0 C--O 1.245 0.855 0 CA-C-N 115.207 -0.906 . . . . 2.61 110.461 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 112.18 -0.368 . . . . 1.6 112.18 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.86 93.14 4.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.689 0.757 . . . . 1.73 110.742 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.536 HG22 ' HD3' ' A' ' 32' ' ' LYS . 21.8 mm -105.59 109.64 28.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.155 -0.93 . . . . 1.92 109.803 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.494 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 29.7 pt -91.09 140.63 15.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.062 0.458 . . . . 1.16 110.83 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -84.68 63.13 7.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.512 0.673 . . . . 2.65 110.1 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.95 126.57 75.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.227 -0.897 . . . . 1.16 109.513 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -55.53 102.57 0.07 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.058 0.456 . . . . 1.81 109.954 174.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.1 p -77.1 83.79 3.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.563 0.697 . . . . 0.74 110.518 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.449 ' O ' HG22 ' A' ' 10' ' ' ILE . 8.3 tptp -76.44 -5.95 49.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.561 -0.904 . . . . 3.08 108.561 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.4 pt -167.59 144.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.329 -1.76 . . . . 1.38 107.496 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.7 m -74.11 -20.33 60.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.831 0.348 . . . . 0.75 110.52 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.37 -37.46 85.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 4.39 111.223 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.648 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 18.2 pt20 -73.83 -14.78 61.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.947 0.403 . . . . 2.2 110.674 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.571 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 35.3 m -97.29 -49.66 4.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 1.18 110.721 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 26' ' ' GLY . 65.5 tp -69.97 -35.01 74.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.009 -0.541 . . . . 1.98 112.343 -173.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.52 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.4 tppt? -58.65 -51.41 82.05 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.796 -0.362 . . . . 2.58 111.261 -178.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 21.6 Cg_exo -67.5 -27.67 39.22 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.681 1.587 . . . . 0.77 111.911 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.88 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 54.1 m -71.16 -51.3 25.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.946 -0.302 . . . . 0.36 110.887 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -64.92 -28.54 69.6 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.739 -0.601 . . . . 2.09 111.007 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.43 -30.76 68.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 1.03 110.975 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.58 -42.85 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.268 -0.424 . . . . 1.15 111.226 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.09 56.59 0.02 OUTLIER Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 111.479 -0.648 . . . . 0.81 111.479 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.88 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.4 mpt? -137.71 109.07 6.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.255 -0.646 . . . . 2.48 109.255 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.583 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -74.32 -26.67 60.31 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.27 -0.877 . . . . 3.87 111.898 -175.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.5 m-85 -115.6 152.56 32.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.119 -0.326 . . . . 1.52 110.119 173.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.445 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -164.71 102.1 0.19 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.762 -0.935 . . . . 0.74 110.762 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -127.83 134.49 49.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.668 0.27 . . . . 3.34 110.496 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.3 t -73.92 127.73 33.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.76 109.788 173.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -138.47 114.72 10.28 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.478 -0.564 . . . . 2.56 109.478 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.4 -86.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.122 -0.945 . . . . 2.99 111.83 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' HA3' ' HZ2' ' A' ' 7' ' ' LYS . . . -132.53 -6.01 3.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.393 -0.908 . . . . 0.9 112.967 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.536 ' HD3' HG22 ' A' ' 3' ' ' ILE . 17.4 ptpt -121.6 160.86 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.312 0.577 . . . . 2.39 111.453 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 39.9 m -99.52 105.96 17.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.329 -0.85 . . . . 0.76 110.198 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.09 107.99 16.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.187 -0.46 . . . . 1.93 110.349 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -115.54 134.36 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.045 0.45 . . . . 0.7 110.683 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 7.4 m -105.52 125.34 33.65 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.814 -0.81 . . . . 1.25 108.814 176.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -53.32 146.91 38.46 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.278 2.652 . . . . 0.91 113.525 -174.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 25.3 mmtp . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.15 -0.929 . . . . 2.61 110.967 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.639 -0.584 . . . . 1.6 111.639 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.557 HG22 ' HE2' ' A' ' 23' ' ' MET . 97.4 t -86.78 99.02 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.504 0.669 . . . . 1.73 110.251 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.478 HD11 ' CG ' ' A' ' 34' ' ' HIS . 18.0 mm -89.44 115.65 29.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 1.92 109.758 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.29 147.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.808 0.337 . . . . 1.16 111.099 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.57 19.2 3.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.956 -0.565 . . . . 2.65 111.081 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.0 t -77.39 128.67 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.847 -0.797 . . . . 1.16 108.847 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.647 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 1.1 tmtp? -71.08 106.58 3.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.343 0.592 . . . . 1.81 109.81 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 13' ' ' GLN . 19.5 p -77.22 91.36 3.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.605 -0.725 . . . . 0.74 109.891 177.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' O ' HG21 ' A' ' 10' ' ' ILE . 15.3 tptp -66.25 -13.07 59.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.57 0.7 . . . . 3.08 109.484 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG13 ' HG2' ' A' ' 13' ' ' GLN . 3.1 pt -162.62 170.01 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 114.121 -1.4 . . . . 1.38 108.122 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.9 m -66.46 -26.95 67.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.58 0.627 . . . . 0.75 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -50.06 -42.27 49.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.164 -0.471 . . . . 4.39 110.548 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.501 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 16.0 mm100 -73.73 -8.34 55.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.721 -0.672 . . . . 2.2 111.231 -175.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.46 -52.63 3.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.317 0.579 . . . . 1.18 110.008 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 tp -75.6 -37.94 59.42 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 1.98 112.109 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 23.3 tptm -55.53 -52.47 71.56 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.861 0.319 . . . . 2.58 111.861 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 12.3 Cg_exo -71.49 -30.74 14.73 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.551 1.501 . . . . 0.77 112.046 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 31.4 m -80.51 -55.18 5.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.36 111.63 -172.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.468 ' HA ' ' H ' ' A' ' 23' ' ' MET . 56.4 tttm -61.46 -32.16 72.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 2.09 110.701 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.47 -36.78 81.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.706 -0.679 . . . . 1.03 110.646 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -34.69 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.422 . . . . 1.15 110.969 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.63 62.03 0.07 OUTLIER Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.465 -0.654 . . . . 0.81 111.465 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.598 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 12.6 mmt -134.68 105.28 6.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.541 -0.911 . . . . 2.48 108.541 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.634 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.88 -24.54 67.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.183 -0.917 . . . . 3.87 112.222 -174.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.554 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.4 m-85 -125.44 154.26 42.25 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.401 -0.187 . . . . 1.52 110.752 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.69 96.83 0.15 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 111.471 -0.652 . . . . 0.74 111.471 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -109.85 134.06 52.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.839 0.352 . . . . 3.34 110.06 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.1 t -77.37 129.54 35.94 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.005 -0.543 . . . . 0.76 109.635 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 58.3 mtt -129.89 98.19 4.71 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.53 -0.305 . . . . 2.56 110.679 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.8 m120 69.61 -77.04 0.06 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.135 0.897 . . . . 2.99 111.269 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.647 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . -135.67 -29.19 0.37 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.21 -0.519 . . . . 0.9 112.211 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -95.35 153.34 17.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.329 0.585 . . . . 2.39 111.077 -178.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.41 130.3 39.25 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.449 -0.796 . . . . 0.76 109.946 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.478 ' CG ' HD11 ' A' ' 3' ' ' ILE . 14.4 m-70 -116.18 87.2 2.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.515 -0.766 . . . . 1.93 109.194 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 p -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.878 0.847 . . . . 0.7 111.864 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.6 m -95.86 127.92 39.41 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.699 -1.137 . . . . 1.25 108.974 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 31.2 Cg_exo -59.39 151.45 68.22 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.167 2.578 . . . . 0.91 112.356 -173.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.634 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.249 1.045 0 CA-C-N 115.323 -0.853 . . . . 2.61 111.083 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.467 -0.253 . . . . 1.6 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.58 104.53 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.064 0.459 . . . . 1.73 110.335 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.436 HD11 ' HA ' ' A' ' 34' ' ' HIS . 17.4 mm -98.34 121.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.602 -0.726 . . . . 1.92 110.029 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 33' ' ' CYS . 27.1 pt -111.97 149.23 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.522 -0.308 . . . . 1.16 110.236 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.69 14.56 5.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 2.65 112.037 -172.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -65.12 123.47 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.631 -0.507 . . . . 1.16 109.631 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -69.85 104.97 2.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.251 0.548 . . . . 1.81 109.832 -176.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.85 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 25.8 p -76.81 103.01 6.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 0.74 111.113 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' O ' HG22 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.65 -18.88 61.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.029 -0.73 . . . . 3.08 109.029 172.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.555 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.0 pt -170.94 167.09 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 113.877 -1.511 . . . . 1.38 108.208 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 48.8 m -64.39 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.14 0.427 . . . . 0.75 110.969 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -52.38 -38.85 59.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.01 -0.541 . . . . 4.39 110.934 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.555 ' HG2' HG13 ' A' ' 10' ' ' ILE . 16.8 mm100 -67.11 -20.52 65.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 2.2 112.159 -173.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.85 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.7 m -105.38 -35.57 7.47 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.536 0.569 . . . . 1.18 112.536 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.658 ' HG ' ' HA2' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -80.89 -21.12 40.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.88 -0.728 . . . . 1.98 111.683 -172.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 34.3 tptt -60.72 -54.62 52.86 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 119.955 -0.698 . . . . 2.58 109.768 171.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.588 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 25.6 Cg_exo -64.75 -33.86 52.46 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.708 1.606 . . . . 0.77 112.838 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.548 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 84.6 m -75.02 -52.82 10.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.566 -0.454 . . . . 0.36 111.106 -176.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 44.8 tttm -64.67 -34.13 77.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.45 0.167 . . . . 2.09 110.834 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.87 -35.33 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 1.03 110.63 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -6.23 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 1.15 111.015 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 56.87 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.969 -0.634 . . . . 0.81 112.494 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.665 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 63.6 mtt -128.59 114.66 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 2.48 110.086 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.953 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 1.3 ptp180 -69.04 -23.57 64.08 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.926 -1.034 . . . . 3.87 112.587 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.567 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 13.8 m-85 -127.27 155.78 42.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 1.52 111.331 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.658 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -167.36 85.43 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.916 -0.873 . . . . 0.74 110.916 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -94.57 134.29 37.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.702 0.287 . . . . 3.34 110.683 -176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 24.4 t -83.89 107.95 16.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.646 -0.501 . . . . 0.76 109.646 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.464 ' HE1' ' HA ' ' A' ' 29' ' ' MET . 0.7 OUTLIER -139.87 131.61 27.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.533 -0.758 . . . . 2.56 109.556 -176.432 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.486 ' OD1' ' HE2' ' A' ' 32' ' ' LYS . 26.5 t-20 69.48 0.97 3.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.439 0.638 . . . . 2.99 111.058 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 95.39 4.05 61.11 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.903 -0.665 . . . . 0.9 111.84 -174.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HE2' ' OD1' ' A' ' 30' ' ' ASN . 56.6 mttm -112.17 156.78 21.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.048 0.452 . . . . 2.39 110.828 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.566 ' HB2' HG12 ' A' ' 4' ' ' ILE . 30.9 m -92.5 97.69 10.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 0.76 109.695 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.436 ' HA ' HD11 ' A' ' 3' ' ' ILE . 76.9 m80 -87.88 91.85 8.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.342 -0.844 . . . . 1.93 109.455 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.31 152.49 23.48 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.38 0.609 . . . . 0.7 111.736 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.1 m -129.41 131.91 23.93 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.412 -0.958 . . . . 1.25 108.412 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 22.7 Cg_exo -63.27 151.81 83.01 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.112 2.541 . . . . 0.91 113.013 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.953 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 50.2 tptt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.202 -0.904 . . . . 2.61 109.346 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.851 -0.5 . . . . 1.6 111.851 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.541 HG12 ' HE3' ' A' ' 23' ' ' MET . 39.9 t -85.31 93.41 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.983 0.421 . . . . 1.73 110.476 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' A' ' 32' ' ' LYS . 6.4 tp -104.61 119.5 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.243 0.544 . . . . 1.92 110.473 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.589 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.8 pt -114.55 154.02 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.799 -0.637 . . . . 1.16 110.821 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.96 24.34 2.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.05 -0.523 . . . . 2.65 111.531 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.5 t -81.39 134.36 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.212 -0.662 . . . . 1.16 109.212 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.592 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -78.18 117.64 19.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.587 0.708 . . . . 1.81 109.551 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.592 ' N ' ' HD3' ' A' ' 7' ' ' LYS . 14.5 p -78.05 85.65 4.25 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.03 -0.986 . . . . 0.74 111.996 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' O ' HG22 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.39 -16.14 43.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.662 0.744 . . . . 3.08 109.425 172.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.614 HG13 ' HG2' ' A' ' 13' ' ' GLN . 4.0 pt -169.03 173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 113.583 -1.644 . . . . 1.38 106.927 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -74.8 -25.2 58.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.392 0.542 . . . . 0.75 110.302 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -63.47 -32.61 74.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.468 . . . . 4.39 111.073 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.614 ' HG2' HG13 ' A' ' 10' ' ' ILE . 17.4 mm100 -58.73 -30.8 67.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.254 0.55 . . . . 2.2 110.628 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.636 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 11.0 m -94.98 -44.58 7.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.076 -0.966 . . . . 1.18 111.078 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.856 HD23 ' HE2' ' A' ' 19' ' ' LYS . 42.2 tp -74.34 -24.59 59.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 1.98 112.261 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.578 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -62.69 -52.75 62.43 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.823 -0.351 . . . . 2.58 111.099 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.636 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 7.8 Cg_exo -74.34 -17.93 20.94 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.84 1.693 . . . . 0.77 112.099 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.767 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.6 m -82.48 -56.75 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.6 -0.44 . . . . 0.36 111.518 -176.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.856 ' HE2' HD23 ' A' ' 15' ' ' LEU . 42.0 mttm -57.18 -38.27 73.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.254 0.479 . . . . 2.09 110.811 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.94 -32.41 73.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.937 -0.574 . . . . 1.03 111.152 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 -11.91 37.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.446 -0.343 . . . . 1.15 111.243 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.76 45.67 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.746 -0.74 . . . . 0.81 112.987 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.767 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.1 mpt? -125.7 106.75 9.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.981 0.896 . . . . 2.48 110.455 170.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.752 ' HB2' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -47.22 -55.3 8.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.517 -1.674 . . . . 3.87 112.137 173.246 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 46.5 m-85 -99.34 158.93 15.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.912 0.387 . . . . 1.52 111.208 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.71 91.69 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.189 -1.164 . . . . 0.74 110.189 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -121.76 138.8 54.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.848 0.356 . . . . 3.34 110.502 -170.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.1 t -70.25 122.67 19.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.76 109.864 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.8 mmt -137.77 102.36 4.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.34 -0.391 . . . . 2.56 111.004 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 64.59 16.56 10.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.841 -0.618 . . . . 2.99 111.788 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.56 -22.48 11.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.631 -0.795 . . . . 0.9 112.366 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.683 ' HB3' HD12 ' A' ' 3' ' ' ILE . 62.9 mttp -102.66 161.61 13.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.139 0.495 . . . . 2.39 110.7 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.589 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 85.3 m -99.32 109.8 22.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.774 -0.648 . . . . 0.76 111.096 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.578 ' CD2' HD11 ' A' ' 3' ' ' ILE . 3.2 m-70 -92.23 103.81 16.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.56 -0.746 . . . . 1.93 110.582 177.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.47 149.96 29.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.384 0.611 . . . . 0.7 111.044 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 9.0 m -126.91 131.81 24.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.707 -0.849 . . . . 1.25 108.707 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.0 Cg_exo -59.85 143.47 99.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.298 2.665 . . . . 0.91 113.124 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.752 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 18.9 ttpt . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.094 -0.957 . . . . 2.61 110.134 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 112.294 -0.322 . . . . 1.6 112.294 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.488 HG22 ' SD ' ' A' ' 23' ' ' MET . 59.0 t -75.95 105.74 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.203 0.525 . . . . 1.73 110.803 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.0 116.93 50.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.313 -0.858 . . . . 1.92 109.562 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -113.41 147.58 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.076 0.465 . . . . 1.16 111.7 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -82.57 69.54 9.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.454 -0.794 . . . . 2.65 111.07 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.2 t -131.65 129.52 61.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.604 . . . . 1.16 109.573 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HE2' ' CA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -75.42 86.43 2.56 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 1.81 109.29 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.3 p -58.79 98.46 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.567 -1.197 . . . . 0.74 112.786 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 10' ' ' ILE . 38.4 mmtm -72.36 -11.96 60.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.328 -0.989 . . . . 3.08 108.328 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.2 pt -169.13 154.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 113.521 -1.672 . . . . 1.38 108.237 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 23.8 m -72.87 -30.63 64.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.356 0.598 . . . . 0.75 110.008 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -62.32 -25.66 68.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.215 -0.902 . . . . 4.39 112.558 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 14.7 pt20 -79.25 -19.88 49.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 2.2 110.312 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.608 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 8.5 m -96.68 -31.23 12.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.98 -0.555 . . . . 1.18 110.193 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.585 HD13 ' HZ3' ' A' ' 19' ' ' LYS . 56.9 tp -69.71 -36.59 76.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.055 -0.521 . . . . 1.98 112.154 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 39.9 tptt -53.7 -55.95 30.17 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 119.225 -0.417 . . . . 2.58 111.086 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 19.1 Cg_exo -67.31 -22.39 46.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.648 1.566 . . . . 0.77 112.249 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.765 ' HA ' ' HE3' ' A' ' 23' ' ' MET . 69.7 m -81.72 -56.03 4.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.798 -0.361 . . . . 0.36 111.952 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.585 ' HZ3' HD13 ' A' ' 15' ' ' LEU . 4.7 ttmp? -67.75 -26.27 66.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.299 0.5 . . . . 2.09 110.216 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.19 -34.21 77.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.696 -0.683 . . . . 1.03 109.926 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.18 -45.59 11.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.777 -0.647 . . . . 1.15 110.792 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.18 40.61 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.174 -0.536 . . . . 0.81 112.407 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.765 ' HE3' ' HA ' ' A' ' 18' ' ' CYS . 5.4 mpp? -124.59 103.44 8.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.249 0.547 . . . . 2.48 110.448 174.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.717 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 5.7 ptp180 -52.18 -33.83 42.48 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.232 -0.895 . . . . 3.87 112.485 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 33.1 m-85 -120.84 160.86 22.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.52 111.118 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -159.83 95.77 0.14 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.337 -1.105 . . . . 0.74 110.337 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 91.7 mttt -120.0 134.64 55.19 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 3.34 110.909 -171.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.7 t -74.34 123.54 24.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.018 -0.537 . . . . 0.76 109.995 176.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.446 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 24.7 mmt -126.16 96.37 4.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 2.56 110.727 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.2 t30 73.58 -62.7 0.46 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.724 -1.125 . . . . 2.99 112.034 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.95 -35.9 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.66 -0.781 . . . . 0.9 112.943 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -107.78 170.61 7.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.385 0.612 . . . . 2.39 110.429 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.524 ' HB2' HG12 ' A' ' 4' ' ' ILE . 15.3 m -94.87 125.89 39.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.153 -0.931 . . . . 0.76 110.018 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.446 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 11.9 m-70 -104.92 108.44 19.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.226 -0.657 . . . . 1.93 109.226 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.3 118.31 36.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.326 0.584 . . . . 0.7 111.493 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.0 m -80.53 130.14 66.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.174 -0.921 . . . . 1.25 108.937 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.5 Cg_exo -69.49 147.98 65.82 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.167 2.578 . . . . 0.91 112.508 -171.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.717 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.0 tttm . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.234 -0.894 . . . . 2.61 110.345 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.585 -0.606 . . . . 1.6 111.585 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.4 t -81.12 93.46 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.353 0.597 . . . . 1.73 110.431 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.871 HD12 ' HB3' ' A' ' 32' ' ' LYS . 6.9 tp -103.65 128.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.692 -0.686 . . . . 1.92 110.733 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.571 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 24.3 pt -121.0 143.49 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.599 -0.519 . . . . 1.16 109.599 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -83.32 14.32 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.836 0.31 . . . . 2.65 111.836 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.24 126.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.0 -0.741 . . . . 1.16 109.0 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.551 ' HE3' ' HA3' ' A' ' 31' ' ' GLY . 2.7 tmtp? -70.95 111.86 6.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.483 0.658 . . . . 1.81 109.81 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 11.8 p -76.94 93.36 3.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.102 -0.954 . . . . 0.74 111.547 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.541 ' O ' HG22 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -61.81 -14.21 31.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.404 0.621 . . . . 3.08 110.036 173.47 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.736 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -171.46 164.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 125.641 1.576 . . . . 1.38 107.577 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -62.03 -38.48 88.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.254 0.479 . . . . 0.75 111.006 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.41 -24.02 64.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.215 0.45 . . . . 4.39 112.215 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.736 ' HG2' HG13 ' A' ' 10' ' ' ILE . 15.7 mm100 -62.52 -30.54 71.37 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.2 0.524 . . . . 2.2 110.691 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 m -101.39 -40.08 7.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.777 -0.647 . . . . 1.18 111.17 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.796 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.4 tt -78.6 -23.69 45.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.286 -0.416 . . . . 1.98 111.614 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 11.1 tmtt? -56.4 -55.1 46.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.619 -0.511 . . . . 2.58 109.619 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 85.5 Cg_endo -77.87 -19.73 12.31 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.207 1.271 . . . . 0.77 112.227 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.796 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 1.2 m -71.42 -56.9 5.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.87 -0.332 . . . . 0.36 110.878 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 38.6 ttmt -64.1 -33.41 75.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.203 -0.295 . . . . 2.09 110.203 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.8 -39.33 84.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 1.03 110.554 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.78 0.69 54.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.015 -0.539 . . . . 1.15 111.39 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.91 53.7 1.88 Allowed Glycine 0 CA--C 1.506 -0.485 0 C-N-CA 120.941 -0.647 . . . . 0.81 112.43 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 17.0 mmt -131.31 97.4 4.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.664 -0.865 . . . . 2.48 108.664 172.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.72 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 6.0 ttt85 -55.54 -37.74 68.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.092 . . . . 3.87 111.454 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 71.6 m-85 -106.29 149.0 27.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.785 0.326 . . . . 1.52 110.613 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.578 ' HA2' ' HG ' ' A' ' 15' ' ' LEU . . . -165.07 72.3 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.221 -1.152 . . . . 0.74 110.221 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.95 135.01 44.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.137 0.494 . . . . 3.34 110.857 -168.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.6 t -78.48 121.77 24.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.76 110.264 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.492 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 21.7 mmt -138.26 106.43 5.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.516 -0.311 . . . . 2.56 111.556 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.7 m120 62.46 13.7 6.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.61 -0.723 . . . . 2.99 112.188 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.551 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 123.47 -32.68 4.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.492 -0.861 . . . . 0.9 112.634 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.871 ' HB3' HD12 ' A' ' 3' ' ' ILE . 10.9 mptt -94.47 157.71 15.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.283 0.563 . . . . 2.39 111.489 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.571 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 45.4 m -96.85 110.41 22.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.207 -0.906 . . . . 0.76 110.479 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.492 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 19.0 m-70 -92.76 95.39 9.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.01 -0.541 . . . . 1.93 110.399 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.73 147.74 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.455 0.645 . . . . 0.7 111.352 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 13.4 m -129.45 129.62 23.24 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.506 -0.924 . . . . 1.25 108.506 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 58.1 Cg_exo -51.39 148.82 18.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.384 2.722 . . . . 0.91 112.804 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.72 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.3 tptm . . . . . 0 C--O 1.248 1.007 0 O-C-N 124.082 0.864 . . . . 2.61 111.669 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.378 0.609 . . . . 1.1599999999999999 110.318 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.611 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -94.48 124.1 46.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.577 -0.738 . . . . 1.48 110.341 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.593 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 27.5 pt -103.39 142.53 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.158 -0.474 . . . . 0.51000000000000001 109.962 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.819 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 24.6 p-10 -84.0 24.41 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 1.9199999999999999 111.627 -174.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -76.03 135.6 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.727 -0.472 . . . . 0.46000000000000002 109.727 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -63.37 105.91 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.467 0.651 . . . . 1.28 110.615 177.265 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 11.0 p -79.24 83.77 5.25 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.059 -0.973 . . . . 0.73999999999999999 111.26 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.71 -18.5 65.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 2.6200000000000001 108.41 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 pt -162.8 146.39 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.499 -1.682 . . . . 0.78000000000000003 108.025 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.97 -28.4 64.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.925 0.343 . . . . 0.40000000000000002 111.925 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -64.8 -29.04 69.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.86 0.318 . . . . 3.7400000000000002 111.86 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.8 pt20 -74.6 -20.14 60.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.106 0.479 . . . . 2.2000000000000002 110.256 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 25.7 m -92.25 -41.73 10.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.888 -0.596 . . . . 1.1799999999999999 110.077 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.3 tp -69.24 -33.99 74.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 1.3100000000000001 112.365 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 6.9 tmtm? -55.85 -56.92 25.05 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 119.501 -0.285 . . . . 2.1299999999999999 110.604 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 73.5 Cg_endo -72.91 -20.49 22.2 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.414 1.409 . . . . 0.53000000000000003 112.714 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.763 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 59.5 m -77.98 -50.58 11.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.804 -0.358 . . . . 0.35999999999999999 110.956 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -65.79 -21.27 66.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 1.6499999999999999 110.172 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.8 -19.9 43.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.666 -0.697 . . . . 1.03 110.54 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.08 -30.19 12.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.69999999999999996 110.977 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.79 45.82 0.1 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.151 -0.547 . . . . 0.81000000000000005 112.106 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.763 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -130.95 106.63 8.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.042 0.448 . . . . 2.0699999999999998 110.021 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.913 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -65.45 -27.32 68.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.667 -0.697 . . . . 3.3599999999999999 111.869 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.561 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 60.5 m-85 -117.91 157.7 26.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 1.26 110.686 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.33 88.65 0.11 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.692 -0.963 . . . . 0.73999999999999999 110.692 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -116.86 134.76 54.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.882 0.372 . . . . 2.9100000000000001 110.686 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 13.9 t -74.14 120.84 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.081 -0.508 . . . . 0.76000000000000001 110.832 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 85.4 mmm -138.66 116.67 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 2.0800000000000001 111.177 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.22 12.09 5.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.1 0.56 . . . . 2.6899999999999999 112.458 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.21 -17.05 22.1 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.718 . . . . 0.48999999999999999 112.334 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.819 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 13.8 mptt -103.72 156.29 17.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 1.9099999999999999 110.957 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.593 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 59.7 m -93.06 109.88 21.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.781 -0.645 . . . . 0.76000000000000001 109.494 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.611 ' HA ' HG13 ' A' ' 3' ' ' ILE . 1.5 m80 -87.7 95.7 10.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.871 -0.604 . . . . 1.28 110.18 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB3' ' HG2' ' A' ' 23' ' ' MET . 74.4 m -100.43 110.29 22.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.591 0.71 . . . . 0.53000000000000003 110.914 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.6 m -89.95 129.59 45.65 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.389 -0.823 . . . . 0.56000000000000005 109.065 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -54.36 149.64 36.88 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.674 2.916 . . . . 0.76000000000000001 113.984 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.913 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 27.8 tptp . . . . . 0 C--O 1.242 0.698 0 CA-C-N 115.248 -0.887 . . . . 2.1899999999999999 110.114 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 121.323 0.582 . . . . 1.1599999999999999 110.348 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.8 mm -83.43 109.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 1.48 110.137 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.5 pt -99.59 130.6 48.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.051 0.453 . . . . 0.51000000000000001 110.932 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.47 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 19.7 m-20 -74.53 63.79 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.482 -0.781 . . . . 1.9199999999999999 111.13 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.64 134.13 59.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.705 -0.68 . . . . 0.46000000000000002 109.513 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.668 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -64.86 106.7 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 1.28 110.781 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.896 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 21.1 p -85.96 83.23 7.85 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.893 -0.594 . . . . 0.73999999999999999 110.568 173.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -61.97 -19.24 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.55 -0.907 . . . . 2.6200000000000001 108.55 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.517 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 10.2 pt -160.52 164.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 113.37 -1.741 . . . . 0.78000000000000003 107.032 174.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -61.98 -33.38 74.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.686 0.675 . . . . 0.40000000000000002 111.391 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -57.67 -31.9 66.79 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.294 -0.412 . . . . 3.7400000000000002 111.834 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.517 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 15.9 mm100 -62.87 -26.37 68.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.869 0.366 . . . . 2.2000000000000002 111.302 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.896 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.5 m -95.27 -46.08 6.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.055 -0.521 . . . . 1.1799999999999999 111.347 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.002 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.2 tt -73.89 -24.42 59.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.293 0.479 . . . . 1.3100000000000001 112.293 -166.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 38.0 tptt -61.22 -57.84 23.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.295 -0.962 . . . . 2.1299999999999999 109.63 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.5 Cg_exo -59.33 -33.96 97.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.437 1.425 . . . . 0.53000000000000003 111.956 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.002 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 12.0 m -64.27 -63.03 1.25 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.35999999999999999 111.506 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.18 -32.25 72.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.385 0.539 . . . . 1.6499999999999999 111.052 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.39 -40.47 97.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.054 -0.521 . . . . 1.03 110.936 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.44 -26.47 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.128 0.49 . . . . 0.69999999999999996 111.0 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.61 65.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.841 -0.618 . . . . 0.81000000000000005 112.232 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.682 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 15.6 mmt -135.68 104.34 5.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.858 -0.793 . . . . 2.0699999999999998 108.858 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.594 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.67 -28.27 69.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.593 -0.73 . . . . 3.3599999999999999 110.962 -177.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.1 m-85 -117.71 153.95 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.207 -0.294 . . . . 1.26 110.207 173.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.667 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -156.08 110.18 0.43 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.836 -0.697 . . . . 0.73999999999999999 111.849 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 9.5 mmtp -129.23 134.95 48.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.931 0.396 . . . . 2.9100000000000001 111.841 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 8.1 t -75.52 132.95 41.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.93 -0.577 . . . . 0.76000000000000001 109.615 174.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.2 mmt -134.36 80.88 1.88 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.962 -0.295 . . . . 2.0800000000000001 111.356 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 p30 62.87 -4.14 0.27 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.224 1.41 . . . . 2.6899999999999999 113.846 171.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -55.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.748 -0.739 . . . . 0.48999999999999999 111.722 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.4 mptm? -89.49 161.07 16.43 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.192 0.52 . . . . 1.9099999999999999 110.908 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 56.4 m -96.73 115.64 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.76000000000000001 109.905 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -97.24 93.15 6.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 1.28 109.808 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.554 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.7 m -112.69 127.02 56.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.042 -0.527 . . . . 0.53000000000000003 111.346 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 35.1 m -86.96 124.99 67.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.42 -0.809 . . . . 0.56000000000000005 109.07 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 50.0 Cg_exo -54.42 152.74 25.17 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.533 2.822 . . . . 0.76000000000000001 113.45 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.4 tptp . . . . . 0 C--O 1.242 0.688 0 CA-C-O 118.189 -0.91 . . . . 2.1899999999999999 111.038 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.167 0.508 . . . . 1.1599999999999999 110.238 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.827 HD11 ' HB3' ' A' ' 32' ' ' LYS . 7.0 tp -91.58 120.17 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.736 -0.666 . . . . 1.48 110.417 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 19.8 pt -102.6 136.54 34.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.041 0.448 . . . . 0.51000000000000001 110.734 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -79.91 64.95 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.702 -0.681 . . . . 1.9199999999999999 111.124 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -125.01 130.45 73.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.229 -0.896 . . . . 0.46000000000000002 109.477 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.7 107.44 3.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.052 -0.721 . . . . 1.28 109.052 178.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 11.5 p -78.18 91.29 4.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.943 -1.026 . . . . 0.73999999999999999 112.428 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HD3' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -70.3 -11.14 60.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.622 0.725 . . . . 2.6200000000000001 109.459 174.119 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.6 pt -165.83 145.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.055 -1.429 . . . . 0.78000000000000003 108.19 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.6 m -70.95 -24.46 62.44 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.816 -0.354 . . . . 0.40000000000000002 110.518 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.17 -34.45 78.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.836 0.31 . . . . 3.7400000000000002 111.836 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 16.3 pt20 -70.63 -20.42 62.73 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.194 0.521 . . . . 2.2000000000000002 110.119 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 12.5 m -94.98 -41.37 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.603 -0.726 . . . . 1.1799999999999999 110.237 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.679 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 1.6 tt -77.02 -37.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.844 -0.617 . . . . 1.3100000000000001 111.913 -171.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 27.0 tptp -50.46 -52.79 51.98 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-O 119.464 -0.303 . . . . 2.1299999999999999 111.411 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 6.9 Cg_exo -73.93 -20.47 19.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.643 1.562 . . . . 0.53000000000000003 112.505 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 37.4 m -83.39 -54.08 5.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.344 -0.543 . . . . 0.35999999999999999 111.821 -175.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.643 ' HE2' HD21 ' A' ' 15' ' ' LEU . 23.0 ttmm -63.77 -35.78 81.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.408 -0.517 . . . . 1.6499999999999999 110.334 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.94 -37.27 86.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.916 0.389 . . . . 1.03 110.184 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.03 0.85 46.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.69999999999999996 111.335 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.49 60.02 1.06 Allowed Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.937 -0.649 . . . . 0.81000000000000005 112.669 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 17.9 mmt -132.77 108.14 8.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.112 -0.699 . . . . 2.0699999999999998 109.112 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.467 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -60.69 -31.4 70.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.867 -1.06 . . . . 3.3599999999999999 110.983 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 51.1 m-85 -120.67 149.64 42.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.695 0.283 . . . . 1.26 111.072 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.679 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -158.48 78.27 0.18 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.695 -0.962 . . . . 0.73999999999999999 110.695 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -114.5 135.0 54.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.955 0.407 . . . . 2.9100000000000001 110.478 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 4.4 t -72.3 127.87 33.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.953 -0.567 . . . . 0.76000000000000001 109.751 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.48 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.472 -0.331 . . . . 2.0800000000000001 110.336 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 72.0 -66.42 0.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.223 0.952 . . . . 2.6899999999999999 112.432 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -126.18 -25.51 1.33 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.236 -0.983 . . . . 0.48999999999999999 113.23 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.827 ' HB3' HD11 ' A' ' 3' ' ' ILE . 35.2 mtmt -121.68 158.35 28.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.235 0.541 . . . . 1.9099999999999999 112.213 -170.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 56.8 m -93.91 109.02 20.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.299 -0.864 . . . . 0.76000000000000001 110.238 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -87.05 100.47 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 1.28 111.0 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -104.23 118.03 35.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.144 0.497 . . . . 0.53000000000000003 110.574 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.3 m -101.83 122.18 48.31 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.078 -0.712 . . . . 0.56000000000000005 109.078 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -51.94 147.21 26.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.385 2.723 . . . . 0.76000000000000001 113.484 -173.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 24.0 tptm . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.129 -0.941 . . . . 2.1899999999999999 111.281 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.812 HG23 ' HG3' ' A' ' 37' ' ' PRO . 47.1 t . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.175 0.512 . . . . 1.1599999999999999 110.469 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -115.24 109.63 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.88 -0.785 . . . . 1.48 108.88 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 33' ' ' CYS . 15.8 pt -123.51 134.62 65.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.07 0.462 . . . . 0.51000000000000001 111.464 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.735 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 m-20 -77.93 63.7 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.608 -0.724 . . . . 1.9199999999999999 110.475 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -115.35 124.03 71.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 0.46000000000000002 109.24 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.593 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -58.04 104.21 0.19 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.232 0.539 . . . . 1.28 110.172 175.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.653 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.6 p -89.87 87.27 6.88 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.781 -0.645 . . . . 0.73999999999999999 110.084 174.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 21.0 tptt -64.43 -13.03 49.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 2.6200000000000001 109.258 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.414 HG13 ' HG2' ' A' ' 13' ' ' GLN . 8.1 pt -154.65 159.41 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 113.782 -1.554 . . . . 0.78000000000000003 108.165 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 61.4 m -67.22 -19.87 65.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.81 0.338 . . . . 0.40000000000000002 111.217 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -59.29 -31.1 68.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.176 -0.465 . . . . 3.7400000000000002 110.879 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 10' ' ' ILE . 14.3 mm100 -67.58 -24.38 65.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.905 -0.589 . . . . 2.2000000000000002 110.676 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.1 m -92.57 -45.5 8.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.281 0.562 . . . . 1.1799999999999999 109.875 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.582 HD12 ' SD ' ' A' ' 23' ' ' MET . 11.4 tp -52.48 -51.38 59.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.877 -1.056 . . . . 1.3100000000000001 112.669 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 40.5 tptt -56.21 -59.73 11.02 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 119.01 -0.519 . . . . 2.1299999999999999 111.42 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.3 Cg_exo -57.83 -34.23 97.99 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.571 1.514 . . . . 0.53000000000000003 112.479 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.79 -54.46 6.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.35999999999999999 111.421 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 25.2 tttm -74.5 -17.95 60.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.71 0.291 . . . . 1.6499999999999999 110.829 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 5.4 t70 -68.3 -30.33 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.412 -0.588 . . . . 1.03 109.412 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.19 3.35 43.67 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.797 -0.638 . . . . 0.69999999999999996 110.544 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.712 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 100.11 105.01 2.66 Favored Glycine 0 CA--C 1.499 -0.919 0 CA-C-N 115.465 -0.789 . . . . 0.81000000000000005 111.435 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.582 ' SD ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -119.43 121.76 40.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.321 1.058 . . . . 2.0699999999999998 109.564 174.07 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.685 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -89.0 -29.2 19.67 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.051 -1.431 . . . . 3.3599999999999999 108.285 168.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.5 m-85 -140.02 151.52 45.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.136 -0.938 . . . . 1.26 109.347 170.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA3' ' SD ' ' A' ' 23' ' ' MET . . . -150.95 108.27 0.38 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.06 -0.591 . . . . 0.73999999999999999 111.807 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -129.41 138.7 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.169 0.509 . . . . 2.9100000000000001 112.0 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 7.8 t -87.24 132.49 33.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.014 -1.106 . . . . 0.76000000000000001 108.014 167.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 52.6 mtt -126.14 77.69 1.7 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.041 -0.664 . . . . 2.0800000000000001 111.208 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 70.97 -58.58 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.385 1.053 . . . . 2.6899999999999999 112.563 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.91 -47.08 0.21 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.958 -0.639 . . . . 0.48999999999999999 112.566 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.735 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.1 mptm? -107.46 164.43 12.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 1.9099999999999999 111.293 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.653 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -92.77 123.46 36.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.36 -0.836 . . . . 0.76000000000000001 110.365 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.41 98.04 5.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 1.28 109.613 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' HB ' ' A' ' 2' ' ' VAL . 7.6 p -121.13 159.22 26.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.036 -0.529 . . . . 0.53000000000000003 110.902 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 24.2 m -112.65 113.37 50.48 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.588 -0.733 . . . . 0.56000000000000005 109.151 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.812 ' HG3' HG23 ' A' ' 2' ' ' VAL . 32.7 Cg_exo -58.98 152.73 56.29 Favored 'Trans proline' 0 CA--C 1.519 -0.238 0 C-N-CA 122.836 2.357 . . . . 0.76000000000000001 112.324 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.685 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 20.3 tptm . . . . . 0 C--O 1.246 0.906 0 CA-C-N 115.565 -0.743 . . . . 2.1899999999999999 110.619 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.449 -0.525 0 N-CA-C 109.375 -0.602 . . . . 1.1599999999999999 109.375 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.8 tp -88.07 110.42 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.855 0.836 . . . . 1.48 111.0 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.422 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -95.23 147.57 5.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.358 -0.837 . . . . 0.51000000000000001 110.679 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -84.42 14.11 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 1.9199999999999999 111.285 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.14 120.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.421 -0.585 . . . . 0.46000000000000002 109.421 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.682 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.8 tmtp? -67.73 115.95 7.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.973 -0.751 . . . . 1.28 108.973 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 28.5 p -77.16 82.96 3.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.525 -0.761 . . . . 0.73999999999999999 111.475 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 10' ' ' ILE . 13.8 mmmm -66.44 -17.58 64.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.744 0.783 . . . . 2.6200000000000001 108.992 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.568 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.4 pt -166.04 148.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.86 -1.518 . . . . 0.78000000000000003 108.123 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -74.08 -19.72 60.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.868 0.366 . . . . 0.40000000000000002 110.897 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.9 mtp180 -54.58 -47.08 73.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 3.7400000000000002 110.731 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.6 pt20 -76.51 -4.15 41.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 2.2000000000000002 111.125 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 75.3 m -95.61 -58.15 2.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.074 -0.512 . . . . 1.1799999999999999 110.44 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.601 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -79.12 -31.74 44.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.638 0.607 . . . . 1.3100000000000001 112.638 -169.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -54.79 -50.75 84.19 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.654 -0.418 . . . . 2.1299999999999999 110.702 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 14.3 Cg_exo -71.59 -29.76 15.75 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.634 1.556 . . . . 0.53000000000000003 112.923 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.712 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 81.3 m -74.18 -52.17 13.28 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.446 -0.501 . . . . 0.35999999999999999 111.422 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.595 ' HA ' ' H ' ' A' ' 23' ' ' MET . 41.2 ttmt -65.77 -27.35 68.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.067 0.46 . . . . 1.6499999999999999 110.267 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.28 -28.42 69.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 1.03 110.082 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.52 5.51 41.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.69999999999999996 111.244 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.86 53.01 1.99 Allowed Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.88 -0.676 . . . . 0.81000000000000005 112.765 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.712 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 56.8 mtt -131.57 102.16 5.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.587 0.708 . . . . 2.0699999999999998 109.366 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.669 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 10.9 ttt180 -60.39 -27.21 67.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.169 -1.378 . . . . 3.3599999999999999 112.335 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.597 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.7 m-85 -117.62 163.3 16.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.852 0.358 . . . . 1.26 110.867 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.601 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -178.6 74.24 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.999 -0.841 . . . . 0.73999999999999999 110.999 -177.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -104.16 133.69 48.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.664 -0.268 . . . . 2.9100000000000001 110.469 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.2 t -70.42 126.84 30.78 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.881 -0.414 . . . . 0.76000000000000001 109.881 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.8 mmm -137.39 103.52 5.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 2.0800000000000001 110.261 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 72.7 -74.72 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.997 0.811 . . . . 2.6899999999999999 110.997 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.682 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . -146.15 4.7 1.18 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.913 -0.66 . . . . 0.48999999999999999 112.863 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.614 ' HB3' HD11 ' A' ' 3' ' ' ILE . 91.1 mttt -131.93 160.41 35.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.036 0.446 . . . . 1.9099999999999999 111.478 -176.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 66.8 m -96.86 113.17 24.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.76000000000000001 110.045 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -86.55 94.6 9.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 1.28 110.498 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.4 m -104.3 115.35 30.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.453 0.644 . . . . 0.53000000000000003 111.485 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.597 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 22.6 m -92.41 129.01 42.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.764 -0.828 . . . . 0.56000000000000005 108.764 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 37.8 Cg_exo -57.14 155.12 30.39 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.852 2.368 . . . . 0.76000000000000001 112.009 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.669 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 7.7 tptp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.078 -0.963 . . . . 2.1899999999999999 112.356 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.595 HG11 ' HE2' ' A' ' 23' ' ' MET . 43.1 t . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 121.095 0.474 . . . . 1.1599999999999999 110.034 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.16 109.51 28.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.75 -0.659 . . . . 1.48 110.494 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.1 pt -99.37 137.29 27.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.079 -0.51 . . . . 0.51000000000000001 109.812 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -81.42 33.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 1.9199999999999999 111.67 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.76 135.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.087 -1.079 . . . . 0.46000000000000002 108.087 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.561 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 1.8 tmtt? -77.76 115.43 17.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.729 -0.788 . . . . 1.28 110.242 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 10.2 p -73.02 85.98 1.31 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.462 -1.244 . . . . 0.73999999999999999 111.884 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.4 mptm? -66.76 -13.44 61.42 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.556 -0.715 . . . . 2.6200000000000001 109.352 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.643 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.2 pt -166.63 150.52 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.384 -1.28 . . . . 0.78000000000000003 108.587 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 50.4 m -63.7 -52.96 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.791 0.293 . . . . 0.40000000000000002 111.791 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 13.8 ptm180 -60.22 -19.47 54.56 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 3.7400000000000002 113.246 -173.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 11.4 pt20 -72.78 -25.43 61.16 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.201 -0.6 . . . . 2.2000000000000002 109.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 32.8 m -93.67 -34.64 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.895 -0.593 . . . . 1.1799999999999999 109.707 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 12' ' ' ARG . 59.0 tp -65.29 -41.27 94.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 1.3100000000000001 112.104 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 18.2 tptm -57.63 -52.04 77.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.329 -0.548 . . . . 2.1299999999999999 111.739 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 23.8 Cg_exo -65.43 -25.46 55.96 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.695 1.597 . . . . 0.53000000000000003 111.94 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.754 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 66.2 m -82.39 -52.42 6.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.619 -0.264 . . . . 0.35999999999999999 110.818 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HA ' ' H ' ' A' ' 23' ' ' MET . 70.2 tttt -64.03 -27.58 69.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.782 0.325 . . . . 1.6499999999999999 110.682 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.86 -45.78 90.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.058 -0.519 . . . . 1.03 110.035 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.83 61.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.69999999999999996 110.664 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.84 54.56 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.834 -0.621 . . . . 0.81000000000000005 112.16 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.754 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -130.95 105.09 7.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 2.0699999999999998 110.545 175.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.579 ' N ' ' HB2' ' A' ' 38' ' ' LYS . 8.3 ptm180 -55.59 -27.49 49.68 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.264 -0.88 . . . . 3.3599999999999999 112.698 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 26.9 m-85 -124.63 160.34 28.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 1.26 110.818 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.78 59.67 0.12 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.602 -0.999 . . . . 0.73999999999999999 110.602 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 97.1 mttt -98.41 152.58 19.34 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.19 0.519 . . . . 2.9100000000000001 110.609 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t -77.61 112.75 14.74 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.323 -0.853 . . . . 0.76000000000000001 110.528 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 62.4 mtt -137.99 125.74 22.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 2.0800000000000001 109.874 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 68.45 -4.72 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.13 0.49 . . . . 2.6899999999999999 111.674 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' HE2' ' A' ' 7' ' ' LYS . . . 114.47 -14.01 20.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.831 -0.7 . . . . 0.48999999999999999 112.137 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -102.24 159.74 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.799 0.333 . . . . 1.9099999999999999 110.504 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 56.8 m -91.13 95.62 10.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.02 -0.733 . . . . 0.76000000000000001 109.02 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -76.8 93.95 3.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.268 -0.878 . . . . 1.28 111.046 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 75.0 m -98.68 111.16 23.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.394 0.616 . . . . 0.53000000000000003 111.034 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.6 m -88.99 130.59 44.01 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.48 -0.933 . . . . 0.56000000000000005 108.48 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.729 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 3.1 Cg_exo -72.22 151.53 54.9 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.175 2.583 . . . . 0.76000000000000001 112.238 -170.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HB2' ' N ' ' A' ' 24' ' ' ARG . 50.1 tttm . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.36 -0.829 . . . . 2.1899999999999999 110.682 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.172 0.51 . . . . 1.1599999999999999 110.256 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 mm -104.76 121.76 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.003 -0.544 . . . . 1.48 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.563 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.7 pt -106.26 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.905 0.383 . . . . 0.51000000000000001 110.323 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.76 31.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 1.9199999999999999 112.112 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.17 139.29 17.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.938 -0.764 . . . . 0.46000000000000002 108.938 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.669 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.6 tmtp? -81.5 115.55 20.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.546 -0.539 . . . . 1.28 109.546 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.2 p -80.21 84.07 5.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.316 -0.856 . . . . 0.73999999999999999 112.584 -173.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -72.99 -11.52 60.6 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.119 -0.988 . . . . 2.6200000000000001 108.81 173.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.626 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.9 pt -169.67 139.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.915 -1.493 . . . . 0.78000000000000003 107.927 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -71.98 -17.12 62.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.651 0.262 . . . . 0.40000000000000002 111.616 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -68.64 -33.7 74.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.745 0.307 . . . . 3.7400000000000002 110.918 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 3.4 pt20 -75.98 -20.48 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.027 0.442 . . . . 2.2000000000000002 110.364 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 57.4 m -88.83 -33.66 17.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.896 -0.593 . . . . 1.1799999999999999 110.461 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.809 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -83.85 -25.36 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.149 -0.478 . . . . 1.3100000000000001 112.062 -172.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 28.0 tptp -56.21 -49.37 93.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.4 -0.52 . . . . 2.1299999999999999 110.907 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 8.6 Cg_exo -73.95 -31.84 7.7 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.829 1.686 . . . . 0.53000000000000003 112.67 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 75.8 m -75.0 -52.19 11.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.291 -0.563 . . . . 0.35999999999999999 111.303 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 1.7 tmtp? -61.95 -35.01 77.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.022 0.439 . . . . 1.6499999999999999 110.355 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.85 -27.85 69.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.769 -0.65 . . . . 1.03 110.788 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' A' ' 23' ' ' MET . . . -96.55 1.06 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 0.69999999999999996 111.342 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.82 46.67 2.64 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.557 -0.83 . . . . 0.81000000000000005 112.849 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.753 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mpp? -123.05 104.46 9.23 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.573 0.702 . . . . 2.0699999999999998 109.634 171.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.888 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -56.81 -35.81 69.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.328 -1.305 . . . . 3.3599999999999999 111.681 -179.126 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 25.1 m-85 -110.25 163.25 13.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.252 0.549 . . . . 1.26 111.617 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.809 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -167.45 57.8 0.22 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.103 -1.199 . . . . 0.73999999999999999 110.103 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -85.98 134.53 33.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.304 -0.448 . . . . 2.9100000000000001 110.995 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 15.3 t -69.6 117.99 11.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.762 -0.654 . . . . 0.76000000000000001 109.719 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.24 109.96 7.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.245 -0.434 . . . . 2.0800000000000001 111.265 -175.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.64 21.46 10.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.088 -0.505 . . . . 2.6899999999999999 111.698 172.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.669 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 113.18 -26.36 10.49 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.785 -0.721 . . . . 0.48999999999999999 112.77 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -101.77 158.93 15.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.948 0.404 . . . . 1.9099999999999999 110.798 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.563 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 23.7 m -93.48 107.98 19.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.341 -0.614 . . . . 0.76000000000000001 109.341 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.32 95.34 10.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.732 -0.667 . . . . 1.28 110.158 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.1 m -98.81 119.26 37.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.578 . . . . 0.53000000000000003 111.098 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 11.8 m -94.81 124.61 54.09 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 0.56000000000000005 109.108 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 12.9 Cg_endo -56.22 144.56 80.91 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.892 2.395 . . . . 0.76000000000000001 112.503 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.888 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tptp . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.512 -0.767 . . . . 2.1899999999999999 111.159 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.927 ' HB ' ' HB2' ' A' ' 35' ' ' CYS . 31.9 t . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.171 0.51 . . . . 1.1599999999999999 109.675 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.86 109.25 24.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.909 -0.587 . . . . 1.48 109.778 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.476 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 21.7 pt -108.4 147.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.167 -0.469 . . . . 0.51000000000000001 110.96 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -83.51 28.12 0.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 1.9199999999999999 111.398 -176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.56 132.65 31.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.603 -0.888 . . . . 0.46000000000000002 108.603 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.613 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -73.08 114.36 11.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.101 -0.703 . . . . 1.28 109.101 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.3 p -74.94 82.72 2.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.594 0.712 . . . . 0.73999999999999999 110.85 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 10' ' ' ILE . 12.4 tptm -79.96 -2.56 44.43 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.505 -0.924 . . . . 2.6200000000000001 108.505 175.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 9' ' ' LYS . 4.8 pt -174.7 142.72 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 113.18 -1.827 . . . . 0.78000000000000003 107.228 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -72.56 -20.7 61.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.531 0.205 . . . . 0.40000000000000002 111.035 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -62.59 -38.78 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 3.7400000000000002 111.504 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 14.6 pt20 -75.29 -14.02 60.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.278 0.561 . . . . 2.2000000000000002 110.285 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 56.5 m -88.47 -37.98 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 1.1799999999999999 109.385 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.635 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -75.21 -43.68 50.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.491 -1.231 . . . . 1.3100000000000001 112.709 -170.435 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 48.9 tptt -55.47 -52.12 74.41 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.708 -0.397 . . . . 2.1299999999999999 111.768 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 20.6 Cg_exo -67.45 -36.27 20.75 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.658 1.572 . . . . 0.53000000000000003 112.203 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.611 ' HB2' ' HE3' ' A' ' 23' ' ' MET . 87.2 m -79.16 -43.84 23.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.669 -0.413 . . . . 0.35999999999999999 111.641 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 21.4 ttmm -70.65 -30.07 66.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.258 -0.177 . . . . 1.6499999999999999 110.706 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.61 -36.55 84.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 1.03 109.882 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -41.1 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.671 . . . . 0.69999999999999996 111.124 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 157.03 85.87 0.05 OUTLIER Glycine 0 CA--C 1.508 -0.4 0 N-CA-C 111.633 -0.587 . . . . 0.81000000000000005 111.633 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . 1.017 ' HE1' ' HA3' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -141.51 121.56 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.172 0.987 . . . . 2.0699999999999998 110.166 176.303 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.6 -26.2 18.82 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.156 -1.384 . . . . 3.3599999999999999 109.59 174.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.554 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.4 m-85 -141.78 164.02 31.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.355 -0.384 . . . . 1.26 110.36 171.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 1.017 ' HA3' ' HE1' ' A' ' 23' ' ' MET . . . -165.85 118.05 0.78 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 121.089 -0.576 . . . . 0.73999999999999999 111.709 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -129.23 139.68 51.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.93 0.395 . . . . 2.9100000000000001 110.828 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.0 t -68.79 123.33 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 0.76000000000000001 109.563 170.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 66.1 mtt -137.11 118.01 14.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.728 -0.214 . . . . 2.0800000000000001 110.921 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 43.01 37.41 1.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.215 0.947 . . . . 2.6899999999999999 113.243 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.613 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 108.93 -27.98 12.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.049 -0.596 . . . . 0.48999999999999999 112.916 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -107.28 159.06 16.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.357 0.598 . . . . 1.9099999999999999 111.432 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 80.9 m -92.6 107.35 19.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.54 -0.755 . . . . 0.76000000000000001 109.791 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -88.54 98.12 11.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.638 -0.71 . . . . 1.28 109.835 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.927 ' HB2' ' HB ' ' A' ' 2' ' ' VAL . 33.4 m -100.13 113.14 25.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.669 -0.696 . . . . 0.53000000000000003 110.944 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.2 m -78.69 112.98 30.99 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.552 -0.749 . . . . 0.56000000000000005 109.325 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.61 ' HG3' HG23 ' A' ' 2' ' ' VAL . 30.3 Cg_exo -60.21 147.1 94.76 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.479 2.119 . . . . 0.76000000000000001 112.191 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 4.3 mmmp? . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.589 -0.72 . . . . 2.1899999999999999 111.058 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.41 HG21 ' CE ' ' A' ' 23' ' ' MET . 2.4 m . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.847 0.832 . . . . 1.1599999999999999 111.365 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -101.44 118.06 47.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.96 . . . . 1.48 109.086 176.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 33' ' ' CYS . 18.4 pt -101.88 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.057 0.456 . . . . 0.51000000000000001 111.379 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.1 39.9 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 1.9199999999999999 111.827 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.07 134.36 44.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.372 -0.603 . . . . 0.46000000000000002 109.372 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.735 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 2.5 tmtp? -78.35 109.36 12.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.475 0.655 . . . . 1.28 109.832 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -80.49 98.26 7.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.172 -0.922 . . . . 0.73999999999999999 111.841 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -66.45 -12.07 55.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.623 0.725 . . . . 2.6200000000000001 109.824 172.424 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.673 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 11.9 pt -163.61 163.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.139 -1.391 . . . . 0.78000000000000003 107.473 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 44.6 m -67.18 -39.82 86.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 118.474 0.579 . . . . 0.40000000000000002 110.81 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -62.0 -19.5 62.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.813 -0.631 . . . . 3.7400000000000002 112.326 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.673 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 11.9 mm100 -54.95 -35.94 64.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.849 0.356 . . . . 2.2000000000000002 110.879 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -113.66 -18.87 11.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.093 -0.503 . . . . 1.1799999999999999 111.871 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.49 -34.07 76.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.147 -0.621 . . . . 1.3100000000000001 110.981 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -59.81 -56.39 36.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.835 -0.346 . . . . 2.1299999999999999 110.468 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -66.06 -25.89 51.01 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.727 1.618 . . . . 0.53000000000000003 112.65 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.6 m -79.19 -56.31 4.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.725 -0.39 . . . . 0.35999999999999999 111.495 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.588 ' HA ' ' H ' ' A' ' 23' ' ' MET . 73.8 tttt -65.92 -26.61 67.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.372 -0.205 . . . . 1.6499999999999999 111.064 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -65.39 -35.95 82.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 1.03 110.451 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.63 -13.27 58.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 0.69999999999999996 110.881 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 64.94 0.6 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.57 -0.612 . . . . 0.81000000000000005 111.57 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.717 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 46.8 mtt -141.13 110.79 6.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.675 0.75 . . . . 2.0699999999999998 110.152 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.79 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 6.4 ptp180 -65.19 -21.24 66.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.579 -1.191 . . . . 3.3599999999999999 112.176 -175.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 47.9 m-85 -128.39 148.07 50.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.043 0.449 . . . . 1.26 110.826 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.05 62.64 0.42 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 109.443 -1.463 . . . . 0.73999999999999999 109.443 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 27' ' ' LYS . 52.1 mtpt -91.1 134.9 34.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.067 0.461 . . . . 2.9100000000000001 111.066 -168.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 39.9 t -81.93 124.11 29.45 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.667 -0.697 . . . . 0.76000000000000001 109.874 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.483 ' HA ' ' CE ' ' A' ' 29' ' ' MET . 1.5 mmt -138.64 105.9 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 2.0800000000000001 111.162 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.05 20.94 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.804 -0.635 . . . . 2.6899999999999999 112.186 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.735 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 119.71 -31.09 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.5 -0.857 . . . . 0.48999999999999999 112.663 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -94.99 154.37 17.2 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.289 0.566 . . . . 1.9099999999999999 111.259 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -93.68 104.27 16.38 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.149 -0.932 . . . . 0.76000000000000001 109.803 176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.588 ' HA ' HG13 ' A' ' 3' ' ' ILE . 29.8 m80 -88.73 94.13 9.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.7 -0.682 . . . . 1.28 109.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.6 m -98.66 130.06 45.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.53000000000000003 110.617 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.7 m -108.36 129.86 23.5 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.139 -1.06 . . . . 0.56000000000000005 108.139 175.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.1 Cg_exo -62.41 155.86 55.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.065 2.51 . . . . 0.76000000000000001 112.396 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.79 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 17.1 mmmt . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.53 -0.748 . . . . 2.1899999999999999 110.53 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.1 t . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.629 0.728 . . . . 1.1599999999999999 111.004 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.876 HD11 ' HB3' ' A' ' 32' ' ' LYS . 2.8 tp -91.94 126.71 44.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.252 -0.885 . . . . 1.48 109.893 175.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 33' ' ' CYS . 28.6 pt -115.05 145.23 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.293 -0.412 . . . . 0.51000000000000001 111.367 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.26 69.36 6.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 1.9199999999999999 111.272 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.91 122.8 65.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.563 -0.532 . . . . 0.46000000000000002 109.563 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -69.29 96.33 0.85 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.492 0.663 . . . . 1.28 110.089 -177.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 8.8 p -80.57 100.49 8.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.24 -0.891 . . . . 0.73999999999999999 111.842 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 10' ' ' ILE . 3.3 mppt? -71.13 -8.1 51.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.171 -0.678 . . . . 2.6200000000000001 109.171 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.777 HG13 ' HG3' ' A' ' 13' ' ' GLN . 3.8 pt -168.58 154.41 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 114.063 -1.426 . . . . 0.78000000000000003 108.126 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.3 m -69.35 -22.23 63.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 0.40000000000000002 111.409 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.422 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.3 mpt_? -60.91 -36.29 78.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.264 -0.425 . . . . 3.7400000000000002 111.682 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.777 ' HG3' HG13 ' A' ' 10' ' ' ILE . 13.9 mt-30 -62.84 -27.63 69.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.5 . . . . 2.2000000000000002 110.56 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.8 m -88.29 -48.74 7.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.394 -0.821 . . . . 1.1799999999999999 111.261 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.7 tp -67.83 -34.08 76.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.003 -0.544 . . . . 1.3100000000000001 112.304 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 8.9 tmtt? -58.38 -58.42 19.13 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.295 -0.562 . . . . 2.1299999999999999 110.448 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 70.5 Cg_endo -70.63 -21.0 30.03 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.612 1.541 . . . . 0.53000000000000003 112.345 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 56.6 m -77.66 -58.63 3.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.629 -0.429 . . . . 0.35999999999999999 109.95 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HA ' ' H ' ' A' ' 23' ' ' MET . 44.9 tttm -60.08 -32.04 70.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.208 -0.451 . . . . 1.6499999999999999 110.637 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 13.9 t70 -56.22 -47.88 77.57 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 1.03 110.496 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.64 -29.23 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.695 . . . . 0.69999999999999996 111.071 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.4 0.11 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.494 -0.642 . . . . 0.81000000000000005 111.494 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.7 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 10.2 mmt -145.01 91.63 2.17 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.132 -1.062 . . . . 2.0699999999999998 108.132 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HG3' ' CD2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -50.39 -47.77 56.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.508 -1.224 . . . . 3.3599999999999999 111.524 -177.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.614 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 98.7 m-85 -99.27 147.3 25.32 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.687 -0.405 . . . . 1.26 110.084 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.88 95.07 0.13 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.708 -0.957 . . . . 0.73999999999999999 110.708 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -122.32 141.17 51.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.198 0.523 . . . . 2.9100000000000001 111.03 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.3 t -75.9 136.19 40.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.466 -0.788 . . . . 0.76000000000000001 110.324 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 32' ' ' LYS . 2.7 ppp? -137.87 100.54 4.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 2.0800000000000001 110.859 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 58.39 18.82 5.86 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.792 . . . . 2.6899999999999999 112.55 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.501 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 119.42 -5.56 13.11 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.576 -0.821 . . . . 0.48999999999999999 113.335 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.876 ' HB3' HD11 ' A' ' 3' ' ' ILE . 53.4 mtpt -120.36 168.62 11.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.045 0.422 . . . . 1.9099999999999999 111.243 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.55 ' HB2' HG12 ' A' ' 4' ' ' ILE . 59.0 m -111.66 102.84 11.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.76000000000000001 111.666 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.441 ' ND1' HD13 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -81.99 97.95 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 1.28 110.529 174.014 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.7 m -106.44 134.49 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.316 0.579 . . . . 0.53000000000000003 110.772 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 17.3 m -112.38 124.09 32.75 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.076 -0.712 . . . . 0.56000000000000005 109.076 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 53.1 Cg_exo -55.4 147.3 57.72 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.616 2.877 . . . . 0.76000000000000001 113.477 -170.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 13.9 tptp . . . . . 0 C--O 1.249 1.047 0 CA-C-N 114.89 -1.05 . . . . 2.1899999999999999 110.068 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 64.2 t . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.354 0.597 . . . . 1.1599999999999999 109.768 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 mm -100.28 121.42 51.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.448 -0.797 . . . . 1.48 110.005 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.508 HD11 ' SG ' ' A' ' 14' ' ' CYS . 24.8 pt -115.76 151.56 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.965 0.412 . . . . 0.51000000000000001 110.61 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.03 45.25 1.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 1.9199999999999999 111.686 -174.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -102.12 126.45 56.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.954 -0.758 . . . . 0.46000000000000002 108.954 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -68.67 120.33 14.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.731 0.777 . . . . 1.28 109.94 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 13.0 p -85.35 86.42 7.38 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.012 -0.995 . . . . 0.73999999999999999 111.734 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -55.96 -23.38 31.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.386 0.612 . . . . 2.6200000000000001 109.614 173.65 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.622 HG13 ' HG2' ' A' ' 13' ' ' GLN . 7.2 pt -164.06 167.52 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.98 -1.464 . . . . 0.78000000000000003 107.482 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.416 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 63.6 m -66.43 -36.93 84.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.295 0.498 . . . . 0.40000000000000002 110.741 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -57.15 -28.84 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.754 -0.657 . . . . 3.7400000000000002 111.828 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.622 ' HG2' HG13 ' A' ' 10' ' ' ILE . 85.6 mm-40 -55.72 -34.55 65.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 111.698 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.623 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 4.9 t -108.63 -21.66 12.6 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.449 -0.5 . . . . 1.1799999999999999 111.736 -176.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.559 HD21 ' HE3' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -74.47 -36.53 63.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.933 -0.707 . . . . 1.3100000000000001 111.369 -174.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.528 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -56.29 -49.46 93.2 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 120.327 -0.549 . . . . 2.1299999999999999 110.592 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.623 ' HD2' ' C ' ' A' ' 14' ' ' CYS . 21.5 Cg_exo -67.7 -35.96 20.4 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.81 1.674 . . . . 0.53000000000000003 112.851 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.759 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 34.2 m -71.14 -54.14 12.08 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.55 -0.46 . . . . 0.35999999999999999 111.713 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.572 ' HA ' ' H ' ' A' ' 23' ' ' MET . 38.2 ttmt -66.4 -25.9 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.833 -0.347 . . . . 1.6499999999999999 110.456 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.78 -33.08 71.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.046 -0.525 . . . . 1.03 110.206 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -6.09 56.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.69999999999999996 110.82 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.74 62.36 0.75 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.795 -0.717 . . . . 0.81000000000000005 112.424 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.759 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 10.0 mmt -138.3 111.99 8.27 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.082 -0.71 . . . . 2.0699999999999998 109.082 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 13.7 ptp180 -63.8 -22.81 67.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.552 -0.749 . . . . 3.3599999999999999 111.894 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.2 m-85 -130.14 155.69 45.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.26 110.953 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -164.62 92.6 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.847 -1.301 . . . . 0.73999999999999999 109.847 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 34.0 mmtp -123.19 147.89 46.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.187 0.517 . . . . 2.9100000000000001 111.46 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 40.2 t -81.25 127.29 32.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.431 -0.804 . . . . 0.76000000000000001 109.833 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.681 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 57.9 mtt -137.39 105.54 5.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.404 -0.591 . . . . 2.0800000000000001 109.404 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 71.04 -73.8 0.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 124.525 1.141 . . . . 2.6899999999999999 111.095 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.31 -33.23 0.13 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.84 -0.695 . . . . 0.48999999999999999 112.813 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 2.4 ptpt -100.35 164.46 11.92 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.473 0.654 . . . . 1.9099999999999999 111.672 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' SG ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -92.81 128.37 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.166 -0.925 . . . . 0.76000000000000001 109.26 177.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.681 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 34.2 m-70 -110.64 109.24 19.44 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.293 -0.867 . . . . 1.28 109.931 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -111.07 133.19 53.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.504 0.668 . . . . 0.53000000000000003 112.091 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.0 m -101.51 127.7 30.86 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.421 -0.955 . . . . 0.56000000000000005 108.421 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 16.9 Cg_exo -66.64 158.74 54.36 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.135 2.557 . . . . 0.76000000000000001 113.343 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 35.8 mmtt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.491 -0.766 . . . . 2.1899999999999999 110.322 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.14 0.495 . . . . 1.1599999999999999 110.143 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 mm -96.44 109.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.705 -0.68 . . . . 1.48 110.388 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.411 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.2 pt -99.72 147.19 7.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.373 -0.376 . . . . 0.51000000000000001 110.902 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.81 12.09 2.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.968 -0.56 . . . . 1.9199999999999999 112.128 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.67 128.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.107 -0.701 . . . . 0.46000000000000002 109.107 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.583 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 6.1 tmtt? -73.25 115.85 13.09 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.781 -0.822 . . . . 1.28 108.781 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 17.4 p -66.33 85.07 0.1 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.731 -1.122 . . . . 0.73999999999999999 111.644 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HB2' HD13 ' A' ' 10' ' ' ILE . 71.0 mmtt -58.89 -25.83 63.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.117 -0.697 . . . . 2.6200000000000001 109.117 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -168.77 152.47 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.545 -1.661 . . . . 0.78000000000000003 107.143 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.5 m -65.51 -28.33 69.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.482 -0.487 . . . . 0.40000000000000002 110.683 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -56.18 -34.41 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 3.7400000000000002 111.266 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.598 ' HG3' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -87.61 -14.53 39.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 2.2000000000000002 110.87 -173.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 57.2 m -89.26 -40.76 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.321 0.581 . . . . 1.1799999999999999 110.029 176.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 26' ' ' GLY . 61.2 tp -73.71 -27.87 61.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.68 -0.691 . . . . 1.3100000000000001 111.505 -175.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 25.6 tptp -55.05 -56.69 25.24 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.692 0.256 . . . . 2.1299999999999999 111.692 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 68.9 Cg_endo -74.54 -19.92 18.55 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.541 1.494 . . . . 0.53000000000000003 112.45 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.832 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 57.5 m -81.72 -56.69 3.83 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 121.082 -0.247 . . . . 0.35999999999999999 111.354 -176.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -62.35 -36.05 81.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.786 -0.366 . . . . 1.6499999999999999 110.547 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.31 -36.25 79.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 1.03 110.687 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.39 -35.09 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.69999999999999996 110.842 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.73 42.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.81000000000000005 112.586 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.832 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -126.29 98.07 5.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.463 -0.569 . . . . 2.0699999999999998 109.463 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.803 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -53.81 -34.83 60.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.987 . . . . 3.3599999999999999 112.123 -178.472 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 59.2 m-85 -109.21 144.31 37.48 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.104 -0.332 . . . . 1.26 110.104 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.419 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -158.06 75.39 0.21 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.325 -1.11 . . . . 0.73999999999999999 110.325 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -108.93 143.89 37.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 2.9100000000000001 111.288 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.3 t -71.95 125.62 27.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.859 -1.064 . . . . 0.76000000000000001 110.492 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.402 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 95.9 mmm -124.7 82.44 2.05 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.572 -0.529 . . . . 2.0800000000000001 109.572 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 73.75 -65.41 0.35 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.421 1.076 . . . . 2.6899999999999999 111.626 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -131.11 -39.8 0.25 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.65 -0.786 . . . . 0.48999999999999999 112.779 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.68 158.71 15.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.189 0.519 . . . . 1.9099999999999999 111.181 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 68.1 m -92.42 116.07 28.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.513 -0.767 . . . . 0.76000000000000001 109.119 174.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 12.2 m-70 -99.81 99.23 10.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.888 -0.412 . . . . 1.28 109.888 -177.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -101.07 135.48 42.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.53000000000000003 111.692 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 16.6 m -115.77 132.74 23.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.372 -0.831 . . . . 0.56000000000000005 109.012 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 51.0 Cg_exo -54.0 152.34 24.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.668 2.912 . . . . 0.76000000000000001 114.032 -172.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.803 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.245 0.858 0 CA-C-N 114.945 -1.025 . . . . 2.1899999999999999 110.921 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.182 0.515 . . . . 1.1599999999999999 110.129 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.789 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.1 tp -92.87 122.94 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.871 -0.604 . . . . 1.48 110.627 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.5 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 20.5 pt -110.95 142.05 24.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 0.51000000000000001 110.348 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -84.81 50.51 1.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.782 0.801 . . . . 1.9199999999999999 111.231 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.63 138.11 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.95 -1.023 . . . . 0.46000000000000002 108.293 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.513 ' C ' ' HD3' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -77.79 109.88 12.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 1.28 109.779 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.8 p -71.76 85.63 0.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.948 -1.023 . . . . 0.73999999999999999 111.768 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 10' ' ' ILE . 32.8 mmtp -55.84 -23.84 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 2.6200000000000001 108.986 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 8.9 pt -163.06 166.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.557 -1.656 . . . . 0.78000000000000003 107.097 175.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -66.44 -37.65 85.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.392 0.542 . . . . 0.40000000000000002 110.85 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -61.54 -19.81 62.54 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.094 -0.503 . . . . 3.7400000000000002 111.966 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.573 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 13.6 mm100 -58.38 -34.59 70.88 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.878 0.37 . . . . 2.2000000000000002 111.217 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 86.8 m -117.27 -25.32 7.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.162 -0.472 . . . . 1.1799999999999999 112.234 -173.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 26' ' ' GLY . 57.0 tp -64.37 -37.98 89.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.28 -0.568 . . . . 1.3100000000000001 111.418 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 25.8 tptp -58.8 -50.89 85.54 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 120.511 -0.475 . . . . 2.1299999999999999 111.419 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 33.4 Cg_exo -60.54 -40.41 56.76 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.82 1.68 . . . . 0.53000000000000003 112.563 170.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.8 m -70.83 -57.95 4.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.888 0.329 . . . . 0.35999999999999999 111.888 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 23' ' ' MET . 71.6 tttt -63.17 -28.38 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.827 0.346 . . . . 1.6499999999999999 110.81 -176.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.75 -31.76 71.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 1.03 109.843 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.67 2.79 52.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 0.69999999999999996 110.962 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.47 66.3 0.98 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 120.973 -0.632 . . . . 0.81000000000000005 112.027 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.804 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 61.0 mtt -145.6 108.69 4.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 2.0699999999999998 109.58 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -65.15 -18.72 65.54 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.421 -0.809 . . . . 3.3599999999999999 111.981 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.556 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.3 m-85 -134.27 149.32 50.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.232 0.539 . . . . 1.26 111.378 175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -153.23 79.64 0.19 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.0 -1.64 . . . . 0.73999999999999999 109.0 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -114.73 134.53 55.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.828 0.347 . . . . 2.9100000000000001 110.661 -163.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.5 t -74.45 121.92 22.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.838 -0.619 . . . . 0.76000000000000001 109.84 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 93.4 mmm -134.93 110.56 9.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 2.0800000000000001 110.633 -175.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 60.64 16.83 6.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 2.6899999999999999 112.438 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.38 -11.1 21.85 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.433 -0.889 . . . . 0.48999999999999999 113.142 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.789 ' HB3' HD11 ' A' ' 3' ' ' ILE . 67.4 mttm -116.79 160.16 21.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.081 0.467 . . . . 1.9099999999999999 110.928 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.5 m -93.88 103.91 16.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.697 -0.683 . . . . 0.76000000000000001 110.66 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.434 ' CE1' HD13 ' A' ' 3' ' ' ILE . 26.7 m80 -92.0 99.49 12.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.751 -0.659 . . . . 1.28 109.854 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -99.41 129.41 45.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.53000000000000003 110.777 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 8.7 m -104.77 126.47 31.14 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.598 -0.89 . . . . 0.56000000000000005 108.598 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.804 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 6.9 Cg_exo -71.74 156.1 57.63 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.129 2.553 . . . . 0.76000000000000001 113.037 -170.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.353 -0.832 . . . . 2.1899999999999999 110.427 174.429 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.477 HG11 ' HE2' ' A' ' 23' ' ' MET . 44.9 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.095 0.474 . . . . 1.1599999999999999 110.158 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mm -111.96 108.97 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.794 -0.639 . . . . 1.48 109.968 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 33' ' ' CYS . 28.0 pt -105.09 149.06 8.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.204 0.526 . . . . 0.51000000000000001 111.336 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -86.66 48.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 1.9199999999999999 111.515 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -112.1 125.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.72 -0.673 . . . . 0.46000000000000002 109.211 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.98 ' HE2' ' HA2' ' A' ' 31' ' ' GLY . 2.5 tmtt? -73.65 102.9 4.06 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.695 0.759 . . . . 1.28 109.721 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.854 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 7.5 p -68.35 106.22 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.794 -1.094 . . . . 0.73999999999999999 111.484 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.3 mppt? -72.71 -2.16 19.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 2.6200000000000001 110.008 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.902 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -178.74 168.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.787 1.635 . . . . 0.78000000000000003 108.534 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -67.54 -40.95 85.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.936 0.334 . . . . 0.40000000000000002 111.875 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -58.95 -27.45 65.33 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.097 0.406 . . . . 3.7400000000000002 112.097 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.902 ' HG2' HG13 ' A' ' 10' ' ' ILE . 16.1 mm100 -62.98 -23.84 67.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.071 0.462 . . . . 2.2000000000000002 110.858 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.854 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.2 m -102.19 -38.98 7.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.705 -0.679 . . . . 1.1799999999999999 110.719 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.34 -34.83 78.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 1.3100000000000001 111.707 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.571 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 32.8 tptt -57.59 -54.69 52.44 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 120.665 -0.414 . . . . 2.1299999999999999 111.273 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 18.8 Cg_exo -67.75 -29.36 35.75 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.74 1.626 . . . . 0.53000000000000003 112.313 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.772 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.3 m -76.62 -55.98 5.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 121.05 -0.26 . . . . 0.35999999999999999 111.239 -174.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -66.63 -22.29 66.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 1.6499999999999999 110.587 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.31 -37.39 83.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 1.03 110.638 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 -45.94 11.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.69999999999999996 110.819 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.57 59.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.821 -0.704 . . . . 0.81000000000000005 112.147 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.772 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -137.94 105.99 5.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.178 0.513 . . . . 2.0699999999999998 110.144 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.534 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 8.9 ptm180 -62.77 -25.7 68.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.365 -0.834 . . . . 3.3599999999999999 112.188 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 57.4 m-85 -126.5 151.83 47.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.699 0.285 . . . . 1.26 110.646 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.39 85.66 0.13 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.741 -0.944 . . . . 0.73999999999999999 110.741 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -108.32 135.1 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 2.9100000000000001 110.939 -173.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 t -76.8 131.11 38.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.813 -0.631 . . . . 0.76000000000000001 109.925 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 91.1 mmm -137.25 91.79 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.581 -0.282 . . . . 2.0800000000000001 111.659 -175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.72 19.82 8.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.715 0.635 . . . . 2.6899999999999999 112.715 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.98 ' HA2' ' HE2' ' A' ' 7' ' ' LYS . . . 134.92 -50.78 0.85 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.637 -0.792 . . . . 0.48999999999999999 112.438 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -88.6 156.79 18.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.466 0.651 . . . . 1.9099999999999999 111.636 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.596 ' HB2' HG12 ' A' ' 4' ' ' ILE . 65.3 m -94.05 117.95 30.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.821 -1.081 . . . . 0.76000000000000001 109.846 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -100.4 100.42 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.968 -0.56 . . . . 1.28 109.778 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -107.64 129.16 55.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.129 0.49 . . . . 0.53000000000000003 111.396 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.4 m -98.06 130.21 29.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.606 -0.887 . . . . 0.56000000000000005 108.606 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.8 Cg_exo -69.78 151.17 68.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.852 2.368 . . . . 0.76000000000000001 113.012 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 18.5 mmmt . . . . . 0 C--O 1.245 0.855 0 CA-C-N 115.207 -0.906 . . . . 2.1899999999999999 110.461 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.689 0.757 . . . . 1.1599999999999999 110.742 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.568 HG21 ' HD3' ' A' ' 32' ' ' LYS . 21.8 mm -105.59 109.64 28.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.155 -0.93 . . . . 1.48 109.803 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 29.7 pt -91.09 140.63 15.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.062 0.458 . . . . 0.51000000000000001 110.83 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -84.68 63.13 7.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.512 0.673 . . . . 1.9199999999999999 110.1 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.95 126.57 75.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.227 -0.897 . . . . 0.46000000000000002 109.513 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.629 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -55.53 102.57 0.07 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.058 0.456 . . . . 1.28 109.954 174.308 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.1 p -77.1 83.79 3.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.563 0.697 . . . . 0.73999999999999999 110.518 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 8.3 tptp -76.44 -5.95 49.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.561 -0.904 . . . . 2.6200000000000001 108.561 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.666 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.4 pt -167.59 144.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.329 -1.76 . . . . 0.78000000000000003 107.496 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.7 m -74.11 -20.33 60.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.831 0.348 . . . . 0.40000000000000002 110.52 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.37 -37.46 85.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 3.7400000000000002 111.223 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 18.2 pt20 -73.83 -14.78 61.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.947 0.403 . . . . 2.2000000000000002 110.674 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.567 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 35.3 m -97.29 -49.66 4.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 1.1799999999999999 110.721 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 26' ' ' GLY . 65.5 tp -69.97 -35.01 74.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.009 -0.541 . . . . 1.3100000000000001 112.343 -173.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.4 tppt? -58.65 -51.41 82.05 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.796 -0.362 . . . . 2.1299999999999999 111.261 -178.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 21.6 Cg_exo -67.5 -27.67 39.22 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.681 1.587 . . . . 0.53000000000000003 111.911 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.899 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 54.1 m -71.16 -51.3 25.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.946 -0.302 . . . . 0.35999999999999999 110.887 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HE3' HD11 ' A' ' 15' ' ' LEU . 84.9 mttt -64.92 -28.54 69.6 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.739 -0.601 . . . . 1.6499999999999999 111.007 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.43 -30.76 68.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 1.03 110.975 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.58 -42.85 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.268 -0.424 . . . . 0.69999999999999996 111.226 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.09 56.59 0.02 OUTLIER Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 111.479 -0.648 . . . . 0.81000000000000005 111.479 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.899 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.4 mpt? -137.71 109.07 6.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.255 -0.646 . . . . 2.0699999999999998 109.255 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.6 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -74.32 -26.67 60.31 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.27 -0.877 . . . . 3.3599999999999999 111.898 -175.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.5 m-85 -115.6 152.56 32.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.119 -0.326 . . . . 1.26 110.119 173.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -164.71 102.1 0.19 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.762 -0.935 . . . . 0.73999999999999999 110.762 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -127.83 134.49 49.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.668 0.27 . . . . 2.9100000000000001 110.496 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.3 t -73.92 127.73 33.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.76000000000000001 109.788 173.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -138.47 114.72 10.28 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.478 -0.564 . . . . 2.0800000000000001 109.478 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.4 -86.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.122 -0.945 . . . . 2.6899999999999999 111.83 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' HA2' ' NZ ' ' A' ' 7' ' ' LYS . . . -132.53 -6.01 3.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.393 -0.908 . . . . 0.48999999999999999 112.967 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.568 ' HD3' HG21 ' A' ' 3' ' ' ILE . 17.4 ptpt -121.6 160.86 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.312 0.577 . . . . 1.9099999999999999 111.453 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 39.9 m -99.52 105.96 17.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.329 -0.85 . . . . 0.76000000000000001 110.198 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -83.09 107.99 16.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.187 -0.46 . . . . 1.28 110.349 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -115.54 134.36 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.045 0.45 . . . . 0.53000000000000003 110.683 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 7.4 m -105.52 125.34 33.65 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.814 -0.81 . . . . 0.56000000000000005 108.814 176.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -53.32 146.91 38.46 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.278 2.652 . . . . 0.76000000000000001 113.525 -174.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.6 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 25.3 mmtp . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.15 -0.929 . . . . 2.1899999999999999 110.967 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.504 0.669 . . . . 1.1599999999999999 110.251 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.493 HD12 ' CG ' ' A' ' 34' ' ' HIS . 18.0 mm -89.44 115.65 29.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 1.48 109.758 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.29 147.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.808 0.337 . . . . 0.51000000000000001 111.099 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.57 19.2 3.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.956 -0.565 . . . . 1.9199999999999999 111.081 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.0 t -77.39 128.67 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.847 -0.797 . . . . 0.46000000000000002 108.847 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.1 tmtp? -71.08 106.58 3.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.343 0.592 . . . . 1.28 109.81 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 13' ' ' GLN . 19.5 p -77.22 91.36 3.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.605 -0.725 . . . . 0.73999999999999999 109.891 177.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 10' ' ' ILE . 15.3 tptp -66.25 -13.07 59.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.57 0.7 . . . . 2.6200000000000001 109.484 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.456 HG13 ' HG2' ' A' ' 13' ' ' GLN . 3.1 pt -162.62 170.01 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 114.121 -1.4 . . . . 0.78000000000000003 108.122 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.9 m -66.46 -26.95 67.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.58 0.627 . . . . 0.40000000000000002 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -50.06 -42.27 49.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.164 -0.471 . . . . 3.7400000000000002 110.548 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 80.4 mm-40 -73.73 -8.34 55.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.721 -0.672 . . . . 2.2000000000000002 111.231 -175.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.46 -52.63 3.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.317 0.579 . . . . 1.1799999999999999 110.008 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 tp -75.6 -37.94 59.42 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 1.3100000000000001 112.109 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 23.3 tptm -55.53 -52.47 71.56 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.861 0.319 . . . . 2.1299999999999999 111.861 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 12.3 Cg_exo -71.49 -30.74 14.73 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.551 1.501 . . . . 0.53000000000000003 112.046 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 31.4 m -80.51 -55.18 5.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.35999999999999999 111.63 -172.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HA ' ' H ' ' A' ' 23' ' ' MET . 56.4 tttm -61.46 -32.16 72.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 1.6499999999999999 110.701 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.47 -36.78 81.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.706 -0.679 . . . . 1.03 110.646 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -34.69 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.422 . . . . 0.69999999999999996 110.969 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.63 62.03 0.07 OUTLIER Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.465 -0.654 . . . . 0.81000000000000005 111.465 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.698 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 12.6 mmt -134.68 105.28 6.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.541 -0.911 . . . . 2.0699999999999998 108.541 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.656 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.88 -24.54 67.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.183 -0.917 . . . . 3.3599999999999999 112.222 -174.488 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.56 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.4 m-85 -125.44 154.26 42.25 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.401 -0.187 . . . . 1.26 110.752 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.69 96.83 0.15 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 111.471 -0.652 . . . . 0.73999999999999999 111.471 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -109.85 134.06 52.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.839 0.352 . . . . 2.9100000000000001 110.06 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.1 t -77.37 129.54 35.94 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.005 -0.543 . . . . 0.76000000000000001 109.635 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 58.3 mtt -129.89 98.19 4.71 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.53 -0.305 . . . . 2.0800000000000001 110.679 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.8 m120 69.61 -77.04 0.06 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.135 0.897 . . . . 2.6899999999999999 111.269 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.671 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . -135.67 -29.19 0.37 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.21 -0.519 . . . . 0.48999999999999999 112.211 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -95.35 153.34 17.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.329 0.585 . . . . 1.9099999999999999 111.077 -178.243 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.41 130.3 39.25 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.449 -0.796 . . . . 0.76000000000000001 109.946 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.493 ' CG ' HD12 ' A' ' 3' ' ' ILE . 14.4 m-70 -116.18 87.2 2.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.515 -0.766 . . . . 1.28 109.194 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 p -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.878 0.847 . . . . 0.53000000000000003 111.864 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.6 m -95.86 127.92 39.41 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.699 -1.137 . . . . 0.56000000000000005 108.974 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 31.2 Cg_exo -59.39 151.45 68.22 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.167 2.578 . . . . 0.76000000000000001 112.356 -173.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.249 1.045 0 CA-C-N 115.323 -0.853 . . . . 2.1899999999999999 111.083 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.064 0.459 . . . . 1.1599999999999999 110.335 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 34' ' ' HIS . 17.4 mm -98.34 121.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.602 -0.726 . . . . 1.48 110.029 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.59 HG12 ' HB2' ' A' ' 33' ' ' CYS . 27.1 pt -111.97 149.23 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.522 -0.308 . . . . 0.51000000000000001 110.236 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.69 14.56 5.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 1.9199999999999999 112.037 -172.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -65.12 123.47 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.631 -0.507 . . . . 0.46000000000000002 109.631 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -69.85 104.97 2.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.251 0.548 . . . . 1.28 109.832 -176.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.871 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 25.8 p -76.81 103.01 6.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 0.73999999999999999 111.113 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.65 -18.88 61.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.029 -0.73 . . . . 2.6200000000000001 109.029 172.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.587 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.0 pt -170.94 167.09 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 113.877 -1.511 . . . . 0.78000000000000003 108.208 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 48.8 m -64.39 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.14 0.427 . . . . 0.40000000000000002 110.969 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -52.38 -38.85 59.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.01 -0.541 . . . . 3.7400000000000002 110.934 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.587 ' HG2' HG13 ' A' ' 10' ' ' ILE . 87.8 mm-40 -67.11 -20.52 65.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 2.2000000000000002 112.159 -173.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.7 m -105.38 -35.57 7.47 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.536 0.569 . . . . 1.1799999999999999 112.536 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.662 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -80.89 -21.12 40.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.88 -0.728 . . . . 1.3100000000000001 111.683 -172.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 34.3 tptt -60.72 -54.62 52.86 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 119.955 -0.698 . . . . 2.1299999999999999 109.768 171.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 25.6 Cg_exo -64.75 -33.86 52.46 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.708 1.606 . . . . 0.53000000000000003 112.838 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 84.6 m -75.02 -52.82 10.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.566 -0.454 . . . . 0.35999999999999999 111.106 -176.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.551 ' HA ' ' H ' ' A' ' 23' ' ' MET . 44.8 tttm -64.67 -34.13 77.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.45 0.167 . . . . 1.6499999999999999 110.834 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.87 -35.33 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 1.03 110.63 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -6.23 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 0.69999999999999996 111.015 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 56.87 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.969 -0.634 . . . . 0.81000000000000005 112.494 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.747 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 63.6 mtt -128.59 114.66 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 2.0699999999999998 110.086 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.968 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 1.3 ptp180 -69.04 -23.57 64.08 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.926 -1.034 . . . . 3.3599999999999999 112.587 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 13.8 m-85 -127.27 155.78 42.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 1.26 111.331 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.662 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -167.36 85.43 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.916 -0.873 . . . . 0.73999999999999999 110.916 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -94.57 134.29 37.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.702 0.287 . . . . 2.9100000000000001 110.683 -176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 24.4 t -83.89 107.95 16.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.646 -0.501 . . . . 0.76000000000000001 109.646 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.449 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -139.87 131.61 27.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.533 -0.758 . . . . 2.0800000000000001 109.556 -176.432 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.489 ' OD1' ' HE2' ' A' ' 32' ' ' LYS . 26.5 t-20 69.48 0.97 3.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.439 0.638 . . . . 2.6899999999999999 111.058 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 95.39 4.05 61.11 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.903 -0.665 . . . . 0.48999999999999999 111.84 -174.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE2' ' OD1' ' A' ' 30' ' ' ASN . 56.6 mttm -112.17 156.78 21.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.048 0.452 . . . . 1.9099999999999999 110.828 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.59 ' HB2' HG12 ' A' ' 4' ' ' ILE . 30.9 m -92.5 97.69 10.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 0.76000000000000001 109.695 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.449 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 70.9 m-70 -87.88 91.85 8.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.342 -0.844 . . . . 1.28 109.455 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.31 152.49 23.48 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.38 0.609 . . . . 0.53000000000000003 111.736 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.1 m -129.41 131.91 23.93 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.412 -0.958 . . . . 0.56000000000000005 108.412 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 22.7 Cg_exo -63.27 151.81 83.01 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.112 2.541 . . . . 0.76000000000000001 113.013 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.968 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 50.2 tptt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.202 -0.904 . . . . 2.1899999999999999 109.346 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 C--O 1.235 0.3 0 CA-C-O 120.983 0.421 . . . . 1.1599999999999999 110.476 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.4 tp -104.61 119.5 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.243 0.544 . . . . 1.48 110.473 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.602 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.8 pt -114.55 154.02 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.799 -0.637 . . . . 0.51000000000000001 110.821 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.96 24.34 2.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.05 -0.523 . . . . 1.9199999999999999 111.531 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.5 t -81.39 134.36 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.212 -0.662 . . . . 0.46000000000000002 109.212 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -78.18 117.64 19.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.587 0.708 . . . . 1.28 109.551 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' N ' ' HD3' ' A' ' 7' ' ' LYS . 14.5 p -78.05 85.65 4.25 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.03 -0.986 . . . . 0.73999999999999999 111.996 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.39 -16.14 43.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.662 0.744 . . . . 2.6200000000000001 109.425 172.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.648 HG13 ' HG2' ' A' ' 13' ' ' GLN . 4.0 pt -169.03 173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 113.583 -1.644 . . . . 0.78000000000000003 106.927 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -74.8 -25.2 58.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.392 0.542 . . . . 0.40000000000000002 110.302 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -63.47 -32.61 74.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.468 . . . . 3.7400000000000002 111.073 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.648 ' HG2' HG13 ' A' ' 10' ' ' ILE . 17.4 mm100 -58.73 -30.8 67.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.254 0.55 . . . . 2.2000000000000002 110.628 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.638 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 11.0 m -94.98 -44.58 7.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.076 -0.966 . . . . 1.1799999999999999 111.078 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.89 HD21 ' HE2' ' A' ' 19' ' ' LYS . 42.2 tp -74.34 -24.59 59.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 1.3100000000000001 112.261 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -62.69 -52.75 62.43 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.823 -0.351 . . . . 2.1299999999999999 111.099 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 7.8 Cg_exo -74.34 -17.93 20.94 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.84 1.693 . . . . 0.53000000000000003 112.099 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.79 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.6 m -82.48 -56.75 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.6 -0.44 . . . . 0.35999999999999999 111.518 -176.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.89 ' HE2' HD21 ' A' ' 15' ' ' LEU . 42.0 mttm -57.18 -38.27 73.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.254 0.479 . . . . 1.6499999999999999 110.811 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.94 -32.41 73.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.937 -0.574 . . . . 1.03 111.152 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 -11.91 37.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.446 -0.343 . . . . 0.69999999999999996 111.243 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.76 45.67 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.746 -0.74 . . . . 0.81000000000000005 112.987 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.79 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.1 mpt? -125.7 106.75 9.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.981 0.896 . . . . 2.0699999999999998 110.455 170.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.747 ' HB2' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -47.22 -55.3 8.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.517 -1.674 . . . . 3.3599999999999999 112.137 173.246 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 46.5 m-85 -99.34 158.93 15.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.912 0.387 . . . . 1.26 111.208 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.71 91.69 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.189 -1.164 . . . . 0.73999999999999999 110.189 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -121.76 138.8 54.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.848 0.356 . . . . 2.9100000000000001 110.502 -170.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.1 t -70.25 122.67 19.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.76000000000000001 109.864 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.8 mmt -137.77 102.36 4.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.34 -0.391 . . . . 2.0800000000000001 111.004 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 64.59 16.56 10.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.841 -0.618 . . . . 2.6899999999999999 111.788 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.56 -22.48 11.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.631 -0.795 . . . . 0.48999999999999999 112.366 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.712 ' HB3' HD11 ' A' ' 3' ' ' ILE . 62.9 mttp -102.66 161.61 13.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.139 0.495 . . . . 1.9099999999999999 110.7 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.602 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 85.3 m -99.32 109.8 22.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.774 -0.648 . . . . 0.76000000000000001 111.096 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.408 ' CE1' HD13 ' A' ' 3' ' ' ILE . 4.9 m80 -92.23 103.81 16.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.56 -0.746 . . . . 1.28 110.582 177.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.47 149.96 29.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.384 0.611 . . . . 0.53000000000000003 111.044 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 9.0 m -126.91 131.81 24.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.707 -0.849 . . . . 0.56000000000000005 108.707 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.0 Cg_exo -59.85 143.47 99.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.298 2.665 . . . . 0.76000000000000001 113.124 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.747 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 18.9 ttpt . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.094 -0.957 . . . . 2.1899999999999999 110.134 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.485 HG21 ' SD ' ' A' ' 23' ' ' MET . 59.0 t . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.203 0.525 . . . . 1.1599999999999999 110.803 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.0 116.93 50.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.313 -0.858 . . . . 1.48 109.562 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.546 HG12 ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -113.41 147.58 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.076 0.465 . . . . 0.51000000000000001 111.7 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -82.57 69.54 9.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.454 -0.794 . . . . 1.9199999999999999 111.07 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.2 t -131.65 129.52 61.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.604 . . . . 0.46000000000000002 109.573 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -75.42 86.43 2.56 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 1.28 109.29 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.3 p -58.79 98.46 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.567 -1.197 . . . . 0.73999999999999999 112.786 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 10' ' ' ILE . 38.4 mmtm -72.36 -11.96 60.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.328 -0.989 . . . . 2.6200000000000001 108.328 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.537 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.2 pt -169.13 154.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 113.521 -1.672 . . . . 0.78000000000000003 108.237 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.507 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 23.8 m -72.87 -30.63 64.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.356 0.598 . . . . 0.40000000000000002 110.008 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -62.32 -25.66 68.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.215 -0.902 . . . . 3.7400000000000002 112.558 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 14.7 pt20 -79.25 -19.88 49.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 2.2000000000000002 110.312 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.613 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 8.5 m -96.68 -31.23 12.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.98 -0.555 . . . . 1.1799999999999999 110.193 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.512 HD11 ' HZ2' ' A' ' 19' ' ' LYS . 56.9 tp -69.71 -36.59 76.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.055 -0.521 . . . . 1.3100000000000001 112.154 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.505 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 39.9 tptt -53.7 -55.95 30.17 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 119.225 -0.417 . . . . 2.1299999999999999 111.086 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 19.1 Cg_exo -67.31 -22.39 46.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.648 1.566 . . . . 0.53000000000000003 112.249 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 69.7 m -81.72 -56.03 4.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.798 -0.361 . . . . 0.35999999999999999 111.952 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.512 ' HZ2' HD11 ' A' ' 15' ' ' LEU . 4.7 ttmp? -67.75 -26.27 66.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.299 0.5 . . . . 1.6499999999999999 110.216 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.19 -34.21 77.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.696 -0.683 . . . . 1.03 109.926 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.414 ' HB3' ' HE1' ' A' ' 23' ' ' MET . . . -85.18 -45.59 11.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.777 -0.647 . . . . 0.69999999999999996 110.792 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.18 40.61 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.174 -0.536 . . . . 0.81000000000000005 112.407 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.677 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 5.4 mpp? -124.59 103.44 8.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.249 0.547 . . . . 2.0699999999999998 110.448 174.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 5.7 ptp180 -52.18 -33.83 42.48 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.232 -0.895 . . . . 3.3599999999999999 112.485 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 33.1 m-85 -120.84 160.86 22.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.26 111.118 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -159.83 95.77 0.14 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.337 -1.105 . . . . 0.73999999999999999 110.337 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 91.7 mttt -120.0 134.64 55.19 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 2.9100000000000001 110.909 -171.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.7 t -74.34 123.54 24.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.018 -0.537 . . . . 0.76000000000000001 109.995 176.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.7 mmt -126.16 96.37 4.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 2.0800000000000001 110.727 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.2 t30 73.58 -62.7 0.46 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.724 -1.125 . . . . 2.6899999999999999 112.034 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.95 -35.9 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.66 -0.781 . . . . 0.48999999999999999 112.943 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -107.78 170.61 7.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.385 0.612 . . . . 1.9099999999999999 110.429 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.546 ' HB2' HG12 ' A' ' 4' ' ' ILE . 15.3 m -94.87 125.89 39.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.153 -0.931 . . . . 0.76000000000000001 110.018 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -104.92 108.44 19.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.226 -0.657 . . . . 1.28 109.226 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.3 118.31 36.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.326 0.584 . . . . 0.53000000000000003 111.493 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.0 m -80.53 130.14 66.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.174 -0.921 . . . . 0.56000000000000005 108.937 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.5 Cg_exo -69.49 147.98 65.82 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.167 2.578 . . . . 0.76000000000000001 112.508 -171.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.0 tttm . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.234 -0.894 . . . . 2.1899999999999999 110.345 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.353 0.597 . . . . 1.1599999999999999 110.431 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.896 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.9 tp -103.65 128.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.692 -0.686 . . . . 1.48 110.733 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.575 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 24.3 pt -121.0 143.49 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.599 -0.519 . . . . 0.51000000000000001 109.599 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -83.32 14.32 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.836 0.31 . . . . 1.9199999999999999 111.836 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.24 126.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.0 -0.741 . . . . 0.46000000000000002 109.0 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.582 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 2.7 tmtp? -70.95 111.86 6.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.483 0.658 . . . . 1.28 109.81 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 11.8 p -76.94 93.36 3.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.102 -0.954 . . . . 0.73999999999999999 111.547 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -61.81 -14.21 31.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.404 0.621 . . . . 2.6200000000000001 110.036 173.47 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.761 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -171.46 164.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 125.641 1.576 . . . . 0.78000000000000003 107.577 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -62.03 -38.48 88.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.254 0.479 . . . . 0.40000000000000002 111.006 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.41 -24.02 64.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.215 0.45 . . . . 3.7400000000000002 112.215 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.761 ' HG2' HG13 ' A' ' 10' ' ' ILE . 15.7 mm100 -62.52 -30.54 71.37 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.2 0.524 . . . . 2.2000000000000002 110.691 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 m -101.39 -40.08 7.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.777 -0.647 . . . . 1.1799999999999999 111.17 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.832 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.4 tt -78.6 -23.69 45.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.286 -0.416 . . . . 1.3100000000000001 111.614 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.497 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 11.1 tmtt? -56.4 -55.1 46.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.619 -0.511 . . . . 2.1299999999999999 109.619 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 85.5 Cg_endo -77.87 -19.73 12.31 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.207 1.271 . . . . 0.53000000000000003 112.227 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.832 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 1.2 m -71.42 -56.9 5.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.87 -0.332 . . . . 0.35999999999999999 110.878 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.587 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 38.6 ttmt -64.1 -33.41 75.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.203 -0.295 . . . . 1.6499999999999999 110.203 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.8 -39.33 84.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 1.03 110.554 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.78 0.69 54.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.015 -0.539 . . . . 0.69999999999999996 111.39 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.91 53.7 1.88 Allowed Glycine 0 CA--C 1.506 -0.485 0 C-N-CA 120.941 -0.647 . . . . 0.81000000000000005 112.43 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 17.0 mmt -131.31 97.4 4.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.664 -0.865 . . . . 2.0699999999999998 108.664 172.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.744 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 6.0 ttt85 -55.54 -37.74 68.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.092 . . . . 3.3599999999999999 111.454 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 71.6 m-85 -106.29 149.0 27.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.785 0.326 . . . . 1.26 110.613 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.578 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -165.07 72.3 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.221 -1.152 . . . . 0.73999999999999999 110.221 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.95 135.01 44.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.137 0.494 . . . . 2.9100000000000001 110.857 -168.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.6 t -78.48 121.77 24.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.76000000000000001 110.264 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.7 mmt -138.26 106.43 5.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.516 -0.311 . . . . 2.0800000000000001 111.556 -175.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.7 m120 62.46 13.7 6.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.61 -0.723 . . . . 2.6899999999999999 112.188 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.582 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 123.47 -32.68 4.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.492 -0.861 . . . . 0.48999999999999999 112.634 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.896 ' HB3' HD11 ' A' ' 3' ' ' ILE . 10.9 mptt -94.47 157.71 15.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.283 0.563 . . . . 1.9099999999999999 111.489 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.575 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 45.4 m -96.85 110.41 22.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.207 -0.906 . . . . 0.76000000000000001 110.479 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -92.76 95.39 9.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.01 -0.541 . . . . 1.28 110.399 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.73 147.74 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.455 0.645 . . . . 0.53000000000000003 111.352 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 13.4 m -129.45 129.62 23.24 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.506 -0.924 . . . . 0.56000000000000005 108.506 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 58.1 Cg_exo -51.39 148.82 18.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.384 2.722 . . . . 0.76000000000000001 112.804 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.744 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.3 tptm . . . . . 0 C--O 1.248 1.007 0 O-C-N 124.082 0.864 . . . . 2.1899999999999999 111.669 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 111.722 -0.551 . . . . 1.0900000000000001 111.722 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.9 t -92.53 93.35 4.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.378 0.609 . . . . 1.1599999999999999 110.318 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.611 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -94.48 124.1 46.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.577 -0.738 . . . . 1.48 110.341 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.593 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 27.5 pt -103.39 142.53 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.158 -0.474 . . . . 0.51000000000000001 109.962 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.819 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 24.6 p-10 -84.0 24.41 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 1.9199999999999999 111.627 -174.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -76.03 135.6 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.727 -0.472 . . . . 0.46000000000000002 109.727 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -63.37 105.91 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.467 0.651 . . . . 1.28 110.615 177.265 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 11.0 p -79.24 83.77 5.25 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.059 -0.973 . . . . 0.73999999999999999 111.26 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.71 -18.5 65.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 2.6200000000000001 108.41 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 pt -162.8 146.39 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.499 -1.682 . . . . 0.78000000000000003 108.025 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.97 -28.4 64.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.925 0.343 . . . . 0.40000000000000002 111.925 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -64.8 -29.04 69.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.86 0.318 . . . . 3.7400000000000002 111.86 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.8 pt20 -74.6 -20.14 60.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.106 0.479 . . . . 2.2000000000000002 110.256 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 25.7 m -92.25 -41.73 10.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.888 -0.596 . . . . 1.1799999999999999 110.077 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.3 tp -69.24 -33.99 74.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 1.3100000000000001 112.365 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 6.9 tmtm? -55.85 -56.92 25.05 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 119.501 -0.285 . . . . 2.1299999999999999 110.604 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 73.5 Cg_endo -72.91 -20.49 22.2 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.414 1.409 . . . . 0.53000000000000003 112.714 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.763 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 59.5 m -77.98 -50.58 11.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.804 -0.358 . . . . 0.35999999999999999 110.956 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -65.79 -21.27 66.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 1.6499999999999999 110.172 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.8 -19.9 43.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.666 -0.697 . . . . 1.03 110.54 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.08 -30.19 12.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.69999999999999996 110.977 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.79 45.82 0.1 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.151 -0.547 . . . . 0.81000000000000005 112.106 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.763 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -130.95 106.63 8.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.042 0.448 . . . . 2.0699999999999998 110.021 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.913 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -65.45 -27.32 68.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.667 -0.697 . . . . 3.3599999999999999 111.869 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.561 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 60.5 m-85 -117.91 157.7 26.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 1.26 110.686 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.33 88.65 0.11 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.692 -0.963 . . . . 0.73999999999999999 110.692 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -116.86 134.76 54.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.882 0.372 . . . . 2.9100000000000001 110.686 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 13.9 t -74.14 120.84 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.081 -0.508 . . . . 0.76000000000000001 110.832 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 85.4 mmm -138.66 116.67 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 2.0800000000000001 111.177 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.22 12.09 5.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.1 0.56 . . . . 2.6899999999999999 112.458 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.21 -17.05 22.1 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.718 . . . . 0.48999999999999999 112.334 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.819 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 13.8 mptt -103.72 156.29 17.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 1.9099999999999999 110.957 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.593 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 59.7 m -93.06 109.88 21.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.781 -0.645 . . . . 0.76000000000000001 109.494 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.611 ' HA ' HG13 ' A' ' 3' ' ' ILE . 1.5 m80 -87.7 95.7 10.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.871 -0.604 . . . . 1.28 110.18 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB3' ' HG2' ' A' ' 23' ' ' MET . 74.4 m -100.43 110.29 22.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.591 0.71 . . . . 0.53000000000000003 110.914 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.6 m -89.95 129.59 45.65 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.389 -0.823 . . . . 0.56000000000000005 109.065 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -54.36 149.64 36.88 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.674 2.916 . . . . 0.76000000000000001 113.984 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.913 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 27.8 tptp . . . . . 0 C--O 1.242 0.698 0 CA-C-N 115.248 -0.887 . . . . 2.1899999999999999 110.114 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 N-CA-C 111.444 -0.662 . . . . 1.0900000000000001 111.444 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.7 t -92.99 94.26 4.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.323 0.582 . . . . 1.1599999999999999 110.348 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.8 mm -83.43 109.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 1.48 110.137 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.5 pt -99.59 130.6 48.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.051 0.453 . . . . 0.51000000000000001 110.932 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.47 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 19.7 m-20 -74.53 63.79 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.482 -0.781 . . . . 1.9199999999999999 111.13 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.64 134.13 59.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.705 -0.68 . . . . 0.46000000000000002 109.513 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.668 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -64.86 106.7 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 1.28 110.781 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.896 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 21.1 p -85.96 83.23 7.85 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.893 -0.594 . . . . 0.73999999999999999 110.568 173.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -61.97 -19.24 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.55 -0.907 . . . . 2.6200000000000001 108.55 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.517 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 10.2 pt -160.52 164.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 113.37 -1.741 . . . . 0.78000000000000003 107.032 174.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -61.98 -33.38 74.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.686 0.675 . . . . 0.40000000000000002 111.391 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -57.67 -31.9 66.79 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.294 -0.412 . . . . 3.7400000000000002 111.834 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.517 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 15.9 mm100 -62.87 -26.37 68.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.869 0.366 . . . . 2.2000000000000002 111.302 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.896 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.5 m -95.27 -46.08 6.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.055 -0.521 . . . . 1.1799999999999999 111.347 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.002 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.2 tt -73.89 -24.42 59.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.293 0.479 . . . . 1.3100000000000001 112.293 -166.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 38.0 tptt -61.22 -57.84 23.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.295 -0.962 . . . . 2.1299999999999999 109.63 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.5 Cg_exo -59.33 -33.96 97.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.437 1.425 . . . . 0.53000000000000003 111.956 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.002 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 12.0 m -64.27 -63.03 1.25 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.35999999999999999 111.506 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.18 -32.25 72.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.385 0.539 . . . . 1.6499999999999999 111.052 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.39 -40.47 97.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.054 -0.521 . . . . 1.03 110.936 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.44 -26.47 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.128 0.49 . . . . 0.69999999999999996 111.0 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.61 65.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.841 -0.618 . . . . 0.81000000000000005 112.232 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.682 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 15.6 mmt -135.68 104.34 5.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.858 -0.793 . . . . 2.0699999999999998 108.858 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.594 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.67 -28.27 69.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.593 -0.73 . . . . 3.3599999999999999 110.962 -177.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.1 m-85 -117.71 153.95 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.207 -0.294 . . . . 1.26 110.207 173.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.667 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -156.08 110.18 0.43 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.836 -0.697 . . . . 0.73999999999999999 111.849 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 9.5 mmtp -129.23 134.95 48.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.931 0.396 . . . . 2.9100000000000001 111.841 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 8.1 t -75.52 132.95 41.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.93 -0.577 . . . . 0.76000000000000001 109.615 174.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.2 mmt -134.36 80.88 1.88 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.962 -0.295 . . . . 2.0800000000000001 111.356 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 p30 62.87 -4.14 0.27 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.224 1.41 . . . . 2.6899999999999999 113.846 171.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -55.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.748 -0.739 . . . . 0.48999999999999999 111.722 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.4 mptm? -89.49 161.07 16.43 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.192 0.52 . . . . 1.9099999999999999 110.908 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 56.4 m -96.73 115.64 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.76000000000000001 109.905 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -97.24 93.15 6.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 1.28 109.808 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.554 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.7 m -112.69 127.02 56.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.042 -0.527 . . . . 0.53000000000000003 111.346 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 35.1 m -86.96 124.99 67.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.42 -0.809 . . . . 0.56000000000000005 109.07 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 50.0 Cg_exo -54.42 152.74 25.17 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.533 2.822 . . . . 0.76000000000000001 113.45 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.4 tptp . . . . . 0 C--O 1.242 0.688 0 CA-C-O 118.189 -0.91 . . . . 2.1899999999999999 111.038 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.038 -0.425 . . . . 1.0900000000000001 112.038 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.17 100.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.167 0.508 . . . . 1.1599999999999999 110.238 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.827 HD11 ' HB3' ' A' ' 32' ' ' LYS . 7.0 tp -91.58 120.17 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.736 -0.666 . . . . 1.48 110.417 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 19.8 pt -102.6 136.54 34.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.041 0.448 . . . . 0.51000000000000001 110.734 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -79.91 64.95 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.702 -0.681 . . . . 1.9199999999999999 111.124 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -125.01 130.45 73.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.229 -0.896 . . . . 0.46000000000000002 109.477 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.7 107.44 3.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.052 -0.721 . . . . 1.28 109.052 178.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 11.5 p -78.18 91.29 4.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.943 -1.026 . . . . 0.73999999999999999 112.428 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HD3' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -70.3 -11.14 60.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.622 0.725 . . . . 2.6200000000000001 109.459 174.119 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.6 pt -165.83 145.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.055 -1.429 . . . . 0.78000000000000003 108.19 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.6 m -70.95 -24.46 62.44 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.816 -0.354 . . . . 0.40000000000000002 110.518 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.17 -34.45 78.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.836 0.31 . . . . 3.7400000000000002 111.836 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 16.3 pt20 -70.63 -20.42 62.73 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.194 0.521 . . . . 2.2000000000000002 110.119 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 12.5 m -94.98 -41.37 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.603 -0.726 . . . . 1.1799999999999999 110.237 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.679 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 1.6 tt -77.02 -37.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.844 -0.617 . . . . 1.3100000000000001 111.913 -171.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 27.0 tptp -50.46 -52.79 51.98 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-O 119.464 -0.303 . . . . 2.1299999999999999 111.411 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 6.9 Cg_exo -73.93 -20.47 19.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.643 1.562 . . . . 0.53000000000000003 112.505 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 37.4 m -83.39 -54.08 5.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.344 -0.543 . . . . 0.35999999999999999 111.821 -175.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.643 ' HE2' HD21 ' A' ' 15' ' ' LEU . 23.0 ttmm -63.77 -35.78 81.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.408 -0.517 . . . . 1.6499999999999999 110.334 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.94 -37.27 86.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.916 0.389 . . . . 1.03 110.184 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.03 0.85 46.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.69999999999999996 111.335 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.49 60.02 1.06 Allowed Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.937 -0.649 . . . . 0.81000000000000005 112.669 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 17.9 mmt -132.77 108.14 8.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.112 -0.699 . . . . 2.0699999999999998 109.112 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.467 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -60.69 -31.4 70.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.867 -1.06 . . . . 3.3599999999999999 110.983 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 51.1 m-85 -120.67 149.64 42.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.695 0.283 . . . . 1.26 111.072 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.679 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -158.48 78.27 0.18 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.695 -0.962 . . . . 0.73999999999999999 110.695 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -114.5 135.0 54.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.955 0.407 . . . . 2.9100000000000001 110.478 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 4.4 t -72.3 127.87 33.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.953 -0.567 . . . . 0.76000000000000001 109.751 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.48 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.472 -0.331 . . . . 2.0800000000000001 110.336 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 72.0 -66.42 0.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.223 0.952 . . . . 2.6899999999999999 112.432 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -126.18 -25.51 1.33 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.236 -0.983 . . . . 0.48999999999999999 113.23 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.827 ' HB3' HD11 ' A' ' 3' ' ' ILE . 35.2 mtmt -121.68 158.35 28.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.235 0.541 . . . . 1.9099999999999999 112.213 -170.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 56.8 m -93.91 109.02 20.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.299 -0.864 . . . . 0.76000000000000001 110.238 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -87.05 100.47 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 1.28 111.0 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -104.23 118.03 35.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.144 0.497 . . . . 0.53000000000000003 110.574 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.3 m -101.83 122.18 48.31 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.078 -0.712 . . . . 0.56000000000000005 109.078 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -51.94 147.21 26.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.385 2.723 . . . . 0.76000000000000001 113.484 -173.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 24.0 tptm . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.129 -0.941 . . . . 2.1899999999999999 111.281 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.766 -0.534 . . . . 1.0900000000000001 111.766 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.812 HG23 ' HG3' ' A' ' 37' ' ' PRO . 47.1 t -92.3 93.04 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.175 0.512 . . . . 1.1599999999999999 110.469 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -115.24 109.63 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.88 -0.785 . . . . 1.48 108.88 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 33' ' ' CYS . 15.8 pt -123.51 134.62 65.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.07 0.462 . . . . 0.51000000000000001 111.464 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.735 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 m-20 -77.93 63.7 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.608 -0.724 . . . . 1.9199999999999999 110.475 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -115.35 124.03 71.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 0.46000000000000002 109.24 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.593 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -58.04 104.21 0.19 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.232 0.539 . . . . 1.28 110.172 175.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.653 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.6 p -89.87 87.27 6.88 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.781 -0.645 . . . . 0.73999999999999999 110.084 174.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 21.0 tptt -64.43 -13.03 49.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 2.6200000000000001 109.258 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.414 HG13 ' HG2' ' A' ' 13' ' ' GLN . 8.1 pt -154.65 159.41 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 113.782 -1.554 . . . . 0.78000000000000003 108.165 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 61.4 m -67.22 -19.87 65.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.81 0.338 . . . . 0.40000000000000002 111.217 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -59.29 -31.1 68.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.176 -0.465 . . . . 3.7400000000000002 110.879 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 10' ' ' ILE . 14.3 mm100 -67.58 -24.38 65.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.905 -0.589 . . . . 2.2000000000000002 110.676 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.1 m -92.57 -45.5 8.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.281 0.562 . . . . 1.1799999999999999 109.875 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.582 HD12 ' SD ' ' A' ' 23' ' ' MET . 11.4 tp -52.48 -51.38 59.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.877 -1.056 . . . . 1.3100000000000001 112.669 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 40.5 tptt -56.21 -59.73 11.02 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 119.01 -0.519 . . . . 2.1299999999999999 111.42 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.3 Cg_exo -57.83 -34.23 97.99 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.571 1.514 . . . . 0.53000000000000003 112.479 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.79 -54.46 6.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.35999999999999999 111.421 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 25.2 tttm -74.5 -17.95 60.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.71 0.291 . . . . 1.6499999999999999 110.829 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 5.4 t70 -68.3 -30.33 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.412 -0.588 . . . . 1.03 109.412 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.19 3.35 43.67 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.797 -0.638 . . . . 0.69999999999999996 110.544 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.712 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 100.11 105.01 2.66 Favored Glycine 0 CA--C 1.499 -0.919 0 CA-C-N 115.465 -0.789 . . . . 0.81000000000000005 111.435 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.582 ' SD ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -119.43 121.76 40.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.321 1.058 . . . . 2.0699999999999998 109.564 174.07 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.685 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -89.0 -29.2 19.67 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.051 -1.431 . . . . 3.3599999999999999 108.285 168.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.5 m-85 -140.02 151.52 45.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.136 -0.938 . . . . 1.26 109.347 170.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA3' ' SD ' ' A' ' 23' ' ' MET . . . -150.95 108.27 0.38 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.06 -0.591 . . . . 0.73999999999999999 111.807 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -129.41 138.7 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.169 0.509 . . . . 2.9100000000000001 112.0 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 7.8 t -87.24 132.49 33.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.014 -1.106 . . . . 0.76000000000000001 108.014 167.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 52.6 mtt -126.14 77.69 1.7 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.041 -0.664 . . . . 2.0800000000000001 111.208 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 70.97 -58.58 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.385 1.053 . . . . 2.6899999999999999 112.563 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.91 -47.08 0.21 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.958 -0.639 . . . . 0.48999999999999999 112.566 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.735 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.1 mptm? -107.46 164.43 12.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 1.9099999999999999 111.293 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.653 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -92.77 123.46 36.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.36 -0.836 . . . . 0.76000000000000001 110.365 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.41 98.04 5.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 1.28 109.613 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' HB ' ' A' ' 2' ' ' VAL . 7.6 p -121.13 159.22 26.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.036 -0.529 . . . . 0.53000000000000003 110.902 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 24.2 m -112.65 113.37 50.48 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.588 -0.733 . . . . 0.56000000000000005 109.151 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.812 ' HG3' HG23 ' A' ' 2' ' ' VAL . 32.7 Cg_exo -58.98 152.73 56.29 Favored 'Trans proline' 0 CA--C 1.519 -0.238 0 C-N-CA 122.836 2.357 . . . . 0.76000000000000001 112.324 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.685 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 20.3 tptm . . . . . 0 C--O 1.246 0.906 0 CA-C-N 115.565 -0.743 . . . . 2.1899999999999999 110.619 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.051 -0.42 . . . . 1.0900000000000001 112.051 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.4 93.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.375 -0.602 . . . . 1.1599999999999999 109.375 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.8 tp -88.07 110.42 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.855 0.836 . . . . 1.48 111.0 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.422 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -95.23 147.57 5.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.358 -0.837 . . . . 0.51000000000000001 110.679 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -84.42 14.11 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 1.9199999999999999 111.285 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.14 120.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.421 -0.585 . . . . 0.46000000000000002 109.421 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.682 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.8 tmtp? -67.73 115.95 7.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.973 -0.751 . . . . 1.28 108.973 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 28.5 p -77.16 82.96 3.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.525 -0.761 . . . . 0.73999999999999999 111.475 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 10' ' ' ILE . 13.8 mmmm -66.44 -17.58 64.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.744 0.783 . . . . 2.6200000000000001 108.992 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.568 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.4 pt -166.04 148.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.86 -1.518 . . . . 0.78000000000000003 108.123 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -74.08 -19.72 60.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.868 0.366 . . . . 0.40000000000000002 110.897 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.9 mtp180 -54.58 -47.08 73.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 3.7400000000000002 110.731 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.6 pt20 -76.51 -4.15 41.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 2.2000000000000002 111.125 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 75.3 m -95.61 -58.15 2.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.074 -0.512 . . . . 1.1799999999999999 110.44 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.601 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -79.12 -31.74 44.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.638 0.607 . . . . 1.3100000000000001 112.638 -169.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -54.79 -50.75 84.19 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.654 -0.418 . . . . 2.1299999999999999 110.702 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 14.3 Cg_exo -71.59 -29.76 15.75 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.634 1.556 . . . . 0.53000000000000003 112.923 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.712 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 81.3 m -74.18 -52.17 13.28 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.446 -0.501 . . . . 0.35999999999999999 111.422 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.595 ' HA ' ' H ' ' A' ' 23' ' ' MET . 41.2 ttmt -65.77 -27.35 68.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.067 0.46 . . . . 1.6499999999999999 110.267 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.28 -28.42 69.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 1.03 110.082 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.52 5.51 41.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.69999999999999996 111.244 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.86 53.01 1.99 Allowed Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.88 -0.676 . . . . 0.81000000000000005 112.765 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.712 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 56.8 mtt -131.57 102.16 5.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.587 0.708 . . . . 2.0699999999999998 109.366 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.669 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 10.9 ttt180 -60.39 -27.21 67.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.169 -1.378 . . . . 3.3599999999999999 112.335 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.597 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.7 m-85 -117.62 163.3 16.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.852 0.358 . . . . 1.26 110.867 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.601 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -178.6 74.24 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.999 -0.841 . . . . 0.73999999999999999 110.999 -177.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -104.16 133.69 48.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.664 -0.268 . . . . 2.9100000000000001 110.469 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.2 t -70.42 126.84 30.78 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.881 -0.414 . . . . 0.76000000000000001 109.881 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.8 mmm -137.39 103.52 5.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 2.0800000000000001 110.261 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 72.7 -74.72 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.997 0.811 . . . . 2.6899999999999999 110.997 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.682 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . -146.15 4.7 1.18 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.913 -0.66 . . . . 0.48999999999999999 112.863 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.614 ' HB3' HD11 ' A' ' 3' ' ' ILE . 91.1 mttt -131.93 160.41 35.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.036 0.446 . . . . 1.9099999999999999 111.478 -176.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 66.8 m -96.86 113.17 24.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.76000000000000001 110.045 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -86.55 94.6 9.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 1.28 110.498 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.4 m -104.3 115.35 30.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.453 0.644 . . . . 0.53000000000000003 111.485 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.597 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 22.6 m -92.41 129.01 42.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.764 -0.828 . . . . 0.56000000000000005 108.764 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 37.8 Cg_exo -57.14 155.12 30.39 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.852 2.368 . . . . 0.76000000000000001 112.009 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.669 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 7.7 tptp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.078 -0.963 . . . . 2.1899999999999999 112.356 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.773 -0.531 . . . . 1.0900000000000001 111.773 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG11 ' HE2' ' A' ' 23' ' ' MET . 43.1 t -79.36 97.1 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.095 0.474 . . . . 1.1599999999999999 110.034 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.16 109.51 28.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.75 -0.659 . . . . 1.48 110.494 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.1 pt -99.37 137.29 27.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.079 -0.51 . . . . 0.51000000000000001 109.812 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -81.42 33.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 1.9199999999999999 111.67 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.76 135.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.087 -1.079 . . . . 0.46000000000000002 108.087 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.561 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 1.8 tmtt? -77.76 115.43 17.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.729 -0.788 . . . . 1.28 110.242 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 10.2 p -73.02 85.98 1.31 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.462 -1.244 . . . . 0.73999999999999999 111.884 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.4 mptm? -66.76 -13.44 61.42 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.556 -0.715 . . . . 2.6200000000000001 109.352 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.643 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.2 pt -166.63 150.52 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.384 -1.28 . . . . 0.78000000000000003 108.587 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 50.4 m -63.7 -52.96 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.791 0.293 . . . . 0.40000000000000002 111.791 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 13.8 ptm180 -60.22 -19.47 54.56 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 3.7400000000000002 113.246 -173.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 11.4 pt20 -72.78 -25.43 61.16 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.201 -0.6 . . . . 2.2000000000000002 109.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 32.8 m -93.67 -34.64 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.895 -0.593 . . . . 1.1799999999999999 109.707 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 12' ' ' ARG . 59.0 tp -65.29 -41.27 94.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 1.3100000000000001 112.104 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 18.2 tptm -57.63 -52.04 77.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.329 -0.548 . . . . 2.1299999999999999 111.739 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 23.8 Cg_exo -65.43 -25.46 55.96 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.695 1.597 . . . . 0.53000000000000003 111.94 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.754 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 66.2 m -82.39 -52.42 6.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.619 -0.264 . . . . 0.35999999999999999 110.818 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HA ' ' H ' ' A' ' 23' ' ' MET . 70.2 tttt -64.03 -27.58 69.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.782 0.325 . . . . 1.6499999999999999 110.682 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.86 -45.78 90.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.058 -0.519 . . . . 1.03 110.035 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.83 61.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.69999999999999996 110.664 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.84 54.56 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.834 -0.621 . . . . 0.81000000000000005 112.16 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.754 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -130.95 105.09 7.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 2.0699999999999998 110.545 175.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.579 ' N ' ' HB2' ' A' ' 38' ' ' LYS . 8.3 ptm180 -55.59 -27.49 49.68 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.264 -0.88 . . . . 3.3599999999999999 112.698 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 26.9 m-85 -124.63 160.34 28.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 1.26 110.818 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.78 59.67 0.12 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.602 -0.999 . . . . 0.73999999999999999 110.602 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 97.1 mttt -98.41 152.58 19.34 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.19 0.519 . . . . 2.9100000000000001 110.609 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t -77.61 112.75 14.74 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.323 -0.853 . . . . 0.76000000000000001 110.528 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 62.4 mtt -137.99 125.74 22.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 2.0800000000000001 109.874 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 68.45 -4.72 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.13 0.49 . . . . 2.6899999999999999 111.674 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' HE2' ' A' ' 7' ' ' LYS . . . 114.47 -14.01 20.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.831 -0.7 . . . . 0.48999999999999999 112.137 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -102.24 159.74 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.799 0.333 . . . . 1.9099999999999999 110.504 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 56.8 m -91.13 95.62 10.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.02 -0.733 . . . . 0.76000000000000001 109.02 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -76.8 93.95 3.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.268 -0.878 . . . . 1.28 111.046 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 75.0 m -98.68 111.16 23.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.394 0.616 . . . . 0.53000000000000003 111.034 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.6 m -88.99 130.59 44.01 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.48 -0.933 . . . . 0.56000000000000005 108.48 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.729 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 3.1 Cg_exo -72.22 151.53 54.9 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.175 2.583 . . . . 0.76000000000000001 112.238 -170.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HB2' ' N ' ' A' ' 24' ' ' ARG . 50.1 tttm . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.36 -0.829 . . . . 2.1899999999999999 110.682 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.904 -0.478 . . . . 1.0900000000000001 111.904 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.25 99.16 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.172 0.51 . . . . 1.1599999999999999 110.256 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 mm -104.76 121.76 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.003 -0.544 . . . . 1.48 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.563 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.7 pt -106.26 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.905 0.383 . . . . 0.51000000000000001 110.323 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.76 31.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 1.9199999999999999 112.112 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.17 139.29 17.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.938 -0.764 . . . . 0.46000000000000002 108.938 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.669 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.6 tmtp? -81.5 115.55 20.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.546 -0.539 . . . . 1.28 109.546 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.2 p -80.21 84.07 5.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.316 -0.856 . . . . 0.73999999999999999 112.584 -173.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -72.99 -11.52 60.6 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.119 -0.988 . . . . 2.6200000000000001 108.81 173.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.626 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.9 pt -169.67 139.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.915 -1.493 . . . . 0.78000000000000003 107.927 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -71.98 -17.12 62.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.651 0.262 . . . . 0.40000000000000002 111.616 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -68.64 -33.7 74.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.745 0.307 . . . . 3.7400000000000002 110.918 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 3.4 pt20 -75.98 -20.48 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.027 0.442 . . . . 2.2000000000000002 110.364 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 57.4 m -88.83 -33.66 17.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.896 -0.593 . . . . 1.1799999999999999 110.461 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.809 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -83.85 -25.36 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.149 -0.478 . . . . 1.3100000000000001 112.062 -172.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 28.0 tptp -56.21 -49.37 93.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.4 -0.52 . . . . 2.1299999999999999 110.907 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 8.6 Cg_exo -73.95 -31.84 7.7 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.829 1.686 . . . . 0.53000000000000003 112.67 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 75.8 m -75.0 -52.19 11.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.291 -0.563 . . . . 0.35999999999999999 111.303 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 1.7 tmtp? -61.95 -35.01 77.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.022 0.439 . . . . 1.6499999999999999 110.355 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.85 -27.85 69.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.769 -0.65 . . . . 1.03 110.788 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' A' ' 23' ' ' MET . . . -96.55 1.06 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 0.69999999999999996 111.342 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.82 46.67 2.64 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.557 -0.83 . . . . 0.81000000000000005 112.849 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.753 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mpp? -123.05 104.46 9.23 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.573 0.702 . . . . 2.0699999999999998 109.634 171.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.888 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -56.81 -35.81 69.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.328 -1.305 . . . . 3.3599999999999999 111.681 -179.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 25.1 m-85 -110.25 163.25 13.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.252 0.549 . . . . 1.26 111.617 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.809 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -167.45 57.8 0.22 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.103 -1.199 . . . . 0.73999999999999999 110.103 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -85.98 134.53 33.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.304 -0.448 . . . . 2.9100000000000001 110.995 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 15.3 t -69.6 117.99 11.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.762 -0.654 . . . . 0.76000000000000001 109.719 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.24 109.96 7.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.245 -0.434 . . . . 2.0800000000000001 111.265 -175.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.64 21.46 10.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.088 -0.505 . . . . 2.6899999999999999 111.698 172.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.669 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 113.18 -26.36 10.49 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.785 -0.721 . . . . 0.48999999999999999 112.77 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -101.77 158.93 15.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.948 0.404 . . . . 1.9099999999999999 110.798 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.563 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 23.7 m -93.48 107.98 19.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.341 -0.614 . . . . 0.76000000000000001 109.341 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.32 95.34 10.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.732 -0.667 . . . . 1.28 110.158 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.1 m -98.81 119.26 37.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.578 . . . . 0.53000000000000003 111.098 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 11.8 m -94.81 124.61 54.09 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 0.56000000000000005 109.108 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 12.9 Cg_endo -56.22 144.56 80.91 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.892 2.395 . . . . 0.76000000000000001 112.503 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.888 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tptp . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.512 -0.767 . . . . 2.1899999999999999 111.159 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.549 -0.62 . . . . 1.0900000000000001 111.549 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.927 ' HB ' ' HB2' ' A' ' 35' ' ' CYS . 31.9 t -90.23 93.18 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.171 0.51 . . . . 1.1599999999999999 109.675 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.86 109.25 24.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.909 -0.587 . . . . 1.48 109.778 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.476 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 21.7 pt -108.4 147.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.167 -0.469 . . . . 0.51000000000000001 110.96 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -83.51 28.12 0.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 1.9199999999999999 111.398 -176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.56 132.65 31.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.603 -0.888 . . . . 0.46000000000000002 108.603 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.613 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -73.08 114.36 11.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.101 -0.703 . . . . 1.28 109.101 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.3 p -74.94 82.72 2.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.594 0.712 . . . . 0.73999999999999999 110.85 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 10' ' ' ILE . 12.4 tptm -79.96 -2.56 44.43 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.505 -0.924 . . . . 2.6200000000000001 108.505 175.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 9' ' ' LYS . 4.8 pt -174.7 142.72 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 113.18 -1.827 . . . . 0.78000000000000003 107.228 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -72.56 -20.7 61.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.531 0.205 . . . . 0.40000000000000002 111.035 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -62.59 -38.78 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 3.7400000000000002 111.504 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 14.6 pt20 -75.29 -14.02 60.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.278 0.561 . . . . 2.2000000000000002 110.285 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 56.5 m -88.47 -37.98 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 1.1799999999999999 109.385 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.635 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -75.21 -43.68 50.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.491 -1.231 . . . . 1.3100000000000001 112.709 -170.435 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 48.9 tptt -55.47 -52.12 74.41 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.708 -0.397 . . . . 2.1299999999999999 111.768 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 20.6 Cg_exo -67.45 -36.27 20.75 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.658 1.572 . . . . 0.53000000000000003 112.203 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.611 ' HB2' ' HE3' ' A' ' 23' ' ' MET . 87.2 m -79.16 -43.84 23.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.669 -0.413 . . . . 0.35999999999999999 111.641 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 21.4 ttmm -70.65 -30.07 66.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.258 -0.177 . . . . 1.6499999999999999 110.706 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.61 -36.55 84.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 1.03 109.882 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -41.1 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.671 . . . . 0.69999999999999996 111.124 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 157.03 85.87 0.05 OUTLIER Glycine 0 CA--C 1.508 -0.4 0 N-CA-C 111.633 -0.587 . . . . 0.81000000000000005 111.633 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . 1.017 ' HE1' ' HA3' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -141.51 121.56 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.172 0.987 . . . . 2.0699999999999998 110.166 176.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.6 -26.2 18.82 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.156 -1.384 . . . . 3.3599999999999999 109.59 174.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.554 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.4 m-85 -141.78 164.02 31.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.355 -0.384 . . . . 1.26 110.36 171.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 1.017 ' HA3' ' HE1' ' A' ' 23' ' ' MET . . . -165.85 118.05 0.78 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 121.089 -0.576 . . . . 0.73999999999999999 111.709 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -129.23 139.68 51.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.93 0.395 . . . . 2.9100000000000001 110.828 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.0 t -68.79 123.33 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 0.76000000000000001 109.563 170.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 66.1 mtt -137.11 118.01 14.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.728 -0.214 . . . . 2.0800000000000001 110.921 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 43.01 37.41 1.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.215 0.947 . . . . 2.6899999999999999 113.243 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.613 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 108.93 -27.98 12.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.049 -0.596 . . . . 0.48999999999999999 112.916 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -107.28 159.06 16.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.357 0.598 . . . . 1.9099999999999999 111.432 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 80.9 m -92.6 107.35 19.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.54 -0.755 . . . . 0.76000000000000001 109.791 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -88.54 98.12 11.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.638 -0.71 . . . . 1.28 109.835 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.927 ' HB2' ' HB ' ' A' ' 2' ' ' VAL . 33.4 m -100.13 113.14 25.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.669 -0.696 . . . . 0.53000000000000003 110.944 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.2 m -78.69 112.98 30.99 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.552 -0.749 . . . . 0.56000000000000005 109.325 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.61 ' HG3' HG23 ' A' ' 2' ' ' VAL . 30.3 Cg_exo -60.21 147.1 94.76 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.479 2.119 . . . . 0.76000000000000001 112.191 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 4.3 mmmp? . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.589 -0.72 . . . . 2.1899999999999999 111.058 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 111.469 -0.652 . . . . 1.0900000000000001 111.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.41 HG21 ' CE ' ' A' ' 23' ' ' MET . 2.4 m -92.41 93.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.847 0.832 . . . . 1.1599999999999999 111.365 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -101.44 118.06 47.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.96 . . . . 1.48 109.086 176.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 33' ' ' CYS . 18.4 pt -101.88 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.057 0.456 . . . . 0.51000000000000001 111.379 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.1 39.9 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 1.9199999999999999 111.827 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.07 134.36 44.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.372 -0.603 . . . . 0.46000000000000002 109.372 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.735 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 2.5 tmtp? -78.35 109.36 12.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.475 0.655 . . . . 1.28 109.832 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -80.49 98.26 7.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.172 -0.922 . . . . 0.73999999999999999 111.841 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -66.45 -12.07 55.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.623 0.725 . . . . 2.6200000000000001 109.824 172.424 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.673 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 11.9 pt -163.61 163.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.139 -1.391 . . . . 0.78000000000000003 107.473 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 44.6 m -67.18 -39.82 86.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 118.474 0.579 . . . . 0.40000000000000002 110.81 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -62.0 -19.5 62.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.813 -0.631 . . . . 3.7400000000000002 112.326 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.673 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 11.9 mm100 -54.95 -35.94 64.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.849 0.356 . . . . 2.2000000000000002 110.879 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -113.66 -18.87 11.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.093 -0.503 . . . . 1.1799999999999999 111.871 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.49 -34.07 76.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.147 -0.621 . . . . 1.3100000000000001 110.981 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -59.81 -56.39 36.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.835 -0.346 . . . . 2.1299999999999999 110.468 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -66.06 -25.89 51.01 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.727 1.618 . . . . 0.53000000000000003 112.65 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.6 m -79.19 -56.31 4.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.725 -0.39 . . . . 0.35999999999999999 111.495 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.588 ' HA ' ' H ' ' A' ' 23' ' ' MET . 73.8 tttt -65.92 -26.61 67.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.372 -0.205 . . . . 1.6499999999999999 111.064 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -65.39 -35.95 82.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 1.03 110.451 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.63 -13.27 58.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 0.69999999999999996 110.881 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 64.94 0.6 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.57 -0.612 . . . . 0.81000000000000005 111.57 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.717 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 46.8 mtt -141.13 110.79 6.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.675 0.75 . . . . 2.0699999999999998 110.152 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.79 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 6.4 ptp180 -65.19 -21.24 66.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.579 -1.191 . . . . 3.3599999999999999 112.176 -175.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 47.9 m-85 -128.39 148.07 50.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.043 0.449 . . . . 1.26 110.826 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.05 62.64 0.42 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 109.443 -1.463 . . . . 0.73999999999999999 109.443 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 27' ' ' LYS . 52.1 mtpt -91.1 134.9 34.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.067 0.461 . . . . 2.9100000000000001 111.066 -168.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 39.9 t -81.93 124.11 29.45 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.667 -0.697 . . . . 0.76000000000000001 109.874 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.483 ' HA ' ' CE ' ' A' ' 29' ' ' MET . 1.5 mmt -138.64 105.9 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 2.0800000000000001 111.162 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.05 20.94 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.804 -0.635 . . . . 2.6899999999999999 112.186 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.735 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 119.71 -31.09 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.5 -0.857 . . . . 0.48999999999999999 112.663 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -94.99 154.37 17.2 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.289 0.566 . . . . 1.9099999999999999 111.259 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -93.68 104.27 16.38 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.149 -0.932 . . . . 0.76000000000000001 109.803 176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.588 ' HA ' HG13 ' A' ' 3' ' ' ILE . 29.8 m80 -88.73 94.13 9.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.7 -0.682 . . . . 1.28 109.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.6 m -98.66 130.06 45.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.53000000000000003 110.617 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.7 m -108.36 129.86 23.5 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.139 -1.06 . . . . 0.56000000000000005 108.139 175.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.1 Cg_exo -62.41 155.86 55.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.065 2.51 . . . . 0.76000000000000001 112.396 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.79 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 17.1 mmmt . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.53 -0.748 . . . . 2.1899999999999999 110.53 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.812 0 N-CA-C 111.436 -0.666 . . . . 1.0900000000000001 111.436 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.71 95.29 5.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.629 0.728 . . . . 1.1599999999999999 111.004 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.876 HD11 ' HB3' ' A' ' 32' ' ' LYS . 2.8 tp -91.94 126.71 44.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.252 -0.885 . . . . 1.48 109.893 175.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 33' ' ' CYS . 28.6 pt -115.05 145.23 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.293 -0.412 . . . . 0.51000000000000001 111.367 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.26 69.36 6.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 1.9199999999999999 111.272 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.91 122.8 65.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.563 -0.532 . . . . 0.46000000000000002 109.563 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -69.29 96.33 0.85 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.492 0.663 . . . . 1.28 110.089 -177.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 8.8 p -80.57 100.49 8.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.24 -0.891 . . . . 0.73999999999999999 111.842 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 10' ' ' ILE . 3.3 mppt? -71.13 -8.1 51.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.171 -0.678 . . . . 2.6200000000000001 109.171 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.777 HG13 ' HG3' ' A' ' 13' ' ' GLN . 3.8 pt -168.58 154.41 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 114.063 -1.426 . . . . 0.78000000000000003 108.126 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.3 m -69.35 -22.23 63.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 0.40000000000000002 111.409 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.422 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.3 mpt_? -60.91 -36.29 78.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.264 -0.425 . . . . 3.7400000000000002 111.682 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.777 ' HG3' HG13 ' A' ' 10' ' ' ILE . 13.9 mt-30 -62.84 -27.63 69.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.5 . . . . 2.2000000000000002 110.56 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.8 m -88.29 -48.74 7.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.394 -0.821 . . . . 1.1799999999999999 111.261 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.7 tp -67.83 -34.08 76.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.003 -0.544 . . . . 1.3100000000000001 112.304 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 8.9 tmtt? -58.38 -58.42 19.13 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.295 -0.562 . . . . 2.1299999999999999 110.448 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 70.5 Cg_endo -70.63 -21.0 30.03 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.612 1.541 . . . . 0.53000000000000003 112.345 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 56.6 m -77.66 -58.63 3.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.629 -0.429 . . . . 0.35999999999999999 109.95 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HA ' ' H ' ' A' ' 23' ' ' MET . 44.9 tttm -60.08 -32.04 70.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.208 -0.451 . . . . 1.6499999999999999 110.637 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 13.9 t70 -56.22 -47.88 77.57 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 1.03 110.496 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.64 -29.23 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.695 . . . . 0.69999999999999996 111.071 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.4 0.11 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.494 -0.642 . . . . 0.81000000000000005 111.494 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.7 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 10.2 mmt -145.01 91.63 2.17 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.132 -1.062 . . . . 2.0699999999999998 108.132 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HG3' ' CD2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -50.39 -47.77 56.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.508 -1.224 . . . . 3.3599999999999999 111.524 -177.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.614 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 98.7 m-85 -99.27 147.3 25.32 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.687 -0.405 . . . . 1.26 110.084 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.88 95.07 0.13 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.708 -0.957 . . . . 0.73999999999999999 110.708 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -122.32 141.17 51.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.198 0.523 . . . . 2.9100000000000001 111.03 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.3 t -75.9 136.19 40.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.466 -0.788 . . . . 0.76000000000000001 110.324 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 32' ' ' LYS . 2.7 ppp? -137.87 100.54 4.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 2.0800000000000001 110.859 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 58.39 18.82 5.86 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.792 . . . . 2.6899999999999999 112.55 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 119.42 -5.56 13.11 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.576 -0.821 . . . . 0.48999999999999999 113.335 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.876 ' HB3' HD11 ' A' ' 3' ' ' ILE . 53.4 mtpt -120.36 168.62 11.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.045 0.422 . . . . 1.9099999999999999 111.243 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.55 ' HB2' HG12 ' A' ' 4' ' ' ILE . 59.0 m -111.66 102.84 11.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.76000000000000001 111.666 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.441 ' ND1' HD13 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -81.99 97.95 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 1.28 110.529 174.014 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.7 m -106.44 134.49 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.316 0.579 . . . . 0.53000000000000003 110.772 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 17.3 m -112.38 124.09 32.75 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.076 -0.712 . . . . 0.56000000000000005 109.076 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 53.1 Cg_exo -55.4 147.3 57.72 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.616 2.877 . . . . 0.76000000000000001 113.477 -170.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 13.9 tptp . . . . . 0 C--O 1.249 1.047 0 CA-C-N 114.89 -1.05 . . . . 2.1899999999999999 110.068 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 112.012 -0.435 . . . . 1.0900000000000001 112.012 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 64.2 t -85.02 100.35 8.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.354 0.597 . . . . 1.1599999999999999 109.768 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 mm -100.28 121.42 51.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.448 -0.797 . . . . 1.48 110.005 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.508 HD11 ' SG ' ' A' ' 14' ' ' CYS . 24.8 pt -115.76 151.56 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.965 0.412 . . . . 0.51000000000000001 110.61 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.03 45.25 1.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 1.9199999999999999 111.686 -174.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -102.12 126.45 56.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.954 -0.758 . . . . 0.46000000000000002 108.954 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -68.67 120.33 14.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.731 0.777 . . . . 1.28 109.94 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 13.0 p -85.35 86.42 7.38 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.012 -0.995 . . . . 0.73999999999999999 111.734 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -55.96 -23.38 31.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.386 0.612 . . . . 2.6200000000000001 109.614 173.65 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.622 HG13 ' HG2' ' A' ' 13' ' ' GLN . 7.2 pt -164.06 167.52 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.98 -1.464 . . . . 0.78000000000000003 107.482 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.416 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 63.6 m -66.43 -36.93 84.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.295 0.498 . . . . 0.40000000000000002 110.741 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -57.15 -28.84 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.754 -0.657 . . . . 3.7400000000000002 111.828 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.622 ' HG2' HG13 ' A' ' 10' ' ' ILE . 85.6 mm-40 -55.72 -34.55 65.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 111.698 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.623 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 4.9 t -108.63 -21.66 12.6 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.449 -0.5 . . . . 1.1799999999999999 111.736 -176.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.559 HD21 ' HE3' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -74.47 -36.53 63.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.933 -0.707 . . . . 1.3100000000000001 111.369 -174.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.528 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -56.29 -49.46 93.2 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 120.327 -0.549 . . . . 2.1299999999999999 110.592 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.623 ' HD2' ' C ' ' A' ' 14' ' ' CYS . 21.5 Cg_exo -67.7 -35.96 20.4 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.81 1.674 . . . . 0.53000000000000003 112.851 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.759 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 34.2 m -71.14 -54.14 12.08 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.55 -0.46 . . . . 0.35999999999999999 111.713 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.572 ' HA ' ' H ' ' A' ' 23' ' ' MET . 38.2 ttmt -66.4 -25.9 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.833 -0.347 . . . . 1.6499999999999999 110.456 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.78 -33.08 71.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.046 -0.525 . . . . 1.03 110.206 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -6.09 56.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.69999999999999996 110.82 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.74 62.36 0.75 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.795 -0.717 . . . . 0.81000000000000005 112.424 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.759 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 10.0 mmt -138.3 111.99 8.27 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.082 -0.71 . . . . 2.0699999999999998 109.082 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 13.7 ptp180 -63.8 -22.81 67.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.552 -0.749 . . . . 3.3599999999999999 111.894 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.2 m-85 -130.14 155.69 45.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.26 110.953 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -164.62 92.6 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.847 -1.301 . . . . 0.73999999999999999 109.847 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 34.0 mmtp -123.19 147.89 46.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.187 0.517 . . . . 2.9100000000000001 111.46 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 40.2 t -81.25 127.29 32.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.431 -0.804 . . . . 0.76000000000000001 109.833 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.681 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 57.9 mtt -137.39 105.54 5.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.404 -0.591 . . . . 2.0800000000000001 109.404 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 71.04 -73.8 0.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 124.525 1.141 . . . . 2.6899999999999999 111.095 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.31 -33.23 0.13 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.84 -0.695 . . . . 0.48999999999999999 112.813 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 2.4 ptpt -100.35 164.46 11.92 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.473 0.654 . . . . 1.9099999999999999 111.672 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' SG ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -92.81 128.37 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.166 -0.925 . . . . 0.76000000000000001 109.26 177.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.681 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 34.2 m-70 -110.64 109.24 19.44 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.293 -0.867 . . . . 1.28 109.931 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -111.07 133.19 53.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.504 0.668 . . . . 0.53000000000000003 112.091 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.0 m -101.51 127.7 30.86 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.421 -0.955 . . . . 0.56000000000000005 108.421 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 16.9 Cg_exo -66.64 158.74 54.36 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.135 2.557 . . . . 0.76000000000000001 113.343 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 35.8 mmtt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.491 -0.766 . . . . 2.1899999999999999 110.322 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.206 -0.358 . . . . 1.0900000000000001 112.206 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.43 102.67 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.14 0.495 . . . . 1.1599999999999999 110.143 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 mm -96.44 109.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.705 -0.68 . . . . 1.48 110.388 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.411 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.2 pt -99.72 147.19 7.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.373 -0.376 . . . . 0.51000000000000001 110.902 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.81 12.09 2.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.968 -0.56 . . . . 1.9199999999999999 112.128 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.67 128.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.107 -0.701 . . . . 0.46000000000000002 109.107 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.583 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 6.1 tmtt? -73.25 115.85 13.09 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.781 -0.822 . . . . 1.28 108.781 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 17.4 p -66.33 85.07 0.1 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.731 -1.122 . . . . 0.73999999999999999 111.644 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HB2' HD13 ' A' ' 10' ' ' ILE . 71.0 mmtt -58.89 -25.83 63.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.117 -0.697 . . . . 2.6200000000000001 109.117 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -168.77 152.47 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.545 -1.661 . . . . 0.78000000000000003 107.143 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.5 m -65.51 -28.33 69.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.482 -0.487 . . . . 0.40000000000000002 110.683 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -56.18 -34.41 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 3.7400000000000002 111.266 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.598 ' HG3' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -87.61 -14.53 39.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 2.2000000000000002 110.87 -173.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 57.2 m -89.26 -40.76 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.321 0.581 . . . . 1.1799999999999999 110.029 176.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 26' ' ' GLY . 61.2 tp -73.71 -27.87 61.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.68 -0.691 . . . . 1.3100000000000001 111.505 -175.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 25.6 tptp -55.05 -56.69 25.24 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.692 0.256 . . . . 2.1299999999999999 111.692 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 68.9 Cg_endo -74.54 -19.92 18.55 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.541 1.494 . . . . 0.53000000000000003 112.45 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.832 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 57.5 m -81.72 -56.69 3.83 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 121.082 -0.247 . . . . 0.35999999999999999 111.354 -176.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -62.35 -36.05 81.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.786 -0.366 . . . . 1.6499999999999999 110.547 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.31 -36.25 79.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 1.03 110.687 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.39 -35.09 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.69999999999999996 110.842 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.73 42.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.81000000000000005 112.586 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.832 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -126.29 98.07 5.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.463 -0.569 . . . . 2.0699999999999998 109.463 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.803 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -53.81 -34.83 60.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.987 . . . . 3.3599999999999999 112.123 -178.472 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 59.2 m-85 -109.21 144.31 37.48 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.104 -0.332 . . . . 1.26 110.104 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.419 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -158.06 75.39 0.21 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.325 -1.11 . . . . 0.73999999999999999 110.325 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -108.93 143.89 37.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 2.9100000000000001 111.288 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.3 t -71.95 125.62 27.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.859 -1.064 . . . . 0.76000000000000001 110.492 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.402 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 95.9 mmm -124.7 82.44 2.05 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.572 -0.529 . . . . 2.0800000000000001 109.572 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 73.75 -65.41 0.35 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.421 1.076 . . . . 2.6899999999999999 111.626 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -131.11 -39.8 0.25 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.65 -0.786 . . . . 0.48999999999999999 112.779 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.68 158.71 15.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.189 0.519 . . . . 1.9099999999999999 111.181 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 68.1 m -92.42 116.07 28.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.513 -0.767 . . . . 0.76000000000000001 109.119 174.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 12.2 m-70 -99.81 99.23 10.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.888 -0.412 . . . . 1.28 109.888 -177.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -101.07 135.48 42.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.53000000000000003 111.692 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 16.6 m -115.77 132.74 23.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.372 -0.831 . . . . 0.56000000000000005 109.012 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 51.0 Cg_exo -54.0 152.34 24.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.668 2.912 . . . . 0.76000000000000001 114.032 -172.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.803 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.245 0.858 0 CA-C-N 114.945 -1.025 . . . . 2.1899999999999999 110.921 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.647 -0.581 . . . . 1.0900000000000001 111.647 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.9 t -77.18 93.7 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.182 0.515 . . . . 1.1599999999999999 110.129 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.789 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.1 tp -92.87 122.94 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.871 -0.604 . . . . 1.48 110.627 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.5 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 20.5 pt -110.95 142.05 24.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 0.51000000000000001 110.348 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -84.81 50.51 1.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.782 0.801 . . . . 1.9199999999999999 111.231 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.63 138.11 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.95 -1.023 . . . . 0.46000000000000002 108.293 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.513 ' C ' ' HD3' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -77.79 109.88 12.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 1.28 109.779 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.8 p -71.76 85.63 0.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.948 -1.023 . . . . 0.73999999999999999 111.768 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 10' ' ' ILE . 32.8 mmtp -55.84 -23.84 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 2.6200000000000001 108.986 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 8.9 pt -163.06 166.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.557 -1.656 . . . . 0.78000000000000003 107.097 175.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -66.44 -37.65 85.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.392 0.542 . . . . 0.40000000000000002 110.85 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -61.54 -19.81 62.54 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.094 -0.503 . . . . 3.7400000000000002 111.966 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.573 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 13.6 mm100 -58.38 -34.59 70.88 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.878 0.37 . . . . 2.2000000000000002 111.217 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 86.8 m -117.27 -25.32 7.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.162 -0.472 . . . . 1.1799999999999999 112.234 -173.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 26' ' ' GLY . 57.0 tp -64.37 -37.98 89.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.28 -0.568 . . . . 1.3100000000000001 111.418 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 25.8 tptp -58.8 -50.89 85.54 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 120.511 -0.475 . . . . 2.1299999999999999 111.419 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 33.4 Cg_exo -60.54 -40.41 56.76 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.82 1.68 . . . . 0.53000000000000003 112.563 170.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.8 m -70.83 -57.95 4.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.888 0.329 . . . . 0.35999999999999999 111.888 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 23' ' ' MET . 71.6 tttt -63.17 -28.38 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.827 0.346 . . . . 1.6499999999999999 110.81 -176.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.75 -31.76 71.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 1.03 109.843 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.67 2.79 52.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 0.69999999999999996 110.962 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.47 66.3 0.98 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 120.973 -0.632 . . . . 0.81000000000000005 112.027 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.804 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 61.0 mtt -145.6 108.69 4.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 2.0699999999999998 109.58 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -65.15 -18.72 65.54 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.421 -0.809 . . . . 3.3599999999999999 111.981 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.556 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.3 m-85 -134.27 149.32 50.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.232 0.539 . . . . 1.26 111.378 175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -153.23 79.64 0.19 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.0 -1.64 . . . . 0.73999999999999999 109.0 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -114.73 134.53 55.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.828 0.347 . . . . 2.9100000000000001 110.661 -163.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.5 t -74.45 121.92 22.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.838 -0.619 . . . . 0.76000000000000001 109.84 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 93.4 mmm -134.93 110.56 9.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 2.0800000000000001 110.633 -175.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 60.64 16.83 6.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 2.6899999999999999 112.438 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.38 -11.1 21.85 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.433 -0.889 . . . . 0.48999999999999999 113.142 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.789 ' HB3' HD11 ' A' ' 3' ' ' ILE . 67.4 mttm -116.79 160.16 21.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.081 0.467 . . . . 1.9099999999999999 110.928 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.5 m -93.88 103.91 16.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.697 -0.683 . . . . 0.76000000000000001 110.66 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.434 ' CE1' HD13 ' A' ' 3' ' ' ILE . 26.7 m80 -92.0 99.49 12.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.751 -0.659 . . . . 1.28 109.854 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -99.41 129.41 45.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.53000000000000003 110.777 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 8.7 m -104.77 126.47 31.14 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.598 -0.89 . . . . 0.56000000000000005 108.598 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.804 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 6.9 Cg_exo -71.74 156.1 57.63 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.129 2.553 . . . . 0.76000000000000001 113.037 -170.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.353 -0.832 . . . . 2.1899999999999999 110.427 174.429 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.823 0 N-CA-C 112.371 -0.292 . . . . 1.0900000000000001 112.371 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.477 HG11 ' HE2' ' A' ' 23' ' ' MET . 44.9 t -90.22 93.53 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.095 0.474 . . . . 1.1599999999999999 110.158 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mm -111.96 108.97 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.794 -0.639 . . . . 1.48 109.968 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 33' ' ' CYS . 28.0 pt -105.09 149.06 8.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.204 0.526 . . . . 0.51000000000000001 111.336 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -86.66 48.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 1.9199999999999999 111.515 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -112.1 125.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.72 -0.673 . . . . 0.46000000000000002 109.211 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.98 ' HE2' ' HA2' ' A' ' 31' ' ' GLY . 2.5 tmtt? -73.65 102.9 4.06 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.695 0.759 . . . . 1.28 109.721 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.854 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 7.5 p -68.35 106.22 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.794 -1.094 . . . . 0.73999999999999999 111.484 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.3 mppt? -72.71 -2.16 19.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 2.6200000000000001 110.008 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.902 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -178.74 168.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.787 1.635 . . . . 0.78000000000000003 108.534 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -67.54 -40.95 85.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.936 0.334 . . . . 0.40000000000000002 111.875 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -58.95 -27.45 65.33 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.097 0.406 . . . . 3.7400000000000002 112.097 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.902 ' HG2' HG13 ' A' ' 10' ' ' ILE . 16.1 mm100 -62.98 -23.84 67.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.071 0.462 . . . . 2.2000000000000002 110.858 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.854 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.2 m -102.19 -38.98 7.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.705 -0.679 . . . . 1.1799999999999999 110.719 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.34 -34.83 78.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 1.3100000000000001 111.707 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.571 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 32.8 tptt -57.59 -54.69 52.44 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 120.665 -0.414 . . . . 2.1299999999999999 111.273 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 18.8 Cg_exo -67.75 -29.36 35.75 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.74 1.626 . . . . 0.53000000000000003 112.313 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.772 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.3 m -76.62 -55.98 5.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 121.05 -0.26 . . . . 0.35999999999999999 111.239 -174.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -66.63 -22.29 66.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 1.6499999999999999 110.587 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.31 -37.39 83.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 1.03 110.638 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 -45.94 11.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.69999999999999996 110.819 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.57 59.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.821 -0.704 . . . . 0.81000000000000005 112.147 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.772 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -137.94 105.99 5.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.178 0.513 . . . . 2.0699999999999998 110.144 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.534 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 8.9 ptm180 -62.77 -25.7 68.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.365 -0.834 . . . . 3.3599999999999999 112.188 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 57.4 m-85 -126.5 151.83 47.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.699 0.285 . . . . 1.26 110.646 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.39 85.66 0.13 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.741 -0.944 . . . . 0.73999999999999999 110.741 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -108.32 135.1 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 2.9100000000000001 110.939 -173.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 t -76.8 131.11 38.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.813 -0.631 . . . . 0.76000000000000001 109.925 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 91.1 mmm -137.25 91.79 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.581 -0.282 . . . . 2.0800000000000001 111.659 -175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.72 19.82 8.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.715 0.635 . . . . 2.6899999999999999 112.715 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.98 ' HA2' ' HE2' ' A' ' 7' ' ' LYS . . . 134.92 -50.78 0.85 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.637 -0.792 . . . . 0.48999999999999999 112.438 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -88.6 156.79 18.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.466 0.651 . . . . 1.9099999999999999 111.636 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.596 ' HB2' HG12 ' A' ' 4' ' ' ILE . 65.3 m -94.05 117.95 30.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.821 -1.081 . . . . 0.76000000000000001 109.846 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -100.4 100.42 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.968 -0.56 . . . . 1.28 109.778 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -107.64 129.16 55.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.129 0.49 . . . . 0.53000000000000003 111.396 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.4 m -98.06 130.21 29.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.606 -0.887 . . . . 0.56000000000000005 108.606 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.8 Cg_exo -69.78 151.17 68.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.852 2.368 . . . . 0.76000000000000001 113.012 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 18.5 mmmt . . . . . 0 C--O 1.245 0.855 0 CA-C-N 115.207 -0.906 . . . . 2.1899999999999999 110.461 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 112.18 -0.368 . . . . 1.0900000000000001 112.18 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.86 93.14 4.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.689 0.757 . . . . 1.1599999999999999 110.742 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.568 HG21 ' HD3' ' A' ' 32' ' ' LYS . 21.8 mm -105.59 109.64 28.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.155 -0.93 . . . . 1.48 109.803 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 29.7 pt -91.09 140.63 15.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.062 0.458 . . . . 0.51000000000000001 110.83 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -84.68 63.13 7.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.512 0.673 . . . . 1.9199999999999999 110.1 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.95 126.57 75.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.227 -0.897 . . . . 0.46000000000000002 109.513 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.629 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -55.53 102.57 0.07 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.058 0.456 . . . . 1.28 109.954 174.308 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.1 p -77.1 83.79 3.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.563 0.697 . . . . 0.73999999999999999 110.518 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 8.3 tptp -76.44 -5.95 49.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.561 -0.904 . . . . 2.6200000000000001 108.561 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.666 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.4 pt -167.59 144.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.329 -1.76 . . . . 0.78000000000000003 107.496 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.7 m -74.11 -20.33 60.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.831 0.348 . . . . 0.40000000000000002 110.52 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.37 -37.46 85.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 3.7400000000000002 111.223 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 18.2 pt20 -73.83 -14.78 61.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.947 0.403 . . . . 2.2000000000000002 110.674 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.567 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 35.3 m -97.29 -49.66 4.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 1.1799999999999999 110.721 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 26' ' ' GLY . 65.5 tp -69.97 -35.01 74.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.009 -0.541 . . . . 1.3100000000000001 112.343 -173.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.4 tppt? -58.65 -51.41 82.05 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.796 -0.362 . . . . 2.1299999999999999 111.261 -178.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 21.6 Cg_exo -67.5 -27.67 39.22 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.681 1.587 . . . . 0.53000000000000003 111.911 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.899 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 54.1 m -71.16 -51.3 25.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.946 -0.302 . . . . 0.35999999999999999 110.887 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HE3' HD11 ' A' ' 15' ' ' LEU . 84.9 mttt -64.92 -28.54 69.6 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.739 -0.601 . . . . 1.6499999999999999 111.007 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.43 -30.76 68.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 1.03 110.975 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.58 -42.85 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.268 -0.424 . . . . 0.69999999999999996 111.226 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.09 56.59 0.02 OUTLIER Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 111.479 -0.648 . . . . 0.81000000000000005 111.479 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.899 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.4 mpt? -137.71 109.07 6.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.255 -0.646 . . . . 2.0699999999999998 109.255 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.6 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -74.32 -26.67 60.31 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.27 -0.877 . . . . 3.3599999999999999 111.898 -175.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.5 m-85 -115.6 152.56 32.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.119 -0.326 . . . . 1.26 110.119 173.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -164.71 102.1 0.19 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.762 -0.935 . . . . 0.73999999999999999 110.762 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -127.83 134.49 49.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.668 0.27 . . . . 2.9100000000000001 110.496 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.3 t -73.92 127.73 33.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.76000000000000001 109.788 173.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -138.47 114.72 10.28 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.478 -0.564 . . . . 2.0800000000000001 109.478 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.4 -86.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.122 -0.945 . . . . 2.6899999999999999 111.83 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' HA2' ' NZ ' ' A' ' 7' ' ' LYS . . . -132.53 -6.01 3.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.393 -0.908 . . . . 0.48999999999999999 112.967 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.568 ' HD3' HG21 ' A' ' 3' ' ' ILE . 17.4 ptpt -121.6 160.86 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.312 0.577 . . . . 1.9099999999999999 111.453 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 39.9 m -99.52 105.96 17.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.329 -0.85 . . . . 0.76000000000000001 110.198 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -83.09 107.99 16.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.187 -0.46 . . . . 1.28 110.349 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -115.54 134.36 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.045 0.45 . . . . 0.53000000000000003 110.683 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 7.4 m -105.52 125.34 33.65 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.814 -0.81 . . . . 0.56000000000000005 108.814 176.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -53.32 146.91 38.46 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.278 2.652 . . . . 0.76000000000000001 113.525 -174.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.6 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 25.3 mmtp . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.15 -0.929 . . . . 2.1899999999999999 110.967 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.639 -0.584 . . . . 1.0900000000000001 111.639 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.4 t -86.78 99.02 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.504 0.669 . . . . 1.1599999999999999 110.251 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.493 HD12 ' CG ' ' A' ' 34' ' ' HIS . 18.0 mm -89.44 115.65 29.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 1.48 109.758 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.29 147.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.808 0.337 . . . . 0.51000000000000001 111.099 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.57 19.2 3.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.956 -0.565 . . . . 1.9199999999999999 111.081 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.0 t -77.39 128.67 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.847 -0.797 . . . . 0.46000000000000002 108.847 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.1 tmtp? -71.08 106.58 3.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.343 0.592 . . . . 1.28 109.81 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 13' ' ' GLN . 19.5 p -77.22 91.36 3.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.605 -0.725 . . . . 0.73999999999999999 109.891 177.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 10' ' ' ILE . 15.3 tptp -66.25 -13.07 59.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.57 0.7 . . . . 2.6200000000000001 109.484 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.456 HG13 ' HG2' ' A' ' 13' ' ' GLN . 3.1 pt -162.62 170.01 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 114.121 -1.4 . . . . 0.78000000000000003 108.122 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.9 m -66.46 -26.95 67.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.58 0.627 . . . . 0.40000000000000002 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -50.06 -42.27 49.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.164 -0.471 . . . . 3.7400000000000002 110.548 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 80.4 mm-40 -73.73 -8.34 55.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.721 -0.672 . . . . 2.2000000000000002 111.231 -175.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.46 -52.63 3.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.317 0.579 . . . . 1.1799999999999999 110.008 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 tp -75.6 -37.94 59.42 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 1.3100000000000001 112.109 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 23.3 tptm -55.53 -52.47 71.56 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.861 0.319 . . . . 2.1299999999999999 111.861 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 12.3 Cg_exo -71.49 -30.74 14.73 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.551 1.501 . . . . 0.53000000000000003 112.046 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 31.4 m -80.51 -55.18 5.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.35999999999999999 111.63 -172.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HA ' ' H ' ' A' ' 23' ' ' MET . 56.4 tttm -61.46 -32.16 72.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 1.6499999999999999 110.701 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.47 -36.78 81.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.706 -0.679 . . . . 1.03 110.646 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -34.69 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.422 . . . . 0.69999999999999996 110.969 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.63 62.03 0.07 OUTLIER Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.465 -0.654 . . . . 0.81000000000000005 111.465 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.698 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 12.6 mmt -134.68 105.28 6.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.541 -0.911 . . . . 2.0699999999999998 108.541 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.656 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.88 -24.54 67.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.183 -0.917 . . . . 3.3599999999999999 112.222 -174.488 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.56 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.4 m-85 -125.44 154.26 42.25 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.401 -0.187 . . . . 1.26 110.752 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.69 96.83 0.15 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 111.471 -0.652 . . . . 0.73999999999999999 111.471 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -109.85 134.06 52.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.839 0.352 . . . . 2.9100000000000001 110.06 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.1 t -77.37 129.54 35.94 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.005 -0.543 . . . . 0.76000000000000001 109.635 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 58.3 mtt -129.89 98.19 4.71 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.53 -0.305 . . . . 2.0800000000000001 110.679 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.8 m120 69.61 -77.04 0.06 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.135 0.897 . . . . 2.6899999999999999 111.269 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.671 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . -135.67 -29.19 0.37 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.21 -0.519 . . . . 0.48999999999999999 112.211 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -95.35 153.34 17.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.329 0.585 . . . . 1.9099999999999999 111.077 -178.243 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.41 130.3 39.25 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.449 -0.796 . . . . 0.76000000000000001 109.946 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.493 ' CG ' HD12 ' A' ' 3' ' ' ILE . 14.4 m-70 -116.18 87.2 2.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.515 -0.766 . . . . 1.28 109.194 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 p -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.878 0.847 . . . . 0.53000000000000003 111.864 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.6 m -95.86 127.92 39.41 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.699 -1.137 . . . . 0.56000000000000005 108.974 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 31.2 Cg_exo -59.39 151.45 68.22 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.167 2.578 . . . . 0.76000000000000001 112.356 -173.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.249 1.045 0 CA-C-N 115.323 -0.853 . . . . 2.1899999999999999 111.083 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.467 -0.253 . . . . 1.0900000000000001 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.58 104.53 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.064 0.459 . . . . 1.1599999999999999 110.335 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 34' ' ' HIS . 17.4 mm -98.34 121.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.602 -0.726 . . . . 1.48 110.029 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.59 HG12 ' HB2' ' A' ' 33' ' ' CYS . 27.1 pt -111.97 149.23 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.522 -0.308 . . . . 0.51000000000000001 110.236 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.69 14.56 5.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 1.9199999999999999 112.037 -172.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -65.12 123.47 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.631 -0.507 . . . . 0.46000000000000002 109.631 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -69.85 104.97 2.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.251 0.548 . . . . 1.28 109.832 -176.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.871 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 25.8 p -76.81 103.01 6.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 0.73999999999999999 111.113 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.65 -18.88 61.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.029 -0.73 . . . . 2.6200000000000001 109.029 172.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.587 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.0 pt -170.94 167.09 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 113.877 -1.511 . . . . 0.78000000000000003 108.208 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 48.8 m -64.39 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.14 0.427 . . . . 0.40000000000000002 110.969 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -52.38 -38.85 59.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.01 -0.541 . . . . 3.7400000000000002 110.934 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.587 ' HG2' HG13 ' A' ' 10' ' ' ILE . 87.8 mm-40 -67.11 -20.52 65.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 2.2000000000000002 112.159 -173.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.7 m -105.38 -35.57 7.47 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.536 0.569 . . . . 1.1799999999999999 112.536 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.662 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -80.89 -21.12 40.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.88 -0.728 . . . . 1.3100000000000001 111.683 -172.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 34.3 tptt -60.72 -54.62 52.86 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 119.955 -0.698 . . . . 2.1299999999999999 109.768 171.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 25.6 Cg_exo -64.75 -33.86 52.46 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.708 1.606 . . . . 0.53000000000000003 112.838 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 84.6 m -75.02 -52.82 10.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.566 -0.454 . . . . 0.35999999999999999 111.106 -176.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.551 ' HA ' ' H ' ' A' ' 23' ' ' MET . 44.8 tttm -64.67 -34.13 77.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.45 0.167 . . . . 1.6499999999999999 110.834 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.87 -35.33 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 1.03 110.63 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -6.23 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 0.69999999999999996 111.015 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 56.87 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.969 -0.634 . . . . 0.81000000000000005 112.494 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.747 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 63.6 mtt -128.59 114.66 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 2.0699999999999998 110.086 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.968 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 1.3 ptp180 -69.04 -23.57 64.08 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.926 -1.034 . . . . 3.3599999999999999 112.587 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 13.8 m-85 -127.27 155.78 42.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 1.26 111.331 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.662 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -167.36 85.43 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.916 -0.873 . . . . 0.73999999999999999 110.916 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -94.57 134.29 37.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.702 0.287 . . . . 2.9100000000000001 110.683 -176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 24.4 t -83.89 107.95 16.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.646 -0.501 . . . . 0.76000000000000001 109.646 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.449 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -139.87 131.61 27.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.533 -0.758 . . . . 2.0800000000000001 109.556 -176.432 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.489 ' OD1' ' HE2' ' A' ' 32' ' ' LYS . 26.5 t-20 69.48 0.97 3.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.439 0.638 . . . . 2.6899999999999999 111.058 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 95.39 4.05 61.11 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.903 -0.665 . . . . 0.48999999999999999 111.84 -174.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE2' ' OD1' ' A' ' 30' ' ' ASN . 56.6 mttm -112.17 156.78 21.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.048 0.452 . . . . 1.9099999999999999 110.828 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.59 ' HB2' HG12 ' A' ' 4' ' ' ILE . 30.9 m -92.5 97.69 10.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 0.76000000000000001 109.695 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.449 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 70.9 m-70 -87.88 91.85 8.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.342 -0.844 . . . . 1.28 109.455 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.31 152.49 23.48 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.38 0.609 . . . . 0.53000000000000003 111.736 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.1 m -129.41 131.91 23.93 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.412 -0.958 . . . . 0.56000000000000005 108.412 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 22.7 Cg_exo -63.27 151.81 83.01 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.112 2.541 . . . . 0.76000000000000001 113.013 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.968 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 50.2 tptt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.202 -0.904 . . . . 2.1899999999999999 109.346 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.851 -0.5 . . . . 1.0900000000000001 111.851 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.31 93.41 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.983 0.421 . . . . 1.1599999999999999 110.476 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.4 tp -104.61 119.5 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.243 0.544 . . . . 1.48 110.473 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.602 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.8 pt -114.55 154.02 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.799 -0.637 . . . . 0.51000000000000001 110.821 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.96 24.34 2.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.05 -0.523 . . . . 1.9199999999999999 111.531 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.5 t -81.39 134.36 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.212 -0.662 . . . . 0.46000000000000002 109.212 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -78.18 117.64 19.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.587 0.708 . . . . 1.28 109.551 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' N ' ' HD3' ' A' ' 7' ' ' LYS . 14.5 p -78.05 85.65 4.25 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.03 -0.986 . . . . 0.73999999999999999 111.996 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.39 -16.14 43.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.662 0.744 . . . . 2.6200000000000001 109.425 172.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.648 HG13 ' HG2' ' A' ' 13' ' ' GLN . 4.0 pt -169.03 173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 113.583 -1.644 . . . . 0.78000000000000003 106.927 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -74.8 -25.2 58.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.392 0.542 . . . . 0.40000000000000002 110.302 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -63.47 -32.61 74.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.468 . . . . 3.7400000000000002 111.073 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.648 ' HG2' HG13 ' A' ' 10' ' ' ILE . 17.4 mm100 -58.73 -30.8 67.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.254 0.55 . . . . 2.2000000000000002 110.628 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.638 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 11.0 m -94.98 -44.58 7.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.076 -0.966 . . . . 1.1799999999999999 111.078 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.89 HD21 ' HE2' ' A' ' 19' ' ' LYS . 42.2 tp -74.34 -24.59 59.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 1.3100000000000001 112.261 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -62.69 -52.75 62.43 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.823 -0.351 . . . . 2.1299999999999999 111.099 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 7.8 Cg_exo -74.34 -17.93 20.94 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.84 1.693 . . . . 0.53000000000000003 112.099 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.79 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.6 m -82.48 -56.75 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.6 -0.44 . . . . 0.35999999999999999 111.518 -176.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.89 ' HE2' HD21 ' A' ' 15' ' ' LEU . 42.0 mttm -57.18 -38.27 73.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.254 0.479 . . . . 1.6499999999999999 110.811 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.94 -32.41 73.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.937 -0.574 . . . . 1.03 111.152 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 -11.91 37.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.446 -0.343 . . . . 0.69999999999999996 111.243 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.76 45.67 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.746 -0.74 . . . . 0.81000000000000005 112.987 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.79 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.1 mpt? -125.7 106.75 9.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.981 0.896 . . . . 2.0699999999999998 110.455 170.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.747 ' HB2' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -47.22 -55.3 8.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.517 -1.674 . . . . 3.3599999999999999 112.137 173.246 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 46.5 m-85 -99.34 158.93 15.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.912 0.387 . . . . 1.26 111.208 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.71 91.69 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.189 -1.164 . . . . 0.73999999999999999 110.189 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -121.76 138.8 54.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.848 0.356 . . . . 2.9100000000000001 110.502 -170.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.1 t -70.25 122.67 19.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.76000000000000001 109.864 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.8 mmt -137.77 102.36 4.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.34 -0.391 . . . . 2.0800000000000001 111.004 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 64.59 16.56 10.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.841 -0.618 . . . . 2.6899999999999999 111.788 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.56 -22.48 11.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.631 -0.795 . . . . 0.48999999999999999 112.366 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.712 ' HB3' HD11 ' A' ' 3' ' ' ILE . 62.9 mttp -102.66 161.61 13.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.139 0.495 . . . . 1.9099999999999999 110.7 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.602 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 85.3 m -99.32 109.8 22.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.774 -0.648 . . . . 0.76000000000000001 111.096 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.408 ' CE1' HD13 ' A' ' 3' ' ' ILE . 4.9 m80 -92.23 103.81 16.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.56 -0.746 . . . . 1.28 110.582 177.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.47 149.96 29.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.384 0.611 . . . . 0.53000000000000003 111.044 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 9.0 m -126.91 131.81 24.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.707 -0.849 . . . . 0.56000000000000005 108.707 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.0 Cg_exo -59.85 143.47 99.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.298 2.665 . . . . 0.76000000000000001 113.124 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.747 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 18.9 ttpt . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.094 -0.957 . . . . 2.1899999999999999 110.134 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 112.294 -0.322 . . . . 1.0900000000000001 112.294 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.485 HG21 ' SD ' ' A' ' 23' ' ' MET . 59.0 t -75.95 105.74 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.203 0.525 . . . . 1.1599999999999999 110.803 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.0 116.93 50.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.313 -0.858 . . . . 1.48 109.562 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.546 HG12 ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -113.41 147.58 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.076 0.465 . . . . 0.51000000000000001 111.7 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -82.57 69.54 9.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.454 -0.794 . . . . 1.9199999999999999 111.07 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.2 t -131.65 129.52 61.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.604 . . . . 0.46000000000000002 109.573 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -75.42 86.43 2.56 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 1.28 109.29 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.3 p -58.79 98.46 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.567 -1.197 . . . . 0.73999999999999999 112.786 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 10' ' ' ILE . 38.4 mmtm -72.36 -11.96 60.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.328 -0.989 . . . . 2.6200000000000001 108.328 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.537 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.2 pt -169.13 154.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 113.521 -1.672 . . . . 0.78000000000000003 108.237 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.507 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 23.8 m -72.87 -30.63 64.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.356 0.598 . . . . 0.40000000000000002 110.008 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -62.32 -25.66 68.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.215 -0.902 . . . . 3.7400000000000002 112.558 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 14.7 pt20 -79.25 -19.88 49.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 2.2000000000000002 110.312 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.613 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 8.5 m -96.68 -31.23 12.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.98 -0.555 . . . . 1.1799999999999999 110.193 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.512 HD11 ' HZ2' ' A' ' 19' ' ' LYS . 56.9 tp -69.71 -36.59 76.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.055 -0.521 . . . . 1.3100000000000001 112.154 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.505 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 39.9 tptt -53.7 -55.95 30.17 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 119.225 -0.417 . . . . 2.1299999999999999 111.086 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 19.1 Cg_exo -67.31 -22.39 46.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.648 1.566 . . . . 0.53000000000000003 112.249 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 69.7 m -81.72 -56.03 4.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.798 -0.361 . . . . 0.35999999999999999 111.952 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.512 ' HZ2' HD11 ' A' ' 15' ' ' LEU . 4.7 ttmp? -67.75 -26.27 66.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.299 0.5 . . . . 1.6499999999999999 110.216 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.19 -34.21 77.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.696 -0.683 . . . . 1.03 109.926 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.414 ' HB3' ' HE1' ' A' ' 23' ' ' MET . . . -85.18 -45.59 11.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.777 -0.647 . . . . 0.69999999999999996 110.792 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.18 40.61 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.174 -0.536 . . . . 0.81000000000000005 112.407 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.677 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 5.4 mpp? -124.59 103.44 8.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.249 0.547 . . . . 2.0699999999999998 110.448 174.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 5.7 ptp180 -52.18 -33.83 42.48 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.232 -0.895 . . . . 3.3599999999999999 112.485 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 33.1 m-85 -120.84 160.86 22.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.26 111.118 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -159.83 95.77 0.14 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.337 -1.105 . . . . 0.73999999999999999 110.337 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 91.7 mttt -120.0 134.64 55.19 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 2.9100000000000001 110.909 -171.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.7 t -74.34 123.54 24.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.018 -0.537 . . . . 0.76000000000000001 109.995 176.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.7 mmt -126.16 96.37 4.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 2.0800000000000001 110.727 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.2 t30 73.58 -62.7 0.46 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.724 -1.125 . . . . 2.6899999999999999 112.034 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.95 -35.9 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.66 -0.781 . . . . 0.48999999999999999 112.943 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -107.78 170.61 7.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.385 0.612 . . . . 1.9099999999999999 110.429 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.546 ' HB2' HG12 ' A' ' 4' ' ' ILE . 15.3 m -94.87 125.89 39.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.153 -0.931 . . . . 0.76000000000000001 110.018 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -104.92 108.44 19.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.226 -0.657 . . . . 1.28 109.226 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.3 118.31 36.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.326 0.584 . . . . 0.53000000000000003 111.493 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.0 m -80.53 130.14 66.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.174 -0.921 . . . . 0.56000000000000005 108.937 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.5 Cg_exo -69.49 147.98 65.82 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.167 2.578 . . . . 0.76000000000000001 112.508 -171.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.0 tttm . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.234 -0.894 . . . . 2.1899999999999999 110.345 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.585 -0.606 . . . . 1.0900000000000001 111.585 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.4 t -81.12 93.46 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.353 0.597 . . . . 1.1599999999999999 110.431 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.896 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.9 tp -103.65 128.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.692 -0.686 . . . . 1.48 110.733 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.575 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 24.3 pt -121.0 143.49 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.599 -0.519 . . . . 0.51000000000000001 109.599 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -83.32 14.32 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.836 0.31 . . . . 1.9199999999999999 111.836 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.24 126.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.0 -0.741 . . . . 0.46000000000000002 109.0 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.582 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 2.7 tmtp? -70.95 111.86 6.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.483 0.658 . . . . 1.28 109.81 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 11.8 p -76.94 93.36 3.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.102 -0.954 . . . . 0.73999999999999999 111.547 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -61.81 -14.21 31.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.404 0.621 . . . . 2.6200000000000001 110.036 173.47 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.761 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -171.46 164.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 125.641 1.576 . . . . 0.78000000000000003 107.577 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -62.03 -38.48 88.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.254 0.479 . . . . 0.40000000000000002 111.006 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.41 -24.02 64.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.215 0.45 . . . . 3.7400000000000002 112.215 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.761 ' HG2' HG13 ' A' ' 10' ' ' ILE . 15.7 mm100 -62.52 -30.54 71.37 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.2 0.524 . . . . 2.2000000000000002 110.691 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 m -101.39 -40.08 7.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.777 -0.647 . . . . 1.1799999999999999 111.17 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.832 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.4 tt -78.6 -23.69 45.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.286 -0.416 . . . . 1.3100000000000001 111.614 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 11.1 tmtt? -56.4 -55.1 46.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.619 -0.511 . . . . 2.1299999999999999 109.619 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 85.5 Cg_endo -77.87 -19.73 12.31 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.207 1.271 . . . . 0.53000000000000003 112.227 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.832 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 1.2 m -71.42 -56.9 5.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.87 -0.332 . . . . 0.35999999999999999 110.878 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.587 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 38.6 ttmt -64.1 -33.41 75.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.203 -0.295 . . . . 1.6499999999999999 110.203 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.8 -39.33 84.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 1.03 110.554 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.78 0.69 54.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.015 -0.539 . . . . 0.69999999999999996 111.39 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.91 53.7 1.88 Allowed Glycine 0 CA--C 1.506 -0.485 0 C-N-CA 120.941 -0.647 . . . . 0.81000000000000005 112.43 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 17.0 mmt -131.31 97.4 4.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.664 -0.865 . . . . 2.0699999999999998 108.664 172.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.744 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 6.0 ttt85 -55.54 -37.74 68.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.092 . . . . 3.3599999999999999 111.454 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 71.6 m-85 -106.29 149.0 27.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.785 0.326 . . . . 1.26 110.613 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.578 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -165.07 72.3 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.221 -1.152 . . . . 0.73999999999999999 110.221 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.95 135.01 44.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.137 0.494 . . . . 2.9100000000000001 110.857 -168.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.6 t -78.48 121.77 24.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.76000000000000001 110.264 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.7 mmt -138.26 106.43 5.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.516 -0.311 . . . . 2.0800000000000001 111.556 -175.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.7 m120 62.46 13.7 6.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.61 -0.723 . . . . 2.6899999999999999 112.188 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.582 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 123.47 -32.68 4.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.492 -0.861 . . . . 0.48999999999999999 112.634 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.896 ' HB3' HD11 ' A' ' 3' ' ' ILE . 10.9 mptt -94.47 157.71 15.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.283 0.563 . . . . 1.9099999999999999 111.489 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.575 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 45.4 m -96.85 110.41 22.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.207 -0.906 . . . . 0.76000000000000001 110.479 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -92.76 95.39 9.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.01 -0.541 . . . . 1.28 110.399 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.73 147.74 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.455 0.645 . . . . 0.53000000000000003 111.352 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 13.4 m -129.45 129.62 23.24 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.506 -0.924 . . . . 0.56000000000000005 108.506 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 58.1 Cg_exo -51.39 148.82 18.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.384 2.722 . . . . 0.76000000000000001 112.804 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.744 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.3 tptm . . . . . 0 C--O 1.248 1.007 0 O-C-N 124.082 0.864 . . . . 2.1899999999999999 111.669 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.378 0.609 . . . . 1.1599999999999999 110.318 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.611 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -94.48 124.1 46.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.577 -0.738 . . . . 1.48 110.341 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.593 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 27.5 pt -103.39 142.53 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.158 -0.474 . . . . 0.51000000000000001 109.962 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.819 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 24.6 p-10 -84.0 24.41 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 1.9199999999999999 111.627 -174.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -76.03 135.6 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.727 -0.472 . . . . 0.46000000000000002 109.727 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -63.37 105.91 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.467 0.651 . . . . 1.28 110.615 177.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 11.0 p -79.24 83.77 5.25 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.059 -0.973 . . . . 0.73999999999999999 111.26 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.71 -18.5 65.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 2.6200000000000001 108.41 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 pt -162.8 146.39 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.499 -1.682 . . . . 0.78000000000000003 108.025 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.97 -28.4 64.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.925 0.343 . . . . 0.40000000000000002 111.925 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -64.8 -29.04 69.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.86 0.318 . . . . 3.7400000000000002 111.86 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.8 pt20 -74.6 -20.14 60.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.106 0.479 . . . . 2.2000000000000002 110.256 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 25.7 m -92.25 -41.73 10.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.888 -0.596 . . . . 1.1799999999999999 110.077 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.3 tp -69.24 -33.99 74.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 1.3100000000000001 112.365 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 6.9 tmtm? -55.85 -56.92 25.05 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 119.501 -0.285 . . . . 2.1299999999999999 110.604 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 73.5 Cg_endo -72.91 -20.49 22.2 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.414 1.409 . . . . 0.53000000000000003 112.714 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.763 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 59.5 m -77.98 -50.58 11.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.804 -0.358 . . . . 0.35999999999999999 110.956 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -65.79 -21.27 66.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 1.6499999999999999 110.172 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.8 -19.9 43.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.666 -0.697 . . . . 1.03 110.54 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.08 -30.19 12.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.69999999999999996 110.977 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.79 45.82 0.1 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.151 -0.547 . . . . 0.81000000000000005 112.106 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.763 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -130.95 106.63 8.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.042 0.448 . . . . 2.0699999999999998 110.021 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.913 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -65.45 -27.32 68.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.667 -0.697 . . . . 3.3599999999999999 111.869 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.561 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 60.5 m-85 -117.91 157.7 26.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 1.26 110.686 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.33 88.65 0.11 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.692 -0.963 . . . . 0.73999999999999999 110.692 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -116.86 134.76 54.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.882 0.372 . . . . 2.9100000000000001 110.686 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 13.9 t -74.14 120.84 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.081 -0.508 . . . . 0.76000000000000001 110.832 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.419 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 85.4 mmm -138.66 116.67 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 2.0800000000000001 111.177 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.22 12.09 5.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.1 0.56 . . . . 2.6899999999999999 112.458 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.21 -17.05 22.1 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.718 . . . . 0.48999999999999999 112.334 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.819 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 13.8 mptt -103.72 156.29 17.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 1.9099999999999999 110.957 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.593 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 59.7 m -93.06 109.88 21.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.781 -0.645 . . . . 0.76000000000000001 109.494 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.611 ' HA ' HG13 ' A' ' 3' ' ' ILE . 9.9 m170 -87.7 95.7 10.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.871 -0.604 . . . . 1.28 110.18 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB3' ' HG2' ' A' ' 23' ' ' MET . 74.4 m -100.43 110.29 22.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.591 0.71 . . . . 0.53000000000000003 110.914 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.6 m -89.95 129.59 45.65 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.389 -0.823 . . . . 0.56000000000000005 109.065 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -54.36 149.64 36.88 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.674 2.916 . . . . 0.76000000000000001 113.984 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.913 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 27.8 tptp . . . . . 0 C--O 1.242 0.698 0 CA-C-N 115.248 -0.887 . . . . 2.1899999999999999 110.114 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 121.323 0.582 . . . . 1.1599999999999999 110.348 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.8 mm -83.43 109.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 1.48 110.137 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.5 pt -99.59 130.6 48.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.051 0.453 . . . . 0.51000000000000001 110.932 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.47 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 19.7 m-20 -74.53 63.79 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.482 -0.781 . . . . 1.9199999999999999 111.13 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.64 134.13 59.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.705 -0.68 . . . . 0.46000000000000002 109.513 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.668 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -64.86 106.7 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 1.28 110.781 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.896 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 21.1 p -85.96 83.23 7.85 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.893 -0.594 . . . . 0.73999999999999999 110.568 173.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -61.97 -19.24 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.55 -0.907 . . . . 2.6200000000000001 108.55 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.517 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 10.2 pt -160.52 164.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 113.37 -1.741 . . . . 0.78000000000000003 107.032 174.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -61.98 -33.38 74.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.686 0.675 . . . . 0.40000000000000002 111.391 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -57.67 -31.9 66.79 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.294 -0.412 . . . . 3.7400000000000002 111.834 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.517 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 15.9 mm100 -62.87 -26.37 68.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.869 0.366 . . . . 2.2000000000000002 111.302 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.896 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.5 m -95.27 -46.08 6.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.055 -0.521 . . . . 1.1799999999999999 111.347 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.002 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.2 tt -73.89 -24.42 59.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.293 0.479 . . . . 1.3100000000000001 112.293 -166.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 38.0 tptt -61.22 -57.84 23.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.295 -0.962 . . . . 2.1299999999999999 109.63 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.5 Cg_exo -59.33 -33.96 97.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.437 1.425 . . . . 0.53000000000000003 111.956 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.002 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 12.0 m -64.27 -63.03 1.25 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.35999999999999999 111.506 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.18 -32.25 72.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.385 0.539 . . . . 1.6499999999999999 111.052 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.39 -40.47 97.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.054 -0.521 . . . . 1.03 110.936 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.44 -26.47 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.128 0.49 . . . . 0.69999999999999996 111.0 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.61 65.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.841 -0.618 . . . . 0.81000000000000005 112.232 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.682 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 15.6 mmt -135.68 104.34 5.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.858 -0.793 . . . . 2.0699999999999998 108.858 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.594 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.67 -28.27 69.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.593 -0.73 . . . . 3.3599999999999999 110.962 -177.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.1 m-85 -117.71 153.95 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.207 -0.294 . . . . 1.26 110.207 173.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.667 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -156.08 110.18 0.43 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.836 -0.697 . . . . 0.73999999999999999 111.849 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 9.5 mmtp -129.23 134.95 48.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.931 0.396 . . . . 2.9100000000000001 111.841 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 8.1 t -75.52 132.95 41.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.93 -0.577 . . . . 0.76000000000000001 109.615 174.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.2 mmt -134.36 80.88 1.88 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.962 -0.295 . . . . 2.0800000000000001 111.356 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 p30 62.87 -4.14 0.27 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.224 1.41 . . . . 2.6899999999999999 113.846 171.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -55.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.748 -0.739 . . . . 0.48999999999999999 111.722 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.4 mptm? -89.49 161.07 16.43 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.192 0.52 . . . . 1.9099999999999999 110.908 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 56.4 m -96.73 115.64 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.76000000000000001 109.905 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -97.24 93.15 6.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 1.28 109.808 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.554 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.7 m -112.69 127.02 56.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.042 -0.527 . . . . 0.53000000000000003 111.346 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 35.1 m -86.96 124.99 67.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.42 -0.809 . . . . 0.56000000000000005 109.07 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 50.0 Cg_exo -54.42 152.74 25.17 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.533 2.822 . . . . 0.76000000000000001 113.45 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.4 tptp . . . . . 0 C--O 1.242 0.688 0 CA-C-O 118.189 -0.91 . . . . 2.1899999999999999 111.038 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.167 0.508 . . . . 1.1599999999999999 110.238 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.827 HD11 ' HB3' ' A' ' 32' ' ' LYS . 7.0 tp -91.58 120.17 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.736 -0.666 . . . . 1.48 110.417 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 19.8 pt -102.6 136.54 34.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.041 0.448 . . . . 0.51000000000000001 110.734 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -79.91 64.95 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.702 -0.681 . . . . 1.9199999999999999 111.124 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -125.01 130.45 73.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.229 -0.896 . . . . 0.46000000000000002 109.477 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.7 107.44 3.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.052 -0.721 . . . . 1.28 109.052 178.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 11.5 p -78.18 91.29 4.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.943 -1.026 . . . . 0.73999999999999999 112.428 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HD3' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -70.3 -11.14 60.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.622 0.725 . . . . 2.6200000000000001 109.459 174.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.6 pt -165.83 145.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.055 -1.429 . . . . 0.78000000000000003 108.19 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.6 m -70.95 -24.46 62.44 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.816 -0.354 . . . . 0.40000000000000002 110.518 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.17 -34.45 78.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.836 0.31 . . . . 3.7400000000000002 111.836 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 16.3 pt20 -70.63 -20.42 62.73 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.194 0.521 . . . . 2.2000000000000002 110.119 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 12.5 m -94.98 -41.37 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.603 -0.726 . . . . 1.1799999999999999 110.237 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.679 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 1.6 tt -77.02 -37.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.844 -0.617 . . . . 1.3100000000000001 111.913 -171.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 27.0 tptp -50.46 -52.79 51.98 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-O 119.464 -0.303 . . . . 2.1299999999999999 111.411 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 6.9 Cg_exo -73.93 -20.47 19.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.643 1.562 . . . . 0.53000000000000003 112.505 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 37.4 m -83.39 -54.08 5.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.344 -0.543 . . . . 0.35999999999999999 111.821 -175.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.643 ' HE2' HD21 ' A' ' 15' ' ' LEU . 23.0 ttmm -63.77 -35.78 81.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.408 -0.517 . . . . 1.6499999999999999 110.334 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.94 -37.27 86.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.916 0.389 . . . . 1.03 110.184 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.03 0.85 46.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.69999999999999996 111.335 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.49 60.02 1.06 Allowed Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.937 -0.649 . . . . 0.81000000000000005 112.669 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 17.9 mmt -132.77 108.14 8.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.112 -0.699 . . . . 2.0699999999999998 109.112 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.467 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -60.69 -31.4 70.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.867 -1.06 . . . . 3.3599999999999999 110.983 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 51.1 m-85 -120.67 149.64 42.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.695 0.283 . . . . 1.26 111.072 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.679 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -158.48 78.27 0.18 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.695 -0.962 . . . . 0.73999999999999999 110.695 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -114.5 135.0 54.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.955 0.407 . . . . 2.9100000000000001 110.478 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 4.4 t -72.3 127.87 33.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.953 -0.567 . . . . 0.76000000000000001 109.751 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.48 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.472 -0.331 . . . . 2.0800000000000001 110.336 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 72.0 -66.42 0.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.223 0.952 . . . . 2.6899999999999999 112.432 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -126.18 -25.51 1.33 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.236 -0.983 . . . . 0.48999999999999999 113.23 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.827 ' HB3' HD11 ' A' ' 3' ' ' ILE . 35.2 mtmt -121.68 158.35 28.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.235 0.541 . . . . 1.9099999999999999 112.213 -170.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 56.8 m -93.91 109.02 20.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.299 -0.864 . . . . 0.76000000000000001 110.238 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.528 ' CD2' HD13 ' A' ' 3' ' ' ILE . 1.8 m-70 -87.05 100.47 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 1.28 111.0 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -104.23 118.03 35.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.144 0.497 . . . . 0.53000000000000003 110.574 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.3 m -101.83 122.18 48.31 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.078 -0.712 . . . . 0.56000000000000005 109.078 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -51.94 147.21 26.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.385 2.723 . . . . 0.76000000000000001 113.484 -173.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 24.0 tptm . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.129 -0.941 . . . . 2.1899999999999999 111.281 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.812 HG23 ' HG3' ' A' ' 37' ' ' PRO . 47.1 t . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.175 0.512 . . . . 1.1599999999999999 110.469 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -115.24 109.63 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.88 -0.785 . . . . 1.48 108.88 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 33' ' ' CYS . 15.8 pt -123.51 134.62 65.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.07 0.462 . . . . 0.51000000000000001 111.464 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.735 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 m-20 -77.93 63.7 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.608 -0.724 . . . . 1.9199999999999999 110.475 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -115.35 124.03 71.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 0.46000000000000002 109.24 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.593 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -58.04 104.21 0.19 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.232 0.539 . . . . 1.28 110.172 175.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.653 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.6 p -89.87 87.27 6.88 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.781 -0.645 . . . . 0.73999999999999999 110.084 174.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 21.0 tptt -64.43 -13.03 49.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 2.6200000000000001 109.258 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.414 HG13 ' HG2' ' A' ' 13' ' ' GLN . 8.1 pt -154.65 159.41 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 113.782 -1.554 . . . . 0.78000000000000003 108.165 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 61.4 m -67.22 -19.87 65.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.81 0.338 . . . . 0.40000000000000002 111.217 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -59.29 -31.1 68.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.176 -0.465 . . . . 3.7400000000000002 110.879 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 10' ' ' ILE . 14.3 mm100 -67.58 -24.38 65.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.905 -0.589 . . . . 2.2000000000000002 110.676 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.1 m -92.57 -45.5 8.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.281 0.562 . . . . 1.1799999999999999 109.875 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.582 HD12 ' SD ' ' A' ' 23' ' ' MET . 11.4 tp -52.48 -51.38 59.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.877 -1.056 . . . . 1.3100000000000001 112.669 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 40.5 tptt -56.21 -59.73 11.02 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 119.01 -0.519 . . . . 2.1299999999999999 111.42 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.3 Cg_exo -57.83 -34.23 97.99 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.571 1.514 . . . . 0.53000000000000003 112.479 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.79 -54.46 6.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.35999999999999999 111.421 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 25.2 tttm -74.5 -17.95 60.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.71 0.291 . . . . 1.6499999999999999 110.829 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 5.4 t70 -68.3 -30.33 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.412 -0.588 . . . . 1.03 109.412 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.19 3.35 43.67 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.797 -0.638 . . . . 0.69999999999999996 110.544 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.712 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 100.11 105.01 2.66 Favored Glycine 0 CA--C 1.499 -0.919 0 CA-C-N 115.465 -0.789 . . . . 0.81000000000000005 111.435 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.582 ' SD ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -119.43 121.76 40.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.321 1.058 . . . . 2.0699999999999998 109.564 174.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.685 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -89.0 -29.2 19.67 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.051 -1.431 . . . . 3.3599999999999999 108.285 168.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.5 m-85 -140.02 151.52 45.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.136 -0.938 . . . . 1.26 109.347 170.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA3' ' SD ' ' A' ' 23' ' ' MET . . . -150.95 108.27 0.38 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.06 -0.591 . . . . 0.73999999999999999 111.807 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -129.41 138.7 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.169 0.509 . . . . 2.9100000000000001 112.0 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 7.8 t -87.24 132.49 33.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.014 -1.106 . . . . 0.76000000000000001 108.014 167.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 52.6 mtt -126.14 77.69 1.7 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.041 -0.664 . . . . 2.0800000000000001 111.208 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 70.97 -58.58 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.385 1.053 . . . . 2.6899999999999999 112.563 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.91 -47.08 0.21 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.958 -0.639 . . . . 0.48999999999999999 112.566 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.735 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.1 mptm? -107.46 164.43 12.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 1.9099999999999999 111.293 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.653 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -92.77 123.46 36.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.36 -0.836 . . . . 0.76000000000000001 110.365 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.41 98.04 5.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 1.28 109.613 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' HB ' ' A' ' 2' ' ' VAL . 7.6 p -121.13 159.22 26.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.036 -0.529 . . . . 0.53000000000000003 110.902 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 24.2 m -112.65 113.37 50.48 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.588 -0.733 . . . . 0.56000000000000005 109.151 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.812 ' HG3' HG23 ' A' ' 2' ' ' VAL . 32.7 Cg_exo -58.98 152.73 56.29 Favored 'Trans proline' 0 CA--C 1.519 -0.238 0 C-N-CA 122.836 2.357 . . . . 0.76000000000000001 112.324 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.685 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 20.3 tptm . . . . . 0 C--O 1.246 0.906 0 CA-C-N 115.565 -0.743 . . . . 2.1899999999999999 110.619 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.449 -0.525 0 N-CA-C 109.375 -0.602 . . . . 1.1599999999999999 109.375 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.8 tp -88.07 110.42 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.855 0.836 . . . . 1.48 111.0 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.422 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -95.23 147.57 5.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.358 -0.837 . . . . 0.51000000000000001 110.679 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -84.42 14.11 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 1.9199999999999999 111.285 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.14 120.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.421 -0.585 . . . . 0.46000000000000002 109.421 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.682 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.8 tmtp? -67.73 115.95 7.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.973 -0.751 . . . . 1.28 108.973 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 28.5 p -77.16 82.96 3.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.525 -0.761 . . . . 0.73999999999999999 111.475 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 10' ' ' ILE . 13.8 mmmm -66.44 -17.58 64.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.744 0.783 . . . . 2.6200000000000001 108.992 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.568 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.4 pt -166.04 148.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.86 -1.518 . . . . 0.78000000000000003 108.123 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -74.08 -19.72 60.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.868 0.366 . . . . 0.40000000000000002 110.897 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.9 mtp180 -54.58 -47.08 73.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 3.7400000000000002 110.731 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.6 pt20 -76.51 -4.15 41.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 2.2000000000000002 111.125 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 75.3 m -95.61 -58.15 2.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.074 -0.512 . . . . 1.1799999999999999 110.44 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.601 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -79.12 -31.74 44.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.638 0.607 . . . . 1.3100000000000001 112.638 -169.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -54.79 -50.75 84.19 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.654 -0.418 . . . . 2.1299999999999999 110.702 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 14.3 Cg_exo -71.59 -29.76 15.75 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.634 1.556 . . . . 0.53000000000000003 112.923 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.712 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 81.3 m -74.18 -52.17 13.28 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.446 -0.501 . . . . 0.35999999999999999 111.422 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.595 ' HA ' ' H ' ' A' ' 23' ' ' MET . 41.2 ttmt -65.77 -27.35 68.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.067 0.46 . . . . 1.6499999999999999 110.267 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.28 -28.42 69.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 1.03 110.082 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.52 5.51 41.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.69999999999999996 111.244 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.86 53.01 1.99 Allowed Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.88 -0.676 . . . . 0.81000000000000005 112.765 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.712 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 56.8 mtt -131.57 102.16 5.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.587 0.708 . . . . 2.0699999999999998 109.366 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.669 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 10.9 ttt180 -60.39 -27.21 67.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.169 -1.378 . . . . 3.3599999999999999 112.335 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.597 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.7 m-85 -117.62 163.3 16.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.852 0.358 . . . . 1.26 110.867 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.601 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -178.6 74.24 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.999 -0.841 . . . . 0.73999999999999999 110.999 -177.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -104.16 133.69 48.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.664 -0.268 . . . . 2.9100000000000001 110.469 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.2 t -70.42 126.84 30.78 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.881 -0.414 . . . . 0.76000000000000001 109.881 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.8 mmm -137.39 103.52 5.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 2.0800000000000001 110.261 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 72.7 -74.72 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.997 0.811 . . . . 2.6899999999999999 110.997 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.682 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . -146.15 4.7 1.18 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.913 -0.66 . . . . 0.48999999999999999 112.863 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.614 ' HB3' HD11 ' A' ' 3' ' ' ILE . 91.1 mttt -131.93 160.41 35.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.036 0.446 . . . . 1.9099999999999999 111.478 -176.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 66.8 m -96.86 113.17 24.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.76000000000000001 110.045 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.519 ' CD2' HD13 ' A' ' 3' ' ' ILE . 1.8 m-70 -86.55 94.6 9.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 1.28 110.498 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.4 m -104.3 115.35 30.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.453 0.644 . . . . 0.53000000000000003 111.485 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.597 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 22.6 m -92.41 129.01 42.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.764 -0.828 . . . . 0.56000000000000005 108.764 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 37.8 Cg_exo -57.14 155.12 30.39 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.852 2.368 . . . . 0.76000000000000001 112.009 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.669 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 7.7 tptp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.078 -0.963 . . . . 2.1899999999999999 112.356 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.595 HG11 ' HE2' ' A' ' 23' ' ' MET . 43.1 t . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 121.095 0.474 . . . . 1.1599999999999999 110.034 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.16 109.51 28.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.75 -0.659 . . . . 1.48 110.494 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.1 pt -99.37 137.29 27.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.079 -0.51 . . . . 0.51000000000000001 109.812 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -81.42 33.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 1.9199999999999999 111.67 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.76 135.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.087 -1.079 . . . . 0.46000000000000002 108.087 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.561 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 1.8 tmtt? -77.76 115.43 17.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.729 -0.788 . . . . 1.28 110.242 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 10.2 p -73.02 85.98 1.31 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.462 -1.244 . . . . 0.73999999999999999 111.884 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.4 mptm? -66.76 -13.44 61.42 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.556 -0.715 . . . . 2.6200000000000001 109.352 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.643 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.2 pt -166.63 150.52 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.384 -1.28 . . . . 0.78000000000000003 108.587 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 50.4 m -63.7 -52.96 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.791 0.293 . . . . 0.40000000000000002 111.791 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 13.8 ptm180 -60.22 -19.47 54.56 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 3.7400000000000002 113.246 -173.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 11.4 pt20 -72.78 -25.43 61.16 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.201 -0.6 . . . . 2.2000000000000002 109.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 32.8 m -93.67 -34.64 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.895 -0.593 . . . . 1.1799999999999999 109.707 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 12' ' ' ARG . 59.0 tp -65.29 -41.27 94.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 1.3100000000000001 112.104 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 18.2 tptm -57.63 -52.04 77.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.329 -0.548 . . . . 2.1299999999999999 111.739 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 23.8 Cg_exo -65.43 -25.46 55.96 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.695 1.597 . . . . 0.53000000000000003 111.94 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.754 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 66.2 m -82.39 -52.42 6.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.619 -0.264 . . . . 0.35999999999999999 110.818 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HA ' ' H ' ' A' ' 23' ' ' MET . 70.2 tttt -64.03 -27.58 69.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.782 0.325 . . . . 1.6499999999999999 110.682 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.86 -45.78 90.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.058 -0.519 . . . . 1.03 110.035 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.83 61.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.69999999999999996 110.664 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.84 54.56 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.834 -0.621 . . . . 0.81000000000000005 112.16 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.754 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -130.95 105.09 7.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 2.0699999999999998 110.545 175.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.579 ' N ' ' HB2' ' A' ' 38' ' ' LYS . 8.3 ptm180 -55.59 -27.49 49.68 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.264 -0.88 . . . . 3.3599999999999999 112.698 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 26.9 m-85 -124.63 160.34 28.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 1.26 110.818 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.78 59.67 0.12 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.602 -0.999 . . . . 0.73999999999999999 110.602 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 97.1 mttt -98.41 152.58 19.34 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.19 0.519 . . . . 2.9100000000000001 110.609 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t -77.61 112.75 14.74 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.323 -0.853 . . . . 0.76000000000000001 110.528 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 62.4 mtt -137.99 125.74 22.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 2.0800000000000001 109.874 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 68.45 -4.72 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.13 0.49 . . . . 2.6899999999999999 111.674 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' HE2' ' A' ' 7' ' ' LYS . . . 114.47 -14.01 20.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.831 -0.7 . . . . 0.48999999999999999 112.137 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -102.24 159.74 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.799 0.333 . . . . 1.9099999999999999 110.504 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 56.8 m -91.13 95.62 10.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.02 -0.733 . . . . 0.76000000000000001 109.02 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -76.8 93.95 3.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.268 -0.878 . . . . 1.28 111.046 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 75.0 m -98.68 111.16 23.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.394 0.616 . . . . 0.53000000000000003 111.034 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.6 m -88.99 130.59 44.01 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.48 -0.933 . . . . 0.56000000000000005 108.48 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.729 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 3.1 Cg_exo -72.22 151.53 54.9 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.175 2.583 . . . . 0.76000000000000001 112.238 -170.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HB2' ' N ' ' A' ' 24' ' ' ARG . 50.1 tttm . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.36 -0.829 . . . . 2.1899999999999999 110.682 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.172 0.51 . . . . 1.1599999999999999 110.256 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 mm -104.76 121.76 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.003 -0.544 . . . . 1.48 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.563 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.7 pt -106.26 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.905 0.383 . . . . 0.51000000000000001 110.323 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.76 31.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 1.9199999999999999 112.112 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.17 139.29 17.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.938 -0.764 . . . . 0.46000000000000002 108.938 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.669 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.6 tmtp? -81.5 115.55 20.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.546 -0.539 . . . . 1.28 109.546 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.2 p -80.21 84.07 5.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.316 -0.856 . . . . 0.73999999999999999 112.584 -173.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -72.99 -11.52 60.6 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.119 -0.988 . . . . 2.6200000000000001 108.81 173.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.626 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.9 pt -169.67 139.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.915 -1.493 . . . . 0.78000000000000003 107.927 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -71.98 -17.12 62.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.651 0.262 . . . . 0.40000000000000002 111.616 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -68.64 -33.7 74.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.745 0.307 . . . . 3.7400000000000002 110.918 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 3.4 pt20 -75.98 -20.48 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.027 0.442 . . . . 2.2000000000000002 110.364 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 57.4 m -88.83 -33.66 17.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.896 -0.593 . . . . 1.1799999999999999 110.461 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.809 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -83.85 -25.36 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.149 -0.478 . . . . 1.3100000000000001 112.062 -172.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 28.0 tptp -56.21 -49.37 93.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.4 -0.52 . . . . 2.1299999999999999 110.907 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 8.6 Cg_exo -73.95 -31.84 7.7 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.829 1.686 . . . . 0.53000000000000003 112.67 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 75.8 m -75.0 -52.19 11.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.291 -0.563 . . . . 0.35999999999999999 111.303 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 1.7 tmtp? -61.95 -35.01 77.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.022 0.439 . . . . 1.6499999999999999 110.355 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.85 -27.85 69.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.769 -0.65 . . . . 1.03 110.788 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' A' ' 23' ' ' MET . . . -96.55 1.06 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 0.69999999999999996 111.342 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.82 46.67 2.64 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.557 -0.83 . . . . 0.81000000000000005 112.849 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.753 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mpp? -123.05 104.46 9.23 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.573 0.702 . . . . 2.0699999999999998 109.634 171.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.888 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -56.81 -35.81 69.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.328 -1.305 . . . . 3.3599999999999999 111.681 -179.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 25.1 m-85 -110.25 163.25 13.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.252 0.549 . . . . 1.26 111.617 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.809 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -167.45 57.8 0.22 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.103 -1.199 . . . . 0.73999999999999999 110.103 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -85.98 134.53 33.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.304 -0.448 . . . . 2.9100000000000001 110.995 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 15.3 t -69.6 117.99 11.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.762 -0.654 . . . . 0.76000000000000001 109.719 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.24 109.96 7.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.245 -0.434 . . . . 2.0800000000000001 111.265 -175.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.515 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER 59.64 21.46 10.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.088 -0.505 . . . . 2.6899999999999999 111.698 172.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.669 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 113.18 -26.36 10.49 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.785 -0.721 . . . . 0.48999999999999999 112.77 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -101.77 158.93 15.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.948 0.404 . . . . 1.9099999999999999 110.798 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.563 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 23.7 m -93.48 107.98 19.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.341 -0.614 . . . . 0.76000000000000001 109.341 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -90.32 95.34 10.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.732 -0.667 . . . . 1.28 110.158 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.1 m -98.81 119.26 37.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.578 . . . . 0.53000000000000003 111.098 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 11.8 m -94.81 124.61 54.09 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 0.56000000000000005 109.108 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 12.9 Cg_endo -56.22 144.56 80.91 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.892 2.395 . . . . 0.76000000000000001 112.503 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.888 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tptp . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.512 -0.767 . . . . 2.1899999999999999 111.159 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.927 ' HB ' ' HB2' ' A' ' 35' ' ' CYS . 31.9 t . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.171 0.51 . . . . 1.1599999999999999 109.675 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.86 109.25 24.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.909 -0.587 . . . . 1.48 109.778 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.476 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 21.7 pt -108.4 147.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.167 -0.469 . . . . 0.51000000000000001 110.96 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -83.51 28.12 0.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 1.9199999999999999 111.398 -176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.56 132.65 31.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.603 -0.888 . . . . 0.46000000000000002 108.603 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.613 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -73.08 114.36 11.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.101 -0.703 . . . . 1.28 109.101 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.3 p -74.94 82.72 2.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.594 0.712 . . . . 0.73999999999999999 110.85 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 10' ' ' ILE . 12.4 tptm -79.96 -2.56 44.43 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.505 -0.924 . . . . 2.6200000000000001 108.505 175.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 9' ' ' LYS . 4.8 pt -174.7 142.72 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 113.18 -1.827 . . . . 0.78000000000000003 107.228 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -72.56 -20.7 61.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.531 0.205 . . . . 0.40000000000000002 111.035 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -62.59 -38.78 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 3.7400000000000002 111.504 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 7.1 pt20 -75.29 -14.02 60.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.278 0.561 . . . . 2.2000000000000002 110.285 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 56.5 m -88.47 -37.98 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 1.1799999999999999 109.385 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.635 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -75.21 -43.68 50.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.491 -1.231 . . . . 1.3100000000000001 112.709 -170.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 48.9 tptt -55.47 -52.12 74.41 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.708 -0.397 . . . . 2.1299999999999999 111.768 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 20.6 Cg_exo -67.45 -36.27 20.75 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.658 1.572 . . . . 0.53000000000000003 112.203 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.611 ' HB2' ' HE3' ' A' ' 23' ' ' MET . 87.2 m -79.16 -43.84 23.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.669 -0.413 . . . . 0.35999999999999999 111.641 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 21.4 ttmm -70.65 -30.07 66.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.258 -0.177 . . . . 1.6499999999999999 110.706 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.61 -36.55 84.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 1.03 109.882 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -41.1 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.671 . . . . 0.69999999999999996 111.124 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 157.03 85.87 0.05 OUTLIER Glycine 0 CA--C 1.508 -0.4 0 N-CA-C 111.633 -0.587 . . . . 0.81000000000000005 111.633 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 1.017 ' HE1' ' HA3' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -141.51 121.56 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.172 0.987 . . . . 2.0699999999999998 110.166 176.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.6 -26.2 18.82 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.156 -1.384 . . . . 3.3599999999999999 109.59 174.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.554 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.4 m-85 -141.78 164.02 31.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.355 -0.384 . . . . 1.26 110.36 171.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 1.017 ' HA3' ' HE1' ' A' ' 23' ' ' MET . . . -165.85 118.05 0.78 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 121.089 -0.576 . . . . 0.73999999999999999 111.709 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -129.23 139.68 51.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.93 0.395 . . . . 2.9100000000000001 110.828 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.0 t -68.79 123.33 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 0.76000000000000001 109.563 170.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 66.1 mtt -137.11 118.01 14.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.728 -0.214 . . . . 2.0800000000000001 110.921 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 43.01 37.41 1.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.215 0.947 . . . . 2.6899999999999999 113.243 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.613 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 108.93 -27.98 12.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.049 -0.596 . . . . 0.48999999999999999 112.916 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -107.28 159.06 16.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.357 0.598 . . . . 1.9099999999999999 111.432 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 80.9 m -92.6 107.35 19.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.54 -0.755 . . . . 0.76000000000000001 109.791 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -88.54 98.12 11.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.638 -0.71 . . . . 1.28 109.835 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.927 ' HB2' ' HB ' ' A' ' 2' ' ' VAL . 33.4 m -100.13 113.14 25.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.669 -0.696 . . . . 0.53000000000000003 110.944 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.2 m -78.69 112.98 30.99 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.552 -0.749 . . . . 0.56000000000000005 109.325 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.61 ' HG3' HG23 ' A' ' 2' ' ' VAL . 30.3 Cg_exo -60.21 147.1 94.76 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.479 2.119 . . . . 0.76000000000000001 112.191 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 4.3 mmmp? . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.589 -0.72 . . . . 2.1899999999999999 111.058 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.41 HG21 ' CE ' ' A' ' 23' ' ' MET . 2.4 m . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.847 0.832 . . . . 1.1599999999999999 111.365 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -101.44 118.06 47.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.96 . . . . 1.48 109.086 176.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 33' ' ' CYS . 18.4 pt -101.88 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.057 0.456 . . . . 0.51000000000000001 111.379 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.1 39.9 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 1.9199999999999999 111.827 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.07 134.36 44.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.372 -0.603 . . . . 0.46000000000000002 109.372 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.735 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 2.5 tmtp? -78.35 109.36 12.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.475 0.655 . . . . 1.28 109.832 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -80.49 98.26 7.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.172 -0.922 . . . . 0.73999999999999999 111.841 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -66.45 -12.07 55.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.623 0.725 . . . . 2.6200000000000001 109.824 172.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.673 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 11.9 pt -163.61 163.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.139 -1.391 . . . . 0.78000000000000003 107.473 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 44.6 m -67.18 -39.82 86.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 118.474 0.579 . . . . 0.40000000000000002 110.81 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -62.0 -19.5 62.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.813 -0.631 . . . . 3.7400000000000002 112.326 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.673 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 11.9 mm100 -54.95 -35.94 64.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.849 0.356 . . . . 2.2000000000000002 110.879 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -113.66 -18.87 11.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.093 -0.503 . . . . 1.1799999999999999 111.871 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.49 -34.07 76.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.147 -0.621 . . . . 1.3100000000000001 110.981 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -59.81 -56.39 36.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.835 -0.346 . . . . 2.1299999999999999 110.468 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -66.06 -25.89 51.01 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.727 1.618 . . . . 0.53000000000000003 112.65 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.6 m -79.19 -56.31 4.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.725 -0.39 . . . . 0.35999999999999999 111.495 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.588 ' HA ' ' H ' ' A' ' 23' ' ' MET . 73.8 tttt -65.92 -26.61 67.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.372 -0.205 . . . . 1.6499999999999999 111.064 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -65.39 -35.95 82.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 1.03 110.451 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.63 -13.27 58.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 0.69999999999999996 110.881 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 64.94 0.6 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.57 -0.612 . . . . 0.81000000000000005 111.57 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.717 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 46.8 mtt -141.13 110.79 6.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.675 0.75 . . . . 2.0699999999999998 110.152 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.79 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 6.4 ptp180 -65.19 -21.24 66.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.579 -1.191 . . . . 3.3599999999999999 112.176 -175.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 47.9 m-85 -128.39 148.07 50.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.043 0.449 . . . . 1.26 110.826 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.05 62.64 0.42 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 109.443 -1.463 . . . . 0.73999999999999999 109.443 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 27' ' ' LYS . 52.1 mtpt -91.1 134.9 34.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.067 0.461 . . . . 2.9100000000000001 111.066 -168.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 39.9 t -81.93 124.11 29.45 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.667 -0.697 . . . . 0.76000000000000001 109.874 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.483 ' HA ' ' CE ' ' A' ' 29' ' ' MET . 1.5 mmt -138.64 105.9 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 2.0800000000000001 111.162 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.05 20.94 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.804 -0.635 . . . . 2.6899999999999999 112.186 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.735 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 119.71 -31.09 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.5 -0.857 . . . . 0.48999999999999999 112.663 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -94.99 154.37 17.2 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.289 0.566 . . . . 1.9099999999999999 111.259 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -93.68 104.27 16.38 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.149 -0.932 . . . . 0.76000000000000001 109.803 176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.588 ' HA ' HG13 ' A' ' 3' ' ' ILE . 17.8 m-70 -88.73 94.13 9.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.7 -0.682 . . . . 1.28 109.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.6 m -98.66 130.06 45.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.53000000000000003 110.617 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.7 m -108.36 129.86 23.5 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.139 -1.06 . . . . 0.56000000000000005 108.139 175.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.1 Cg_exo -62.41 155.86 55.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.065 2.51 . . . . 0.76000000000000001 112.396 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.79 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 17.1 mmmt . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.53 -0.748 . . . . 2.1899999999999999 110.53 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.1 t . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.629 0.728 . . . . 1.1599999999999999 111.004 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.876 HD11 ' HB3' ' A' ' 32' ' ' LYS . 2.8 tp -91.94 126.71 44.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.252 -0.885 . . . . 1.48 109.893 175.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 33' ' ' CYS . 28.6 pt -115.05 145.23 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.293 -0.412 . . . . 0.51000000000000001 111.367 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.26 69.36 6.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 1.9199999999999999 111.272 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.91 122.8 65.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.563 -0.532 . . . . 0.46000000000000002 109.563 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -69.29 96.33 0.85 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.492 0.663 . . . . 1.28 110.089 -177.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 8.8 p -80.57 100.49 8.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.24 -0.891 . . . . 0.73999999999999999 111.842 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 10' ' ' ILE . 3.3 mppt? -71.13 -8.1 51.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.171 -0.678 . . . . 2.6200000000000001 109.171 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.777 HG13 ' HG3' ' A' ' 13' ' ' GLN . 3.8 pt -168.58 154.41 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 114.063 -1.426 . . . . 0.78000000000000003 108.126 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.3 m -69.35 -22.23 63.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 0.40000000000000002 111.409 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.422 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.3 mpt_? -60.91 -36.29 78.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.264 -0.425 . . . . 3.7400000000000002 111.682 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.777 ' HG3' HG13 ' A' ' 10' ' ' ILE . 13.9 mt-30 -62.84 -27.63 69.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.5 . . . . 2.2000000000000002 110.56 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.8 m -88.29 -48.74 7.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.394 -0.821 . . . . 1.1799999999999999 111.261 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.7 tp -67.83 -34.08 76.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.003 -0.544 . . . . 1.3100000000000001 112.304 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 8.9 tmtt? -58.38 -58.42 19.13 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.295 -0.562 . . . . 2.1299999999999999 110.448 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 70.5 Cg_endo -70.63 -21.0 30.03 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.612 1.541 . . . . 0.53000000000000003 112.345 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 56.6 m -77.66 -58.63 3.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.629 -0.429 . . . . 0.35999999999999999 109.95 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HA ' ' H ' ' A' ' 23' ' ' MET . 44.9 tttm -60.08 -32.04 70.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.208 -0.451 . . . . 1.6499999999999999 110.637 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 13.9 t70 -56.22 -47.88 77.57 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 1.03 110.496 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.64 -29.23 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.695 . . . . 0.69999999999999996 111.071 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.4 0.11 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.494 -0.642 . . . . 0.81000000000000005 111.494 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.7 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 10.2 mmt -145.01 91.63 2.17 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.132 -1.062 . . . . 2.0699999999999998 108.132 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HG3' ' CD2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -50.39 -47.77 56.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.508 -1.224 . . . . 3.3599999999999999 111.524 -177.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.614 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 98.7 m-85 -99.27 147.3 25.32 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.687 -0.405 . . . . 1.26 110.084 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.88 95.07 0.13 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.708 -0.957 . . . . 0.73999999999999999 110.708 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -122.32 141.17 51.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.198 0.523 . . . . 2.9100000000000001 111.03 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.3 t -75.9 136.19 40.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.466 -0.788 . . . . 0.76000000000000001 110.324 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 32' ' ' LYS . 2.7 ppp? -137.87 100.54 4.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 2.0800000000000001 110.859 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 58.39 18.82 5.86 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.792 . . . . 2.6899999999999999 112.55 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.501 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 119.42 -5.56 13.11 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.576 -0.821 . . . . 0.48999999999999999 113.335 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.876 ' HB3' HD11 ' A' ' 3' ' ' ILE . 53.4 mtpt -120.36 168.62 11.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.045 0.422 . . . . 1.9099999999999999 111.243 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.55 ' HB2' HG12 ' A' ' 4' ' ' ILE . 59.0 m -111.66 102.84 11.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.76000000000000001 111.666 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.876 ' HD2' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -81.99 97.95 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 1.28 110.529 174.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.7 m -106.44 134.49 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.316 0.579 . . . . 0.53000000000000003 110.772 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 17.3 m -112.38 124.09 32.75 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.076 -0.712 . . . . 0.56000000000000005 109.076 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 53.1 Cg_exo -55.4 147.3 57.72 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.616 2.877 . . . . 0.76000000000000001 113.477 -170.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 13.9 tptp . . . . . 0 C--O 1.249 1.047 0 CA-C-N 114.89 -1.05 . . . . 2.1899999999999999 110.068 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 64.2 t . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.354 0.597 . . . . 1.1599999999999999 109.768 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.585 HD12 ' CD2' ' A' ' 34' ' ' HIS . 7.0 mm -100.28 121.42 51.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.448 -0.797 . . . . 1.48 110.005 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.508 HD11 ' SG ' ' A' ' 14' ' ' CYS . 24.8 pt -115.76 151.56 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.965 0.412 . . . . 0.51000000000000001 110.61 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.03 45.25 1.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 1.9199999999999999 111.686 -174.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -102.12 126.45 56.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.954 -0.758 . . . . 0.46000000000000002 108.954 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -68.67 120.33 14.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.731 0.777 . . . . 1.28 109.94 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 13.0 p -85.35 86.42 7.38 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.012 -0.995 . . . . 0.73999999999999999 111.734 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -55.96 -23.38 31.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.386 0.612 . . . . 2.6200000000000001 109.614 173.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.622 HG13 ' HG2' ' A' ' 13' ' ' GLN . 7.2 pt -164.06 167.52 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.98 -1.464 . . . . 0.78000000000000003 107.482 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.416 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 63.6 m -66.43 -36.93 84.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.295 0.498 . . . . 0.40000000000000002 110.741 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -57.15 -28.84 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.754 -0.657 . . . . 3.7400000000000002 111.828 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.622 ' HG2' HG13 ' A' ' 10' ' ' ILE . 15.4 mm100 -55.72 -34.55 65.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 111.698 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.623 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 4.9 t -108.63 -21.66 12.6 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.449 -0.5 . . . . 1.1799999999999999 111.736 -176.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.559 HD21 ' HE3' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -74.47 -36.53 63.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.933 -0.707 . . . . 1.3100000000000001 111.369 -174.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.528 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -56.29 -49.46 93.2 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 120.327 -0.549 . . . . 2.1299999999999999 110.592 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.623 ' HD2' ' C ' ' A' ' 14' ' ' CYS . 21.5 Cg_exo -67.7 -35.96 20.4 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.81 1.674 . . . . 0.53000000000000003 112.851 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.759 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 34.2 m -71.14 -54.14 12.08 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.55 -0.46 . . . . 0.35999999999999999 111.713 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.572 ' HA ' ' H ' ' A' ' 23' ' ' MET . 38.2 ttmt -66.4 -25.9 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.833 -0.347 . . . . 1.6499999999999999 110.456 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.78 -33.08 71.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.046 -0.525 . . . . 1.03 110.206 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -6.09 56.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.69999999999999996 110.82 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.74 62.36 0.75 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.795 -0.717 . . . . 0.81000000000000005 112.424 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.759 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 10.0 mmt -138.3 111.99 8.27 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.082 -0.71 . . . . 2.0699999999999998 109.082 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 13.7 ptp180 -63.8 -22.81 67.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.552 -0.749 . . . . 3.3599999999999999 111.894 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.2 m-85 -130.14 155.69 45.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.26 110.953 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -164.62 92.6 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.847 -1.301 . . . . 0.73999999999999999 109.847 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 34.0 mmtp -123.19 147.89 46.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.187 0.517 . . . . 2.9100000000000001 111.46 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 40.2 t -81.25 127.29 32.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.431 -0.804 . . . . 0.76000000000000001 109.833 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.536 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 57.9 mtt -137.39 105.54 5.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.404 -0.591 . . . . 2.0800000000000001 109.404 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 71.04 -73.8 0.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 124.525 1.141 . . . . 2.6899999999999999 111.095 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.31 -33.23 0.13 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.84 -0.695 . . . . 0.48999999999999999 112.813 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' HG3' ' HE1' ' A' ' 34' ' ' HIS . 2.4 ptpt -100.35 164.46 11.92 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.473 0.654 . . . . 1.9099999999999999 111.672 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' SG ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -92.81 128.37 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.166 -0.925 . . . . 0.76000000000000001 109.26 177.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.585 ' CD2' HD12 ' A' ' 3' ' ' ILE . 42.6 m80 -110.64 109.24 19.44 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.293 -0.867 . . . . 1.28 109.931 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -111.07 133.19 53.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.504 0.668 . . . . 0.53000000000000003 112.091 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.0 m -101.51 127.7 30.86 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.421 -0.955 . . . . 0.56000000000000005 108.421 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 16.9 Cg_exo -66.64 158.74 54.36 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.135 2.557 . . . . 0.76000000000000001 113.343 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 35.8 mmtt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.491 -0.766 . . . . 2.1899999999999999 110.322 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.14 0.495 . . . . 1.1599999999999999 110.143 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 mm -96.44 109.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.705 -0.68 . . . . 1.48 110.388 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.411 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.2 pt -99.72 147.19 7.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.373 -0.376 . . . . 0.51000000000000001 110.902 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.81 12.09 2.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.968 -0.56 . . . . 1.9199999999999999 112.128 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.67 128.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.107 -0.701 . . . . 0.46000000000000002 109.107 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.583 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 6.1 tmtt? -73.25 115.85 13.09 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.781 -0.822 . . . . 1.28 108.781 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 17.4 p -66.33 85.07 0.1 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.731 -1.122 . . . . 0.73999999999999999 111.644 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HB2' HD13 ' A' ' 10' ' ' ILE . 71.0 mmtt -58.89 -25.83 63.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.117 -0.697 . . . . 2.6200000000000001 109.117 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -168.77 152.47 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.545 -1.661 . . . . 0.78000000000000003 107.143 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.5 m -65.51 -28.33 69.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.482 -0.487 . . . . 0.40000000000000002 110.683 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -56.18 -34.41 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 3.7400000000000002 111.266 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.598 ' HG3' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -87.61 -14.53 39.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 2.2000000000000002 110.87 -173.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 57.2 m -89.26 -40.76 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.321 0.581 . . . . 1.1799999999999999 110.029 176.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 26' ' ' GLY . 61.2 tp -73.71 -27.87 61.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.68 -0.691 . . . . 1.3100000000000001 111.505 -175.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 25.6 tptp -55.05 -56.69 25.24 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.692 0.256 . . . . 2.1299999999999999 111.692 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 68.9 Cg_endo -74.54 -19.92 18.55 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.541 1.494 . . . . 0.53000000000000003 112.45 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.832 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 57.5 m -81.72 -56.69 3.83 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 121.082 -0.247 . . . . 0.35999999999999999 111.354 -176.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -62.35 -36.05 81.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.786 -0.366 . . . . 1.6499999999999999 110.547 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.31 -36.25 79.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 1.03 110.687 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.39 -35.09 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.69999999999999996 110.842 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.73 42.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.81000000000000005 112.586 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.832 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -126.29 98.07 5.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.463 -0.569 . . . . 2.0699999999999998 109.463 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.803 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -53.81 -34.83 60.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.987 . . . . 3.3599999999999999 112.123 -178.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 59.2 m-85 -109.21 144.31 37.48 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.104 -0.332 . . . . 1.26 110.104 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.419 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -158.06 75.39 0.21 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.325 -1.11 . . . . 0.73999999999999999 110.325 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -108.93 143.89 37.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 2.9100000000000001 111.288 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.3 t -71.95 125.62 27.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.859 -1.064 . . . . 0.76000000000000001 110.492 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.402 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 95.9 mmm -124.7 82.44 2.05 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.572 -0.529 . . . . 2.0800000000000001 109.572 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 73.75 -65.41 0.35 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.421 1.076 . . . . 2.6899999999999999 111.626 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -131.11 -39.8 0.25 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.65 -0.786 . . . . 0.48999999999999999 112.779 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.68 158.71 15.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.189 0.519 . . . . 1.9099999999999999 111.181 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 68.1 m -92.42 116.07 28.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.513 -0.767 . . . . 0.76000000000000001 109.119 174.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 12.2 m-70 -99.81 99.23 10.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.888 -0.412 . . . . 1.28 109.888 -177.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -101.07 135.48 42.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.53000000000000003 111.692 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 16.6 m -115.77 132.74 23.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.372 -0.831 . . . . 0.56000000000000005 109.012 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 51.0 Cg_exo -54.0 152.34 24.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.668 2.912 . . . . 0.76000000000000001 114.032 -172.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.803 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.245 0.858 0 CA-C-N 114.945 -1.025 . . . . 2.1899999999999999 110.921 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.182 0.515 . . . . 1.1599999999999999 110.129 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.789 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.1 tp -92.87 122.94 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.871 -0.604 . . . . 1.48 110.627 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.5 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 20.5 pt -110.95 142.05 24.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 0.51000000000000001 110.348 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -84.81 50.51 1.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.782 0.801 . . . . 1.9199999999999999 111.231 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.63 138.11 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.95 -1.023 . . . . 0.46000000000000002 108.293 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.513 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -77.79 109.88 12.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 1.28 109.779 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.8 p -71.76 85.63 0.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.948 -1.023 . . . . 0.73999999999999999 111.768 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 10' ' ' ILE . 32.8 mmtp -55.84 -23.84 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 2.6200000000000001 108.986 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 8.9 pt -163.06 166.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.557 -1.656 . . . . 0.78000000000000003 107.097 175.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -66.44 -37.65 85.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.392 0.542 . . . . 0.40000000000000002 110.85 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -61.54 -19.81 62.54 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.094 -0.503 . . . . 3.7400000000000002 111.966 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.573 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 13.6 mm100 -58.38 -34.59 70.88 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.878 0.37 . . . . 2.2000000000000002 111.217 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 86.8 m -117.27 -25.32 7.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.162 -0.472 . . . . 1.1799999999999999 112.234 -173.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 26' ' ' GLY . 57.0 tp -64.37 -37.98 89.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.28 -0.568 . . . . 1.3100000000000001 111.418 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 25.8 tptp -58.8 -50.89 85.54 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 120.511 -0.475 . . . . 2.1299999999999999 111.419 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 33.4 Cg_exo -60.54 -40.41 56.76 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.82 1.68 . . . . 0.53000000000000003 112.563 170.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.8 m -70.83 -57.95 4.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.888 0.329 . . . . 0.35999999999999999 111.888 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 23' ' ' MET . 71.6 tttt -63.17 -28.38 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.827 0.346 . . . . 1.6499999999999999 110.81 -176.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.75 -31.76 71.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 1.03 109.843 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.67 2.79 52.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 0.69999999999999996 110.962 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.47 66.3 0.98 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 120.973 -0.632 . . . . 0.81000000000000005 112.027 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.804 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 61.0 mtt -145.6 108.69 4.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 2.0699999999999998 109.58 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -65.15 -18.72 65.54 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.421 -0.809 . . . . 3.3599999999999999 111.981 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.556 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.3 m-85 -134.27 149.32 50.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.232 0.539 . . . . 1.26 111.378 175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -153.23 79.64 0.19 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.0 -1.64 . . . . 0.73999999999999999 109.0 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -114.73 134.53 55.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.828 0.347 . . . . 2.9100000000000001 110.661 -163.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.5 t -74.45 121.92 22.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.838 -0.619 . . . . 0.76000000000000001 109.84 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.437 ' HB2' ' HD2' ' A' ' 34' ' ' HIS . 93.4 mmm -134.93 110.56 9.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 2.0800000000000001 110.633 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 60.64 16.83 6.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 2.6899999999999999 112.438 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.38 -11.1 21.85 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.433 -0.889 . . . . 0.48999999999999999 113.142 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.789 ' HB3' HD11 ' A' ' 3' ' ' ILE . 67.4 mttm -116.79 160.16 21.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.081 0.467 . . . . 1.9099999999999999 110.928 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.5 m -93.88 103.91 16.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.697 -0.683 . . . . 0.76000000000000001 110.66 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.563 ' CD2' HD13 ' A' ' 3' ' ' ILE . 27.6 m-70 -92.0 99.49 12.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.751 -0.659 . . . . 1.28 109.854 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -99.41 129.41 45.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.53000000000000003 110.777 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 8.7 m -104.77 126.47 31.14 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.598 -0.89 . . . . 0.56000000000000005 108.598 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.804 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 6.9 Cg_exo -71.74 156.1 57.63 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.129 2.553 . . . . 0.76000000000000001 113.037 -170.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.353 -0.832 . . . . 2.1899999999999999 110.427 174.429 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.477 HG11 ' HE2' ' A' ' 23' ' ' MET . 44.9 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.095 0.474 . . . . 1.1599999999999999 110.158 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mm -111.96 108.97 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.794 -0.639 . . . . 1.48 109.968 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 33' ' ' CYS . 28.0 pt -105.09 149.06 8.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.204 0.526 . . . . 0.51000000000000001 111.336 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -86.66 48.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 1.9199999999999999 111.515 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -112.1 125.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.72 -0.673 . . . . 0.46000000000000002 109.211 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.98 ' HE2' ' HA2' ' A' ' 31' ' ' GLY . 2.5 tmtt? -73.65 102.9 4.06 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.695 0.759 . . . . 1.28 109.721 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.854 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 7.5 p -68.35 106.22 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.794 -1.094 . . . . 0.73999999999999999 111.484 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.3 mppt? -72.71 -2.16 19.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 2.6200000000000001 110.008 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.902 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -178.74 168.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.787 1.635 . . . . 0.78000000000000003 108.534 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -67.54 -40.95 85.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.936 0.334 . . . . 0.40000000000000002 111.875 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -58.95 -27.45 65.33 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.097 0.406 . . . . 3.7400000000000002 112.097 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.902 ' HG2' HG13 ' A' ' 10' ' ' ILE . 16.1 mm100 -62.98 -23.84 67.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.071 0.462 . . . . 2.2000000000000002 110.858 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.854 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.2 m -102.19 -38.98 7.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.705 -0.679 . . . . 1.1799999999999999 110.719 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.34 -34.83 78.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 1.3100000000000001 111.707 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.571 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 32.8 tptt -57.59 -54.69 52.44 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 120.665 -0.414 . . . . 2.1299999999999999 111.273 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 18.8 Cg_exo -67.75 -29.36 35.75 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.74 1.626 . . . . 0.53000000000000003 112.313 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.772 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.3 m -76.62 -55.98 5.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 121.05 -0.26 . . . . 0.35999999999999999 111.239 -174.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -66.63 -22.29 66.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 1.6499999999999999 110.587 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.31 -37.39 83.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 1.03 110.638 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 -45.94 11.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.69999999999999996 110.819 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.57 59.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.821 -0.704 . . . . 0.81000000000000005 112.147 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.772 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -137.94 105.99 5.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.178 0.513 . . . . 2.0699999999999998 110.144 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.534 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 8.9 ptm180 -62.77 -25.7 68.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.365 -0.834 . . . . 3.3599999999999999 112.188 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 57.4 m-85 -126.5 151.83 47.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.699 0.285 . . . . 1.26 110.646 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.39 85.66 0.13 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.741 -0.944 . . . . 0.73999999999999999 110.741 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -108.32 135.1 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 2.9100000000000001 110.939 -173.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 t -76.8 131.11 38.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.813 -0.631 . . . . 0.76000000000000001 109.925 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.462 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 91.1 mmm -137.25 91.79 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.581 -0.282 . . . . 2.0800000000000001 111.659 -175.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.72 19.82 8.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.715 0.635 . . . . 2.6899999999999999 112.715 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.98 ' HA2' ' HE2' ' A' ' 7' ' ' LYS . . . 134.92 -50.78 0.85 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.637 -0.792 . . . . 0.48999999999999999 112.438 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -88.6 156.79 18.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.466 0.651 . . . . 1.9099999999999999 111.636 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.596 ' HB2' HG12 ' A' ' 4' ' ' ILE . 65.3 m -94.05 117.95 30.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.821 -1.081 . . . . 0.76000000000000001 109.846 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.462 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 11.8 m-70 -100.4 100.42 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.968 -0.56 . . . . 1.28 109.778 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -107.64 129.16 55.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.129 0.49 . . . . 0.53000000000000003 111.396 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.4 m -98.06 130.21 29.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.606 -0.887 . . . . 0.56000000000000005 108.606 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.8 Cg_exo -69.78 151.17 68.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.852 2.368 . . . . 0.76000000000000001 113.012 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 18.5 mmmt . . . . . 0 C--O 1.245 0.855 0 CA-C-N 115.207 -0.906 . . . . 2.1899999999999999 110.461 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.689 0.757 . . . . 1.1599999999999999 110.742 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.568 HG21 ' HD3' ' A' ' 32' ' ' LYS . 21.8 mm -105.59 109.64 28.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.155 -0.93 . . . . 1.48 109.803 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 29.7 pt -91.09 140.63 15.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.062 0.458 . . . . 0.51000000000000001 110.83 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -84.68 63.13 7.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.512 0.673 . . . . 1.9199999999999999 110.1 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.95 126.57 75.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.227 -0.897 . . . . 0.46000000000000002 109.513 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.629 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -55.53 102.57 0.07 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.058 0.456 . . . . 1.28 109.954 174.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.1 p -77.1 83.79 3.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.563 0.697 . . . . 0.73999999999999999 110.518 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 8.3 tptp -76.44 -5.95 49.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.561 -0.904 . . . . 2.6200000000000001 108.561 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.666 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.4 pt -167.59 144.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.329 -1.76 . . . . 0.78000000000000003 107.496 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.7 m -74.11 -20.33 60.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.831 0.348 . . . . 0.40000000000000002 110.52 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.37 -37.46 85.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 3.7400000000000002 111.223 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 18.2 pt20 -73.83 -14.78 61.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.947 0.403 . . . . 2.2000000000000002 110.674 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.567 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 35.3 m -97.29 -49.66 4.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 1.1799999999999999 110.721 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 26' ' ' GLY . 65.5 tp -69.97 -35.01 74.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.009 -0.541 . . . . 1.3100000000000001 112.343 -173.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.4 tppt? -58.65 -51.41 82.05 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.796 -0.362 . . . . 2.1299999999999999 111.261 -178.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 21.6 Cg_exo -67.5 -27.67 39.22 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.681 1.587 . . . . 0.53000000000000003 111.911 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.899 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 54.1 m -71.16 -51.3 25.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.946 -0.302 . . . . 0.35999999999999999 110.887 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HE3' HD11 ' A' ' 15' ' ' LEU . 84.9 mttt -64.92 -28.54 69.6 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.739 -0.601 . . . . 1.6499999999999999 111.007 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.43 -30.76 68.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 1.03 110.975 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.58 -42.85 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.268 -0.424 . . . . 0.69999999999999996 111.226 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.09 56.59 0.02 OUTLIER Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 111.479 -0.648 . . . . 0.81000000000000005 111.479 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.899 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.4 mpt? -137.71 109.07 6.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.255 -0.646 . . . . 2.0699999999999998 109.255 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.6 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -74.32 -26.67 60.31 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.27 -0.877 . . . . 3.3599999999999999 111.898 -175.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.5 m-85 -115.6 152.56 32.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.119 -0.326 . . . . 1.26 110.119 173.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -164.71 102.1 0.19 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.762 -0.935 . . . . 0.73999999999999999 110.762 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -127.83 134.49 49.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.668 0.27 . . . . 2.9100000000000001 110.496 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.3 t -73.92 127.73 33.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.76000000000000001 109.788 173.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -138.47 114.72 10.28 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.478 -0.564 . . . . 2.0800000000000001 109.478 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.4 -86.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.122 -0.945 . . . . 2.6899999999999999 111.83 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' HA2' ' NZ ' ' A' ' 7' ' ' LYS . . . -132.53 -6.01 3.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.393 -0.908 . . . . 0.48999999999999999 112.967 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.568 ' HD3' HG21 ' A' ' 3' ' ' ILE . 17.4 ptpt -121.6 160.86 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.312 0.577 . . . . 1.9099999999999999 111.453 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 39.9 m -99.52 105.96 17.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.329 -0.85 . . . . 0.76000000000000001 110.198 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.09 107.99 16.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.187 -0.46 . . . . 1.28 110.349 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -115.54 134.36 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.045 0.45 . . . . 0.53000000000000003 110.683 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 7.4 m -105.52 125.34 33.65 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.814 -0.81 . . . . 0.56000000000000005 108.814 176.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -53.32 146.91 38.46 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.278 2.652 . . . . 0.76000000000000001 113.525 -174.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.6 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 25.3 mmtp . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.15 -0.929 . . . . 2.1899999999999999 110.967 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.504 0.669 . . . . 1.1599999999999999 110.251 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.493 HD12 ' CG ' ' A' ' 34' ' ' HIS . 18.0 mm -89.44 115.65 29.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 1.48 109.758 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.29 147.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.808 0.337 . . . . 0.51000000000000001 111.099 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.57 19.2 3.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.956 -0.565 . . . . 1.9199999999999999 111.081 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.0 t -77.39 128.67 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.847 -0.797 . . . . 0.46000000000000002 108.847 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.1 tmtp? -71.08 106.58 3.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.343 0.592 . . . . 1.28 109.81 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 13' ' ' GLN . 19.5 p -77.22 91.36 3.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.605 -0.725 . . . . 0.73999999999999999 109.891 177.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 10' ' ' ILE . 15.3 tptp -66.25 -13.07 59.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.57 0.7 . . . . 2.6200000000000001 109.484 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.456 HG13 ' HG2' ' A' ' 13' ' ' GLN . 3.1 pt -162.62 170.01 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 114.121 -1.4 . . . . 0.78000000000000003 108.122 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.9 m -66.46 -26.95 67.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.58 0.627 . . . . 0.40000000000000002 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -50.06 -42.27 49.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.164 -0.471 . . . . 3.7400000000000002 110.548 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 16.0 mm100 -73.73 -8.34 55.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.721 -0.672 . . . . 2.2000000000000002 111.231 -175.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.46 -52.63 3.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.317 0.579 . . . . 1.1799999999999999 110.008 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 tp -75.6 -37.94 59.42 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 1.3100000000000001 112.109 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 23.3 tptm -55.53 -52.47 71.56 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.861 0.319 . . . . 2.1299999999999999 111.861 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 12.3 Cg_exo -71.49 -30.74 14.73 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.551 1.501 . . . . 0.53000000000000003 112.046 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 31.4 m -80.51 -55.18 5.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.35999999999999999 111.63 -172.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HA ' ' H ' ' A' ' 23' ' ' MET . 56.4 tttm -61.46 -32.16 72.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 1.6499999999999999 110.701 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.47 -36.78 81.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.706 -0.679 . . . . 1.03 110.646 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -34.69 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.422 . . . . 0.69999999999999996 110.969 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.63 62.03 0.07 OUTLIER Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.465 -0.654 . . . . 0.81000000000000005 111.465 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.698 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 12.6 mmt -134.68 105.28 6.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.541 -0.911 . . . . 2.0699999999999998 108.541 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.656 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.88 -24.54 67.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.183 -0.917 . . . . 3.3599999999999999 112.222 -174.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.56 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.4 m-85 -125.44 154.26 42.25 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.401 -0.187 . . . . 1.26 110.752 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.69 96.83 0.15 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 111.471 -0.652 . . . . 0.73999999999999999 111.471 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -109.85 134.06 52.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.839 0.352 . . . . 2.9100000000000001 110.06 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.1 t -77.37 129.54 35.94 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.005 -0.543 . . . . 0.76000000000000001 109.635 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 58.3 mtt -129.89 98.19 4.71 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.53 -0.305 . . . . 2.0800000000000001 110.679 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.8 m120 69.61 -77.04 0.06 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.135 0.897 . . . . 2.6899999999999999 111.269 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.671 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . -135.67 -29.19 0.37 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.21 -0.519 . . . . 0.48999999999999999 112.211 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -95.35 153.34 17.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.329 0.585 . . . . 1.9099999999999999 111.077 -178.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.41 130.3 39.25 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.449 -0.796 . . . . 0.76000000000000001 109.946 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.493 ' CG ' HD12 ' A' ' 3' ' ' ILE . 14.4 m-70 -116.18 87.2 2.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.515 -0.766 . . . . 1.28 109.194 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 p -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.878 0.847 . . . . 0.53000000000000003 111.864 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.6 m -95.86 127.92 39.41 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.699 -1.137 . . . . 0.56000000000000005 108.974 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 31.2 Cg_exo -59.39 151.45 68.22 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.167 2.578 . . . . 0.76000000000000001 112.356 -173.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.249 1.045 0 CA-C-N 115.323 -0.853 . . . . 2.1899999999999999 111.083 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.064 0.459 . . . . 1.1599999999999999 110.335 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 34' ' ' HIS . 17.4 mm -98.34 121.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.602 -0.726 . . . . 1.48 110.029 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.59 HG12 ' HB2' ' A' ' 33' ' ' CYS . 27.1 pt -111.97 149.23 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.522 -0.308 . . . . 0.51000000000000001 110.236 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.69 14.56 5.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 1.9199999999999999 112.037 -172.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -65.12 123.47 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.631 -0.507 . . . . 0.46000000000000002 109.631 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -69.85 104.97 2.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.251 0.548 . . . . 1.28 109.832 -176.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.871 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 25.8 p -76.81 103.01 6.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 0.73999999999999999 111.113 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.65 -18.88 61.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.029 -0.73 . . . . 2.6200000000000001 109.029 172.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.587 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.0 pt -170.94 167.09 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 113.877 -1.511 . . . . 0.78000000000000003 108.208 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 48.8 m -64.39 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.14 0.427 . . . . 0.40000000000000002 110.969 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -52.38 -38.85 59.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.01 -0.541 . . . . 3.7400000000000002 110.934 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.587 ' HG2' HG13 ' A' ' 10' ' ' ILE . 16.8 mm100 -67.11 -20.52 65.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 2.2000000000000002 112.159 -173.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.7 m -105.38 -35.57 7.47 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.536 0.569 . . . . 1.1799999999999999 112.536 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.662 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -80.89 -21.12 40.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.88 -0.728 . . . . 1.3100000000000001 111.683 -172.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 34.3 tptt -60.72 -54.62 52.86 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 119.955 -0.698 . . . . 2.1299999999999999 109.768 171.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 25.6 Cg_exo -64.75 -33.86 52.46 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.708 1.606 . . . . 0.53000000000000003 112.838 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 84.6 m -75.02 -52.82 10.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.566 -0.454 . . . . 0.35999999999999999 111.106 -176.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.551 ' HA ' ' H ' ' A' ' 23' ' ' MET . 44.8 tttm -64.67 -34.13 77.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.45 0.167 . . . . 1.6499999999999999 110.834 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.87 -35.33 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 1.03 110.63 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -6.23 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 0.69999999999999996 111.015 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 56.87 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.969 -0.634 . . . . 0.81000000000000005 112.494 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.747 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 63.6 mtt -128.59 114.66 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 2.0699999999999998 110.086 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.968 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 1.3 ptp180 -69.04 -23.57 64.08 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.926 -1.034 . . . . 3.3599999999999999 112.587 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 13.8 m-85 -127.27 155.78 42.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 1.26 111.331 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.662 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -167.36 85.43 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.916 -0.873 . . . . 0.73999999999999999 110.916 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -94.57 134.29 37.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.702 0.287 . . . . 2.9100000000000001 110.683 -176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 24.4 t -83.89 107.95 16.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.646 -0.501 . . . . 0.76000000000000001 109.646 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.87 131.61 27.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.533 -0.758 . . . . 2.0800000000000001 109.556 -176.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.489 ' OD1' ' HE2' ' A' ' 32' ' ' LYS . 26.5 t-20 69.48 0.97 3.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.439 0.638 . . . . 2.6899999999999999 111.058 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 95.39 4.05 61.11 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.903 -0.665 . . . . 0.48999999999999999 111.84 -174.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE2' ' OD1' ' A' ' 30' ' ' ASN . 56.6 mttm -112.17 156.78 21.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.048 0.452 . . . . 1.9099999999999999 110.828 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.59 ' HB2' HG12 ' A' ' 4' ' ' ILE . 30.9 m -92.5 97.69 10.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 0.76000000000000001 109.695 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.435 ' HA ' HD12 ' A' ' 3' ' ' ILE . 76.9 m80 -87.88 91.85 8.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.342 -0.844 . . . . 1.28 109.455 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.31 152.49 23.48 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.38 0.609 . . . . 0.53000000000000003 111.736 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.1 m -129.41 131.91 23.93 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.412 -0.958 . . . . 0.56000000000000005 108.412 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 22.7 Cg_exo -63.27 151.81 83.01 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.112 2.541 . . . . 0.76000000000000001 113.013 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.968 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 50.2 tptt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.202 -0.904 . . . . 2.1899999999999999 109.346 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 C--O 1.235 0.3 0 CA-C-O 120.983 0.421 . . . . 1.1599999999999999 110.476 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.4 tp -104.61 119.5 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.243 0.544 . . . . 1.48 110.473 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.602 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.8 pt -114.55 154.02 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.799 -0.637 . . . . 0.51000000000000001 110.821 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.96 24.34 2.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.05 -0.523 . . . . 1.9199999999999999 111.531 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.5 t -81.39 134.36 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.212 -0.662 . . . . 0.46000000000000002 109.212 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -78.18 117.64 19.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.587 0.708 . . . . 1.28 109.551 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' N ' ' HD3' ' A' ' 7' ' ' LYS . 14.5 p -78.05 85.65 4.25 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.03 -0.986 . . . . 0.73999999999999999 111.996 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.39 -16.14 43.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.662 0.744 . . . . 2.6200000000000001 109.425 172.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.648 HG13 ' HG2' ' A' ' 13' ' ' GLN . 4.0 pt -169.03 173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 113.583 -1.644 . . . . 0.78000000000000003 106.927 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -74.8 -25.2 58.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.392 0.542 . . . . 0.40000000000000002 110.302 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -63.47 -32.61 74.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.468 . . . . 3.7400000000000002 111.073 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.648 ' HG2' HG13 ' A' ' 10' ' ' ILE . 17.4 mm100 -58.73 -30.8 67.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.254 0.55 . . . . 2.2000000000000002 110.628 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.638 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 11.0 m -94.98 -44.58 7.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.076 -0.966 . . . . 1.1799999999999999 111.078 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.89 HD21 ' HE2' ' A' ' 19' ' ' LYS . 42.2 tp -74.34 -24.59 59.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 1.3100000000000001 112.261 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -62.69 -52.75 62.43 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.823 -0.351 . . . . 2.1299999999999999 111.099 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 7.8 Cg_exo -74.34 -17.93 20.94 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.84 1.693 . . . . 0.53000000000000003 112.099 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.79 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.6 m -82.48 -56.75 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.6 -0.44 . . . . 0.35999999999999999 111.518 -176.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.89 ' HE2' HD21 ' A' ' 15' ' ' LEU . 42.0 mttm -57.18 -38.27 73.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.254 0.479 . . . . 1.6499999999999999 110.811 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.94 -32.41 73.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.937 -0.574 . . . . 1.03 111.152 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 -11.91 37.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.446 -0.343 . . . . 0.69999999999999996 111.243 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.76 45.67 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.746 -0.74 . . . . 0.81000000000000005 112.987 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.79 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.1 mpt? -125.7 106.75 9.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.981 0.896 . . . . 2.0699999999999998 110.455 170.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.747 ' HB2' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -47.22 -55.3 8.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.517 -1.674 . . . . 3.3599999999999999 112.137 173.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 46.5 m-85 -99.34 158.93 15.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.912 0.387 . . . . 1.26 111.208 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.71 91.69 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.189 -1.164 . . . . 0.73999999999999999 110.189 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -121.76 138.8 54.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.848 0.356 . . . . 2.9100000000000001 110.502 -170.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.1 t -70.25 122.67 19.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.76000000000000001 109.864 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.8 mmt -137.77 102.36 4.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.34 -0.391 . . . . 2.0800000000000001 111.004 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 64.59 16.56 10.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.841 -0.618 . . . . 2.6899999999999999 111.788 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.56 -22.48 11.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.631 -0.795 . . . . 0.48999999999999999 112.366 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.712 ' HB3' HD11 ' A' ' 3' ' ' ILE . 62.9 mttp -102.66 161.61 13.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.139 0.495 . . . . 1.9099999999999999 110.7 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.602 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 85.3 m -99.32 109.8 22.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.774 -0.648 . . . . 0.76000000000000001 111.096 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.592 ' CD2' HD13 ' A' ' 3' ' ' ILE . 3.2 m-70 -92.23 103.81 16.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.56 -0.746 . . . . 1.28 110.582 177.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.47 149.96 29.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.384 0.611 . . . . 0.53000000000000003 111.044 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 9.0 m -126.91 131.81 24.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.707 -0.849 . . . . 0.56000000000000005 108.707 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.0 Cg_exo -59.85 143.47 99.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.298 2.665 . . . . 0.76000000000000001 113.124 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.747 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 18.9 ttpt . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.094 -0.957 . . . . 2.1899999999999999 110.134 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.485 HG21 ' SD ' ' A' ' 23' ' ' MET . 59.0 t . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.203 0.525 . . . . 1.1599999999999999 110.803 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.0 116.93 50.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.313 -0.858 . . . . 1.48 109.562 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.546 HG12 ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -113.41 147.58 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.076 0.465 . . . . 0.51000000000000001 111.7 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -82.57 69.54 9.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.454 -0.794 . . . . 1.9199999999999999 111.07 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.2 t -131.65 129.52 61.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.604 . . . . 0.46000000000000002 109.573 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -75.42 86.43 2.56 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 1.28 109.29 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.3 p -58.79 98.46 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.567 -1.197 . . . . 0.73999999999999999 112.786 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 10' ' ' ILE . 38.4 mmtm -72.36 -11.96 60.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.328 -0.989 . . . . 2.6200000000000001 108.328 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.537 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.2 pt -169.13 154.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 113.521 -1.672 . . . . 0.78000000000000003 108.237 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.507 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 23.8 m -72.87 -30.63 64.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.356 0.598 . . . . 0.40000000000000002 110.008 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -62.32 -25.66 68.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.215 -0.902 . . . . 3.7400000000000002 112.558 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 14.7 pt20 -79.25 -19.88 49.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 2.2000000000000002 110.312 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.613 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 8.5 m -96.68 -31.23 12.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.98 -0.555 . . . . 1.1799999999999999 110.193 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.512 HD11 ' HZ2' ' A' ' 19' ' ' LYS . 56.9 tp -69.71 -36.59 76.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.055 -0.521 . . . . 1.3100000000000001 112.154 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.505 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 39.9 tptt -53.7 -55.95 30.17 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 119.225 -0.417 . . . . 2.1299999999999999 111.086 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 19.1 Cg_exo -67.31 -22.39 46.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.648 1.566 . . . . 0.53000000000000003 112.249 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 69.7 m -81.72 -56.03 4.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.798 -0.361 . . . . 0.35999999999999999 111.952 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.512 ' HZ2' HD11 ' A' ' 15' ' ' LEU . 4.7 ttmp? -67.75 -26.27 66.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.299 0.5 . . . . 1.6499999999999999 110.216 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.19 -34.21 77.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.696 -0.683 . . . . 1.03 109.926 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.414 ' HB3' ' HE1' ' A' ' 23' ' ' MET . . . -85.18 -45.59 11.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.777 -0.647 . . . . 0.69999999999999996 110.792 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.18 40.61 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.174 -0.536 . . . . 0.81000000000000005 112.407 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.677 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 5.4 mpp? -124.59 103.44 8.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.249 0.547 . . . . 2.0699999999999998 110.448 174.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 5.7 ptp180 -52.18 -33.83 42.48 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.232 -0.895 . . . . 3.3599999999999999 112.485 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 33.1 m-85 -120.84 160.86 22.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.26 111.118 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -159.83 95.77 0.14 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.337 -1.105 . . . . 0.73999999999999999 110.337 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 91.7 mttt -120.0 134.64 55.19 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 2.9100000000000001 110.909 -171.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.7 t -74.34 123.54 24.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.018 -0.537 . . . . 0.76000000000000001 109.995 176.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.455 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 24.7 mmt -126.16 96.37 4.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 2.0800000000000001 110.727 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.2 t30 73.58 -62.7 0.46 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.724 -1.125 . . . . 2.6899999999999999 112.034 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.95 -35.9 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.66 -0.781 . . . . 0.48999999999999999 112.943 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -107.78 170.61 7.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.385 0.612 . . . . 1.9099999999999999 110.429 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.546 ' HB2' HG12 ' A' ' 4' ' ' ILE . 15.3 m -94.87 125.89 39.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.153 -0.931 . . . . 0.76000000000000001 110.018 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 11.9 m-70 -104.92 108.44 19.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.226 -0.657 . . . . 1.28 109.226 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.3 118.31 36.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.326 0.584 . . . . 0.53000000000000003 111.493 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.0 m -80.53 130.14 66.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.174 -0.921 . . . . 0.56000000000000005 108.937 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.5 Cg_exo -69.49 147.98 65.82 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.167 2.578 . . . . 0.76000000000000001 112.508 -171.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.0 tttm . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.234 -0.894 . . . . 2.1899999999999999 110.345 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.353 0.597 . . . . 1.1599999999999999 110.431 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.896 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.9 tp -103.65 128.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.692 -0.686 . . . . 1.48 110.733 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.575 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 24.3 pt -121.0 143.49 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.599 -0.519 . . . . 0.51000000000000001 109.599 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -83.32 14.32 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.836 0.31 . . . . 1.9199999999999999 111.836 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.24 126.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.0 -0.741 . . . . 0.46000000000000002 109.0 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.582 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 2.7 tmtp? -70.95 111.86 6.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.483 0.658 . . . . 1.28 109.81 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 11.8 p -76.94 93.36 3.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.102 -0.954 . . . . 0.73999999999999999 111.547 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -61.81 -14.21 31.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.404 0.621 . . . . 2.6200000000000001 110.036 173.47 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.761 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -171.46 164.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 125.641 1.576 . . . . 0.78000000000000003 107.577 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -62.03 -38.48 88.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.254 0.479 . . . . 0.40000000000000002 111.006 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.41 -24.02 64.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.215 0.45 . . . . 3.7400000000000002 112.215 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.761 ' HG2' HG13 ' A' ' 10' ' ' ILE . 15.7 mm100 -62.52 -30.54 71.37 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.2 0.524 . . . . 2.2000000000000002 110.691 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 m -101.39 -40.08 7.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.777 -0.647 . . . . 1.1799999999999999 111.17 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.832 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.4 tt -78.6 -23.69 45.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.286 -0.416 . . . . 1.3100000000000001 111.614 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.497 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 11.1 tmtt? -56.4 -55.1 46.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.619 -0.511 . . . . 2.1299999999999999 109.619 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 85.5 Cg_endo -77.87 -19.73 12.31 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.207 1.271 . . . . 0.53000000000000003 112.227 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.832 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 1.2 m -71.42 -56.9 5.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.87 -0.332 . . . . 0.35999999999999999 110.878 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.587 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 38.6 ttmt -64.1 -33.41 75.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.203 -0.295 . . . . 1.6499999999999999 110.203 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.8 -39.33 84.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 1.03 110.554 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.78 0.69 54.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.015 -0.539 . . . . 0.69999999999999996 111.39 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.91 53.7 1.88 Allowed Glycine 0 CA--C 1.506 -0.485 0 C-N-CA 120.941 -0.647 . . . . 0.81000000000000005 112.43 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 17.0 mmt -131.31 97.4 4.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.664 -0.865 . . . . 2.0699999999999998 108.664 172.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.744 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 6.0 ttt85 -55.54 -37.74 68.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.092 . . . . 3.3599999999999999 111.454 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 71.6 m-85 -106.29 149.0 27.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.785 0.326 . . . . 1.26 110.613 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.578 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -165.07 72.3 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.221 -1.152 . . . . 0.73999999999999999 110.221 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.95 135.01 44.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.137 0.494 . . . . 2.9100000000000001 110.857 -168.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.6 t -78.48 121.77 24.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.76000000000000001 110.264 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.504 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 21.7 mmt -138.26 106.43 5.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.516 -0.311 . . . . 2.0800000000000001 111.556 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.7 m120 62.46 13.7 6.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.61 -0.723 . . . . 2.6899999999999999 112.188 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.582 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 123.47 -32.68 4.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.492 -0.861 . . . . 0.48999999999999999 112.634 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.896 ' HB3' HD11 ' A' ' 3' ' ' ILE . 10.9 mptt -94.47 157.71 15.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.283 0.563 . . . . 1.9099999999999999 111.489 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.575 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 45.4 m -96.85 110.41 22.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.207 -0.906 . . . . 0.76000000000000001 110.479 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.504 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 19.0 m-70 -92.76 95.39 9.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.01 -0.541 . . . . 1.28 110.399 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.73 147.74 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.455 0.645 . . . . 0.53000000000000003 111.352 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 13.4 m -129.45 129.62 23.24 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.506 -0.924 . . . . 0.56000000000000005 108.506 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 58.1 Cg_exo -51.39 148.82 18.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.384 2.722 . . . . 0.76000000000000001 112.804 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.744 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.3 tptm . . . . . 0 C--O 1.248 1.007 0 O-C-N 124.082 0.864 . . . . 2.1899999999999999 111.669 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 111.722 -0.551 . . . . 1.0900000000000001 111.722 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.9 t -92.53 93.35 4.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.378 0.609 . . . . 1.1599999999999999 110.318 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.611 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -94.48 124.1 46.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.577 -0.738 . . . . 1.48 110.341 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.593 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 27.5 pt -103.39 142.53 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.158 -0.474 . . . . 0.51000000000000001 109.962 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.819 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 24.6 p-10 -84.0 24.41 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 1.9199999999999999 111.627 -174.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -76.03 135.6 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.727 -0.472 . . . . 0.46000000000000002 109.727 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -63.37 105.91 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.467 0.651 . . . . 1.28 110.615 177.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 11.0 p -79.24 83.77 5.25 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.059 -0.973 . . . . 0.73999999999999999 111.26 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.71 -18.5 65.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 2.6200000000000001 108.41 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 pt -162.8 146.39 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.499 -1.682 . . . . 0.78000000000000003 108.025 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.97 -28.4 64.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.925 0.343 . . . . 0.40000000000000002 111.925 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -64.8 -29.04 69.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.86 0.318 . . . . 3.7400000000000002 111.86 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.8 pt20 -74.6 -20.14 60.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.106 0.479 . . . . 2.2000000000000002 110.256 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 25.7 m -92.25 -41.73 10.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.888 -0.596 . . . . 1.1799999999999999 110.077 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.3 tp -69.24 -33.99 74.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 1.3100000000000001 112.365 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 6.9 tmtm? -55.85 -56.92 25.05 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 119.501 -0.285 . . . . 2.1299999999999999 110.604 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 73.5 Cg_endo -72.91 -20.49 22.2 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.414 1.409 . . . . 0.53000000000000003 112.714 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.763 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 59.5 m -77.98 -50.58 11.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.804 -0.358 . . . . 0.35999999999999999 110.956 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -65.79 -21.27 66.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 1.6499999999999999 110.172 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.8 -19.9 43.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.666 -0.697 . . . . 1.03 110.54 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.08 -30.19 12.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.69999999999999996 110.977 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.79 45.82 0.1 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.151 -0.547 . . . . 0.81000000000000005 112.106 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.763 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -130.95 106.63 8.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.042 0.448 . . . . 2.0699999999999998 110.021 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.913 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -65.45 -27.32 68.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.667 -0.697 . . . . 3.3599999999999999 111.869 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.561 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 60.5 m-85 -117.91 157.7 26.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 1.26 110.686 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.33 88.65 0.11 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.692 -0.963 . . . . 0.73999999999999999 110.692 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -116.86 134.76 54.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.882 0.372 . . . . 2.9100000000000001 110.686 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 13.9 t -74.14 120.84 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.081 -0.508 . . . . 0.76000000000000001 110.832 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.419 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 85.4 mmm -138.66 116.67 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 2.0800000000000001 111.177 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.22 12.09 5.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.1 0.56 . . . . 2.6899999999999999 112.458 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.21 -17.05 22.1 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.718 . . . . 0.48999999999999999 112.334 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.819 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 13.8 mptt -103.72 156.29 17.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 1.9099999999999999 110.957 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.593 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 59.7 m -93.06 109.88 21.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.781 -0.645 . . . . 0.76000000000000001 109.494 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.611 ' HA ' HG13 ' A' ' 3' ' ' ILE . 9.9 m170 -87.7 95.7 10.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.871 -0.604 . . . . 1.28 110.18 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB3' ' HG2' ' A' ' 23' ' ' MET . 74.4 m -100.43 110.29 22.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.591 0.71 . . . . 0.53000000000000003 110.914 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.6 m -89.95 129.59 45.65 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.389 -0.823 . . . . 0.56000000000000005 109.065 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -54.36 149.64 36.88 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.674 2.916 . . . . 0.76000000000000001 113.984 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.913 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 27.8 tptp . . . . . 0 C--O 1.242 0.698 0 CA-C-N 115.248 -0.887 . . . . 2.1899999999999999 110.114 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 N-CA-C 111.444 -0.662 . . . . 1.0900000000000001 111.444 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.7 t -92.99 94.26 4.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.323 0.582 . . . . 1.1599999999999999 110.348 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.8 mm -83.43 109.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 1.48 110.137 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.5 pt -99.59 130.6 48.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.051 0.453 . . . . 0.51000000000000001 110.932 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.47 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 19.7 m-20 -74.53 63.79 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.482 -0.781 . . . . 1.9199999999999999 111.13 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.64 134.13 59.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.705 -0.68 . . . . 0.46000000000000002 109.513 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.668 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -64.86 106.7 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 1.28 110.781 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.896 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 21.1 p -85.96 83.23 7.85 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.893 -0.594 . . . . 0.73999999999999999 110.568 173.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -61.97 -19.24 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.55 -0.907 . . . . 2.6200000000000001 108.55 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.517 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 10.2 pt -160.52 164.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 113.37 -1.741 . . . . 0.78000000000000003 107.032 174.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -61.98 -33.38 74.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.686 0.675 . . . . 0.40000000000000002 111.391 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -57.67 -31.9 66.79 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.294 -0.412 . . . . 3.7400000000000002 111.834 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.517 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 15.9 mm100 -62.87 -26.37 68.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.869 0.366 . . . . 2.2000000000000002 111.302 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.896 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.5 m -95.27 -46.08 6.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.055 -0.521 . . . . 1.1799999999999999 111.347 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.002 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.2 tt -73.89 -24.42 59.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.293 0.479 . . . . 1.3100000000000001 112.293 -166.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 38.0 tptt -61.22 -57.84 23.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.295 -0.962 . . . . 2.1299999999999999 109.63 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.5 Cg_exo -59.33 -33.96 97.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.437 1.425 . . . . 0.53000000000000003 111.956 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.002 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 12.0 m -64.27 -63.03 1.25 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.35999999999999999 111.506 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.18 -32.25 72.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.385 0.539 . . . . 1.6499999999999999 111.052 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.39 -40.47 97.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.054 -0.521 . . . . 1.03 110.936 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.44 -26.47 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.128 0.49 . . . . 0.69999999999999996 111.0 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.61 65.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.841 -0.618 . . . . 0.81000000000000005 112.232 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.682 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 15.6 mmt -135.68 104.34 5.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.858 -0.793 . . . . 2.0699999999999998 108.858 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.594 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.67 -28.27 69.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.593 -0.73 . . . . 3.3599999999999999 110.962 -177.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.1 m-85 -117.71 153.95 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.207 -0.294 . . . . 1.26 110.207 173.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.667 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -156.08 110.18 0.43 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.836 -0.697 . . . . 0.73999999999999999 111.849 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 9.5 mmtp -129.23 134.95 48.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.931 0.396 . . . . 2.9100000000000001 111.841 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 8.1 t -75.52 132.95 41.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.93 -0.577 . . . . 0.76000000000000001 109.615 174.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.2 mmt -134.36 80.88 1.88 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.962 -0.295 . . . . 2.0800000000000001 111.356 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 p30 62.87 -4.14 0.27 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.224 1.41 . . . . 2.6899999999999999 113.846 171.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -55.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.748 -0.739 . . . . 0.48999999999999999 111.722 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.4 mptm? -89.49 161.07 16.43 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.192 0.52 . . . . 1.9099999999999999 110.908 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 56.4 m -96.73 115.64 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.76000000000000001 109.905 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -97.24 93.15 6.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 1.28 109.808 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.554 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.7 m -112.69 127.02 56.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.042 -0.527 . . . . 0.53000000000000003 111.346 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 35.1 m -86.96 124.99 67.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.42 -0.809 . . . . 0.56000000000000005 109.07 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 50.0 Cg_exo -54.42 152.74 25.17 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.533 2.822 . . . . 0.76000000000000001 113.45 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.4 tptp . . . . . 0 C--O 1.242 0.688 0 CA-C-O 118.189 -0.91 . . . . 2.1899999999999999 111.038 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.038 -0.425 . . . . 1.0900000000000001 112.038 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.17 100.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.167 0.508 . . . . 1.1599999999999999 110.238 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.827 HD11 ' HB3' ' A' ' 32' ' ' LYS . 7.0 tp -91.58 120.17 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.736 -0.666 . . . . 1.48 110.417 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 19.8 pt -102.6 136.54 34.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.041 0.448 . . . . 0.51000000000000001 110.734 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -79.91 64.95 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.702 -0.681 . . . . 1.9199999999999999 111.124 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.5 t -125.01 130.45 73.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.229 -0.896 . . . . 0.46000000000000002 109.477 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.7 107.44 3.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.052 -0.721 . . . . 1.28 109.052 178.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 11.5 p -78.18 91.29 4.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.943 -1.026 . . . . 0.73999999999999999 112.428 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HD3' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -70.3 -11.14 60.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.622 0.725 . . . . 2.6200000000000001 109.459 174.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.6 pt -165.83 145.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.055 -1.429 . . . . 0.78000000000000003 108.19 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.6 m -70.95 -24.46 62.44 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.816 -0.354 . . . . 0.40000000000000002 110.518 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.17 -34.45 78.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.836 0.31 . . . . 3.7400000000000002 111.836 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 16.3 pt20 -70.63 -20.42 62.73 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.194 0.521 . . . . 2.2000000000000002 110.119 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 12.5 m -94.98 -41.37 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.603 -0.726 . . . . 1.1799999999999999 110.237 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.679 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 1.6 tt -77.02 -37.71 54.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.844 -0.617 . . . . 1.3100000000000001 111.913 -171.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 27.0 tptp -50.46 -52.79 51.98 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-O 119.464 -0.303 . . . . 2.1299999999999999 111.411 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 6.9 Cg_exo -73.93 -20.47 19.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.643 1.562 . . . . 0.53000000000000003 112.505 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 37.4 m -83.39 -54.08 5.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.344 -0.543 . . . . 0.35999999999999999 111.821 -175.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.643 ' HE2' HD21 ' A' ' 15' ' ' LEU . 23.0 ttmm -63.77 -35.78 81.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.408 -0.517 . . . . 1.6499999999999999 110.334 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.94 -37.27 86.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.916 0.389 . . . . 1.03 110.184 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.03 0.85 46.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.69999999999999996 111.335 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.49 60.02 1.06 Allowed Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.937 -0.649 . . . . 0.81000000000000005 112.669 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 17.9 mmt -132.77 108.14 8.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.112 -0.699 . . . . 2.0699999999999998 109.112 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.467 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -60.69 -31.4 70.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.867 -1.06 . . . . 3.3599999999999999 110.983 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 51.1 m-85 -120.67 149.64 42.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.695 0.283 . . . . 1.26 111.072 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.679 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -158.48 78.27 0.18 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.695 -0.962 . . . . 0.73999999999999999 110.695 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -114.5 135.0 54.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.955 0.407 . . . . 2.9100000000000001 110.478 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 4.4 t -72.3 127.87 33.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.953 -0.567 . . . . 0.76000000000000001 109.751 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.48 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.472 -0.331 . . . . 2.0800000000000001 110.336 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 72.0 -66.42 0.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.223 0.952 . . . . 2.6899999999999999 112.432 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -126.18 -25.51 1.33 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.236 -0.983 . . . . 0.48999999999999999 113.23 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.827 ' HB3' HD11 ' A' ' 3' ' ' ILE . 35.2 mtmt -121.68 158.35 28.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.235 0.541 . . . . 1.9099999999999999 112.213 -170.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 56.8 m -93.91 109.02 20.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.299 -0.864 . . . . 0.76000000000000001 110.238 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.528 ' CD2' HD13 ' A' ' 3' ' ' ILE . 1.8 m-70 -87.05 100.47 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 1.28 111.0 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -104.23 118.03 35.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.144 0.497 . . . . 0.53000000000000003 110.574 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.3 m -101.83 122.18 48.31 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.078 -0.712 . . . . 0.56000000000000005 109.078 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -51.94 147.21 26.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.385 2.723 . . . . 0.76000000000000001 113.484 -173.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 24.0 tptm . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.129 -0.941 . . . . 2.1899999999999999 111.281 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.766 -0.534 . . . . 1.0900000000000001 111.766 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.812 HG23 ' HG3' ' A' ' 37' ' ' PRO . 47.1 t -92.3 93.04 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.175 0.512 . . . . 1.1599999999999999 110.469 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -115.24 109.63 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.88 -0.785 . . . . 1.48 108.88 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 33' ' ' CYS . 15.8 pt -123.51 134.62 65.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.07 0.462 . . . . 0.51000000000000001 111.464 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.735 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 m-20 -77.93 63.7 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.608 -0.724 . . . . 1.9199999999999999 110.475 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -115.35 124.03 71.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 0.46000000000000002 109.24 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.593 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -58.04 104.21 0.19 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.232 0.539 . . . . 1.28 110.172 175.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.653 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 9.6 p -89.87 87.27 6.88 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.781 -0.645 . . . . 0.73999999999999999 110.084 174.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 21.0 tptt -64.43 -13.03 49.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 2.6200000000000001 109.258 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.414 HG13 ' HG2' ' A' ' 13' ' ' GLN . 8.1 pt -154.65 159.41 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 113.782 -1.554 . . . . 0.78000000000000003 108.165 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 61.4 m -67.22 -19.87 65.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.81 0.338 . . . . 0.40000000000000002 111.217 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -59.29 -31.1 68.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.176 -0.465 . . . . 3.7400000000000002 110.879 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 10' ' ' ILE . 14.3 mm100 -67.58 -24.38 65.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.905 -0.589 . . . . 2.2000000000000002 110.676 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.1 m -92.57 -45.5 8.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.281 0.562 . . . . 1.1799999999999999 109.875 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.582 HD12 ' SD ' ' A' ' 23' ' ' MET . 11.4 tp -52.48 -51.38 59.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.877 -1.056 . . . . 1.3100000000000001 112.669 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 40.5 tptt -56.21 -59.73 11.02 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 119.01 -0.519 . . . . 2.1299999999999999 111.42 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 32.3 Cg_exo -57.83 -34.23 97.99 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.571 1.514 . . . . 0.53000000000000003 112.479 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.79 -54.46 6.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.35999999999999999 111.421 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 25.2 tttm -74.5 -17.95 60.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.71 0.291 . . . . 1.6499999999999999 110.829 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 5.4 t70 -68.3 -30.33 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.412 -0.588 . . . . 1.03 109.412 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.19 3.35 43.67 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.797 -0.638 . . . . 0.69999999999999996 110.544 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.712 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 100.11 105.01 2.66 Favored Glycine 0 CA--C 1.499 -0.919 0 CA-C-N 115.465 -0.789 . . . . 0.81000000000000005 111.435 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.582 ' SD ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -119.43 121.76 40.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.321 1.058 . . . . 2.0699999999999998 109.564 174.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.685 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -89.0 -29.2 19.67 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.051 -1.431 . . . . 3.3599999999999999 108.285 168.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.5 m-85 -140.02 151.52 45.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.136 -0.938 . . . . 1.26 109.347 170.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA3' ' SD ' ' A' ' 23' ' ' MET . . . -150.95 108.27 0.38 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.06 -0.591 . . . . 0.73999999999999999 111.807 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -129.41 138.7 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.169 0.509 . . . . 2.9100000000000001 112.0 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 7.8 t -87.24 132.49 33.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.014 -1.106 . . . . 0.76000000000000001 108.014 167.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 52.6 mtt -126.14 77.69 1.7 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.041 -0.664 . . . . 2.0800000000000001 111.208 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 70.97 -58.58 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.385 1.053 . . . . 2.6899999999999999 112.563 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.91 -47.08 0.21 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.958 -0.639 . . . . 0.48999999999999999 112.566 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.735 ' HG3' ' HA ' ' A' ' 5' ' ' ASN . 1.1 mptm? -107.46 164.43 12.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 1.9099999999999999 111.293 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.653 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -92.77 123.46 36.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.36 -0.836 . . . . 0.76000000000000001 110.365 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.41 98.04 5.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 1.28 109.613 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' HB ' ' A' ' 2' ' ' VAL . 7.6 p -121.13 159.22 26.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.036 -0.529 . . . . 0.53000000000000003 110.902 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 24.2 m -112.65 113.37 50.48 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.588 -0.733 . . . . 0.56000000000000005 109.151 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.812 ' HG3' HG23 ' A' ' 2' ' ' VAL . 32.7 Cg_exo -58.98 152.73 56.29 Favored 'Trans proline' 0 CA--C 1.519 -0.238 0 C-N-CA 122.836 2.357 . . . . 0.76000000000000001 112.324 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.685 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 20.3 tptm . . . . . 0 C--O 1.246 0.906 0 CA-C-N 115.565 -0.743 . . . . 2.1899999999999999 110.619 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.051 -0.42 . . . . 1.0900000000000001 112.051 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.4 93.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.375 -0.602 . . . . 1.1599999999999999 109.375 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.8 tp -88.07 110.42 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.855 0.836 . . . . 1.48 111.0 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.422 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -95.23 147.57 5.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.358 -0.837 . . . . 0.51000000000000001 110.679 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -84.42 14.11 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 1.9199999999999999 111.285 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.14 120.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.421 -0.585 . . . . 0.46000000000000002 109.421 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.682 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.8 tmtp? -67.73 115.95 7.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.973 -0.751 . . . . 1.28 108.973 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 28.5 p -77.16 82.96 3.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.525 -0.761 . . . . 0.73999999999999999 111.475 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 10' ' ' ILE . 13.8 mmmm -66.44 -17.58 64.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.744 0.783 . . . . 2.6200000000000001 108.992 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.568 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 5.4 pt -166.04 148.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.86 -1.518 . . . . 0.78000000000000003 108.123 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -74.08 -19.72 60.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.868 0.366 . . . . 0.40000000000000002 110.897 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.9 mtp180 -54.58 -47.08 73.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 3.7400000000000002 110.731 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 17.6 pt20 -76.51 -4.15 41.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 2.2000000000000002 111.125 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 75.3 m -95.61 -58.15 2.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.074 -0.512 . . . . 1.1799999999999999 110.44 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.601 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -79.12 -31.74 44.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.638 0.607 . . . . 1.3100000000000001 112.638 -169.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -54.79 -50.75 84.19 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.654 -0.418 . . . . 2.1299999999999999 110.702 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 14.3 Cg_exo -71.59 -29.76 15.75 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.634 1.556 . . . . 0.53000000000000003 112.923 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.712 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 81.3 m -74.18 -52.17 13.28 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.446 -0.501 . . . . 0.35999999999999999 111.422 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.595 ' HA ' ' H ' ' A' ' 23' ' ' MET . 41.2 ttmt -65.77 -27.35 68.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.067 0.46 . . . . 1.6499999999999999 110.267 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.28 -28.42 69.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 1.03 110.082 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.52 5.51 41.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.69999999999999996 111.244 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.86 53.01 1.99 Allowed Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.88 -0.676 . . . . 0.81000000000000005 112.765 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.712 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 56.8 mtt -131.57 102.16 5.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.587 0.708 . . . . 2.0699999999999998 109.366 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.669 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 10.9 ttt180 -60.39 -27.21 67.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.169 -1.378 . . . . 3.3599999999999999 112.335 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.597 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.7 m-85 -117.62 163.3 16.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.852 0.358 . . . . 1.26 110.867 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.601 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -178.6 74.24 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.999 -0.841 . . . . 0.73999999999999999 110.999 -177.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -104.16 133.69 48.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.664 -0.268 . . . . 2.9100000000000001 110.469 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.2 t -70.42 126.84 30.78 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.881 -0.414 . . . . 0.76000000000000001 109.881 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.8 mmm -137.39 103.52 5.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 2.0800000000000001 110.261 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 72.7 -74.72 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.997 0.811 . . . . 2.6899999999999999 110.997 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.682 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . -146.15 4.7 1.18 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.913 -0.66 . . . . 0.48999999999999999 112.863 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.614 ' HB3' HD11 ' A' ' 3' ' ' ILE . 91.1 mttt -131.93 160.41 35.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.036 0.446 . . . . 1.9099999999999999 111.478 -176.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 66.8 m -96.86 113.17 24.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.76000000000000001 110.045 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.519 ' CD2' HD13 ' A' ' 3' ' ' ILE . 1.8 m-70 -86.55 94.6 9.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 1.28 110.498 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.4 m -104.3 115.35 30.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.453 0.644 . . . . 0.53000000000000003 111.485 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.597 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 22.6 m -92.41 129.01 42.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.764 -0.828 . . . . 0.56000000000000005 108.764 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 37.8 Cg_exo -57.14 155.12 30.39 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.852 2.368 . . . . 0.76000000000000001 112.009 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.669 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 7.7 tptp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.078 -0.963 . . . . 2.1899999999999999 112.356 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.773 -0.531 . . . . 1.0900000000000001 111.773 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG11 ' HE2' ' A' ' 23' ' ' MET . 43.1 t -79.36 97.1 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.095 0.474 . . . . 1.1599999999999999 110.034 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.16 109.51 28.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.75 -0.659 . . . . 1.48 110.494 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.1 pt -99.37 137.29 27.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.079 -0.51 . . . . 0.51000000000000001 109.812 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -81.42 33.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 1.9199999999999999 111.67 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.76 135.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.087 -1.079 . . . . 0.46000000000000002 108.087 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.561 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 1.8 tmtt? -77.76 115.43 17.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.729 -0.788 . . . . 1.28 110.242 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 10.2 p -73.02 85.98 1.31 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.462 -1.244 . . . . 0.73999999999999999 111.884 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.4 mptm? -66.76 -13.44 61.42 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.556 -0.715 . . . . 2.6200000000000001 109.352 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.643 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.2 pt -166.63 150.52 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.384 -1.28 . . . . 0.78000000000000003 108.587 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 50.4 m -63.7 -52.96 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.791 0.293 . . . . 0.40000000000000002 111.791 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 13.8 ptm180 -60.22 -19.47 54.56 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 3.7400000000000002 113.246 -173.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 11.4 pt20 -72.78 -25.43 61.16 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.201 -0.6 . . . . 2.2000000000000002 109.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 32.8 m -93.67 -34.64 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.895 -0.593 . . . . 1.1799999999999999 109.707 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 12' ' ' ARG . 59.0 tp -65.29 -41.27 94.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 1.3100000000000001 112.104 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 18.2 tptm -57.63 -52.04 77.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.329 -0.548 . . . . 2.1299999999999999 111.739 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 23.8 Cg_exo -65.43 -25.46 55.96 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.695 1.597 . . . . 0.53000000000000003 111.94 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.754 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 66.2 m -82.39 -52.42 6.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.619 -0.264 . . . . 0.35999999999999999 110.818 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HA ' ' H ' ' A' ' 23' ' ' MET . 70.2 tttt -64.03 -27.58 69.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.782 0.325 . . . . 1.6499999999999999 110.682 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.86 -45.78 90.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.058 -0.519 . . . . 1.03 110.035 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.83 61.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.69999999999999996 110.664 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.84 54.56 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.834 -0.621 . . . . 0.81000000000000005 112.16 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.754 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -130.95 105.09 7.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 2.0699999999999998 110.545 175.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.579 ' N ' ' HB2' ' A' ' 38' ' ' LYS . 8.3 ptm180 -55.59 -27.49 49.68 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.264 -0.88 . . . . 3.3599999999999999 112.698 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 26.9 m-85 -124.63 160.34 28.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 1.26 110.818 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.78 59.67 0.12 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.602 -0.999 . . . . 0.73999999999999999 110.602 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 97.1 mttt -98.41 152.58 19.34 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.19 0.519 . . . . 2.9100000000000001 110.609 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t -77.61 112.75 14.74 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.323 -0.853 . . . . 0.76000000000000001 110.528 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 62.4 mtt -137.99 125.74 22.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 2.0800000000000001 109.874 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 68.45 -4.72 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.13 0.49 . . . . 2.6899999999999999 111.674 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' HE2' ' A' ' 7' ' ' LYS . . . 114.47 -14.01 20.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.831 -0.7 . . . . 0.48999999999999999 112.137 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -102.24 159.74 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.799 0.333 . . . . 1.9099999999999999 110.504 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 56.8 m -91.13 95.62 10.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.02 -0.733 . . . . 0.76000000000000001 109.02 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -76.8 93.95 3.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.268 -0.878 . . . . 1.28 111.046 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 75.0 m -98.68 111.16 23.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.394 0.616 . . . . 0.53000000000000003 111.034 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 6.6 m -88.99 130.59 44.01 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.48 -0.933 . . . . 0.56000000000000005 108.48 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.729 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 3.1 Cg_exo -72.22 151.53 54.9 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.175 2.583 . . . . 0.76000000000000001 112.238 -170.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HB2' ' N ' ' A' ' 24' ' ' ARG . 50.1 tttm . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.36 -0.829 . . . . 2.1899999999999999 110.682 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.904 -0.478 . . . . 1.0900000000000001 111.904 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.25 99.16 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.172 0.51 . . . . 1.1599999999999999 110.256 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 mm -104.76 121.76 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.003 -0.544 . . . . 1.48 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.563 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.7 pt -106.26 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.905 0.383 . . . . 0.51000000000000001 110.323 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.76 31.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 1.9199999999999999 112.112 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.17 139.29 17.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.938 -0.764 . . . . 0.46000000000000002 108.938 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.669 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.6 tmtp? -81.5 115.55 20.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.546 -0.539 . . . . 1.28 109.546 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.2 p -80.21 84.07 5.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.316 -0.856 . . . . 0.73999999999999999 112.584 -173.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -72.99 -11.52 60.6 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.119 -0.988 . . . . 2.6200000000000001 108.81 173.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.626 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.9 pt -169.67 139.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.915 -1.493 . . . . 0.78000000000000003 107.927 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -71.98 -17.12 62.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.651 0.262 . . . . 0.40000000000000002 111.616 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -68.64 -33.7 74.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.745 0.307 . . . . 3.7400000000000002 110.918 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 3.4 pt20 -75.98 -20.48 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.027 0.442 . . . . 2.2000000000000002 110.364 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 57.4 m -88.83 -33.66 17.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.896 -0.593 . . . . 1.1799999999999999 110.461 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.809 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -83.85 -25.36 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.149 -0.478 . . . . 1.3100000000000001 112.062 -172.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 28.0 tptp -56.21 -49.37 93.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.4 -0.52 . . . . 2.1299999999999999 110.907 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 8.6 Cg_exo -73.95 -31.84 7.7 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.829 1.686 . . . . 0.53000000000000003 112.67 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 75.8 m -75.0 -52.19 11.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.291 -0.563 . . . . 0.35999999999999999 111.303 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 1.7 tmtp? -61.95 -35.01 77.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.022 0.439 . . . . 1.6499999999999999 110.355 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.85 -27.85 69.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.769 -0.65 . . . . 1.03 110.788 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' A' ' 23' ' ' MET . . . -96.55 1.06 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 0.69999999999999996 111.342 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.82 46.67 2.64 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.557 -0.83 . . . . 0.81000000000000005 112.849 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.753 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mpp? -123.05 104.46 9.23 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.573 0.702 . . . . 2.0699999999999998 109.634 171.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.888 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -56.81 -35.81 69.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.328 -1.305 . . . . 3.3599999999999999 111.681 -179.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 25.1 m-85 -110.25 163.25 13.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.252 0.549 . . . . 1.26 111.617 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.809 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -167.45 57.8 0.22 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.103 -1.199 . . . . 0.73999999999999999 110.103 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -85.98 134.53 33.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.304 -0.448 . . . . 2.9100000000000001 110.995 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 15.3 t -69.6 117.99 11.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.762 -0.654 . . . . 0.76000000000000001 109.719 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.24 109.96 7.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.245 -0.434 . . . . 2.0800000000000001 111.265 -175.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.515 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER 59.64 21.46 10.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.088 -0.505 . . . . 2.6899999999999999 111.698 172.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.669 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 113.18 -26.36 10.49 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.785 -0.721 . . . . 0.48999999999999999 112.77 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -101.77 158.93 15.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.948 0.404 . . . . 1.9099999999999999 110.798 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.563 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 23.7 m -93.48 107.98 19.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.341 -0.614 . . . . 0.76000000000000001 109.341 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -90.32 95.34 10.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.732 -0.667 . . . . 1.28 110.158 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.1 m -98.81 119.26 37.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.578 . . . . 0.53000000000000003 111.098 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 11.8 m -94.81 124.61 54.09 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 0.56000000000000005 109.108 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 12.9 Cg_endo -56.22 144.56 80.91 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.892 2.395 . . . . 0.76000000000000001 112.503 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.888 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tptp . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.512 -0.767 . . . . 2.1899999999999999 111.159 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.549 -0.62 . . . . 1.0900000000000001 111.549 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.927 ' HB ' ' HB2' ' A' ' 35' ' ' CYS . 31.9 t -90.23 93.18 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.171 0.51 . . . . 1.1599999999999999 109.675 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.86 109.25 24.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.909 -0.587 . . . . 1.48 109.778 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.476 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 21.7 pt -108.4 147.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.167 -0.469 . . . . 0.51000000000000001 110.96 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -83.51 28.12 0.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 1.9199999999999999 111.398 -176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.56 132.65 31.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.603 -0.888 . . . . 0.46000000000000002 108.603 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.613 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -73.08 114.36 11.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.101 -0.703 . . . . 1.28 109.101 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.3 p -74.94 82.72 2.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.594 0.712 . . . . 0.73999999999999999 110.85 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 10' ' ' ILE . 12.4 tptm -79.96 -2.56 44.43 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.505 -0.924 . . . . 2.6200000000000001 108.505 175.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 9' ' ' LYS . 4.8 pt -174.7 142.72 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 113.18 -1.827 . . . . 0.78000000000000003 107.228 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -72.56 -20.7 61.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.531 0.205 . . . . 0.40000000000000002 111.035 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -62.59 -38.78 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 3.7400000000000002 111.504 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 7.1 pt20 -75.29 -14.02 60.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.278 0.561 . . . . 2.2000000000000002 110.285 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 56.5 m -88.47 -37.98 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 1.1799999999999999 109.385 175.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.635 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -75.21 -43.68 50.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.491 -1.231 . . . . 1.3100000000000001 112.709 -170.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 48.9 tptt -55.47 -52.12 74.41 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.708 -0.397 . . . . 2.1299999999999999 111.768 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 20.6 Cg_exo -67.45 -36.27 20.75 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.658 1.572 . . . . 0.53000000000000003 112.203 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.611 ' HB2' ' HE3' ' A' ' 23' ' ' MET . 87.2 m -79.16 -43.84 23.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.669 -0.413 . . . . 0.35999999999999999 111.641 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HA ' ' HB3' ' A' ' 23' ' ' MET . 21.4 ttmm -70.65 -30.07 66.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.258 -0.177 . . . . 1.6499999999999999 110.706 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.61 -36.55 84.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 1.03 109.882 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -41.1 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.671 . . . . 0.69999999999999996 111.124 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 157.03 85.87 0.05 OUTLIER Glycine 0 CA--C 1.508 -0.4 0 N-CA-C 111.633 -0.587 . . . . 0.81000000000000005 111.633 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 1.017 ' HE1' ' HA3' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -141.51 121.56 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.172 0.987 . . . . 2.0699999999999998 110.166 176.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.6 -26.2 18.82 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.156 -1.384 . . . . 3.3599999999999999 109.59 174.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.554 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 30.4 m-85 -141.78 164.02 31.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.355 -0.384 . . . . 1.26 110.36 171.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 1.017 ' HA3' ' HE1' ' A' ' 23' ' ' MET . . . -165.85 118.05 0.78 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 121.089 -0.576 . . . . 0.73999999999999999 111.709 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -129.23 139.68 51.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.93 0.395 . . . . 2.9100000000000001 110.828 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.0 t -68.79 123.33 20.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 0.76000000000000001 109.563 170.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 66.1 mtt -137.11 118.01 14.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.728 -0.214 . . . . 2.0800000000000001 110.921 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 43.01 37.41 1.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.215 0.947 . . . . 2.6899999999999999 113.243 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.613 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 108.93 -27.98 12.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.049 -0.596 . . . . 0.48999999999999999 112.916 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -107.28 159.06 16.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.357 0.598 . . . . 1.9099999999999999 111.432 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 80.9 m -92.6 107.35 19.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.54 -0.755 . . . . 0.76000000000000001 109.791 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -88.54 98.12 11.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.638 -0.71 . . . . 1.28 109.835 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.927 ' HB2' ' HB ' ' A' ' 2' ' ' VAL . 33.4 m -100.13 113.14 25.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.669 -0.696 . . . . 0.53000000000000003 110.944 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.2 m -78.69 112.98 30.99 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.552 -0.749 . . . . 0.56000000000000005 109.325 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.61 ' HG3' HG23 ' A' ' 2' ' ' VAL . 30.3 Cg_exo -60.21 147.1 94.76 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.479 2.119 . . . . 0.76000000000000001 112.191 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 4.3 mmmp? . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.589 -0.72 . . . . 2.1899999999999999 111.058 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 111.469 -0.652 . . . . 1.0900000000000001 111.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.41 HG21 ' CE ' ' A' ' 23' ' ' MET . 2.4 m -92.41 93.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.847 0.832 . . . . 1.1599999999999999 111.365 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' A' ' 34' ' ' HIS . 1.7 mp -101.44 118.06 47.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.96 . . . . 1.48 109.086 176.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 33' ' ' CYS . 18.4 pt -101.88 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.057 0.456 . . . . 0.51000000000000001 111.379 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.1 39.9 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 1.9199999999999999 111.827 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.07 134.36 44.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.372 -0.603 . . . . 0.46000000000000002 109.372 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.735 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 2.5 tmtp? -78.35 109.36 12.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.475 0.655 . . . . 1.28 109.832 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -80.49 98.26 7.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.172 -0.922 . . . . 0.73999999999999999 111.841 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -66.45 -12.07 55.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.623 0.725 . . . . 2.6200000000000001 109.824 172.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.673 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 11.9 pt -163.61 163.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.139 -1.391 . . . . 0.78000000000000003 107.473 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 44.6 m -67.18 -39.82 86.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 118.474 0.579 . . . . 0.40000000000000002 110.81 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -62.0 -19.5 62.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.813 -0.631 . . . . 3.7400000000000002 112.326 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.673 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 11.9 mm100 -54.95 -35.94 64.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.849 0.356 . . . . 2.2000000000000002 110.879 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -113.66 -18.87 11.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.093 -0.503 . . . . 1.1799999999999999 111.871 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.49 -34.07 76.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.147 -0.621 . . . . 1.3100000000000001 110.981 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -59.81 -56.39 36.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.835 -0.346 . . . . 2.1299999999999999 110.468 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -66.06 -25.89 51.01 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.727 1.618 . . . . 0.53000000000000003 112.65 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.6 m -79.19 -56.31 4.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.725 -0.39 . . . . 0.35999999999999999 111.495 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.588 ' HA ' ' H ' ' A' ' 23' ' ' MET . 73.8 tttt -65.92 -26.61 67.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.372 -0.205 . . . . 1.6499999999999999 111.064 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -65.39 -35.95 82.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 1.03 110.451 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.63 -13.27 58.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 0.69999999999999996 110.881 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.4 64.94 0.6 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.57 -0.612 . . . . 0.81000000000000005 111.57 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.717 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 46.8 mtt -141.13 110.79 6.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.675 0.75 . . . . 2.0699999999999998 110.152 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.79 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 6.4 ptp180 -65.19 -21.24 66.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.579 -1.191 . . . . 3.3599999999999999 112.176 -175.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 47.9 m-85 -128.39 148.07 50.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.043 0.449 . . . . 1.26 110.826 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.05 62.64 0.42 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 109.443 -1.463 . . . . 0.73999999999999999 109.443 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 27' ' ' LYS . 52.1 mtpt -91.1 134.9 34.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.067 0.461 . . . . 2.9100000000000001 111.066 -168.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 39.9 t -81.93 124.11 29.45 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.667 -0.697 . . . . 0.76000000000000001 109.874 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.483 ' HA ' ' CE ' ' A' ' 29' ' ' MET . 1.5 mmt -138.64 105.9 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 2.0800000000000001 111.162 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.05 20.94 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.804 -0.635 . . . . 2.6899999999999999 112.186 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.735 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 119.71 -31.09 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.5 -0.857 . . . . 0.48999999999999999 112.663 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -94.99 154.37 17.2 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.289 0.566 . . . . 1.9099999999999999 111.259 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.9 m -93.68 104.27 16.38 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.149 -0.932 . . . . 0.76000000000000001 109.803 176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.588 ' HA ' HG13 ' A' ' 3' ' ' ILE . 17.8 m-70 -88.73 94.13 9.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.7 -0.682 . . . . 1.28 109.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.6 m -98.66 130.06 45.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.497 0.665 . . . . 0.53000000000000003 110.617 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.7 m -108.36 129.86 23.5 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.139 -1.06 . . . . 0.56000000000000005 108.139 175.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.1 Cg_exo -62.41 155.86 55.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.065 2.51 . . . . 0.76000000000000001 112.396 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.79 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 17.1 mmmt . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.53 -0.748 . . . . 2.1899999999999999 110.53 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.812 0 N-CA-C 111.436 -0.666 . . . . 1.0900000000000001 111.436 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.71 95.29 5.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.629 0.728 . . . . 1.1599999999999999 111.004 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.876 HD11 ' HB3' ' A' ' 32' ' ' LYS . 2.8 tp -91.94 126.71 44.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.252 -0.885 . . . . 1.48 109.893 175.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 33' ' ' CYS . 28.6 pt -115.05 145.23 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.293 -0.412 . . . . 0.51000000000000001 111.367 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.26 69.36 6.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 1.9199999999999999 111.272 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.91 122.8 65.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.563 -0.532 . . . . 0.46000000000000002 109.563 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -69.29 96.33 0.85 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.492 0.663 . . . . 1.28 110.089 -177.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 8.8 p -80.57 100.49 8.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.24 -0.891 . . . . 0.73999999999999999 111.842 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 10' ' ' ILE . 3.3 mppt? -71.13 -8.1 51.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.171 -0.678 . . . . 2.6200000000000001 109.171 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.777 HG13 ' HG3' ' A' ' 13' ' ' GLN . 3.8 pt -168.58 154.41 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 114.063 -1.426 . . . . 0.78000000000000003 108.126 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.3 m -69.35 -22.23 63.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 0.40000000000000002 111.409 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.422 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.3 mpt_? -60.91 -36.29 78.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.264 -0.425 . . . . 3.7400000000000002 111.682 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.777 ' HG3' HG13 ' A' ' 10' ' ' ILE . 13.9 mt-30 -62.84 -27.63 69.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.5 . . . . 2.2000000000000002 110.56 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.8 m -88.29 -48.74 7.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.394 -0.821 . . . . 1.1799999999999999 111.261 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.7 tp -67.83 -34.08 76.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.003 -0.544 . . . . 1.3100000000000001 112.304 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 8.9 tmtt? -58.38 -58.42 19.13 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.295 -0.562 . . . . 2.1299999999999999 110.448 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 70.5 Cg_endo -70.63 -21.0 30.03 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.612 1.541 . . . . 0.53000000000000003 112.345 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 56.6 m -77.66 -58.63 3.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.629 -0.429 . . . . 0.35999999999999999 109.95 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HA ' ' H ' ' A' ' 23' ' ' MET . 44.9 tttm -60.08 -32.04 70.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.208 -0.451 . . . . 1.6499999999999999 110.637 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 13.9 t70 -56.22 -47.88 77.57 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 1.03 110.496 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.64 -29.23 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.67 -0.695 . . . . 0.69999999999999996 111.071 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.4 0.11 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.494 -0.642 . . . . 0.81000000000000005 111.494 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.7 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 10.2 mmt -145.01 91.63 2.17 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.132 -1.062 . . . . 2.0699999999999998 108.132 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HG3' ' CD2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -50.39 -47.77 56.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.508 -1.224 . . . . 3.3599999999999999 111.524 -177.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.614 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 98.7 m-85 -99.27 147.3 25.32 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.687 -0.405 . . . . 1.26 110.084 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.88 95.07 0.13 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.708 -0.957 . . . . 0.73999999999999999 110.708 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -122.32 141.17 51.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.198 0.523 . . . . 2.9100000000000001 111.03 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.3 t -75.9 136.19 40.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.466 -0.788 . . . . 0.76000000000000001 110.324 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 32' ' ' LYS . 2.7 ppp? -137.87 100.54 4.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 2.0800000000000001 110.859 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 58.39 18.82 5.86 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.792 . . . . 2.6899999999999999 112.55 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 119.42 -5.56 13.11 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.576 -0.821 . . . . 0.48999999999999999 113.335 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.876 ' HB3' HD11 ' A' ' 3' ' ' ILE . 53.4 mtpt -120.36 168.62 11.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.045 0.422 . . . . 1.9099999999999999 111.243 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.55 ' HB2' HG12 ' A' ' 4' ' ' ILE . 59.0 m -111.66 102.84 11.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.76000000000000001 111.666 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.876 ' HD2' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -81.99 97.95 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 1.28 110.529 174.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.7 m -106.44 134.49 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.316 0.579 . . . . 0.53000000000000003 110.772 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 17.3 m -112.38 124.09 32.75 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.076 -0.712 . . . . 0.56000000000000005 109.076 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 53.1 Cg_exo -55.4 147.3 57.72 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.616 2.877 . . . . 0.76000000000000001 113.477 -170.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 13.9 tptp . . . . . 0 C--O 1.249 1.047 0 CA-C-N 114.89 -1.05 . . . . 2.1899999999999999 110.068 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 112.012 -0.435 . . . . 1.0900000000000001 112.012 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 64.2 t -85.02 100.35 8.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.354 0.597 . . . . 1.1599999999999999 109.768 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.585 HD12 ' CD2' ' A' ' 34' ' ' HIS . 7.0 mm -100.28 121.42 51.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.448 -0.797 . . . . 1.48 110.005 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.508 HD11 ' SG ' ' A' ' 14' ' ' CYS . 24.8 pt -115.76 151.56 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.965 0.412 . . . . 0.51000000000000001 110.61 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.03 45.25 1.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 1.9199999999999999 111.686 -174.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.7 t -102.12 126.45 56.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.954 -0.758 . . . . 0.46000000000000002 108.954 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -68.67 120.33 14.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.731 0.777 . . . . 1.28 109.94 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 13.0 p -85.35 86.42 7.38 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.012 -0.995 . . . . 0.73999999999999999 111.734 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -55.96 -23.38 31.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.386 0.612 . . . . 2.6200000000000001 109.614 173.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.622 HG13 ' HG2' ' A' ' 13' ' ' GLN . 7.2 pt -164.06 167.52 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.98 -1.464 . . . . 0.78000000000000003 107.482 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.416 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 63.6 m -66.43 -36.93 84.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.295 0.498 . . . . 0.40000000000000002 110.741 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -57.15 -28.84 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.754 -0.657 . . . . 3.7400000000000002 111.828 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.622 ' HG2' HG13 ' A' ' 10' ' ' ILE . 15.4 mm100 -55.72 -34.55 65.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 111.698 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.623 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 4.9 t -108.63 -21.66 12.6 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.449 -0.5 . . . . 1.1799999999999999 111.736 -176.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.559 HD21 ' HE3' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -74.47 -36.53 63.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.933 -0.707 . . . . 1.3100000000000001 111.369 -174.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.528 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -56.29 -49.46 93.2 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 120.327 -0.549 . . . . 2.1299999999999999 110.592 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.623 ' HD2' ' C ' ' A' ' 14' ' ' CYS . 21.5 Cg_exo -67.7 -35.96 20.4 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.81 1.674 . . . . 0.53000000000000003 112.851 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.759 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 34.2 m -71.14 -54.14 12.08 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.55 -0.46 . . . . 0.35999999999999999 111.713 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.572 ' HA ' ' H ' ' A' ' 23' ' ' MET . 38.2 ttmt -66.4 -25.9 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.833 -0.347 . . . . 1.6499999999999999 110.456 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.78 -33.08 71.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.046 -0.525 . . . . 1.03 110.206 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -6.09 56.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.69999999999999996 110.82 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.74 62.36 0.75 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.795 -0.717 . . . . 0.81000000000000005 112.424 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.759 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 10.0 mmt -138.3 111.99 8.27 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.082 -0.71 . . . . 2.0699999999999998 109.082 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 13.7 ptp180 -63.8 -22.81 67.09 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.552 -0.749 . . . . 3.3599999999999999 111.894 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.2 m-85 -130.14 155.69 45.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.26 110.953 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -164.62 92.6 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.847 -1.301 . . . . 0.73999999999999999 109.847 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 34.0 mmtp -123.19 147.89 46.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.187 0.517 . . . . 2.9100000000000001 111.46 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 40.2 t -81.25 127.29 32.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.431 -0.804 . . . . 0.76000000000000001 109.833 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.536 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 57.9 mtt -137.39 105.54 5.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.404 -0.591 . . . . 2.0800000000000001 109.404 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 71.04 -73.8 0.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 124.525 1.141 . . . . 2.6899999999999999 111.095 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.31 -33.23 0.13 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.84 -0.695 . . . . 0.48999999999999999 112.813 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' HG3' ' HE1' ' A' ' 34' ' ' HIS . 2.4 ptpt -100.35 164.46 11.92 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.473 0.654 . . . . 1.9099999999999999 111.672 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' SG ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -92.81 128.37 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.166 -0.925 . . . . 0.76000000000000001 109.26 177.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.585 ' CD2' HD12 ' A' ' 3' ' ' ILE . 42.6 m80 -110.64 109.24 19.44 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.293 -0.867 . . . . 1.28 109.931 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -111.07 133.19 53.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.504 0.668 . . . . 0.53000000000000003 112.091 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 18.0 m -101.51 127.7 30.86 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.421 -0.955 . . . . 0.56000000000000005 108.421 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 16.9 Cg_exo -66.64 158.74 54.36 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.135 2.557 . . . . 0.76000000000000001 113.343 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 35.8 mmtt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.491 -0.766 . . . . 2.1899999999999999 110.322 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.206 -0.358 . . . . 1.0900000000000001 112.206 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.43 102.67 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.14 0.495 . . . . 1.1599999999999999 110.143 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 mm -96.44 109.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.705 -0.68 . . . . 1.48 110.388 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.411 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 18.2 pt -99.72 147.19 7.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.373 -0.376 . . . . 0.51000000000000001 110.902 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.81 12.09 2.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.968 -0.56 . . . . 1.9199999999999999 112.128 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.67 128.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.107 -0.701 . . . . 0.46000000000000002 109.107 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.583 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 6.1 tmtt? -73.25 115.85 13.09 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.781 -0.822 . . . . 1.28 108.781 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 17.4 p -66.33 85.07 0.1 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.731 -1.122 . . . . 0.73999999999999999 111.644 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HB2' HD13 ' A' ' 10' ' ' ILE . 71.0 mmtt -58.89 -25.83 63.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.117 -0.697 . . . . 2.6200000000000001 109.117 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -168.77 152.47 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.545 -1.661 . . . . 0.78000000000000003 107.143 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.5 m -65.51 -28.33 69.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.482 -0.487 . . . . 0.40000000000000002 110.683 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -56.18 -34.41 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 3.7400000000000002 111.266 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.598 ' HG3' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -87.61 -14.53 39.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 2.2000000000000002 110.87 -173.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 33' ' ' CYS . 57.2 m -89.26 -40.76 12.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.321 0.581 . . . . 1.1799999999999999 110.029 176.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 26' ' ' GLY . 61.2 tp -73.71 -27.87 61.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.68 -0.691 . . . . 1.3100000000000001 111.505 -175.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 25.6 tptp -55.05 -56.69 25.24 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.692 0.256 . . . . 2.1299999999999999 111.692 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 68.9 Cg_endo -74.54 -19.92 18.55 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.541 1.494 . . . . 0.53000000000000003 112.45 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.832 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 57.5 m -81.72 -56.69 3.83 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 121.082 -0.247 . . . . 0.35999999999999999 111.354 -176.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -62.35 -36.05 81.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.786 -0.366 . . . . 1.6499999999999999 110.547 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.31 -36.25 79.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 1.03 110.687 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.39 -35.09 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.69999999999999996 110.842 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.73 42.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.81000000000000005 112.586 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.832 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.2 mpt? -126.29 98.07 5.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.463 -0.569 . . . . 2.0699999999999998 109.463 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.803 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -53.81 -34.83 60.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.987 . . . . 3.3599999999999999 112.123 -178.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 59.2 m-85 -109.21 144.31 37.48 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.104 -0.332 . . . . 1.26 110.104 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.419 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -158.06 75.39 0.21 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.325 -1.11 . . . . 0.73999999999999999 110.325 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -108.93 143.89 37.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 2.9100000000000001 111.288 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.3 t -71.95 125.62 27.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.859 -1.064 . . . . 0.76000000000000001 110.492 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.402 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 95.9 mmm -124.7 82.44 2.05 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.572 -0.529 . . . . 2.0800000000000001 109.572 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 73.75 -65.41 0.35 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.421 1.076 . . . . 2.6899999999999999 111.626 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . -131.11 -39.8 0.25 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.65 -0.786 . . . . 0.48999999999999999 112.779 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -98.68 158.71 15.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.189 0.519 . . . . 1.9099999999999999 111.181 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 68.1 m -92.42 116.07 28.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.513 -0.767 . . . . 0.76000000000000001 109.119 174.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 12.2 m-70 -99.81 99.23 10.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.888 -0.412 . . . . 1.28 109.888 -177.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -101.07 135.48 42.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.53000000000000003 111.692 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 16.6 m -115.77 132.74 23.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.372 -0.831 . . . . 0.56000000000000005 109.012 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 51.0 Cg_exo -54.0 152.34 24.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.668 2.912 . . . . 0.76000000000000001 114.032 -172.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.803 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.245 0.858 0 CA-C-N 114.945 -1.025 . . . . 2.1899999999999999 110.921 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.647 -0.581 . . . . 1.0900000000000001 111.647 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.9 t -77.18 93.7 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.182 0.515 . . . . 1.1599999999999999 110.129 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.789 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.1 tp -92.87 122.94 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.871 -0.604 . . . . 1.48 110.627 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.5 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 20.5 pt -110.95 142.05 24.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 0.51000000000000001 110.348 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -84.81 50.51 1.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.782 0.801 . . . . 1.9199999999999999 111.231 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.63 138.11 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.95 -1.023 . . . . 0.46000000000000002 108.293 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.513 ' HD3' ' C ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -77.79 109.88 12.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 1.28 109.779 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.8 p -71.76 85.63 0.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.948 -1.023 . . . . 0.73999999999999999 111.768 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 10' ' ' ILE . 32.8 mmtp -55.84 -23.84 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 2.6200000000000001 108.986 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' CG1' ' HG2' ' A' ' 13' ' ' GLN . 8.9 pt -163.06 166.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.557 -1.656 . . . . 0.78000000000000003 107.097 175.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -66.44 -37.65 85.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.392 0.542 . . . . 0.40000000000000002 110.85 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -61.54 -19.81 62.54 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.094 -0.503 . . . . 3.7400000000000002 111.966 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.573 ' HG2' ' CG1' ' A' ' 10' ' ' ILE . 13.6 mm100 -58.38 -34.59 70.88 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.878 0.37 . . . . 2.2000000000000002 111.217 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 86.8 m -117.27 -25.32 7.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.162 -0.472 . . . . 1.1799999999999999 112.234 -173.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 26' ' ' GLY . 57.0 tp -64.37 -37.98 89.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.28 -0.568 . . . . 1.3100000000000001 111.418 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 25.8 tptp -58.8 -50.89 85.54 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 120.511 -0.475 . . . . 2.1299999999999999 111.419 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 33.4 Cg_exo -60.54 -40.41 56.76 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.82 1.68 . . . . 0.53000000000000003 112.563 170.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.8 m -70.83 -57.95 4.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.888 0.329 . . . . 0.35999999999999999 111.888 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 23' ' ' MET . 71.6 tttt -63.17 -28.38 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.827 0.346 . . . . 1.6499999999999999 110.81 -176.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.75 -31.76 71.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 1.03 109.843 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.67 2.79 52.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 0.69999999999999996 110.962 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.47 66.3 0.98 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 120.973 -0.632 . . . . 0.81000000000000005 112.027 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.804 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 61.0 mtt -145.6 108.69 4.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 2.0699999999999998 109.58 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -65.15 -18.72 65.54 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.421 -0.809 . . . . 3.3599999999999999 111.981 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.556 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 41.3 m-85 -134.27 149.32 50.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.232 0.539 . . . . 1.26 111.378 175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -153.23 79.64 0.19 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.0 -1.64 . . . . 0.73999999999999999 109.0 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -114.73 134.53 55.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.828 0.347 . . . . 2.9100000000000001 110.661 -163.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.5 t -74.45 121.92 22.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.838 -0.619 . . . . 0.76000000000000001 109.84 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.437 ' HB2' ' HD2' ' A' ' 34' ' ' HIS . 93.4 mmm -134.93 110.56 9.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 2.0800000000000001 110.633 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 60.64 16.83 6.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 2.6899999999999999 112.438 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.38 -11.1 21.85 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.433 -0.889 . . . . 0.48999999999999999 113.142 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.789 ' HB3' HD11 ' A' ' 3' ' ' ILE . 67.4 mttm -116.79 160.16 21.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.081 0.467 . . . . 1.9099999999999999 110.928 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.5 m -93.88 103.91 16.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.697 -0.683 . . . . 0.76000000000000001 110.66 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.563 ' CD2' HD13 ' A' ' 3' ' ' ILE . 27.6 m-70 -92.0 99.49 12.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.751 -0.659 . . . . 1.28 109.854 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -99.41 129.41 45.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.53000000000000003 110.777 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 8.7 m -104.77 126.47 31.14 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.598 -0.89 . . . . 0.56000000000000005 108.598 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.804 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 6.9 Cg_exo -71.74 156.1 57.63 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.129 2.553 . . . . 0.76000000000000001 113.037 -170.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.353 -0.832 . . . . 2.1899999999999999 110.427 174.429 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.823 0 N-CA-C 112.371 -0.292 . . . . 1.0900000000000001 112.371 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.477 HG11 ' HE2' ' A' ' 23' ' ' MET . 44.9 t -90.22 93.53 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.095 0.474 . . . . 1.1599999999999999 110.158 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mm -111.96 108.97 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.794 -0.639 . . . . 1.48 109.968 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 33' ' ' CYS . 28.0 pt -105.09 149.06 8.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.204 0.526 . . . . 0.51000000000000001 111.336 -176.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -86.66 48.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 1.9199999999999999 111.515 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -112.1 125.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.72 -0.673 . . . . 0.46000000000000002 109.211 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.98 ' HE2' ' HA2' ' A' ' 31' ' ' GLY . 2.5 tmtt? -73.65 102.9 4.06 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.695 0.759 . . . . 1.28 109.721 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.854 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 7.5 p -68.35 106.22 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.794 -1.094 . . . . 0.73999999999999999 111.484 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.3 mppt? -72.71 -2.16 19.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 2.6200000000000001 110.008 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.902 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -178.74 168.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.787 1.635 . . . . 0.78000000000000003 108.534 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -67.54 -40.95 85.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.936 0.334 . . . . 0.40000000000000002 111.875 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -58.95 -27.45 65.33 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.097 0.406 . . . . 3.7400000000000002 112.097 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.902 ' HG2' HG13 ' A' ' 10' ' ' ILE . 16.1 mm100 -62.98 -23.84 67.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.071 0.462 . . . . 2.2000000000000002 110.858 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.854 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.2 m -102.19 -38.98 7.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.705 -0.679 . . . . 1.1799999999999999 110.719 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.34 -34.83 78.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 1.3100000000000001 111.707 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.571 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 32.8 tptt -57.59 -54.69 52.44 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 120.665 -0.414 . . . . 2.1299999999999999 111.273 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.575 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 18.8 Cg_exo -67.75 -29.36 35.75 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.74 1.626 . . . . 0.53000000000000003 112.313 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.772 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.3 m -76.62 -55.98 5.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 121.05 -0.26 . . . . 0.35999999999999999 111.239 -174.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -66.63 -22.29 66.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 1.6499999999999999 110.587 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.31 -37.39 83.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 1.03 110.638 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 -45.94 11.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.69999999999999996 110.819 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.57 59.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.821 -0.704 . . . . 0.81000000000000005 112.147 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.772 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.3 mpt? -137.94 105.99 5.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.178 0.513 . . . . 2.0699999999999998 110.144 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.534 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 8.9 ptm180 -62.77 -25.7 68.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.365 -0.834 . . . . 3.3599999999999999 112.188 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 57.4 m-85 -126.5 151.83 47.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.699 0.285 . . . . 1.26 110.646 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.39 85.66 0.13 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.741 -0.944 . . . . 0.73999999999999999 110.741 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -108.32 135.1 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 2.9100000000000001 110.939 -173.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 t -76.8 131.11 38.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.813 -0.631 . . . . 0.76000000000000001 109.925 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.462 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 91.1 mmm -137.25 91.79 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.581 -0.282 . . . . 2.0800000000000001 111.659 -175.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.72 19.82 8.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.715 0.635 . . . . 2.6899999999999999 112.715 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.98 ' HA2' ' HE2' ' A' ' 7' ' ' LYS . . . 134.92 -50.78 0.85 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.637 -0.792 . . . . 0.48999999999999999 112.438 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -88.6 156.79 18.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.466 0.651 . . . . 1.9099999999999999 111.636 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.596 ' HB2' HG12 ' A' ' 4' ' ' ILE . 65.3 m -94.05 117.95 30.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.821 -1.081 . . . . 0.76000000000000001 109.846 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.462 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 11.8 m-70 -100.4 100.42 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.968 -0.56 . . . . 1.28 109.778 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -107.64 129.16 55.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.129 0.49 . . . . 0.53000000000000003 111.396 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.4 m -98.06 130.21 29.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.606 -0.887 . . . . 0.56000000000000005 108.606 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.8 Cg_exo -69.78 151.17 68.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.852 2.368 . . . . 0.76000000000000001 113.012 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 18.5 mmmt . . . . . 0 C--O 1.245 0.855 0 CA-C-N 115.207 -0.906 . . . . 2.1899999999999999 110.461 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 112.18 -0.368 . . . . 1.0900000000000001 112.18 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.86 93.14 4.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.689 0.757 . . . . 1.1599999999999999 110.742 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.568 HG21 ' HD3' ' A' ' 32' ' ' LYS . 21.8 mm -105.59 109.64 28.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.155 -0.93 . . . . 1.48 109.803 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 29.7 pt -91.09 140.63 15.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.062 0.458 . . . . 0.51000000000000001 110.83 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -84.68 63.13 7.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.512 0.673 . . . . 1.9199999999999999 110.1 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.95 126.57 75.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.227 -0.897 . . . . 0.46000000000000002 109.513 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.629 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -55.53 102.57 0.07 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.058 0.456 . . . . 1.28 109.954 174.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 26.1 p -77.1 83.79 3.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.563 0.697 . . . . 0.73999999999999999 110.518 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 8.3 tptp -76.44 -5.95 49.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.561 -0.904 . . . . 2.6200000000000001 108.561 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.666 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.4 pt -167.59 144.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.329 -1.76 . . . . 0.78000000000000003 107.496 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.7 m -74.11 -20.33 60.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.831 0.348 . . . . 0.40000000000000002 110.52 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.37 -37.46 85.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 3.7400000000000002 111.223 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 18.2 pt20 -73.83 -14.78 61.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.947 0.403 . . . . 2.2000000000000002 110.674 -177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.567 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 35.3 m -97.29 -49.66 4.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 1.1799999999999999 110.721 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 26' ' ' GLY . 65.5 tp -69.97 -35.01 74.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.009 -0.541 . . . . 1.3100000000000001 112.343 -173.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.4 tppt? -58.65 -51.41 82.05 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.796 -0.362 . . . . 2.1299999999999999 111.261 -178.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 21.6 Cg_exo -67.5 -27.67 39.22 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.681 1.587 . . . . 0.53000000000000003 111.911 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.899 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 54.1 m -71.16 -51.3 25.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.946 -0.302 . . . . 0.35999999999999999 110.887 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HE3' HD11 ' A' ' 15' ' ' LEU . 84.9 mttt -64.92 -28.54 69.6 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.739 -0.601 . . . . 1.6499999999999999 111.007 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.43 -30.76 68.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 1.03 110.975 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.58 -42.85 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.268 -0.424 . . . . 0.69999999999999996 111.226 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.09 56.59 0.02 OUTLIER Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 111.479 -0.648 . . . . 0.81000000000000005 111.479 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.899 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.4 mpt? -137.71 109.07 6.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.255 -0.646 . . . . 2.0699999999999998 109.255 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.6 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -74.32 -26.67 60.31 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.27 -0.877 . . . . 3.3599999999999999 111.898 -175.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 62.5 m-85 -115.6 152.56 32.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.119 -0.326 . . . . 1.26 110.119 173.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -164.71 102.1 0.19 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.762 -0.935 . . . . 0.73999999999999999 110.762 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -127.83 134.49 49.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.668 0.27 . . . . 2.9100000000000001 110.496 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 5.3 t -73.92 127.73 33.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.76000000000000001 109.788 173.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -138.47 114.72 10.28 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.478 -0.564 . . . . 2.0800000000000001 109.478 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.4 -86.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.122 -0.945 . . . . 2.6899999999999999 111.83 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' HA2' ' NZ ' ' A' ' 7' ' ' LYS . . . -132.53 -6.01 3.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.393 -0.908 . . . . 0.48999999999999999 112.967 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.568 ' HD3' HG21 ' A' ' 3' ' ' ILE . 17.4 ptpt -121.6 160.86 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.312 0.577 . . . . 1.9099999999999999 111.453 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 39.9 m -99.52 105.96 17.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.329 -0.85 . . . . 0.76000000000000001 110.198 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.09 107.99 16.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.187 -0.46 . . . . 1.28 110.349 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -115.54 134.36 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.045 0.45 . . . . 0.53000000000000003 110.683 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 7.4 m -105.52 125.34 33.65 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.814 -0.81 . . . . 0.56000000000000005 108.814 176.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 52.3 Cg_exo -53.32 146.91 38.46 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.278 2.652 . . . . 0.76000000000000001 113.525 -174.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.6 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 25.3 mmtp . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.15 -0.929 . . . . 2.1899999999999999 110.967 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.639 -0.584 . . . . 1.0900000000000001 111.639 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.4 t -86.78 99.02 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.504 0.669 . . . . 1.1599999999999999 110.251 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.493 HD12 ' CG ' ' A' ' 34' ' ' HIS . 18.0 mm -89.44 115.65 29.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 1.48 109.758 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.29 147.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.808 0.337 . . . . 0.51000000000000001 111.099 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.57 19.2 3.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.956 -0.565 . . . . 1.9199999999999999 111.081 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.0 t -77.39 128.67 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.847 -0.797 . . . . 0.46000000000000002 108.847 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 1.1 tmtp? -71.08 106.58 3.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.343 0.592 . . . . 1.28 109.81 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 13' ' ' GLN . 19.5 p -77.22 91.36 3.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.605 -0.725 . . . . 0.73999999999999999 109.891 177.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 10' ' ' ILE . 15.3 tptp -66.25 -13.07 59.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.57 0.7 . . . . 2.6200000000000001 109.484 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.456 HG13 ' HG2' ' A' ' 13' ' ' GLN . 3.1 pt -162.62 170.01 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 114.121 -1.4 . . . . 0.78000000000000003 108.122 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.9 m -66.46 -26.95 67.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.58 0.627 . . . . 0.40000000000000002 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -50.06 -42.27 49.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.164 -0.471 . . . . 3.7400000000000002 110.548 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 16.0 mm100 -73.73 -8.34 55.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.721 -0.672 . . . . 2.2000000000000002 111.231 -175.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.46 -52.63 3.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.317 0.579 . . . . 1.1799999999999999 110.008 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 tp -75.6 -37.94 59.42 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 1.3100000000000001 112.109 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 23.3 tptm -55.53 -52.47 71.56 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.861 0.319 . . . . 2.1299999999999999 111.861 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 12.3 Cg_exo -71.49 -30.74 14.73 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.551 1.501 . . . . 0.53000000000000003 112.046 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 31.4 m -80.51 -55.18 5.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.35999999999999999 111.63 -172.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HA ' ' H ' ' A' ' 23' ' ' MET . 56.4 tttm -61.46 -32.16 72.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 1.6499999999999999 110.701 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.47 -36.78 81.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.706 -0.679 . . . . 1.03 110.646 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -34.69 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.422 . . . . 0.69999999999999996 110.969 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.63 62.03 0.07 OUTLIER Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.465 -0.654 . . . . 0.81000000000000005 111.465 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.698 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 12.6 mmt -134.68 105.28 6.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.541 -0.911 . . . . 2.0699999999999998 108.541 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.656 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.88 -24.54 67.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.183 -0.917 . . . . 3.3599999999999999 112.222 -174.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.56 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 50.4 m-85 -125.44 154.26 42.25 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.401 -0.187 . . . . 1.26 110.752 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.69 96.83 0.15 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 111.471 -0.652 . . . . 0.73999999999999999 111.471 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -109.85 134.06 52.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.839 0.352 . . . . 2.9100000000000001 110.06 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.1 t -77.37 129.54 35.94 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.005 -0.543 . . . . 0.76000000000000001 109.635 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 58.3 mtt -129.89 98.19 4.71 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.53 -0.305 . . . . 2.0800000000000001 110.679 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.8 m120 69.61 -77.04 0.06 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.135 0.897 . . . . 2.6899999999999999 111.269 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.671 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . -135.67 -29.19 0.37 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.21 -0.519 . . . . 0.48999999999999999 112.211 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -95.35 153.34 17.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.329 0.585 . . . . 1.9099999999999999 111.077 -178.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.41 130.3 39.25 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.449 -0.796 . . . . 0.76000000000000001 109.946 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.493 ' CG ' HD12 ' A' ' 3' ' ' ILE . 14.4 m-70 -116.18 87.2 2.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.515 -0.766 . . . . 1.28 109.194 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 p -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.878 0.847 . . . . 0.53000000000000003 111.864 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 10.6 m -95.86 127.92 39.41 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.699 -1.137 . . . . 0.56000000000000005 108.974 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 31.2 Cg_exo -59.39 151.45 68.22 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.167 2.578 . . . . 0.76000000000000001 112.356 -173.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 23.6 tptm . . . . . 0 C--O 1.249 1.045 0 CA-C-N 115.323 -0.853 . . . . 2.1899999999999999 111.083 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.467 -0.253 . . . . 1.0900000000000001 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.58 104.53 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.064 0.459 . . . . 1.1599999999999999 110.335 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 34' ' ' HIS . 17.4 mm -98.34 121.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.602 -0.726 . . . . 1.48 110.029 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.59 HG12 ' HB2' ' A' ' 33' ' ' CYS . 27.1 pt -111.97 149.23 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.522 -0.308 . . . . 0.51000000000000001 110.236 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.69 14.56 5.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 1.9199999999999999 112.037 -172.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -65.12 123.47 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.631 -0.507 . . . . 0.46000000000000002 109.631 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -69.85 104.97 2.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.251 0.548 . . . . 1.28 109.832 -176.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.871 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 25.8 p -76.81 103.01 6.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 0.73999999999999999 111.113 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.65 -18.88 61.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.029 -0.73 . . . . 2.6200000000000001 109.029 172.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.587 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.0 pt -170.94 167.09 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 113.877 -1.511 . . . . 0.78000000000000003 108.208 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 48.8 m -64.39 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.14 0.427 . . . . 0.40000000000000002 110.969 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -52.38 -38.85 59.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.01 -0.541 . . . . 3.7400000000000002 110.934 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.587 ' HG2' HG13 ' A' ' 10' ' ' ILE . 16.8 mm100 -67.11 -20.52 65.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 2.2000000000000002 112.159 -173.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.7 m -105.38 -35.57 7.47 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.536 0.569 . . . . 1.1799999999999999 112.536 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.662 ' HG ' ' HA3' ' A' ' 26' ' ' GLY . 0.4 OUTLIER -80.89 -21.12 40.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.88 -0.728 . . . . 1.3100000000000001 111.683 -172.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 34.3 tptt -60.72 -54.62 52.86 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 119.955 -0.698 . . . . 2.1299999999999999 109.768 171.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 25.6 Cg_exo -64.75 -33.86 52.46 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.708 1.606 . . . . 0.53000000000000003 112.838 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 84.6 m -75.02 -52.82 10.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.566 -0.454 . . . . 0.35999999999999999 111.106 -176.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.551 ' HA ' ' H ' ' A' ' 23' ' ' MET . 44.8 tttm -64.67 -34.13 77.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.45 0.167 . . . . 1.6499999999999999 110.834 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.87 -35.33 74.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 1.03 110.63 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -6.23 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 0.69999999999999996 111.015 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 56.87 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.969 -0.634 . . . . 0.81000000000000005 112.494 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.747 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 63.6 mtt -128.59 114.66 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 2.0699999999999998 110.086 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.968 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 1.3 ptp180 -69.04 -23.57 64.08 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.926 -1.034 . . . . 3.3599999999999999 112.587 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 13.8 m-85 -127.27 155.78 42.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 1.26 111.331 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.662 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -167.36 85.43 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.916 -0.873 . . . . 0.73999999999999999 110.916 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -94.57 134.29 37.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.702 0.287 . . . . 2.9100000000000001 110.683 -176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 24.4 t -83.89 107.95 16.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.646 -0.501 . . . . 0.76000000000000001 109.646 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.87 131.61 27.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.533 -0.758 . . . . 2.0800000000000001 109.556 -176.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.489 ' OD1' ' HE2' ' A' ' 32' ' ' LYS . 26.5 t-20 69.48 0.97 3.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.439 0.638 . . . . 2.6899999999999999 111.058 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 95.39 4.05 61.11 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.903 -0.665 . . . . 0.48999999999999999 111.84 -174.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE2' ' OD1' ' A' ' 30' ' ' ASN . 56.6 mttm -112.17 156.78 21.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.048 0.452 . . . . 1.9099999999999999 110.828 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.59 ' HB2' HG12 ' A' ' 4' ' ' ILE . 30.9 m -92.5 97.69 10.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 0.76000000000000001 109.695 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.435 ' HA ' HD12 ' A' ' 3' ' ' ILE . 76.9 m80 -87.88 91.85 8.91 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.342 -0.844 . . . . 1.28 109.455 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.31 152.49 23.48 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.38 0.609 . . . . 0.53000000000000003 111.736 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 21.1 m -129.41 131.91 23.93 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.412 -0.958 . . . . 0.56000000000000005 108.412 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 22.7 Cg_exo -63.27 151.81 83.01 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.112 2.541 . . . . 0.76000000000000001 113.013 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.968 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 50.2 tptt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.202 -0.904 . . . . 2.1899999999999999 109.346 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.851 -0.5 . . . . 1.0900000000000001 111.851 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.31 93.41 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.983 0.421 . . . . 1.1599999999999999 110.476 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.4 tp -104.61 119.5 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.243 0.544 . . . . 1.48 110.473 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.602 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 28.8 pt -114.55 154.02 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.799 -0.637 . . . . 0.51000000000000001 110.821 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.96 24.34 2.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.05 -0.523 . . . . 1.9199999999999999 111.531 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.5 t -81.39 134.36 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.212 -0.662 . . . . 0.46000000000000002 109.212 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 8' ' ' CYS . 1.7 tmtp? -78.18 117.64 19.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.587 0.708 . . . . 1.28 109.551 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' N ' ' HD3' ' A' ' 7' ' ' LYS . 14.5 p -78.05 85.65 4.25 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.03 -0.986 . . . . 0.73999999999999999 111.996 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.1 mptm? -61.39 -16.14 43.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.662 0.744 . . . . 2.6200000000000001 109.425 172.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.648 HG13 ' HG2' ' A' ' 13' ' ' GLN . 4.0 pt -169.03 173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 113.583 -1.644 . . . . 0.78000000000000003 106.927 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -74.8 -25.2 58.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.392 0.542 . . . . 0.40000000000000002 110.302 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -63.47 -32.61 74.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.468 . . . . 3.7400000000000002 111.073 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.648 ' HG2' HG13 ' A' ' 10' ' ' ILE . 17.4 mm100 -58.73 -30.8 67.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.254 0.55 . . . . 2.2000000000000002 110.628 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.638 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 11.0 m -94.98 -44.58 7.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.076 -0.966 . . . . 1.1799999999999999 111.078 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.89 HD21 ' HE2' ' A' ' 19' ' ' LYS . 42.2 tp -74.34 -24.59 59.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 1.3100000000000001 112.261 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 16.9 tppt? -62.69 -52.75 62.43 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.823 -0.351 . . . . 2.1299999999999999 111.099 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 7.8 Cg_exo -74.34 -17.93 20.94 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.84 1.693 . . . . 0.53000000000000003 112.099 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.79 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 55.6 m -82.48 -56.75 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.6 -0.44 . . . . 0.35999999999999999 111.518 -176.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.89 ' HE2' HD21 ' A' ' 15' ' ' LEU . 42.0 mttm -57.18 -38.27 73.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.254 0.479 . . . . 1.6499999999999999 110.811 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.94 -32.41 73.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.937 -0.574 . . . . 1.03 111.152 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 -11.91 37.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.446 -0.343 . . . . 0.69999999999999996 111.243 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.76 45.67 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.746 -0.74 . . . . 0.81000000000000005 112.987 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.79 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 2.1 mpt? -125.7 106.75 9.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.981 0.896 . . . . 2.0699999999999998 110.455 170.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.747 ' HB2' ' HA ' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -47.22 -55.3 8.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.517 -1.674 . . . . 3.3599999999999999 112.137 173.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 46.5 m-85 -99.34 158.93 15.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.912 0.387 . . . . 1.26 111.208 -177.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.71 91.69 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.189 -1.164 . . . . 0.73999999999999999 110.189 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -121.76 138.8 54.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.848 0.356 . . . . 2.9100000000000001 110.502 -170.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.1 t -70.25 122.67 19.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.76000000000000001 109.864 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.8 mmt -137.77 102.36 4.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.34 -0.391 . . . . 2.0800000000000001 111.004 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 64.59 16.56 10.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.841 -0.618 . . . . 2.6899999999999999 111.788 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.56 -22.48 11.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.631 -0.795 . . . . 0.48999999999999999 112.366 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.712 ' HB3' HD11 ' A' ' 3' ' ' ILE . 62.9 mttp -102.66 161.61 13.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.139 0.495 . . . . 1.9099999999999999 110.7 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.602 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 85.3 m -99.32 109.8 22.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.774 -0.648 . . . . 0.76000000000000001 111.096 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.592 ' CD2' HD13 ' A' ' 3' ' ' ILE . 3.2 m-70 -92.23 103.81 16.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.56 -0.746 . . . . 1.28 110.582 177.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.47 149.96 29.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.384 0.611 . . . . 0.53000000000000003 111.044 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 9.0 m -126.91 131.81 24.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.707 -0.849 . . . . 0.56000000000000005 108.707 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 27.0 Cg_exo -59.85 143.47 99.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.298 2.665 . . . . 0.76000000000000001 113.124 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.747 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 18.9 ttpt . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.094 -0.957 . . . . 2.1899999999999999 110.134 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 112.294 -0.322 . . . . 1.0900000000000001 112.294 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.485 HG21 ' SD ' ' A' ' 23' ' ' MET . 59.0 t -75.95 105.74 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.203 0.525 . . . . 1.1599999999999999 110.803 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.0 116.93 50.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.313 -0.858 . . . . 1.48 109.562 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.546 HG12 ' HB2' ' A' ' 33' ' ' CYS . 26.3 pt -113.41 147.58 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.076 0.465 . . . . 0.51000000000000001 111.7 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -82.57 69.54 9.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.454 -0.794 . . . . 1.9199999999999999 111.07 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.2 t -131.65 129.52 61.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.604 . . . . 0.46000000000000002 109.573 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -75.42 86.43 2.56 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 1.28 109.29 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 7.3 p -58.79 98.46 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.567 -1.197 . . . . 0.73999999999999999 112.786 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 10' ' ' ILE . 38.4 mmtm -72.36 -11.96 60.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.328 -0.989 . . . . 2.6200000000000001 108.328 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.537 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 4.2 pt -169.13 154.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 113.521 -1.672 . . . . 0.78000000000000003 108.237 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.507 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 23.8 m -72.87 -30.63 64.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.356 0.598 . . . . 0.40000000000000002 110.008 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -62.32 -25.66 68.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.215 -0.902 . . . . 3.7400000000000002 112.558 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 14.7 pt20 -79.25 -19.88 49.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 2.2000000000000002 110.312 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.613 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 8.5 m -96.68 -31.23 12.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.98 -0.555 . . . . 1.1799999999999999 110.193 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.512 HD11 ' HZ2' ' A' ' 19' ' ' LYS . 56.9 tp -69.71 -36.59 76.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.055 -0.521 . . . . 1.3100000000000001 112.154 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.505 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 39.9 tptt -53.7 -55.95 30.17 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 119.225 -0.417 . . . . 2.1299999999999999 111.086 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 14' ' ' CYS . 19.1 Cg_exo -67.31 -22.39 46.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.648 1.566 . . . . 0.53000000000000003 112.249 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 23' ' ' MET . 69.7 m -81.72 -56.03 4.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.798 -0.361 . . . . 0.35999999999999999 111.952 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.512 ' HZ2' HD11 ' A' ' 15' ' ' LEU . 4.7 ttmp? -67.75 -26.27 66.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.299 0.5 . . . . 1.6499999999999999 110.216 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.19 -34.21 77.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.696 -0.683 . . . . 1.03 109.926 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.414 ' HB3' ' HE1' ' A' ' 23' ' ' MET . . . -85.18 -45.59 11.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.777 -0.647 . . . . 0.69999999999999996 110.792 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.18 40.61 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.174 -0.536 . . . . 0.81000000000000005 112.407 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.677 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 5.4 mpp? -124.59 103.44 8.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.249 0.547 . . . . 2.0699999999999998 110.448 174.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 38' ' ' LYS . 5.7 ptp180 -52.18 -33.83 42.48 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.232 -0.895 . . . . 3.3599999999999999 112.485 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 33.1 m-85 -120.84 160.86 22.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.26 111.118 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -159.83 95.77 0.14 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.337 -1.105 . . . . 0.73999999999999999 110.337 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 91.7 mttt -120.0 134.64 55.19 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 2.9100000000000001 110.909 -171.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 18.7 t -74.34 123.54 24.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.018 -0.537 . . . . 0.76000000000000001 109.995 176.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.455 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 24.7 mmt -126.16 96.37 4.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 2.0800000000000001 110.727 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.2 t30 73.58 -62.7 0.46 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.724 -1.125 . . . . 2.6899999999999999 112.034 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.95 -35.9 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.66 -0.781 . . . . 0.48999999999999999 112.943 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -107.78 170.61 7.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.385 0.612 . . . . 1.9099999999999999 110.429 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.546 ' HB2' HG12 ' A' ' 4' ' ' ILE . 15.3 m -94.87 125.89 39.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.153 -0.931 . . . . 0.76000000000000001 110.018 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.455 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 11.9 m-70 -104.92 108.44 19.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.226 -0.657 . . . . 1.28 109.226 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.3 118.31 36.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.326 0.584 . . . . 0.53000000000000003 111.493 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 2.0 m -80.53 130.14 66.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.174 -0.921 . . . . 0.56000000000000005 108.937 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 9.5 Cg_exo -69.49 147.98 65.82 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.167 2.578 . . . . 0.76000000000000001 112.508 -171.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 28.0 tttm . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.234 -0.894 . . . . 2.1899999999999999 110.345 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.585 -0.606 . . . . 1.0900000000000001 111.585 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.4 t -81.12 93.46 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.353 0.597 . . . . 1.1599999999999999 110.431 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.896 HD11 ' HB3' ' A' ' 32' ' ' LYS . 6.9 tp -103.65 128.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.692 -0.686 . . . . 1.48 110.733 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.575 ' CG1' ' HB2' ' A' ' 33' ' ' CYS . 24.3 pt -121.0 143.49 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.599 -0.519 . . . . 0.51000000000000001 109.599 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -83.32 14.32 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.836 0.31 . . . . 1.9199999999999999 111.836 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.24 126.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.0 -0.741 . . . . 0.46000000000000002 109.0 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.582 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 2.7 tmtp? -70.95 111.86 6.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.483 0.658 . . . . 1.28 109.81 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 11.8 p -76.94 93.36 3.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.102 -0.954 . . . . 0.73999999999999999 111.547 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -61.81 -14.21 31.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.404 0.621 . . . . 2.6200000000000001 110.036 173.47 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.761 HG13 ' HG2' ' A' ' 13' ' ' GLN . 2.7 pt -171.46 164.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 125.641 1.576 . . . . 0.78000000000000003 107.577 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m -62.03 -38.48 88.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.254 0.479 . . . . 0.40000000000000002 111.006 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.41 -24.02 64.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.215 0.45 . . . . 3.7400000000000002 112.215 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.761 ' HG2' HG13 ' A' ' 10' ' ' ILE . 15.7 mm100 -62.52 -30.54 71.37 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.2 0.524 . . . . 2.2000000000000002 110.691 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 m -101.39 -40.08 7.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.777 -0.647 . . . . 1.1799999999999999 111.17 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.832 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 1.4 tt -78.6 -23.69 45.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.286 -0.416 . . . . 1.3100000000000001 111.614 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 11.1 tmtt? -56.4 -55.1 46.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.619 -0.511 . . . . 2.1299999999999999 109.619 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 85.5 Cg_endo -77.87 -19.73 12.31 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.207 1.271 . . . . 0.53000000000000003 112.227 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.832 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 1.2 m -71.42 -56.9 5.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.87 -0.332 . . . . 0.35999999999999999 110.878 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.587 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 38.6 ttmt -64.1 -33.41 75.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.203 -0.295 . . . . 1.6499999999999999 110.203 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.8 -39.33 84.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 1.03 110.554 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.78 0.69 54.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.015 -0.539 . . . . 0.69999999999999996 111.39 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.91 53.7 1.88 Allowed Glycine 0 CA--C 1.506 -0.485 0 C-N-CA 120.941 -0.647 . . . . 0.81000000000000005 112.43 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 17.0 mmt -131.31 97.4 4.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.664 -0.865 . . . . 2.0699999999999998 108.664 172.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.744 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 6.0 ttt85 -55.54 -37.74 68.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.092 . . . . 3.3599999999999999 111.454 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 71.6 m-85 -106.29 149.0 27.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.785 0.326 . . . . 1.26 110.613 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.578 ' HA3' ' HG ' ' A' ' 15' ' ' LEU . . . -165.07 72.3 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.221 -1.152 . . . . 0.73999999999999999 110.221 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.95 135.01 44.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.137 0.494 . . . . 2.9100000000000001 110.857 -168.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.6 t -78.48 121.77 24.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.76000000000000001 110.264 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.504 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 21.7 mmt -138.26 106.43 5.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.516 -0.311 . . . . 2.0800000000000001 111.556 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.7 m120 62.46 13.7 6.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.61 -0.723 . . . . 2.6899999999999999 112.188 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.582 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . 123.47 -32.68 4.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.492 -0.861 . . . . 0.48999999999999999 112.634 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.896 ' HB3' HD11 ' A' ' 3' ' ' ILE . 10.9 mptt -94.47 157.71 15.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.283 0.563 . . . . 1.9099999999999999 111.489 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.575 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 45.4 m -96.85 110.41 22.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.207 -0.906 . . . . 0.76000000000000001 110.479 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.504 ' CD2' ' HB2' ' A' ' 29' ' ' MET . 19.0 m-70 -92.76 95.39 9.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.01 -0.541 . . . . 1.28 110.399 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.73 147.74 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.455 0.645 . . . . 0.53000000000000003 111.352 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 25' ' ' PHE . 13.4 m -129.45 129.62 23.24 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.506 -0.924 . . . . 0.56000000000000005 108.506 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 23' ' ' MET . 58.1 Cg_exo -51.39 148.82 18.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.384 2.722 . . . . 0.76000000000000001 112.804 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.744 ' HD2' ' HB2' ' A' ' 24' ' ' ARG . 24.3 tptm . . . . . 0 C--O 1.248 1.007 0 O-C-N 124.082 0.864 . . . . 2.1899999999999999 111.669 -175.205 . . . . . . . . 1 1 . 1 stop_ save_